Professional Documents
Culture Documents
Strategy - Motilal Oswal PDF
Strategy - Motilal Oswal PDF
India Strategy
Happy
2017
Growth
Guru
?
? ?
Budget
ities
com obal
mod
Gl
n
s
tio
omic
on Re
n
iza
umpo
Tr
et
Note: All stock prices and indices for companies as on 4 January 2017, unless otherwise stated
Investors are advised to refer through important disclosures made at the last page of the Research Report.
India Strategy | New Year, New Cards
India Strategy
BSE Sensex: 26,633 S&P CNX: 8,191
Sources of exhibits in this report include RBI, CMIE, Bloomberg, IMF, Industry, Companies, and MOSL database
January 2017 3
India Strategy | New Year, New Cards
3. No respite for Healthcare (11.7% YoY revenue growth in 3QFY17 v/s 18.4%
CAGR in 10 years) and Technology (8.6% YoY revenue growth in 3QFY17; one of
the weakest in 10 years).
January 2017 4
India Strategy | New Year, New Cards
January 2017 5
India Strategy | New Year, New Cards
NBFCs should post a healthy 16% YoY PAT growth – the impact of
demonetization on asset quality could come with a quarter’s lag.
Defensives’ share in MOSL earnings would continue to decline to 35% (recent
high was 47% in 4QFY16); the share of Global Cyclicals would be 31% in 3QFY17,
up from 26% in 3QFY16 and 24% in 2QFY17.
Nifty sales would grow 4% YoY, the highest in nine quarters. PAT is likely to grow
13% YoY, the highest in 10 quarters. EBITDA is likely to post robust 10% YoY
growth. Nifty aggregates would be influenced by Cyclicals – excluding PSU Banks
and Metals, Nifty sales would grow 4% YoY, EBITDA would grow 5% YoY, and
PAT would grow 1% YoY.
Post demonetization, we have cut our 2HFY17E earnings for MOSL Universe by
3%, driven by cuts in Cement (22.5%), Autos (12%), Consumer (11%), NBFCs (6%)
and Capital Goods (~8%). Also, Telecom sectors’ 2HFY17E PAT has seen sharp
cut of ~75%, reflecting tectonic shift in competitive intensity.
January 2017 6
India Strategy | New Year, New Cards
18.6 24.8
15.9 22.7
14.4 19.1
11.8 11.4
9.9 12.3 18.6
7.7 11.3 7.2 17.7 17.7
6.6 14.9
4.5 13.2
2.9 12.6 11.9 11.9
0.2 10.8 9.6 11.2
9.0 9.1 8.0 8.5
-0.9 5.54.8
-2.3
-6.7 -7.1
-8.4
-11.3
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Mar-17E
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Mar-17E
Source: MOSL Source: MOSL
Exhibit 3: 3QFY17 EBITDA margin (ex-OMCs, Financials) at Exhibit 4: PAT growth for MOSL Universe will be boosted by
20.6% (+170bp YoY) low base in cyclicals…
22.4
85.3
21.9
71.3
21.6
20.2
20.4
18.9
20.6
35.0
20.0
19.9
21.3
20.2
19.0
20.9
31.4
18.8
30.2
19.1
20.1
21.3
19.3
11.7
18.8
19.4
19.0
5.3 5.2
18.5
18.4
18.5
19.2
18.6
18.4
-3.0
18.0
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Mar-17E
FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17
Exhibit 5: …first PAT decline in multiple quarters for Exhibit 6: 3QFY17 PAT margin (ex-OMCs, Financials) would
Defensives… expand 80 bps to 10.4% led by Metals, O&G and Cements
14.1
33.1
12.9
21.1
11.5
18.5
11.0
13.1
10.7
11.2
12.6
16.1
10.7
10.7
12.2
10.9
10.3
11.6
10.6
10.4
10.0
6.3 10.6
11.0
11.0
5.7
10.5
10.5
10.3
10.5
5.1
10.2
10.5
10.3
10.4
10.0
10.0
9.9
9.6
9.3
-2.7-4.6
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Mar-17E
1Q
3Q
1Q
3Q
1Q
3Q
1Q
3Q
1Q
3Q
1Q
3Q
1Q
3Q
1Q
3Q
1Q
3QE
January 2017 7
India Strategy | New Year, New Cards
January 2017 8
India Strategy | New Year, New Cards
January 2017 9
India Strategy | New Year, New Cards
HUVR and ITC are likely to report flattish YoY PAT performance.
For Private Banks, aggregate PAT is likely to decline 12% YoY, driven by Axis
Bank (-69%) and ICICI Bank (-26%). Yes Bank (+25%), Kotak Mahindra Bank
(27%), and IndusInd Bank (+23%) would report strong growth.
Utilities would post 6% YoY PAT decline, largely led by Coal India (-22%).
Telecom would report PAT decline (-67% YoY), despite the low base (PAT was
down 7% in 3QFY16).
Exhibit 10: 3QFY17 sectoral sales growth (%)
22
15
12
9 8 8 8 6 4 4 3
0
0 -1 -2
Utilities
Oil Ex. OMCs
Health Care
Telecom
Technology
Logistics
Consumer
Cement
Auto
Cap Goods
Media
Retail
LP
77
59
26 25 24
8 3 0
-1 -3 -5 -6 -10
-67
MOSL Ex. OMCs
Utilities
Metals
Health Care
Telecom
Oil Ex. OMCs
Consumer
Logistics
Cement
Auto
Technology
Media
Cap Goods
Retail
Financials
21 24 23 26 27 25 24 31 26
42 41 32 35 31 30 27 34 30 35 35 37 47 36 39 36 33 33 37 34
42 40 38 39 42 41 37 38
45
14
19 24 9 9 10 20 18 18
26 14 14 27
21 11 13 24 19
13 27 17 16 20 24 22 25 25 18 17 18 21 22 21
18 17 22 18 23 16 17 21 22
18 22 10 16 19
22 21
18 19 21 18 12 18
10 14 24 25 18 22 18 17 19 16 18 13 22 21 27 14
18 19 23 16 13
44 45 51
35 30 41 43 38 32 39 35
32 29 27
26 27 21 21 24 25 25 28 26 24 19 26 25 20 20 26 18 22 21 20 24 29 28 28
Dec 07
June 08
June 09
Mar 08
Sep 08
Dec 08
Mar 09
Sep 09
Dec 09
June 10
June 11
June 12
Mar 10
Sep 10
Dec 10
Mar 11
Sep 11
Dec 11
Mar 12
Sep 12
Dec 12
June 13
June 14
June 15
Mar 13
Sep 13
Dec 13
Mar 14
Sep 14
Dec 14
Mar 15
Sep 15
Dec 15
June 16
Mar 16
Sep 16
Dec 16E
Mar 17E
January 2017 10
India Strategy | New Year, New Cards
Exhibit 13: Demonetization to impact PAT growth for sectors like Auto, Cement, Consumers etc (% YoY)
Consumer
30
24 26
22 24 22
21 19 19 20 19 21
17 18 16 17 17
15 15 14 15 14 16 13 13 12 14 11 13
9 8 9 11 13 12
7
5 5
-1
June-07
June-08
June-09
June-10
June-11
June-12
June-13
June-14
June-15
June-16
Sep- 07
Dec-07
Mar-08
Sep- 08
Dec-08
Mar-09
Sep-09
Dec-09
Mar-10
Sep-10
Dec-10
Mar-11
Sep-11
Dec-11
Mar-12
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Exhibit 14: PAT growth moderates sharply for Autos & Cement sector (%)
June-13
June-14
June-15
June-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
June-12
June-13
June-14
June-15
June-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
January 2017 11
India Strategy | New Year, New Cards
and Aluminum (up 15%). More importantly, PAT is likely to grow ~72% QoQ
(from loss to profit on YoY basis).
Exhibit 15: Global cyclicals showing smart recovery in PAT on the back of rising commodity prices (INR b)
Oil & Gas PAT (INR b) Metals PAT (INR b)
403 100
342 346
248 278 265
89 84 87 90 77
217 251 71 75 73
203 187153 187191 213 67 66
137 131 59 59
94 71 50
41
33 37 42
-251 -10
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
3] No respite for Healthcare (expect 11.7% YoY revenue growth in 3QFY17
v/s 18.4% CAGR in 10 years) and Technology (expect 8.6% YoY revenue
growth in 3QFY17, one of the weakest in 10 years)
We estimate revenue growth for our Technology universe at 8.6% YoY, one of
the lowest in 10 years. For the first time in 12 years, PAT would remain flat YoY.
For our Healthcare universe, we expect moderation in revenue growth (11.7%
YoY in 3QFY17 v/s 10-year CAGR of 18.4%), reflecting in 8.4% YoY PAT growth.
Exhibit 16: PAT growth for defensives like Technology and Healthcare continues to be weak (%YoY)
Technology 64 Healthcare
36 35 38 51 53 47
33 45 42
31 38 38
26 27 21 21
25
19 5 10 6 8 8
15 17 13 11 13 14
9 9
6 8
4 0 -10
-28
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
January 2017 12
India Strategy | New Year, New Cards
Exhibit 17: Cyclicals are expected to drive the entire earnings growth in 2H
94 Contribution to 1HFY17 PAT growth (%) Contribution to 2HFY17 PAT growth (%)
57
16 15 13 12 11 24
7 6 4 1 1 18
3 3 2 2 1 1 1 1 0 0
0 -1 -4
-12
-25 0 -1 -2
-37 -9
Capital Goods
Healthcare
Banks-PSU
Utilities
Metals
NBFC
Others
Telecom
Consumer
Logistics
Cement
Banks-Pvt
Technology
Media
Automobiles
Oil & Gas
Retail
Capital Goods
Healthcare
NBFC
Utilities
Others
Telecom
Metals
Banks-PSU
Consumer
Technology
Cement
Logistics
Banks-Pvt
Media
Automobiles
Oil & Gas
Retail
Exhibit 18: Cyclicals are expected to grow significantly ahead of MOSL Universe average in 2HFY17
Utilities
Capital Goods
Healthcare
Utilities
Capital Goods
Telecom
Telecom
Others
NBFC
Others
Metals
Banks-PSU
Banks-PSU
Metals
NBFC
Logistics
Logistics
Consumer
Cement
Consumer
Cement
Technology
Media
Banks-Pvt
Media
Automobiles
Automobiles
Banks-Pvt
Technology
MOSL
MOSL
Retail
Oil & Gas
Retail
January 2017 13
India Strategy | New Year, New Cards
6 6 4 4 3 2 1
78
82 -0 -0 -0 -1 -5 -13
91 -17
1,042
801
Capital Goods
Healthcare
Banks-PSU
Utilities
Metals
NBFC
Others
Telecom
Logistics
Consumer
Cement
MOSL 3QFY16
Technology
Media
Automobiles
Banks-Pvt
MOSL 3QFY17E
Oil & Gas
Retail
PAT (INRb)
PAT (INRb)
Source: MOSL
Exhibit 20: PAT share of global cyclicals to see sharp sequential pick up
100%
Defensives
33 26 23 27
36 39 40 39 35 33
75%
Global cyclicals
25 33 40 45 41 31 29
50% 37 36 27 26 26 24
Domestic cyclicals 34 37 34 38
25%
42 38 37
35 31 34 34 32 35
0%
June-09
June-10
June-11
June-12
June-13
June-14
June-15
June-16
Mar-09
Sep-09
Dec-09
Mar-10
Sep-10
Dec-10
Mar-11
Sep-11
Dec-11
Mar-12
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16E
Mar-17E
January 2017 14
India Strategy | New Year, New Cards
3.1 1.5 9.4 4.0 6.3 11.3 6.6 14.4 3.0 0.8 0.8 10.1 4.4 21.5 2.3
66.9
Contr to growth for 3QFY17 (%) Weight in Index (%)
29.2 26.0
Utilities
Banks-PSU
Metals
NBFC
Telecom
Consumer
Cap. Goods
Auto
Technology
Cement
Media
Banks-Pvt
Oil & Gas
Infra
Exhibit 22: Nifty sales to grow 4% in 3QFY17, fourth consecutive quarter of positive sales growth
37
35 33
30 32 30
26 25 28 26 26
23 23 26 LPA: 14%
19 20 22 18 22 21 21
16
16 16 15
14 14 14 14 15
8 8 8
4 4 4 3 3 4
-1 0
-6
-4
-8 -6 -4
-9
-12
1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3Q 1Q 3QE
FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17
Exhibit 23: 3QFY17 Nifty PAT to grow 13% YoY, highest in ten quarters
65
38 36 LPA: 11%
34 29
22 27 24 24
20 16 16 19 13 12 21 19 16 20
11 10 12 11 13
7 4 5 5 9 9 6
0 2 4 1 0 4
-1 0 0 -5
-7 -8 -5 -15 -7
-12
-20
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3QE
4QE
FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17
January 2017 15
India Strategy | New Year, New Cards
January 2017 16
India Strategy | New Year, New Cards
-67
Healthcare
Utilities
Telecom
Banks-PSU
Metals
Oil Ex BPCL
NBFC
Consumer
Auto
Cap Goods
Media
Cement
Technology
Banks-Pvt
Nifty Ex BPCL
Infra
Key trends to watch out for in 4QFY17 and thereafter
Trend # 1: Re-monetization
Re-monetization has been faster than expected. Value-wise, almost 50% of the
withdrawn currency has been replaced as at the end of December 2016.
We expect it to pick up pace over the next quarter. Overall, by the end of March
2017, we expect things to normalize in the economy.
The government’s digitization push coupled with lazy money coming back into
the banking system should lead to currency in circulation being less than earlier.
With the banking system flushed with funds and lower inflation, we expect
lower interest rates than in the pre-demonetization era.
We expect a shift from unorganized credit sources to organized credit. Banks
with strong liability franchise are likely to be key beneficiaries of this shift. Even
mid-size private sector banks with strong management and under-utilized
capacity are likely to benefit.
Apart from banks, other financial intermediaries like insurance and asset
management companies also stand to benefit.
Normalization of liquidity by March 2017 would also help in restoring normalcy
for consumer-focused businesses, especially in rural markets.
Trend # 2: Government actions to improve economic activity
Exhibit 26: While some measures have been announced post demonetization, we expect more relief measures over next few
months
Measures announced New measures expected
1. 4% subsidy in interest rate for housing loan upto INR0.9m, and 1. A 1-2pp cut in corporate tax rate, providing a relief of INR 150-300b
3% subsidy for housing loan upto ~INR1.2m. to corporates.
2. Loan @3% on housing in rural area for construction/renovation of 2. Increasing income tax slab and 80C exemptions by INR50k each.
home. This will cost government ~INR300b.
3. Small traders credit guarantee to increase from loan of INR10m 3. Some compensation to states could help fasten GST passage. It
to INR20m. could cost ~INR100-200b.
4. 60 days interest on agriculture loan from cooperative bank will be 4. Since states would be restricted in terms of their ability to invest,
paid by the government. higher capex (by 15-20%) is expected from the Central Govt.
5. INR6k will be paid to pregnant ladies in rural area to reduce death 5. An increase in MGNREGA by INR50b to INR430b.
rate of ladies.
6. Senior citizen to get 8% interest on 10 years fixed deposit of upto
~INR0.75m.
7. 30m Kisan Credit Cards holders to be given RuPay Debit Cards.
Source: GoI, MOSL
January 2017 17
India Strategy | New Year, New Cards
Exhibit 27: Base commodities have started recovering, after sharp fall over last 2 years
Bloomberg Base Metals Spot Price Steel (USD/Ton) Brent Crude (USD/Barrel)
Commodity Index (Ex Steel) 700 125
260
600
100
220
500
180 75
400
140 300 50
100 200 25
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Apr-12
Apr-13
Apr-14
Apr-15
Apr-16
Oct-12
Oct-13
Oct-14
Oct-15
Oct-16
Oct-12
Oct-13
Oct-14
Oct-15
Oct-16
Oct-12
Oct-13
Oct-14
Oct-15
Oct-16
Source: Bloomberg, MOSL
Exhibit 28: EBITDA margin improvement over last 2 years partly driven by lower
commodity prices
26.9
26.8
26.7
26.4
26.3
26.2
25.4
24.5
24.1
24.0
23.8
23.7
23.6
23.5
23.5
23.5
23.4
23.0
June-12
June-13
June-14
June-15
June-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Mar-17
Source: MOSL
January 2017 18
India Strategy | New Year, New Cards
Exhibit 29: Earnings cut in Cement, Autos, Consumer, Financials diluted by upgrades in
Metals and Oil & Gas
11.0
8.4
-4.5
-7.9
-11.4
-20.4 -17.4
-22.5
Cement Retail Auto Ex JLR Consumer Capital Financials Metals Oil & Gas
Goods
Source: MOSL
Exhibit 30: Auto Ex JLR Exhibit 31: Consumer
PAT growth Pre-Demon YoY (%) PAT growth Pre-Demon YoY (%)
Current est. PAT growth YoY (%) Current est. PAT growth YoY (%)
20.4 14.5 14.5 14.5
16.5
13.3
4.3
1.5
2.6 2.0 2.3
-1.3
3QFY17 4QFY17 2HFY17 3QFY17 4QFY17 2HFY17
24.8
16.0
133.5 12.5
99.9 9.1 8.0
LP LP
January 2017 19
India Strategy | New Year, New Cards
SHOP: -52%,
Retail -10 TTAN: 1%
JUBI: -56%
KMB: 27%,YES: 25%,
Banks FB: 15%, IDFCBK: -21%,
-5 IIB: 23%,DCBB: 21%,
Private EQUITAS: 0% ICICIBC: -26%,AXSB: -69%
HDFCB: 16%
BHARTI: -14%,
Telecom -67 BHIN: 58%
IDEA: PL%
January 2017 20
India Strategy | New Year, New Cards
January 2017 21
India Strategy | New Year, New Cards
Consumer We expect our consumer universe’s revenue 0.1 -4.5 -1.2 -1.1 We expect ITC’s sales to decline 7% YoY
and PAT to decline 0.5% and 2.8%, (led by 10% fall in cigarette volumes)
respectively, in 3QFY17. Demonetization is and PAT to decline 6.5%. HUVR’s sales
likely to affect all companies, particularly growth is estimated at 1.5% (volume
those selling products with discretionary decline of 1%), with 100bp EBITDA
demand and which have higher proportion margin contraction. Barring PAGE, for
of wholesale trade vis-à-vis direct which we expect 13% PAT growth YoY,
distribution. The anticipated rural demand none of the other companies is expected
recovery after a good monsoon was dented to report any material growth in PAT. 11
by the effect of demonetization-led liquidity out of 18 companies under coverage
crunch. MOSL Consumer universe EBITDA is actually are expected to report YoY
likely to decline 6.1%, with 130bp margin decline in PAT.
decline. PFAD and Palm Oil prices saw steep
YoY inflation of 70% and 37%, respectively.
Ti02 and Mentha prices have not increased
sharply, up just 4% YoY and 3% YoY on
average for 3QFY17. Mentha prices over
past 20 days are up 10% YoY, though. LLP
and HDPE prices still remain benign, with
low-single-digit growth YoY.
Financials 7.7 13.6 76.8 4.3
Private Mixed picture expected with sustained 10.1 0.9 -11.7 -7.8 Prefer ICICIBC and YES among corporate
Banks earnings pressure at corporate lenders like lenders; HDFCB and IIB top pick among
ICICIBC and AXSB (led by asset quality strain) retail lenders.
and sustained growth trajectory at lenders
like YES and IIB. We expect most private
banks to report a drop in loan growth post
demonetization, but deposit intake will be
strong. CASA ratio will receive a boost
during the quarter, leading to lower cost of
funds. Lower C-D ratio and blended yields
may have marginal impact on NIMs.
PSU Banks Loan growth trajectory will continue 4.2 26.6 LP 14.5 Prefer SBIN, PNB and BOB among PSU
remaining muted, while deposit influx will banks.
be strong, leading to downward pressure on
NIMs. Provisions are expected to remain at
elevated levels during the quarter, and
operating expenses will increase steeply.
Although core revenue will remain under
pressure, strong trading gains owing to
falling bond yields will provide cushion to
earnings.
NBFC Housing finance companies with low share 13.7 13.9 16.0 0.1 We expect LICHF to post strong results
of LAP and corporate loans are expected to among HFCs. Other key stocks to watch
perform relatively well than others. Those out for are BHAFIN, MUTH and BAF.
with high share of LAP/corporate loans will
see significant slowdown in disbursements
as well as problems in collections.
Companies dealing in vehicle finance are
also likely to witness significant slowdown
and poor collection levels due to high share
January 2017 22
India Strategy | New Year, New Cards
Media We expect our universe ad revenue growth 3.2 -0.2 -5.1 -1.1 Zee Ent: 4%/12% ad/domestic
to grow at a meager ~1% YoY, lower than 7- subscription CAGR.
13% in the preceding four quarters. Both
Broadcasters and Print companies are
expected to face the demonetization brunt.
The ad pain is expected to be more
debilitating for Print media, given their
higher reliance on local/retail advertisers –
most impacted group by the cash squeeze.
Zee’s ad growth is expected to moderate to
~4% YoY post six quarters of strong ad
revenues. Apart from FMCG, Auto, Telecom,
other sectors such as Auto, Consumer
Durables, Traditional retail too have cut
back on ad spends. Regional/niche channels
and publishers are expected to take a bigger
hit. Our industry interactions suggest that a
full recovery could be expected by 1QFY18.
DTH companies are expected take a hit in 20% EPS CAGR (adj. for pref dividend)
recharges and fresh seeding as over FY16-19.
demonetization impacts both. One can
expect cable companies to step up their
seeding rates from 1H levels as Delhi HC has
quashed all stay orders pertaining to DAS III
implementation. Phase III monetization
remains a key concern for all stakeholders.
Monetization expected to improve in
4QFY17.
Metals Across-the-board increase in commodity 22.3 167.6 LP 10.4 NMDC EBITDA to increase 79% QoQ on
prices. Zinc/lead average LME up 11/15%. higher volumes and realization.
EBITDA for our coverage universe is NALCO EBITDA to almost double QoQ to
expected to increase 18% QoQ (2.7x YoY) on INR3.5b on higher aluminum and
higher realization and volume increase. alumina prices.
NMDC, Nalco and Vedanta to report strong Vedanta to report 44% QoQ EBITDA
performance. increase, led by strong volume and price
growth in zinc and aluminum.
January 2017 23
India Strategy | New Year, New Cards
Excl. OMCs Brent averaged USD49.1/bbl v/s 15.3 23.1 24.5 1.4 ONGC/OINL (+ve; Oil producer countries'
USD45.7/bbl in 2QFY17 and USD43.4/bbl in efforts to cap production could revive
3QFY16. Expect better realization YoY. the oil price realization).
However, operating cost may be higher IGL (+ve; Expect double-digit volume
sequentially. growth to continue).
Expect RIL's PAT to be up +11% YoY, led by PLNG (+ve; Capacity expansion + take-
higher petchem volume and largely flat or-pay contracts to boost earnings).
refining profit benefited by exchange rate.
IGL witnessed slowdown in conversion of
vehicles due to clampdown of authorities on
spurious kits. We expect flat sequential
performance for GAIL and GSPL.
Retail For our Retail coverage universe, we expect 8.1 -1.0 -9.5 -0.7 Titan’s jewelry retail revenue reportedly
tepid 8.1% revenue growth and 9.5% PAT grew at 15% YoY due to healthy festive
decline in 3QFY17. EBITDA is likely to decline season growth. However, its watches
1% YoY. Retail companies under our segment sales through the trade channel
coverage are moderating store expansion. (50% of segment sales) continue to be
Titan added four Tanishq stores (adding badly affected. We expect Jubilant
12ksf), Jubilant has likely added 30 stores, Foodworks’ sales to decline by 8%, with
while Shoppers Stop is likely to have actually same-store sales declining by 14% due
reduced its net store count by 1 in 3QFY17. to adverse effect of demonetization on
Expansion plans are likely to be a function of discretionary consumption as well as
pickup in consumer sentiment, which is likely weak festive season sales.
getting delayed. Shoppers Stop’s LTL growth is likely to
be flat YoY and sales growth to be only
5% YoY.
Technology Seasonality and subdued spend in the BFSI 8.6 4.2 0.3 -1.0 TECHM is expected to lead QoQ growth
vertical have kept expectations muted for at 3.1% CC. It would include residual
revenue growth in 3Q. Revenue growth has one-month contribution from the
been tepid despite strength in deal wins, acquisition of Target, but organically too
and that is expected to continue playing out. growth at 2.5% CC would be better than
peers.
To add to this, currencies have depreciated INFO: Revenue decline expected as the
against the USD, which means yet another RBS deal cancellation takes effect.
quarter of significant cross-currency impact, Guidance for FY17 (implying growth for
and lower USD revenue growth. 4Q) and outlook for the year ahead
would be keenly watched.
Pricing pressure in traditional WPRO (Outlook for 4QFY17; post a
services/renewals and necessary disappointing guidance of -1 to +1%
investments for transitioning to Digital have organic revenue growth for 3Q, given
been weighing on margins. Although the INR bottoming out of the Energy vertical,
has depreciated against the USD by 2% QoQ, and restructuring of the India and
the impact of depreciation of other Middle East business).
currencies limits any tailwind.
Telecom Expect 3QFY17 to see the strong effect of -0.2 -3.4 -66.5 -1.2
disruption in the telecom market led by
RJio's free usage. We expect revenue de-
growth of 6-7% for Bharti/Idea with ~300-
400bp margin decline. Despite being
seasonally strong quarter, 3Q is likely to see
no respite. Idea is expected to report loss at
net level for the first time in the history of
January 2017 24
India Strategy | New Year, New Cards
January 2017 25
India Strategy | New Year, New Cards
EARNINGS FY17-FY19
Demonetization mars 2HFY17, Sensex EPS to grow ~3%
Low base drive growth expectations for FY18, risk to growth from unknowns
FY17 to be third consecutive year of muted Sensex EPS growth: After YoY flat Sensex
EPS in 1HFY17, there were expectations of a recovery from 2HFY17, driven by normal
monsoon, the 7th Pay Commission, and bottoming out of Global Cyclicals among others.
However, demonetization is likely to defer the recovery by at least six months. We
expect muted EPS growth (~3% to ~INR1,360) in FY17 – the third consecutive year of no
growth. However, the broader MOSL Universe is likely to witness ~20% earnings growth
in FY17, driven by sharp recovery in Cyclicals on low base of 2HFY16.
FY18 to see smart recovery, albeit on low base (4% CAGR over FY12-17E): We expect
Sensex EPS to grow 22.6% to INR1,668 in FY18 and at a CAGR of ~21% over FY17-19.
These growth estimates come on a low base of the last five years, when EPS grew at just
4% CAGR (FY12-17E). Cyclicals are likely to outperform the Defensives over FY17-19,
with Financials, Cement, Metals, Capital Goods and Autos delivering 35%, 29%, 31%,
24% and 31% FY17-19E PAT CAGR, respectively. Cyclicals would contribute 2/3rd of
Sensex EPS growth and ~73% of MOSL Universe EPS growth in FY18.
Risk to earnings – fear the unknown: Given the unprecedented nature of
demonetization and multiple moving parts, the exercise has been rendered a little more
challenging than usual. Normalization in sectors impacted by demonetization
(contributing ~45% of MOSL Universe earnings) would depend on the pace of re-
monetization. However, there are several unknowns that could materially influence
earnings in FY18/19 – GST (timing and magnitude of change), commodity prices
(runaway inflation in base commodity prices), further government measures (on direct
tax, black money, investments, etc), global factors (Trumponomics, fed rate, etc).
Exhibit 37: Recovery in Cyclicals to drive robust 21% CAGR (FY17-19E) in Sensex EPS
EBITDA
Sales Gr. / EBIDTA EBIDTA PAT PAT Gr. / PAT delta
Sector margin
CAGR (%) Margin (%) CAGR (%) (INR B) CAGR (%) Share (%)
change (bp)
(No of Companies) (FY17-19) FY17E (FY17-19) FY17-19 FY17E FY17E FY18E FY19E (FY17-19) FY17-19
High PAT CAGR (>25%) 14 29.7 17 168 1,912 31 37 28 32 72
Financials (35) 18 84.8 15 -391 888 44 39 32 35 37
PSU Banks (10) 15 80.1 11 -478 168 LP 107 36 68 15
Private Banks (12) 20 89.4 16 -592 406 -1 27 32 30 14
NBFC (13) 20 88.8 21 58 313 10 17 27 22 8
Media (11) 15 28.3 24 447 33 1 43 26 34 1
Auto (14) 15 13.9 23 197 363 7 33 30 31 13
Metals (9) 8 18.1 13 161 222 66 41 22 31 8
Cement (13) 11 18.6 20 291 111 42 32 26 29 4
Others (25) 18 19.3 24 188 71 15 29 25 27 2
Healthcare (17) 15 23.8 20 221 225 15 33 18 25 6
Medium PAT CAGR (20-25%) 12 9.7 22 170 136 26 24 24 24 4
Capital Goods (16) 12 9.6 22 178 117 34 23 25 24 3
Logistics (3) 11 13.9 18 193 11 -9 29 18 24 0
Retail (3) 15 7.9 21 86 9 1 22 22 22 0
Low PAT CAGR (up to 20%) 11 25.4 13 70 1,873 4 12 12 12 25
Consumer (19) 14 22.4 16 93 259 6 17 17 17 5
Utilities (5) 12 31.1 20 436 287 -11 17 15 16 5
Technology (15) 12 23 11 -48 636 6 12 9 10 7
Oil & Gas (12) 11 14.8 8 -85 1,006 32 4 9 6 7
Excl. OMCs (9) 11 22.9 12 28 633 16 15 10 13 8
Telecom (3) 7 35.4 7 36 59 -42 -59 102 -9 0
MOSL Excl. OMCs (197) 13 26.4 15.4 133.7 3,922 16 25 21 23 100
MOSL (200) 12 23.4 14.4 88.9 4,295 20 21 20 21 NA
Sensex (30) 13 26.2 14.5 90.4 1,250 5 23 20 21 NA
Nifty (50) 12 24.9 14.6 111.3 1,532 9 22 20 21 NA
January 17 26
India Strategy | New Year, New Cards
Demonetization overshadows other positives: FY17 to be another year of flat Sensex EPS; several sectors
to report multi-year low earnings growth
The narrative for FY17 was shaping up well (normal monsoon, 7th Pay Commission awards, softening interest
rates) till 2QFY17, and confidence of double-digit Sensex earnings growth was building up.
However, this was pre-demonetization. The aforementioned positive narrative has since been overshadowed by
demonetization and its consequences for the economy as well as various sectors.
This is reflected in our earnings estimates for FY17. Post demonetization, we now expect another flat year of
Sensex EPS - just 2% YoY growth v/s the 14% YoY growth prediction we began with.
Several sectors would report multi-year low earnings growth in FY17 - Autos, Consumer, Private Banks, NBFCs,
Telecom, Technology, and Utilities. Technology, Utilities and Telecom are impacted by sector-specific issues
while deceleration in earnings growth for Autos, Consumer, Private Banks and NBFCs can be largely attributed to
demonetization.
FY17-19E estimates: Sensex EPS CAGR at 21%
We expect Sensex EPS CAGR of 21% over FY17-19, significantly higher than the
4% CAGR over FY12-17. Cyclicals would contribute 2/3rd of FY18E Sensex EPS
growth and ~73% of MOSL Universe EPS growth.
We estimate Sensex EPS at INR1,360 (3% growth) for FY17, INR1,668 for FY18
(23% growth), and ~INR2,005 for FY19 (20% growth).
Exhibit 38: Sensex EPS – expect rebound in FY17-19, with 21% CAGR versus 6% CAGR witnessed during FY08-17
FY01-08: FY08-17: FY17-19E:
21% CAGR 6% CAGR 21% CAGR
20%
23% 2,005
3%
1,668
1,337 1,356 1,324 1,360
1,181
1,024 1,120
833 820 834
720
446 540
272 361
216 236
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17E
FY18E
FY19E
Exhibit 39: Nifty EPS – expect rebound in FY17-19, with 21% CAGR versus 4% CAGR witnessed during FY08-17
FY01-08: FY08-17: FY17-19E:
21% CAGR 4% CAGR 21% CAGR 20%
22% 612
6% 508
406 415 393 417
351 369
315
281 251 247
236
169 184
131
73 78 92
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17E
FY18E
FY19E
January 17 27
India Strategy | New Year, New Cards
FY17/18E Sensex EPS cut 1%/2%; FY18 estimate builds in sharp recovery
We have cut our FY17 and FY18 Sensex EPS estimates by 1% and 2%,
respectively. This follows our 2% cut in Sensex EPS estimates in December 2016,
post demonetization. Essentially, our Sensex EPS growth for FY17 now stands
revised downwards to 3%.
However, the lower base of FY17 (especially in 2HFY17 due to demonetization)
should aid sharp rebound in FY18. In FY18, we build 23% Sensex EPS growth.
However, we note that visibility of FY18 growth is hazy, given the multiple
moving parts around [1] GST implementation, and [2] pace of re-monetization
and consequent restoration of normalcy in trade.
Exhibit 40: Top Sensex companies EPS Upgrade/Downgrade since 2QFY17 review (%)
Company FY17 Company FY18
Tata Steel 33.3 ONGC 10.6
SBI 19.8 Tata Steel 6.3
Adani Ports 3 SBI 4.9
M&M -2.6 Reliance Ind. 2.5
Reliance Ind. -2.8 Axis Bank 2.1
ONGC -2.9 ICICI Bank 1.9
Tata Motors -2.9 Wipro -2.1
ITC -3.3 M&M -2.4
Sun Pharma -3.7 Sun Pharma -3.7
Coal India -4.6 ITC -5.4
ICICI Bank -6.1 L&T -7.6
L&T -7 Bajaj Auto -7.9
Hero Moto -7.2 Hero Moto -7.9
Dr Reddy’s -7.6 Coal India -12.8
Bajaj Auto -8.1 Tata Motors -15.3
Bharti -11.2 Bharti -21.1
Estimate Nifty PAT CAGR at 21%, sales CAGR at 12% over FY17-19
50% of the Nifty universe is expected to post 20%+ PAT CAGR over FY17-19.
Only Idea is expected to report negative PAT CAGR over FY17-19.
EBITDA margin for Nifty is expected to expand 117bp to 24.9% in FY17 and
further increase at 25.3% in FY18. PAT margin is likely to expand 25bp in FY17 to
11.4% and 80bp in FY18 to 12.2%.
January 17 28
India Strategy | New Year, New Cards
January 17 29
NIFTY FY17E 2969 NIFTY FY16 2787
SBI 105 BOB 82
January 17
Tata Motors 56 Maruti 31
ONGC 53 HCL Tech. 24
HDFC Bank 30 HDFC Bank 24
Tata Steel 29 Reliance Ind. 23
TCS 27 Sun Pharma 20
Axis Bank 24 BHEL 19
Sun Pharma 24 TCS 16
Reliance Ind. 24 ONGC 16
NTPC 20 Power Grid 14
Maruti 17 Kotak Mah. Bk 14
BOB 15 Hindalco 14
Coal India 15 GAIL 13
ITC 14 Grasim 13
Infosys 14 Bharti Infratel 9
Power Grid 13 L&T 8
Wipro 11 ITC 3127.292931 8
Ultratech 11 M&M 7
Kotak Mah. Bk 11 Tata Power 6
M&M 11 Infosys 6
Dr Reddy’s 10 Yes Bank 6
HCL Tech. 10 Adani Ports 6
GAIL 10 IndusInd Bk 5
HDFC 10 Lupin 5
Yes Bank 9 Aurobindo 5
L&T 8 Ultratech 4
Hindalco 7 HDFC 4
Bajaj Auto 7 Zee Ent. 3
IndusInd Bk 7 Eicher Mot. 3
Eicher Mot. 7 ICICI Bank 3
Lupin 7 Ambuja Cem 3
Cipla 6 Hero Moto 2
Grasim 6 Bharti Airtel 2
HUL 6 HUL 1
Aurobindo 5 Asian Paints 1
ICICI Bank 5 BPCL 0
Bosch 5 Bajaj Auto 0
Hero Moto 5 Bosch 0
Tech Mah. 5 ACC 0
BHEL 4 Tata Steel 0
Zee Ent. 4 Cipla -1
ACC 3 Tech Mah. -4
Ambuja Cem 2 NTPC -4
Asian Paints 2 Wipro -4
Tata Power 2 Dr Reddy’s -8
BPCL 1 Tata Motors -27
Bharti Infratel 1 Coal India -43
Adani Ports 0 SBI -46
Bharti Airtel -12 Axis Bank -51
Idea Cellular -24 Idea Cellular -53
NIFTY FY18E 3,611 NIFTY FY17E 2,969
30
India Strategy | New Year, New Cards
India Strategy | New Year, New Cards
The Nifty ended just 3% higher (in INR terms; flat in USD terms) in a year which until
November looked set for an encouraging finish. Key events like Brexit, US elections,
India’s demonetization, US Fed hike and geopolitical tensions with Pakistan took the
center stage in the second half of CY16, fueling significant volatility in the markets.
However, the Indian government’s decision to demonetize high-value currency notes
triumphed over other narratives, wiping out bulk of the CY16 gains (Nifty was up 8.5%
until 8-November).
In CY16, Brazil (+39%), Russia (+24%) and the UK (+14%) were the best performers
among the key global markets. Over the last 12 months, MSCI EM delivered 9% return,
as against MSCI India’s flat return. Over the last ten years, MSCI India outperformed
MSCI EM by 81%.
In the sectoral space, Metals (+37%) and Oil (+27%) – the underperformers of CY15 –
were the top performers in CY16, led by the bottoming out of commodity prices and
inexpensive valuations. Cement (+17%), Auto (+9%), PSU Banks (+9%), Media (+6%),
Private Banks (+5%), NBFC (+4%), Consumer (+3%) and Utilities (+2%) too ended the
year on a positive note. On the other hand, Telecom (-25%), Healthcare (-13%),
Technology (-8%), Real Estate (-6%) and Capital Goods (-3%) were the losers for CY16.
Midcaps outperformed large caps, delivering +7% returns.
Market breadth was positive in CY16, with 30 of the Nifty-50 stocks ending higher.
Notably, all Technology, Healthcare and Telecom stocks on the Nifty delivered
negative returns.
Among the Nifty components, Hindalco (+83%), Yes Bank (+59%), Tata Steel (+51%),
BPCL (+42%) and Power Grid (+30%) were the top performers of CY16. Idea (-49%),
BHEL (-28%), Aurobindo (-24%), Sun Pharma (-23%) and Bharti Infratel (-20%) were the
worst performers.
India witnessed FII equity inflows of USD2.9b in CY16 (USD6.8b until 8-November),
while DII equity inflows stood at USD5.3b. Domestic MFs recorded inflows of USD7.1b,
while DIIs (ex-MFs) saw outflows of USD1.9b in CY16.
FII debt outflows were more pronounced at USD6.5b in CY16 (USD5.9b post 8-
November). Despite these outflows, the INR remained relatively stable with just 2.5%
annual depreciation.
Correction in 4QCY16 has brought valuations marginally below the 10-year averages.
Nifty trades at a P/E of 16.6x, near its long-period average of 16.7x.
Mid-cap outperformance continued in CY16, delivering return of +7% v/s +3% by Nifty.
However, valuation premium of mid-caps over large-caps has come off to just 1%.
Exhibit 44: After delivering negative return of 4% in CY15, Nifty staged a comeback to end 3% higher in CY16
2016 3
2015 -4 2013 7
2011 -25 2012 28 2014 31
2001 -16 2010 18 2007 55
2000 -15 2004 11 2006 40 2009 76
1998 -18 2002 3 2005 36 2003 72
1996 -1 1997 20 1993 37 1999 67
2008 -52 1995 -23 1994 13 1992 36 1991 69
Year % Year % Year % Year % Year %
-30 to -60 -30 to 0 0 to 30 30 to 60 >60
Percentage return range
January 17 31
India Strategy | New Year, New Cards
Exhibit 45: Over CY06-16, Indian markets recorded a CAGR of Exhibit 46: In CY16, losses in the last quarter offset gains of
7.5% in local currency and 3.0% in USD preceding two quarters
40 55 -52 76 18 -25 28 7 31 -4 3 QoQ Return (%)
42 74 -61 84 23 -37 24 -5 29 -8 0
0
0 -1
-2 -3
3,966
6,139
2,959
5,201
6,135
4,624
5,905
6,304
8,283
7,946
8,186
-4 -5 -5
-6
CY06 CY07 CY08 CY09 CY10 CY11 CY12 CY13 CY14 CY15 CY16
Jun-12
Jun-14
Jun-15
Jun-16
June-13
Dec-11
Mar-12
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Annual Return in INR (%) Annual Return in USD (%)
Exhibit 47: World equity indices (CY16) – local currency (%) Exhibit 48: World equity indices (CY16) – USD (%)
Brazil 39 Brazil 69
UK 14 Taiwan 13
MSCI EM 9 Japan 4
China (HSCEI) -3 UK -4
January 2017 32
India Strategy | New Year, New Cards
-3 -6 -8
-13
-25
Utilities
Healthcare
Metal
Midcap 100
Nifty
Capital Goods
Telecom
Pvt - Banks
NBFC
Sensex
Oil
Consumer
Technology
Cement
Auto
Media
Real Estate
PSU - Banks
January 2017 33
India Strategy | New Year, New Cards
0 -1 -2 -2 -2 -3 -3 -4 -6 -7
-8 -9 -10-13-15
-19-20-23-24-28
-49
L&T
Idea Cellular
Zee Ent.
Dr Reddy's
ICICI Bank
Infosys
Tata Motors
Maruti
Sun Pharma
Hero Moto
Bosch
Bharti Airtel
Wipro
Grasim Ind.
Yes Bank
NTPC
SBI
HDFC Bank
Nifty
Ambuja Cem.
Tech Mah.
Tata Steel
Eicher Mot.
Bajaj Auto
ONGC
Asian Paints
Axis Bank
HDFC
ACC
TCS
HCL Tech
Coal India
Cipla
Bharti Infratel
Hindalco
BPCL
Power Grid
IndusInd Bk
Tata Power
ITC
Reliance Ind.
Tata Mot.-DVR
Adani Ports
M&M
BoB
GAIL
UltraTech
Kotak Mah.Bk
HUL
BHEL
Lupin
Aurobindo
Source: Company, MOSL
Exhibit 52: Stocks that delivered positive returns in at least 4 of the last 5 years
Absolute return YoY (%) CAGR (%) Relative to Nifty (%) CAGR (%)
Company CY12 CY13 CY14 CY15 CY16 CY11-16 CY12 CY13 CY14 CY15 CY16 CY11-16
BPCL 49 -2 86 38 42 40 21 -9 54 42 39 27
Power Grid 15 -13 39 2 30 13 -13 -20 7 6 27 1
Eicher Motors 97 71 203 12 29 71 69 65 172 16 26 59
Tata Motors 75 20 32 -20 20 22 47 14 0 -16 17 10
ONGC 4 8 18 -29 19 2 -24 1 -13 -25 16 -10
UltraTech 71 -11 51 4 17 23 43 -18 20 8 14 11
Maruti Suzuki 62 18 89 39 15 42 34 12 57 43 12 30
Grasim Inds 26 -14 25 10 15 11 -2 -21 -6 15 12 -1
IndusInd Bk 85 1 91 21 14 37 57 -6 60 25 11 25
Bosch 40 6 93 -4 12 25 12 0 62 0 9 13
HDFC Bank 59 -2 43 14 11 23 31 -9 12 18 8 11
ITC 42 12 15 -11 10 12 15 5 -17 -7 7 0
Reliance Ind. 21 7 0 14 7 9 -7 0 -32 18 4 -3
Bajaj Auto 34 -10 28 4 4 11 6 -17 -4 8 1 -2
Zee Entert. 87 25 38 15 3 31 59 18 6 19 0 19
Adani Ports 12 15 105 -18 3 17 -16 8 74 -14 0 5
Asian Paints 70 11 53 18 1 28 43 4 22 22 -2 16
Kotak Mah. Bk 50 12 73 14 0 27 23 5 42 18 -3 15
January 2017 34
India Strategy | New Year, New Cards
Exhibit 53: Stocks that delivered negative return for the first time in the last 5 years
Absolute return YoY (%) CAGR (%) Relative to Nifty (%) CAGR (%)
Company CY12 CY13 CY14 CY15 CY16 CY11-16 CY12 CY13 CY14 CY15 CY16 CY11-16
Aurobindo 122 108 189 54 -24 73 95 101 158 58 -27 61
Lupin 37 48 57 29 -19 27 9 41 26 33 -22 15
M&M 36 1 31 3 -7 12 8 -5 -1 7 -10 0
HUL 29 9 33 14 -4 15 1 2 2 18 -7 3
HCL Tech. 59 104 26 7 -3 34 32 97 -5 11 -6 22
Source: Company, MOSL
Exhibit 54: Stocks that delivered negative returns in at least 3 of the last 5 years
Absolute return YoY (%) CAGR (%) Relative to Nifty (%) CAGR (%)
Company CY12 CY13 CY14 CY15 CY16 CY11-16 CY12 CY13 CY14 CY15 CY16 CY11-16
Tata Steel 28 -1 -6 -35 51 3 0 -8 -37 -31 48 -9
GAIL -7 -4 30 -16 17 3 -35 -11 -1 -12 14 -9
Tata Power 26 -17 -7 -17 11 -2 -1 -24 -38 -13 8 -14
ACC 26 -22 26 -3 -2 3 -2 -29 -5 1 -5 -9
ICICI Bank 66 -3 61 -26 -2 13 38 -10 29 -22 -5 1
Bank of Baroda 31 -26 68 -28 -2 3 3 -32 37 -24 -6 -9
Coal India 18 -18 32 -14 -9 0 -10 -25 1 -10 -12 -12
Bharti Airtel -8 4 7 -4 -10 -2 -35 -2 -25 0 -13 -14
Wipro -1 42 -1 1 -15 4 -29 35 -32 5 -18 -9
BHEL -4 -23 50 -36 -28 -13 -32 -30 19 -32 -31 -25
Idea Cellular 26 61 -8 -7 -49 -2 -1 54 -39 -2 -52 -14
Source: Company, MOSL
Exhibit 55: % of stocks delivering positive and negative return on the Nifty
Nifty Positive return (%) Negative return (%)
Return
YoY (%)
40 55 -52 76 18 -25 28 7 31 -4 3
2
12 17 14 10
30
48 42
52
76
96 98
88 83 86 90
70
52 58
48
24
4
CY06 CY07 CY08 CY09 CY10 CY11 CY12 CY13 CY14 CY15 CY16
January 2017 35
India Strategy | New Year, New Cards
2.0 -2.5
USD3.9b outflows since
-1.0
demonetization reform
-4.0
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Aug-16
Dec-16
Jan-16
Jan-16
Mar-16
Mar-16
Sep-16
Oct-16
Exhibit 57: Yearly FII flows in equity (USD b) Exhibit 58: Half-yearly FII flows in equity (USD b)
2012
2013
2014
2015
2016
CY06
CY07
CY08
CY09
CY10
CY11
CY12
CY13
CY14
CY15
CY16
Exhibit 59: Yearly FII flows in debt (USD b) Exhibit 60: Half-yearly FII flows in debt (USD b)
26.3 1st half 2nd half
15.7
2012
2013
2014
2015
2016
-8.0
CY06
CY07
CY08
CY09
CY10
CY11
CY12
CY13
CY14
CY15
CY16
January 2017 36
India Strategy | New Year, New Cards
2.0 -0.6
0.0
-2.0
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Aug-16
Dec-16
Jan-16
Jan-16
Mar-16
Mar-16
Sep-16
Oct-16
Exhibit 62: Yearly domestic MF flows in equity (USD b) Exhibit 63: Half-yearly domestic MF flows in equity (USD b)
7.1
6.0
3.4 3.3 3.9
1.7 5.7
1.3
0.7 5.0 5.2
1.4
0.6 -1.2 -1.1
-1.2 -2.4
-3.9 -3.7 -2.7 -1.4
-6.1
2011
2012
2013
2014
2015
2016
CY06
CY07
CY08
CY09
CY10
CY11
CY12
CY13
CY14
CY15
CY16
Exhibit 64: Yearly DII ex-MF flows in equity (USD b) Exhibit 65: Half-yearly DII ex-MF flows in equity (USD b)
13.6
1st half 2nd half
2.0
6.5
4.7 0.2
3.7 2.6
-1.1 -0.1
1.4 -2.7 -3.8
0.3 -5.2 -1.8
-4.2
-5.0
-1.0 -4.1
-1.9
-7.0
-9.3 -8.8
2011
2012
2013
2014
2015
2016
CY06
CY07
CY08
CY09
CY10
CY11
CY12
CY13
CY14
CY15
CY16
January 2017 37
India Strategy | New Year, New Cards
11.11 1.7
9 1.5
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
Exhibit 68: 12-month forward Nifty RoE (%) Exhibit 69: India’s market cap to GDP (%)
22.5 Average of 78%
103
95 for the period
20.0 88
82 83 81
71 70 72
10 Year Avg: 64 66
17.5
15.8% 55
15.0 14.7
12.5
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
116 225
107 230
104 175 177
103
92 125
80 75
Apr-12
Dec-11
Aug-12
Apr-13
Dec-12
Aug-13
Apr-14
Dec-13
Aug-14
Apr-15
Dec-14
Aug-15
Apr-16
Dec-15
Aug-16
Dec-16
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
January 2017 38
India Strategy | New Year, New Cards
Exhibit 72: Midcaps v/s Nifty P/E (x) – 12-month forward Exhibit 73: Midcaps trading at 1% premium to Sensex
Midcap PE (x) Nifty PE (x) Midcap Vs Nifty PE Prem/(Disc) (%)
26.5 25
23.0 Nifty Avg: 17.2x 10
Midcap Avg: 16.2x Average: -6% 1
19.5 16.9 -5
16.0
16.6
-20
12.5
9.0 -35
May-12
May-13
May-14
May-15
May-16
Jan-12
Sep-12
Jan-13
Sep-13
Jan-14
Sep-14
Jan-15
Sep-15
Jan-16
Sep-16
Jan-17
May-12
May-13
May-14
May-15
May-16
Jan-12
Sep-12
Jan-13
Sep-13
Jan-14
Sep-14
Jan-15
Sep-15
Jan-16
Sep-16
Jan-17
Sector valuations: Earnings growth remains elusive; expect 2HFY17 earnings
growth to remain subdued
Technology sector trades at a P/E of 15x (8% discount to historical average).
Stocks have been holding on to current levels, despite seasonal weakness in
3QFY17. The support comes from the sector being shielded from
demonetization, INR depreciation post US elections, and expectations of a
better FY18. The sector was the top performer for December (+3.3%), but
delivered 8% negative return in CY16.
Oil & Gas trades at a P/B of 1.4x (12% discount to historical average) and a P/E
of 10.5x (10% discount). Oil prices rose ~10% in Nov-Dec’16 due to production
cuts agreed upon by OPEC and non-OPEC. OMCs (HPCL, BPCL and IOCL)
debunked the threat of regulation by increasing retail prices again in mid-
December 2016.
PSU Banks trade at a 32% discount to historical average P/B. The sector was
second worst performer for December (-6% MoM) after six months of
continuous outperformance. Impact of demonetization is expected to hurt loan
growth and NIM. Overall, we expect stress addition in FY17 to be lower than in
FY16. Sustained traction in large corporate deleveraging and a reduction in net
slippages are the key catalysts for a re-rating.
Exhibit 74: Sector valuations - Snapshot
Relative to Relative to
PE (x) PB (x)
Nifty P/E (%) Nifty P/B (%)
Sector
Prem/ Prem/
Current 10 Yr Avg Current 10 Yr Avg Current 10 Yr Avg Current 10 Yr Avg
Disc (%) Disc (%)
Auto 15.6 14.5 7.3 -6 -15 3.2 3.0 5.6 32 17
Banks - Private 17.2 16.5 4.3 3 -2 2.3 2.2 6.5 -4 -16
Banks - PSU 9.7 8.9 8.7 -41 -46 0.7 1.1 -31.6 -70 -59
NBFC 12.5 12.6 -0.5 -25 -25 2.2 2.3 -4.4 -11 -13
Capital Goods 26.8 27.0 -0.6 61 56 2.6 4.1 -36.5 7 52
Cement 20.8 17.2 20.9 25 2 2.6 2.3 10.4 5 -12
Consumer 33.4 29.2 14.6 101 76 10.0 9.5 4.7 309 273
Healthcare 19.7 21.9 -10.2 18 31 3.8 4.1 -5.6 57 57
Media 22.3 22.6 -1.6 34 36 5.0 4.4 14.2 105 67
Metals 12.2 12.1 1.1 -26 -29 1.2 1.6 -23.9 -51 -41
Oil & Gas 10.5 11.6 -9.6 -37 -30 1.4 1.6 -12.0 -42 -39
Retail 38.7 35.5 9.0 133 110 6.4 8.1 -21.3 161 212
Technology 15.0 16.3 -8.4 -10 -2 3.4 4.4 -21.7 40 67
Utilities 11.7 14.9 -21.1 -29 -9 1.5 1.8 -20.6 -40 -29
January 2017 39
India Strategy | New Year, New Cards
January 2017 40
India Strategy | New Year, New Cards
January 2017 41
India Strategy | New Year, New Cards
MOSL Universe:
3QFY17 Highlights
&
Ready Reckoner
Note: In our quarterly performance tables, our four-quarter numbers may not always add up to the full-year
numbers. This is because of differences in classification of account heads in the company’s quarterly and annual
results or because of differences in the way we classify account heads as opposed to the company.
All stock prices and indices as on 4 January 2017, unless otherwise stated.
January 2017 42
India Strategy | New Year, New Cards
Quarter-wise sales growth ex OMCs (% YoY) Quarter-wise net profit growth ex OMCs (% YoY)
26.3%
8.1%
4.5% 6.2%
3.4%
-1.3%
0.9%
-14.2%
Mar-16 Jun-16 Sep-16 Dec-16E Mar-16 Jun-16 Sep-16 Dec-16E
Sectoral sales growth - quarter ended Dec-16 (%) Sectoral net profit growth - quarter ended Dec-16 (%)
22
LP 77
15 59
12 26 25 24
9 8 8 8 8 3 0
6 4 4 3
0 -6 -10
-1 -3 -5
0 -1 -2 -67
Utilities
MOSL Ex. OMCs
Utilities
Oil Ex. OMCs
Health Care
Metals
Health Care
Telecom
Telecom
Consumer
Logistics
Technology
Logistics
Consumer
Cement
Auto
Technology
Media
Cement
Auto
Cap Goods
Cap Goods
Media
Retail
Retail
Financials
Financials
January 2017 43
India Strategy | New Year, New Cards
January 2017 44
India Strategy | New Year, New Cards
Capital Goods
ABB 1,037 Neutral 26,779 10.4 30.3 2,721 0.9 79.5 1,424 4.8 63.5
Bharat Electronics 1,431 Buy 18,500 21.9 8.6 3,427 17.1 2.3 3,219 8.9 -6.1
BHEL 127 Sell 60,500 13.6 -9.2 -7,500 Loss PL -6,755 Loss PL
CG Consumer Elect. 152 Buy 7,700 -4.9 -13.5 555 -33.0 -43.0 325 -23.3 -41.3
Crompton Greaves 61 Sell 13,160 7.5 -12.0 1,090 13.0 30.7 969 132.8 261.2
Cummins India 809 Neutral 12,219 6.5 -4.5 1,792 15.6 -10.0 1,680 3.5 -14.7
GE T&D India 302 Neutral 8,500 14.3 1.9 370 LP 9.0 40 LP -80.6
Havells India 351 Buy 13,318 -0.9 -8.3 1,034 -43.0 -49.2 704 -40.9 -50.0
Larsen & Toubro 1,376 Buy 273,000 5.7 9.2 27,700 4.5 20.6 11,000 6.3 6.6
Siemens 1,121 Neutral 22,650 -2.1 -26.7 1,940 0.0 -19.7 1,340 17.5 -27.4
Thermax 780 Sell 9,664 -7.0 11.0 902 -8.7 16.7 614 -9.5 2.9
Voltas 335 Buy 11,688 -10.6 20.8 575 -1.4 -16.3 505 -2.9 -30.0
Sector Aggregate 477,678 6.1 3.1 34,606 41.9 -12.3 15,065 59.3 -35.3
Cement
ACC 1,320 Neutral 26,566 -6.7 7.5 1,880 -13.0 -16.3 583 -43.2 -30.7
Ambuja Cements 212 Buy 21,800 -7.5 8.8 2,664 -12.4 -3.5 1,612 10.9 -41.8
Grasim Industries 867 UR 24,792 7.2 -0.4 5,238 22.1 -1.2 3,701 42.2 -37.5
India Cements 122 Neutral 11,919 28.2 -8.8 2,011 37.6 -10.4 481 780.8 -22.9
Ramco Cements 575 Buy 9,264 14.1 -8.5 2,627 7.4 -24.8 1,409 19.7 -31.9
Shree Cement 14,131 Buy 18,879 3.3 -5.9 4,941 16.5 -24.7 2,592 151.8 -11.1
Ultratech Cement 3,299 Buy 53,435 -7.0 -1.0 9,634 -7.7 -11.9 5,078 -0.2 -15.5
Sector Aggregate 166,654 -1.0 -0.1 28,995 3.3 -13.6 15,457 24.3 -26.9
Consumer
Asian Paints 906 Neutral 40,343 5.0 7.2 7,632 -2.7 7.0 5,025 -3.6 5.6
Britannia 2,851 Buy 20,158 -6.0 -14.6 2,483 -19.1 -20.7 1,827 -19.5 -22.0
Colgate 895 Buy 9,953 7.5 -5.1 2,440 3.9 -11.2 1,417 3.5 -21.8
Dabur 277 Neutral 19,943 2.0 0.9 3,505 -6.0 -13.0 3,007 -5.1 -14.4
Emami 1,031 Buy 7,608 5.0 30.2 2,543 1.9 45.1 1,820 -6.8 36.2
Godrej Consumer 1,532 Neutral 25,145 10.0 6.7 4,617 1.7 -0.3 3,270 -1.2 1.8
GSK Consumer 5,058 Neutral 9,517 -3.0 -11.9 1,577 -4.2 -35.7 1,356 1.8 -26.2
Hind. Unilever 821 Neutral 78,804 1.5 0.5 13,728 -4.0 -2.3 9,898 1.9 -8.5
ITC 245 Buy 88,097 -4.0 -8.8 33,729 -6.4 -7.1 25,824 -2.7 3.3
Jyothy Labs 335 Neutral 3,763 1.0 -8.6 468 -10.0 -26.6 218 42.1 -31.9
Marico 258 Buy 14,526 -5.0 0.9 2,654 -7.5 6.5 1,858 -8.0 2.9
Nestle 5,893 Neutral 19,376 -0.5 -17.4 3,474 -0.5 -22.6 1,972 -5.5 -31.5
January 2017 45
India Strategy | New Year, New Cards
Healthcare
Alembic Pharma 605 Neutral 8,075 -12.3 -7.3 1,696 -55.8 -4.2 1,137 -57.7 -4.2
Alkem Lab 1,670 Neutral 14,404 13.0 -12.1 2,548 8.2 -17.9 2,083 11.2 -26.4
Aurobindo Pharma 666 Buy 38,595 10.4 2.2 9,456 14.9 1.8 6,106 16.3 3.3
Biocon 936 Sell 9,273 12.0 -1.3 2,253 25.3 0.2 1,382 34.2 -6.0
Cadila Health 362 Buy 25,827 6.4 9.8 5,553 -4.0 7.6 3,688 -5.5 9.2
Cipla 568 Neutral 39,015 25.6 4.0 6,897 30.3 1.3 4,077 18.3 15.1
Divis Labs 753 Neutral 10,349 21.5 4.3 3,881 20.8 5.5 2,764 12.1 -8.8
Dr Reddy’ s Labs 3,091 Neutral 37,242 -6.1 3.9 7,821 -22.0 29.8 4,494 -22.4 38.5
Fortis Health 189 Buy 11,244 8.0 -6.0 1,054 665.5 6.5 -766 Loss PL
Glenmark Pharma 899 Neutral 23,424 35.8 7.8 5,388 59.5 35.4 3,108 82.9 41.7
Granules India 110 Buy 4,070 18.0 11.9 834 23.2 12.4 389 43.2 -4.7
GSK Pharma 2,747 Neutral 8,016 10.0 2.4 1,523 48.3 22.3 1,166 40.2 18.2
IPCA Labs. 550 Neutral 8,098 18.4 -7.1 1,218 36.5 -4.8 567 135.8 20.3
Lupin 1,494 Buy 42,453 19.4 -1.1 10,499 19.7 2.1 6,241 17.8 -5.8
Sanofi India 4,290 Buy 6,145 8.1 -1.6 1,438 27.3 -0.7 809 14.8 0.3
Sun Pharma 638 Buy 80,368 13.5 -2.8 26,834 23.7 -15.3 17,534 23.8 -21.6
Torrent Pharma 1,351 Buy 14,773 -4.0 5.1 3,565 -41.8 8.0 2,250 -35.4 8.7
Sector Aggregate 381,370 11.7 0.7 92,456 9.6 -0.6 57,028 8.4 -6.2
Logistics
Allcargo Logistics 179 Buy 14,613 9.3 3.8 1,316 11.2 4.4 680 10.5 5.5
Concor 1,151 Neutral 13,674 -2.6 -0.8 2,738 -2.2 19.7 1,924 -6.7 21.9
Gateway Distriparks 255 Buy 2,876 7.6 0.6 616 -0.4 6.0 280 -9.6 28.8
Sector Aggregate 31,163 3.6 1.4 4,671 1.5 13.1 2,883 -3.4 18.2
Media
D B Corp 374 Buy 6,137 4.8 16.1 1,811 -3.1 20.3 1,039 -2.8 17.3
Dish TV 85 Buy 7,935 2.9 1.8 2,731 2.9 3.4 441 -35.7 -37.1
Hathway Cable 37 Buy 3,387 12.7 5.5 569 14.3 6.7 -413 Loss Loss
HT Media 75 Neutral 6,595 -3.2 9.5 1,002 -15.5 98.6 476 -30.8 54.0
Jagran Prakashan 181 Buy 5,833 1.2 27.1 1,586 -7.9 30.7 782 -16.2 7.7
PVR 1,173 Buy 5,505 10.0 -0.7 881 3.3 -5.3 258 -15.6 -11.6
Siti Networks 38 Buy 3,347 -9.5 15.8 957 -23.5 102.1 167 -57.2 LP
Sun TV 524 UR 6,252 8.9 0.0 4,785 8.6 2.6 2,439 13.1 -9.8
Zee Entertainment 458 Buy 16,492 3.4 -2.7 4,373 1.7 -10.6 3,024 10.0 26.8
Sector Aggregate 61,484 3.2 5.0 18,694 -0.2 7.7 8,212 -5.1 15.2
Metals
Hindalco 159 Buy 254,247 8.8 3.7 32,029 39.0 5.7 10,044 130.0 8.1
Hindustan Zinc 251 Neutral 56,904 65.9 61.4 33,801 128.6 62.8 29,300 61.8 54.1
JSPL 71 Neutral 56,664 23.3 16.6 13,574 146.6 60.0 -3,293 Loss Loss
JSW Steel 163 Buy 149,227 71.6 12.8 24,441 174.1 -17.4 4,170 LP -42.6
Nalco 66 Buy 18,766 14.8 1.7 3,581 162.6 107.8 1,922 93.4 58.5
January 2017 46
India Strategy | New Year, New Cards
Retail
Jubilant Foodworks 860 Neutral 5,832 -8.0 -12.4 552 -24.0 -14.1 130 -55.6 -39.7
Shopper's Stop 295 Neutral 9,573 5.0 1.9 507 -28.8 53.6 113 -52.2 5.6
Titan Company 359 Neutral 38,062 12.0 44.4 3,144 12.0 20.7 2,276 0.9 23.9
Sector Aggregate 53,468 8.1 26.1 4,204 -1.0 17.5 2,519 -9.5 16.6
Technology
Cyient 494 Buy 9,234 18.1 1.1 1,243 12.8 -3.1 1,031 18.8 6.0
HCL Technologies 859 Buy 117,094 13.2 1.7 24,779 11.4 -1.3 19,735 2.8 -2.1
Hexaware Tech. 213 Neutral 9,148 11.6 1.2 1,591 22.2 0.9 1,196 20.4 7.4
Infosys 998 Buy 170,887 7.5 -1.3 45,358 4.8 -4.2 34,912 0.8 -3.2
KPIT Tech. 137 Neutral 8,283 1.9 -0.3 997 -15.5 9.1 619 -15.8 10.2
L&T Infotech 695 Buy 16,279 12.1 1.6 3,007 13.2 -1.2 2,367 -25.6 1.8
Mindtree 526 Neutral 12,995 7.0 0.3 1,633 -23.9 0.8 1,058 -29.9 11.6
MphasiS 534 Neutral 14,904 -1.7 -1.8 2,186 0.9 -11.3 1,952 12.4 -9.9
NIIT Tech. 437 Neutral 7,175 5.7 3.8 1,209 -2.1 7.8 712 -3.9 -1.1
Persistent Systems 647 Neutral 7,326 23.7 4.1 1,196 7.7 8.0 680 -12.2 -7.4
Tata Elxsi 1,419 Buy 3,097 13.0 2.1 773 16.6 3.8 494 23.8 14.7
TCS 2,379 Neutral 294,529 7.6 0.6 80,095 3.4 -1.3 62,523 2.3 -5.1
Tech Mahindra 500 Buy 73,632 9.9 2.7 11,502 1.3 7.5 7,063 -7.0 9.5
Wipro 476 Neutral 138,960 8.1 0.9 27,351 2.3 3.1 21,863 -2.1 5.8
Zensar Tech 944 Buy 7,954 5.1 2.4 1,119 2.7 2.4 820 14.7 19.4
Sector Aggregate 891,494 8.6 0.6 204,039 4.2 -0.8 157,026 0.3 -1.8
Telecom
Bharti Airtel 314 Buy 240,516 -0.1 -2.4 86,965 3.4 -7.9 10,894 -14.3 -25.6
Bharti Infratel 353 Buy 33,587 8.1 2.0 14,727 8.1 1.6 7,798 57.5 0.8
Idea Cellular 74 Sell 86,883 -3.6 -6.6 22,903 -26.8 -19.4 -10,222 PL PL
Sector Aggregate 360,986 -0.2 -3.1 124,595 -3.4 -9.3 8,471 -66.5 -63.6
January 2017 47
India Strategy | New Year, New Cards
Others
Arvind 358 Buy 22,869 6.0 -1.9 2,767 -1.3 19.1 1,123 7.7 47.1
Bata India 463 Buy 5,682 -8.0 -2.7 540 -32.3 0.9 314 -29.5 -9.2
Castrol India 386 Buy 7,834 -0.6 3.2 2,179 4.1 3.7 1,461 3.7 5.2
Coromandel International 304 Buy 28,381 3.0 -20.6 2,327 40.8 -39.5 1,177 82.9 -44.8
Dynamatic Tech. 2,960 Buy 3,809 5.0 -0.3 430 43.3 -2.4 85 244.5 5.3
Indo Count Inds. 166 Buy 5,529 10.0 -4.1 1,205 11.2 3.5 701 10.5 11.8
Info Edge 859 Buy 2,133 23.0 1.5 634 64.8 -8.7 573 163.3 -28.5
Inox Leisure 230 Sell 3,122 5.0 5.0 518 -1.9 90.6 178 -6.7 1017.2
Interglobe Aviation 843 Neutral 58,156 35.3 39.6 22,255 33.6 130.0 9,446 43.7 575.6
Jain Irrigation 93 Buy 14,474 5.0 0.5 1,737 13.8 -9.1 49 LP -82.5
Just Dial 343 Buy 1,713 0.0 -5.0 274 -26.7 22.2 221 -18.3 -25.5
Kaveri Seed 414 Neutral 1,057 15.0 56.0 63 -50.9 87.8 26 -71.7 -66.3
MCX 1,281 Buy 601 20.7 0.9 194 44.5 -0.6 343 45.5 -8.8
Manpasand Beverages 557 Buy 989 10.0 -3.5 179 0.7 -19.5 66 34.7 22.4
Monsanto India 2,254 Buy 1,767 15.0 83.2 498 7.0 2715.8 448 -3.1 4938.2
P I Industries 825 Buy 5,621 10.0 -1.7 1,282 22.3 0.2 939 33.5 -7.4
SRF 1,554 Buy 11,468 4.5 0.3 2,236 -4.3 -3.9 970 -8.1 -14.5
S H Kelkar 336 Buy 2,416 5.0 -1.5 403 -2.6 -3.1 242 3.6 -0.2
TTK Prestige 5,718 Neutral 5,016 12.0 0.1 627 7.9 0.9 377 1.4 -3.0
Other Sector Aggregate 182,637 12.9 5.6 40,350 20.5 42.6 18,741 30.2 64.0
PL: Profit to Loss; LP: Loss to Profit; UR: Under Review
January 2017 48
India Strategy | New Year, New Cards
January 2017 49
India Strategy | New Year, New Cards
Capital Goods
ABB 1,037 Neutral 18.2 26.9 32.2 57.0 38.5 32.3 29.1 19.3 16.5 11.4 14.5 15.4
Bharat Electronics 1,431 Buy 60.0 69.9 80.3 23.8 20.5 17.8 18.8 16.5 13.5 19.2 18.3 18.5
BHEL 127 Sell 3.9 5.5 8.5 32.2 23.1 15.0 17.0 9.2 7.4 2.9 3.9 5.8
CG Consumer Elect. 152 Buy 3.7 5.1 6.3 40.6 29.5 24.1 24.8 18.8 15.6 80.9 74.2 66.1
Crompton Greaves 61 Sell 0.6 1.9 3.2 109.3 32.9 19.0 7.8 6.3 5.1 4.2 6.0 8.0
Cummins India 809 Neutral 26.0 30.2 36.3 31.1 26.8 22.3 28.7 23.8 19.2 22.0 23.1 25.2
GE T&D India 302 Neutral 5.6 10.7 15.0 53.6 28.4 20.2 32.6 15.5 11.6 -6.8 20.1 25.1
Havells India 351 Buy 7.5 11.3 13.6 46.8 31.0 25.9 26.4 20.4 16.4 16.9 23.3 24.6
Inox Wind 183 Neutral 17.5 20.0 23.8 10.5 9.2 7.7 7.4 6.8 5.4 19.3 18.6 18.8
K E C International 144 Buy 10.1 12.1 14.0 14.3 11.9 10.3 7.7 6.8 5.9 16.0 16.7 16.8
Larsen & Toubro 1,376 Buy 53.6 62.2 76.1 25.7 22.1 18.1 18.8 14.9 13.1 10.9 11.7 13.0
Siemens 1,121 Neutral 17.0 25.4 31.6 65.9 44.1 35.5 37.3 28.4 22.9 9.2 12.6 14.3
Solar Inds. 713 Neutral 19.3 22.9 29.6 37.0 31.1 24.1 20.5 17.6 14.0 18.6 19.0 20.9
Thermax 780 Sell 24.8 27.6 32.0 31.5 28.3 24.4 20.3 17.6 14.7 12.2 12.5 13.4
Va Tech Wabag 486 Buy 25.2 32.6 36.0 19.2 14.9 13.5 9.7 7.4 6.7 13.2 15.4 15.2
Voltas 335 Buy 11.8 14.0 17.6 28.4 23.8 19.0 19.5 17.0 12.9 15.4 16.4 18.1
Sector Aggregate 30.8 24.9 20.0 19.8 15.4 13.0 9.5 10.9 12.4
Cement
ACC 1,320 Neutral 32.6 48.9 65.6 40.5 27.0 20.1 19.6 15.3 12.9 7.2 10.9 14.6
Ambuja Cements 212 Buy 5.7 6.9 7.4 37.4 30.6 28.8 25.9 22.6 20.2 5.9 7.1 7.3
Birla Corporation 675 Buy 33.8 44.5 56.6 20.0 15.2 11.9 9.9 7.3 5.9 8.5 9.8 11.9
Dalmia Bharat 1,580 Buy 34.2 50.4 72.3 46.2 31.3 21.9 11.8 9.8 9.3 7.6 10.3 13.1
Grasim Industries 867 UR 76.1 88.7 113.4 11.4 9.8 7.6 5.7 4.6 2.7 12.9 13.3 14.9
India Cements 122 Neutral 8.9 10.6 12.7 13.6 11.5 9.6 7.5 7.4 6.6 7.0 7.4 8.0
J K Cements 728 Buy 26.4 36.5 48.7 27.5 20.0 15.0 12.7 10.6 9.5 10.9 13.7 16.1
JK Lakshmi Cem. 365 Buy 4.7 12.2 17.6 77.3 29.9 20.7 15.8 12.6 10.4 4.2 10.5 14.7
Orient Cement 126 Buy -1.1 3.3 5.7 -114.9 37.8 21.9 19.2 12.1 10.6 -2.3 6.8 11.0
Prism Cement 84 Buy 0.9 3.5 5.1 94.4 24.0 16.6 22.2 13.0 8.9 4.5 16.0 19.8
Ramco Cements 575 Buy 29.4 31.5 42.3 19.5 18.3 13.6 12.4 10.4 8.2 20.6 18.6 21.0
Shree Cement 14,131 Buy 394.3 582.0 725.4 35.8 24.3 19.5 19.0 14.1 11.2 20.2 24.3 24.2
Ultratech Cement 3,299 Buy 94.6 134.8 168.4 34.9 24.5 19.6 19.0 14.1 11.7 11.9 15.0 16.4
Sector Aggregate 27.1 20.5 16.2 13.6 10.7 8.6 10.5 12.6 14.2
January 2017 50
India Strategy | New Year, New Cards
Healthcare
Alembic Pharma 605 Neutral 23.5 30.7 36.5 25.7 19.7 16.6 16.7 12.7 10.2 25.1 26.8 25.6
Alkem Lab 1,670 Neutral 77.3 84.4 98.4 21.6 19.8 17.0 18.0 14.8 11.6 23.9 21.8 21.5
Aurobindo Pharma 666 Buy 42.0 50.0 56.9 15.8 13.3 11.7 11.2 9.2 7.7 29.9 27.2 24.2
Biocon 936 Sell 27.1 34.3 45.0 34.6 27.3 20.8 19.8 15.7 12.2 12.2 13.9 16.2
Cadila Health 362 Buy 13.6 18.7 22.9 26.6 19.3 15.8 17.5 13.0 10.5 23.9 27.2 26.8
Cipla 568 Neutral 18.1 25.6 32.4 31.4 22.2 17.5 17.8 13.5 10.8 11.2 13.9 15.1
Divis Labs 753 Neutral 45.4 51.0 57.0 16.6 14.8 13.2 11.7 10.0 8.5 26.7 26.5 25.7
Dr Reddy’ s Labs 3,091 Neutral 82.7 141.7 170.0 37.4 21.8 18.2 19.7 13.0 10.3 10.6 16.1 16.8
Fortis Health 189 Buy -1.3 3.5 6.7 -143.0 53.6 28.2 19.7 11.4 9.0 -1.5 3.8 6.4
Glenmark Pharma 899 Neutral 41.4 49.7 60.5 21.7 18.1 14.9 11.1 9.8 9.6 20.4 19.1 19.0
Granules India 110 Buy 7.1 10.0 13.9 15.6 11.0 7.9 8.3 6.4 4.8 20.5 22.7 26.0
GSK Pharma 2,747 Neutral 50.4 61.8 71.6 54.5 44.5 38.3 45.7 36.4 29.9 29.6 40.8 50.3
IPCA Labs. 550 Neutral 17.0 29.4 39.0 32.3 18.7 14.1 15.1 11.2 8.7 9.0 14.1 16.5
Lupin 1,494 Buy 61.6 77.0 89.0 24.3 19.4 16.8 15.6 12.5 10.4 22.8 23.4 22.2
Sanofi India 4,290 Buy 142.2 172.8 198.9 30.2 24.8 21.6 16.2 13.7 11.6 17.8 19.4 19.7
Sun Pharma 638 Buy 27.8 37.9 42.9 22.9 16.8 14.9 14.0 11.1 9.0 20.3 23.9 22.3
Torrent Pharma 1,351 Buy 57.7 78.4 96.0 23.4 17.2 14.1 15.4 12.3 9.8 26.4 29.9 30.2
Sector Aggregate 25.0 18.8 16.0 15.4 12.1 9.9 17.8 19.8 19.6
Logistics
Allcargo Logistics 179 Buy 10.5 12.8 14.3 17.0 14.0 12.5 8.3 6.8 5.8 13.3 16.9 16.5
Concor 1,151 Neutral 36.6 46.8 54.4 31.4 24.6 21.1 18.4 14.7 12.5 8.7 10.5 11.5
Gateway Distriparks 255 Buy 9.9 15.6 22.4 25.8 16.3 11.4 11.1 8.8 6.3 8.5 12.8 16.9
Sector Aggregate 27.4 21.1 17.8 14.5 11.8 9.9 9.5 11.4 12.4
January 2017 51
India Strategy | New Year, New Cards
Metals
Hindalco 159 Buy 18.5 22.1 24.7 8.6 7.2 6.4 6.4 5.7 5.0 17.3 18.1 17.1
Hindustan Zinc 251 Neutral 21.5 25.4 25.3 11.7 9.9 9.9 7.4 5.5 5.1 22.5 22.6 19.4
JSPL 71 Neutral -23.8 -8.4 -5.3 -3.0 -8.4 -13.3 11.8 11.0 10.1 -12.8 -5.0 -3.3
JSW Steel 163 Buy 12.3 18.7 19.1 13.3 8.7 8.5 7.6 6.0 5.5 14.9 19.6 17.1
Nalco 66 Buy 3.7 4.8 4.9 17.8 13.7 13.4 8.2 5.4 5.1 7.1 8.7 8.5
NMDC 134 Buy 10.9 10.8 11.3 12.3 12.4 11.9 8.7 8.0 7.6 12.8 14.2 13.7
SAIL 51 Sell -10.4 -14.3 -1.4 -4.9 -3.5 -36.9 938.5 133.7 11.4 -11.5 -18.4 -2.0
Tata Steel 405 Sell 7.7 37.1 40.7 52.8 10.9 9.9 10.0 7.7 7.3 5.8 29.2 26.0
Vedanta 217 Neutral 21.3 27.3 27.9 10.2 7.9 7.8 5.0 4.0 3.7 13.0 14.8 14.0
Sector Aggregate 17.1 12.2 10.0 8.1 6.7 5.9 7.8 10.2 11.5
Retail
Jubilant Foodworks 860 Neutral 10.8 18.5 27.2 80.0 46.4 31.7 22.7 16.0 11.5 8.9 15.3 20.2
Shopper's Stop 295 Neutral 3.0 9.2 13.8 96.9 32.2 21.5 17.9 10.6 7.8 3.1 8.8 11.9
Titan Company 359 Neutral 8.7 9.8 11.3 41.0 36.8 31.6 30.5 27.3 23.4 20.2 19.7 20.1
Sector Aggregate 45.8 37.5 30.7 27.9 22.8 18.5 15.2 16.7 17.9
Technology
Cyient 494 Buy 34.6 44.2 47.5 14.3 11.2 10.4 9.4 7.2 6.2 16.4 18.3 17.3
HCL Technologies 859 Buy 56.7 63.2 67.2 15.2 13.6 12.8 10.8 9.1 8.1 26.6 25.5 23.2
Hexaware Tech. 213 Neutral 13.6 15.5 15.9 15.6 13.8 13.4 11.0 9.0 8.4 27.7 27.5 24.0
Infosys 998 Buy 61.7 67.8 75.0 16.2 14.7 13.3 10.1 8.7 7.7 22.8 22.6 22.5
KPIT Tech. 137 Neutral 12.6 15.6 16.3 10.9 8.8 8.4 4.7 3.2 2.5 16.9 17.6 15.5
January 2017 52
India Strategy | New Year, New Cards
Telecom
Bharti Airtel 314 Buy 12.4 9.4 13.4 25.3 33.4 23.4 6.1 5.8 4.7 7.3 5.3 7.1
Bharti Infratel 353 Buy 17.2 17.8 19.7 20.5 19.8 17.9 10.3 8.8 7.5 17.2 16.6 16.2
Idea Cellular 74 Sell -6.3 -12.9 -11.4 -11.8 -5.7 -6.5 8.1 8.8 7.8 -9.2 -21.9 -24.1
Sector Aggregate 37.2 90.5 44.8 7.0 6.7 5.6 5.3 2.1 4.2
Utilities
CESC 646 Buy 48.4 70.7 77.6 13.4 9.1 8.3 6.5 5.8 5.4 4.7 6.3 6.6
Coal India 306 Neutral 16.1 18.4 20.8 19.1 16.6 14.7 14.3 11.6 10.0 32.9 37.7 42.6
JSW Energy 61 Buy 5.1 3.2 1.5 11.9 18.8 41.8 6.5 7.5 8.3 9.6 5.9 2.6
NTPC 165 Buy 11.9 14.3 17.3 13.9 11.5 9.5 11.2 9.1 7.3 10.6 11.9 13.3
Power Grid Corp. 186 Buy 14.2 16.8 19.3 13.1 11.1 9.7 9.2 7.9 7.1 16.1 16.6 16.9
Sector Aggregate 15.4 13.2 11.5 10.5 8.9 7.7 15.1 16.3 17.4
Others
Arvind 358 Buy 14.8 24.0 29.8 24.1 14.9 12.0 10.9 8.4 7.0 11.3 15.2 16.5
Bata India 463 Buy 10.9 14.2 17.7 42.5 32.6 26.2 23.3 18.1 14.4 11.3 13.4 15.0
Castrol India 386 Buy 13.4 14.3 15.9 28.8 27.0 24.3 18.2 17.3 15.4 108.8 104.6 105.2
Century Plyboards 175 Buy 4.6 8.8 11.3 38.4 20.0 15.6 20.6 12.2 10.0 18.2 29.8 30.7
Coromandel International 304 Buy 16.3 20.0 25.5 18.7 15.2 11.9 10.1 8.7 7.1 18.5 20.4 22.8
Dynamatic Tech. 2,960 Buy 67.6 112.9 166.7 43.8 26.2 17.8 13.5 11.0 8.8 15.1 20.7 24.3
Eveready Inds. 224 Buy 9.2 12.9 16.7 24.2 17.4 13.4 14.7 11.9 9.6 29.5 33.7 34.9
Indo Count Inds. 166 Buy 15.7 18.5 21.5 10.6 9.0 7.7 6.5 5.5 4.5 37.8 31.2 26.6
Info Edge 859 Buy 18.4 20.7 23.5 46.6 41.4 36.5 38.5 33.4 29.1 12.0 12.3 12.9
Inox Leisure 230 Sell 4.1 8.6 10.9 55.9 26.8 21.1 14.8 10.5 8.9 6.2 11.8 13.2
Interglobe Aviation 843 Neutral 58.3 72.5 91.2 14.4 11.6 9.2 4.6 3.4 2.7 105.1 110.2 116.0
Jain Irrigation 93 Buy 5.5 7.6 10.0 16.8 12.2 9.3 7.2 5.9 5.1 8.6 11.7 14.8
Just Dial 343 Buy 15.6 18.5 23.0 22.0 18.5 14.9 13.8 10.5 7.5 15.1 15.7 16.9
Kaveri Seed 414 Neutral 23.1 28.8 36.3 18.0 14.4 11.4 13.7 10.4 8.0 17.1 20.0 23.1
Kitex Garments 409 Buy 29.3 35.1 41.7 14.0 11.7 9.8 8.1 6.6 5.0 33.1 31.0 29.3
MCX 1,281 Buy 28.6 47.4 65.2 44.8 27.0 19.6 70.4 28.1 18.1 11.5 17.5 21.7
Manpasand Beverages 557 Buy 14.9 23.8 39.0 37.3 23.4 14.3 17.5 12.9 7.6 8.6 9.9 16.5
Monsanto India 2,254 Buy 68.4 87.2 106.6 33.0 25.9 21.2 28.0 22.0 18.0 28.8 35.9 39.8
P I Industries 825 Buy 31.3 38.4 47.6 26.4 21.5 17.3 19.8 15.1 11.9 31.7 30.1 29.2
S H Kelkar 336 Buy 7.5 10.1 13.0 44.9 33.1 25.8 26.8 20.4 16.1 13.5 16.6 18.9
SRF 1,554 Buy 81.0 106.8 129.7 19.2 14.6 12.0 10.5 8.6 6.9 16.2 18.5 19.4
Symphony 1,169 Sell 27.0 35.1 42.9 43.3 33.3 27.2 32.2 24.7 20.1 56.8 65.0 66.3
TTK Prestige 5,718 Neutral 107.8 139.9 178.6 53.0 40.9 32.0 32.2 24.9 20.1 16.6 19.7 22.4
V-Guard Inds 165 Neutral 4.5 5.8 7.0 36.5 28.6 23.4 24.3 19.1 15.7 26.1 27.4 27.3
Wonderla Holiday 340 Buy 7.0 11.9 16.0 48.7 28.5 21.2 22.5 14.2 10.8 9.5 14.8 17.5
Sector Aggregate 23.8 18.5 14.8 11.2 8.7 7.0 22.7 25.5 27.4
January 2017 53
India Strategy | New Year, New Cards
January 2017 54
India Strategy | New Year, New Cards
Note: In our quarterly performance tables, our four-quarter numbers may not always add up to the full-year
numbers. This is because of differences in classification of account heads in the company’s quarterly and
annual results or because of differences in the way we classify account heads as opposed to the company.
All stock prices and indices as on 4 January 2017, unless otherwise stated.
January 2017 55
December 2016 Results Preview | Sector:
December Automobiles
2016 Results Preview
Automobiles
Company name
Demonetization derails 3QFY17 auto volumes
2Ws/3Ws/CVs likely to see a decline; PVs relatively well placed
Amara Raja Batteries
We expect the automobile industry’s performance in 3QFY17 to be subdued due to
Ashok Leyland the impact of demonetization. We believe 2Ws and 3Ws are likely to be worst hit as
Bajaj Auto the cash component in transactions in this space is relatively high compared to other
segments like PVs and CVs. We estimate 2W and 3W volumes to decline 4% and 20%
Bharat Forge YoY, respectively. Volumes in PVs are expected to grow by 5% YoY, while those in CVs
BOSCH should decline 4% YoY.
EBITDA margin for our auto OEM (ex-JLR) coverage universe is likely to remain
Eicher Motors constant YoY (-140bp QoQ) at 13%. The 2W pack along with MSIL and ALL are
Escorts
expected to see a QoQ margin decline.
We lower our FY18E EPS for TTMT (-17%), HMCL (-8%), BJAUT (-5%), BOS (-6%), but
Exide Industries increase for BHFC (+6.5%).
Hero MotoCorp
Our top picks are MSIL and TTMT among large caps, and AL and Amara Raja among
midcaps.
Mahindra & Mahindra
2W/CV volumes to decline, PVs relatively well placed
Maruti Suzuki 2W sales are expected to decline 4% YoY in 3QFY17, which is relatively steep
Tata Motors compared to other segments, as the cash component in 2W transactions is relatively
high due to lower ticket size of vehicles and higher exposure to rural areas. Besides,
TVS Motor Company
currency-related issues are likely to pull down 2W exports. Growth in passenger car
volumes is expected to moderate to be flat YoY, while UV volumes are expected to
increase robustly by 16% driven by new launches. PVs were less impacted, primarily
due to waiting periods in many models of OEMs and lower cash component. CV
volumes are expected to decline 4% YoY in 3QFY17, with volumes declining by 9% in
LCVs offset by 4% growth in MHCV volumes. Many fleet operators have postponed
their purchases due to the cash crunch post demonetization.
EBITDA margin to contract as negative operating leverage kicks in
EBITDA margin for our auto OEM (ex-JLR) universe is likely to contract 140bp QoQ
(stable YoY), given pressure from negative operating leverage due to lower volumes.
Among 2Ws, we expect margin contraction in BJAUT (-170bp YoY), HMCL (-100bp),
TTMT S/A (-240bp), and expansion in M&M (+100bp) and EIM (+290bp).
Exhibit 3: Trend in segment-wise EBITDA margin (%) Exhibit 4: Commodity prices recover from lows (index)
3QFY16 4QFY16 1QFY17 2QFY17 3QFY17 3QFY16 4QFY16 1QFY17 2QFY17 3QFY17
17.0
16.1
15.9 16.3 14.8 14.6 16.1
14.0 14.2 14.9
9.6
8.1
7.1
6.1 5.6
100
147
146
156
155
100
101
119
117
100
112
112
112
100
126
142
134
139
98
99
January 2017 57
December 2016 Results Preview | Sector: Automobiles
Exhibit 5: Trend in key currencies v/s INR Exhibit 6: Continued improvement in EBITDA margins (%)
USD GBP JPY Aggregate (excld JLR) Aggregate (incl JLR)
170
15
140
12
110
9
80 6
Jun-11
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Sep-11
Dec-11
Mar-12
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
Source: Bloomberg, MOSL Source: Company, MOSL
January 2017 58
December 2016 Results Preview | Sector: Automobiles
Exhibit 9: Relative performance – Three months (%) Exhibit 10: Relative performance – One-year (%)
Sensex Index MOSL Automobiles Index Sensex Index MOSL Automobiles Index
102
125
99
115
96 105
93 95
90 85
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
January 2017 59
December 2016 Results Preview | Sector: Automobiles
Quarterly Performance
Y/E March (INR m) FY16 FY17 FY16 FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Net Sales 11,376 11,511 12,251 11,697 13,208 13,455 12,558 13,316 46,907 52,537
YoY Change (%) 10.5 8.6 14.9 9.7 16.1 16.9 2.5 13.8 11.4 12.0
RM Cost(% of sales) 64.6 64.4 61.6 62.7 66.2 64.3 65.2 65.8 63.2 65.4
Staff Cost (% of sales) 4.9 5.0 5.0 5.3 5.0 5.2 5.1 5.4 4.6 4.7
Other Exp(% of sales) 13.0 13.2 14.7 15.7 11.6 13.5 13.3 12.8 13.3 13.9
EBITDA 1,988 1,999 2,286 1,908 2,273 2,297 2,066 2,126 8,169 8,761
Margins (%) 17.5 17.4 18.7 16.3 17.2 17.1 16.5 16.0 17.4 16.7
Depreciation 328 343 355 372 441 457 475 485 1,399 1,858
Interest 13 13 3 1 14 15 4 2 5 35
Other Income 136 112 113 97 90 120 125 141 457 475
PBT before EO expense 1,782 1,756 2,041 1,632 1,908 1,945 1,712 1,779 7,222 7,344
PBT 1,782 1,756 2,041 1,632 1,908 1,945 1,712 1,779 7,222 7,344
Rate (%) 32.1 29.7 33.3 33.5 31.5 29.9 30.0 32.6 32.2 31.0
Adj PAT 1,210 1,234 1,362 1,086 1,307 1,363 1,198 1,199 4,894 5,067
YoY Change (%) 14.2 23.1 33.0 6.2 8.0 10.4 -12.0 10.4 24.8 3.5
E: MOSL Estimates
January 2017 60
December 2016 Results Preview | Sector: Automobiles
Ashok Leyland
Bloomberg AL IN CMP: INR84 TP:INR92 (+9%) Buy
Equity Shares (m) 2845.9
Volumes grew 6% YoY (-2% QoQ). M&HCV sales grew 9% YoY, while
M. Cap. (INR b)/(USD b) 239 / 4
LCV sales declined 3% YoY led by demonetization impact, especially
52-Week Range (INR) 113 / 74
1,6,12 Rel Perf. (%) 8 / -12 / -13
in Dec-16.
We expect realization to improve 4.9% YoY (flat QoQ) on price
increase and higher contribution from Defense business.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
Net revenue is likely to grow ~13% YoY (flat QoQ), led by growth in
Sales 188.2 205.2 239.2 273.7
volume and realization.
EBITDA 21.7 24.4 29.7 34.1 EBITDA margin is likely to expand 40bp YoY (-70bp QoQ), driven by
NP 11.1 14.1 18.7 22.5 lower RM costs YoY.
Adj. EPS (INR) 3.9 4.9 6.6 7.9 EBITDA should grow 17% YoY (decline 6% QoQ) to ~INR5b.
EPS Gr. (%) 375.1 26.6 32.9 20.2 Further, lower interest and higher other income would boost
BV/Sh. (INR) 19.4 22.7 26.9 32.1 adjusted PAT growth by 38% YoY (+1% QoQ) to INR2.8b.
RoE (%) 20.9 23.5 26.5 26.8 The stock trades at EV of 7.8x FY18E and 6.4x FY19E EBITDA. Buy.
RoCE (%) 12.8 17.3 20.8 21.8
Payout (%) 25.6 30.4 30.4 28.5 Key issues to watch
Valuations Current demand environment and discounting trend, as well as
P/E (x) 21.5 17.0 12.8 10.6 plant and channel inventory for MHCVs post demonetization.
P/BV (x) 4.3 3.7 3.1 2.6 Pre-buying in 4QFY17.
EV/EBITDA (x) 11.5 9.9 7.8 6.4
Raw material cost outlook and margin guidance for FY17–18.
Div. Yield (%) 1.2 1.8 2.4 2.7
Capex and investment guidance for FY17.
Quarterly Performance
FY16 FY17E FY16 FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Total Volumes (nos) 28,154 37,369 30,928 43,991 31,163 33,446 32,838 47,751 140,457 145,198
Growth % 41.2 47.3 21.8 28.8 10.7 -10.5 6.2 8.5 33.9 3.4
Realizations (INR '000) 1,379 1,329 1,321 1,354 1,367 1,382 1,386 1,468 1,340 1,413
% change 11.0 4.8 -0.2 2.6 -0.9 4.0 4.9 8.5 3.7 5.5
Net operating revenues 38,831 49,672 40,853 59,553 42,588 46,224 46,272 70,120 188,216 205,205
RM/sales % 68.4 69.7 70.8 71.0 68.7 67.8 68.3 69.2 70.5 68.6
Staff/sales % 8.5 7.6 8.5 5.7 8.4 8.0 7.8 7.0 7.4 7.7
Other exp/sales % 13.0 10.2 10.1 10.7 11.6 12.6 13.0 10.8 10.6 11.9
EBITDA 3,925 6,240 4,297 7,531 4,820 5,365 5,021 9,173 21,660 24,380
EBITDA Margins(%) 10.1 12.6 10.5 12.6 11.3 11.6 10.9 13.1 11.5 11.9
Other Income 78 454 259 320 385 316 475 680 1,099 1,856
Interest 701 631 666 602 338 339 425 500 2,735 1,603
PBT before EO Item 1,984 4,754 2,803 6,071 4,154 4,146 3,846 8,168 15,586 20,315
EO Exp/(Inc) 1,570 65 3,793 0 0 0 3,858 0
Effective Tax Rate (%) 36.3 45.9 27.5 66.2 30.0 29.0 27.0 26.9 38.1 28.0
Adj. PAT 1,264 2,571 2,034 4,563 2,908 2,944 2,808 5,967 11,112 14,627
Change (%) -364 527 534 93 130 14 38 31 330.0 31.6
E: MOSL Estimates
January 2017 61
December 2016 Results Preview | Sector: Automobiles
Bajaj Auto
Bloomberg BJAUT IN CMP: INR2,689 TP:INR3,097 (+18%) Buy
Equity Shares (m) 289.4
Overall volume declined 10.5% YoY (-17% QoQ) to 851.6k units due
M. Cap. (INR b)/(USD b) 778 / 11
to a 17.5% YoY fall in exports, while domestic sales volumes
52-Week Range (INR) 3122 / 2173
1,6,12 Rel Perf. (%) -3 / 4 / 4
declined 5% YoY due to the impact of demonetization in November
and December. Total 2W sales declined 10% YoY in 3QFY17. 3W
volumes fell sharply by 17% YoY primarily due to a fall in exports as
Financial Snapshot (INR b)
Y/E MARCH 2016 2017E 2018E 2019E
currency issues in African markets continued along with a decline in
Sales 225.9 221.4 259.8 298.6
domestic 3Ws.
EBITDA 47.8 45.1 53.3 61.0 We expect realization to grow 1% YoY (+1% QoQ) as the launch of
NP 38.1 38.5 46.0 54.0 premium products in 2Ws is shadowed by a decline in 3Ws. As a
Adj. EPS (INR) 131.8 133.0 158.9 186.5 result, net revenues are expected to decline by 9.3% YoY.
EPS Gr. (%) 25.1 0.9 19.4 17.4 EBITDA margin should contract 160bp YoY (-200bp QoQ) to 19.4%
BV/Sh. (INR) 424.8 479.7 548.4 623.0 due to deterioration of product mix as well as negative operating
RoE (%) 33.2 29.4 30.9 31.8 leverage.
RoCE (%) 32.3 28.6 30.0 30.7 We expect PAT to decline ~5.7% YoY (-24% QoQ) to INR8.4b.
Payout (%) 50.2 58.7 56.7 60.0 We have lowered our total volume estimates by 4%, resulting in EPS
Valuation
cut of 5% for FY17E/FY18E.
P/E (x) 20.4 20.2 16.9 14.4
The stock trades at 16.9x FY18E and 14.4x FY19E EPS; maintain Buy.
P/BV (x) 6.3 5.6 4.9 4.3
EV/EBITDA (x) 14.1 14.1 11.5 9.6
Div. Yield (%) 2.0 2.4 2.8 3.6 Key issues to watch
Update on demand environment at the retail level, channel
inventory; outlook for FY18 based on impact of demonetization.
Outlook for export demand and pricing, especially the Nigerian
market (sharp currency depreciation); outlook for FY18.
January 2017 62
December 2016 Results Preview | Sector: Automobiles
Bharat Forge
Bloomberg BHFC IN CMP: INR913 TP: INR1,096 (+19%) Buy
Equity Shares (m) 232.8
We expect BHFC’s shipment tonnage to decline 7% YoY to 47,358
M. Cap. (INR b)/(USD b) 213 / 3
tons, which is an improvement from the previous quarters as
52-Week Range (INR) 1009 / 687
demand for class 8 trucks are showing signs of improvements
1,6,12 Rel Perf. (%) 4 / 20 / 1
along with revival in industrial segments. Net realization is likely to
dip ~6% YoY to ~INR194.7k/ton.
Financial Snapshot (INR b)
As a result, net revenue would decline 12.3% YoY (+3.5% QoQ) to
Y/E Mar 2016 2017E 2018E 2019E
Sales 76.5 72.9 82.2 92.7
~INR9.2b.
EBITDA 14.2 13.3 16.3 19.1
EBITDA margin is likely to contract 200bp YoY (+40bp QoQ) to
NP 6.6 6.0 8.5 10.8 28.2%, as negative operating leverage due to decline in volumes is
EPS (INR) 28.1 25.8 36.4 46.3 likely to put pressure on margins (rise in staff expenses).
EPS Gr. (%) -10.9 -8.4 41.3 27.1 PAT is likely to decline ~18% YoY (+9% QoQ) to INR1.4b.
BV/Sh. (INR) 153.6 169.7 194.1 228.4 The stock trades at 25.1x FY18E and 19.7x FY19E EPS; maintain
RoE (%) 18.7 15.9 20.0 21.9 Buy.
RoCE (%) 12.5 10.9 14.4 16.7
Key issues to watch
Valuations
Outlook for US Class 8 Trucks for CY16–17.
P/E (x) 32.4 35.4 25.1 19.7
Outlook for oil & gas and mining segments, primarily with regard
P/BV (x) 5.9 5.4 4.7 4.0
to price recovery.
EV/EBITDA (x) 16.4 17.1 13.6 11.1
EV/Sales (x) 3.0 3.1 2.7 2.3
Update on ramp-up of new orders under commercial vehicles,
PVs, aerospace and rail.
Consolidated
January 2017 63
December 2016 Results Preview | Sector: Automobiles
Bosch
Bloomberg BOS IN CMP: INR20,450 TP:INR20,937 (+1%) Neutral
Equity Shares (m) 31.4
Net revenue is likely to grow ~3% YoY (+8.1% QoQ) to INR28.2b.
M. Cap. (INR b)/(USD b) 642 / 9
Sales to OEM (especially 2W OEMs) are likely to moderate on
52-Week Range (INR) 25650 / 15753
1,6,12 Rel Perf. (%) -3 / -6 / 5
demonetization impact. Exports too are likely to decline.
EBITDA margin is expected to remain flat YoY (-520bp QoQ) as the
decline in raw material costs is likely to be offset by a rise other
Financial Snapshot (INR b)
Y/E March FY16 FY17E FY18E FY19E
expenses.
EBITDA is projected to grow just 4% YoY (-23% QoQ) to ~INR3.6b.
Sales 96.6 107.1 127.8 144.8
Adjusted PAT is likely to grow 39% YoY to INR3b on higher other
EBITDA 18.2 18.7 24.4 28.3
NP 15.2 15.5 20.1 22.5 income.
EPS (INR) 483.3 507.6 657.7 738.1 We are downgrading our EPS estimate for FY17/FY18 by ~6% each
EPS Gr. (%) 11.8 5.0 29.6 12.2 due to the expected decline in revenues post demonetization.
BV/Sh. (INR) 2,639.8 2,434.7 2,928.0 3,481.5 The stock trades at 41.2x FY17E and 32.2x FY18E EPS; maintain
RoE (%) 19.4 19.7 24.5 23.0 Neutral.
RoCE (%) 26.5 27.9 33.6 31.6 Key issues to watch
Valuations Rollout of BS-IV emission norms and implication on Bosch’s
P/E (x) 41.8 39.8 30.7 27.3 revenue.
P/BV (x) 7.6 8.3 6.9 5.8 Implementation of BS-VI norms for 2Ws and underlying
EV/EBITDA 33.9 31.3 23.4 19.8
(x)
opportunity for Bosch.
EV/Sales (x) 6.4 5.5 4.5 3.9
Advancement of BS-VI implementation and its impact on Bosch.
Consolidated Capex plans for BS VI norms.
January 2017 64
December 2016 Results Preview | Sector: Automobiles
Eicher Motors
Bloomberg EIM IN CMP: INR22,178 TP:INR28,755 (+30%) Buy
Equity Shares (m) 27.2
Royal Enfield’s volumes grew by 38% YoY (+4% QoQ) to 173,838 units.
M. Cap. (INR b)/(USD b) 602 / 9
It was insulated from demonetization impact as it has an average
52-Week Range (INR) 26602 / 14818
1,6,12 Rel Perf. (%) -4 / 16 / 23
waiting period of 2-3 months. Net realization is expected to improve by
4% YoY (flat QoQ), supported by price hikes. EBITDA margin should
Financial Snapshot (INR b) expand 290bp YoY to 31.5% (+20bp QoQ), driven by lower commodity
Y/E March FY16 (15m) FY17E FY18E FY19E prices and staff expenses, as well as operating leverage.
Net Income 61.7 70.2 90.2 106.9 VECV’s volume declined by 7% YoY (flat QoQ) due to the impact of
EBITDA 16.9 21.8 29.2 35.4 demonetization as major fleet operators postponed their purchases
Net Profit 13.4 16.5 23.6 29.6
on account of cash crunch. Net realization should decline by 8.7%
Adj. EPS (INR) 492.9 608.7 869.5 1,091.6
YoY (-1% QoQ) as discounts are expected to be at peak. Margin is
EPS Gr. (%) 73.7 54.4 42.9 25.5
expected to be at 5.5%, down 190bp YoY (-180bp QoQ).
BV/Sh. (INR) 1,276 1,744 2,440 3,332
Consolidated revenue would decline ~44% YoY (+5% QoQ) to
RoE (%) 35.8 40.3 41.6 37.8
RoCE (%) 21.3 27.1 30.7 29.4
INR18.4b. Consolidated margin is likely to be 31.5%. Consolidated
Payout (%) 0.5 0.6 0.7 0.8 PAT is estimated to rise 56% YoY (+2% QoQ) to INR4.2b.
Valuations The stock trades at 25.5x FY17E and 20.3x CY18E EPS. Maintain Buy.
P/E (x) 45.0 36.4 25.5 20.3 Key issues to watch
P/BV (x) 17.4 12.7 9.1 6.7 Demand for RE at the retail level to assess the impact of
EV/EBITDA (x) 27.9 22.7 16.6 12.9 demonetization on order book.
Div. Yield (%) 0.5 0.6 0.7 0.8 Update on current demand trends for commercial vehicles,
discount levels and channel inventory.
January 2017 65
December 2016 Results Preview | Sector: Automobiles
Escorts
Bloomberg ESC IN CMP: INR321 TP: INR410 (+30%) Buy
Equity Shares (m) 119.3
We expect 21% YoY growth (+8% QoQ) in revenue (on a very low
M. Cap. (INR b)/(USD b) 38 / 1
base) to INR10.74b led by strong performance in tractor division.
52-Week Range (INR) 414 / 113
1,6,12 Rel Perf. (%) -1 / 47 / 90
Construction equipment division is currently facing headwinds
while we expect some impact in this quarter due to divestment of
Financial Snapshot (INR b) its Auto equipment business (done in August 2016).
INR million 2016 2017E 2018E 2019E EBITDA margin is likely to expand 395bp YoY to 7.8%, translating
Sales 35.4 41.1 47.8 53.8 into EBITDA growth of 146% YoY to INR838m.
EBITDA 1.5 3.0 4.4 5.5 We expect PAT to grow 137% YoY to INR483m.
NP 0.9 1.7 2.8 3.8
EPS (INR) 11.1 20.7 34.2 46.2
EPS Gr. (%) -16.6 86.2 65.0 35.2
BV/Sh. (INR) 184.3 196.3 223.4 260.9
RoE (%) 6.1 10.9 16.3 19.1
RoCE (%) 7.4 10.6 15.7 18.9
Key issues to watch
Valuations
P/E (x) 29.3 15.7 9.5 7.1
Progress on key initiatives on tractor volume growth strategy, raw
P/BV (x) 1.8 1.7 1.5 1.2
material rationalizations and VRS of employees.
EV/EBITDA (x) 31.4 14.8 9.7 7.1 Management commentary on volumes and outlook given
EV/Sales (x) 1.3 1.1 0.9 0.7 expectations of normal monsoon.
January 2017 66
December 2016 Results Preview | Sector: Automobiles
Exide Industries
Bloomberg EXID IN CMP: INR182 TP:INR205 (+12%) Buy
Equity Shares (m) 850.0
We expect net revenue to grow 2% YoY (-19% QoQ) to INR15.5b as
M. Cap. (INR b)/(USD b) 155 / 2
moderation in OEM demand due to the impact of demonetization is
52-Week Range (INR) 208 / 116
1,6,12 Rel Perf. (%) 2 / 6 / 22
likely to slow down sales.
EBITDA margin is likely to contract by 150bp YoY (-120bp QoQ) to
13.9%, as employee expenses are likely to jump on account of lower
Financial Snapshot (INR b)
Y/E MARCH 2016 2017E 2018E 2019E
volumes.
Net Sales 68.1 73.4 82.7 94.6
Lead prices increased 9% QoQ in 2QFY17, the effect of which will be
EBITDA 10.2 10.9 12.7 14.9 reflected in 3Q raw material costs.
Adj. PAT 6.2 6.6 8.0 9.5 EBITDA is estimated to decrease 7.5% YoY (-25% QoQ) to ~INR2.1b.
Adj. EPS (INR) 7.3 7.8 9.4 11.2 PAT is likely to decline by 4% YoY (-28% QoQ) to INR1.3b. The fall in
EPS Gr. (%) 14.1 6.7 20.7 18.2 PAT is likely to be arrested due to higher other income.
BV/Sh. (INR) 52.2 57.4 64.3 72.9 The stock trades at 19.3x FY18E and 16.3x FY19E EPS; maintain Buy.
RoE (%) 14.0 13.6 14.7 15.3
RoCE (%) 14.5 14.0 15.3 16.0
Payout (%) 32.8 28.1 23.3 19.7 Key issues to watch
Valuations Update on demand environment for OEMs, auto replacement and
P/E (x) 24.8 23.3 19.3 16.3 industrial battery segments post demonetization.
P/BV (x) 3.5 3.2 2.8 2.5 Update on market share in autos and non-autos.
EV/EBITDA (x) 12.6 11.8 9.9 7.9 Outlook for raw material cost trend, recent pricing action and
Div. Yield (%) 1.3 1.2 1.2 1.2 currency hedges, if any.
Update on technological upgradation.
Update on capacity expansion plans across product segments.
January 2017 67
December 2016 Results Preview | Sector: Automobiles
Hero MotoCorp
Bloomberg HMCL IN CMP: INR3,014 TP:INR3,011 (+1%) Neutral
Equity Shares (m) 199.7
Sales volume declined 13% YoY (-19% QoQ) to 1.47m units, as
M. Cap. (INR b)/(USD b) 602 / 9
demonetization impact derailed November and December sales
52-Week Range (INR) 3740 / 2375
1,6,12 Rel Perf. (%) -8 / -2 / 10
volumes. Volume decline for Hero was steeper due to higher rural
exposure.
Realization should grow by 1% YoY (+2% QoQ) to INR43,659 per
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
unit.
Sales 284.4 287.7 328.9 359.8
Net revenue is likely to decline 12% YoY (~2% QoQ) to INR64.3b.
EBITDA 44.6 46.5 52.4 52.7 EBITDA margin is expected to contract 90bp YoY (-290bp QoQ) to
NP 31.6 33.8 38.4 38.9 14.7% on higher fixed costs due to decline in volumes.
Adj. EPS (INR) 158.3 169.5 192.2 195.0 EBITDA is likely to decline 17% YoY (-31% QoQ) to ~INR9.4b.
EPS Gr. (%) 26.6 7.1 13.4 1.5 We expect PAT to decline 13% YoY (-31% QoQ) to INR6.9b.
BV/Sh. (INR) 397.8 470.9 554.7 641.2 The stock trades at 15.7x FY18E and 15.5x FY19E EPS; maintain
RoE (%) 43.6 39.0 37.5 32.6 Neutral.
RoCE (%) 42.9 38.1 36.7 32.0
Payout (%) 52.3 54.3 53.9 53.1 Key issues to watch
Valuations Update on demand environment (especially rural areas) at the
P/E (x) 19.0 17.8 15.7 15.5 retail level, channel inventory to assess the impact of
P/BV (x) 7.6 6.4 5.4 4.7 demonetization.
EV/EBITDA (x) 12.5 11.8 10.2 9.9 Guidance on export plans and new launches along with timelines.
Div. Yield (%) 2.4 2.7 3.0 3.0 Update on cost-saving initiatives.
January 2017 68
December 2016 Results Preview | Sector: Automobiles
January 2017 69
December 2016 Results Preview | Sector: Automobiles
Maruti Suzuki
Bloomberg MSIL IN CMP: INR5,510 TP:INR6,415 (+16%) Buy
Equity Shares (m) 302.1
Volume growth moderated to ~3.5% YoY (-7.5% QoQ) in 3QFY17 to
M. Cap. (INR b)/(USD b) 1664 / 24
52-Week Range (INR) 5972 / 3202
~387,251 units, as growth for the mini and compact segment took a
1,6,12 Rel Perf. (%) 5 / 34 / 16 hit on demonetization woes. Moderation in volumes was limited due
to the waiting period of Baleno and Brezza.
Net realization is likely to improve 6.3% YoY (flat QoQ) to INR428,514
Financial Snapshot (INR b)
Y/E MARCH 2016 2017E 2018E 2019E per unit, boosting net revenue by 10% YoY (-7% QoQ) to INR165.9b.
Sales 576.5 667.8 805.1 930.1 Growth in realization is likely to be driven by improvement in product
EBITDA 89.0 106.2 132.4 156.0 mix due to compact UV, Vitarra Brezza, and premium hatchback,
Adj. PAT 53.7 76.2 92.7 112.7 Baleno.
EPS (INR)* 155.5 257.4 312.5 379.1 We expect margin to expand 80bp YoY (+180bp QoQ) to 15.2% on
EPS Gr. (%) 23.4 65.5 21.4 21.3 marginally lower fixed costs on operating leverage benefits as well as
BV/Sh. (INR) 894.0 1,092 1,327 1,616 increased exports to Japan on a YoY basis.
RoE (%) 19.9 23.1 23.1 23.1 EBITDA is estimated to grow 16% YoY (-17% QoQ) to INR25.2b.
RoCE (%) 27.2 31.1 31.0 30.5 We expect PAT to grow 39% YoY (-19% QoQ) to INR19.4b.
Payout (%) 23.7 21.4 23.5 22.6 We are lowering our EPS estimate by ~3% for FY17/FY18 to
Valuations ~INR257/INR312 to factor in cut in volumes due to demonetization.
P/E (x) 35.4 21.4 17.6 14.5 The stock trades at 17.6x FY18E and 14.5x FY19E EPS. Maintain Buy.
P/CE (x) 22.1 16.0 13.4 11.3
EV/EBITDA (x) 16.7 13.6 10.3 8.2
Div. Yield (%) 0.6 0.8 1.1 1.3 Key issues to watch
*Consol. & adjusted Update on retail demand scenario, channel inventory, discounting
trends and new launches (Brezza) post demonetization impact.
Progress on commissioning of Gujarat plant.
Total Volumes (nos) 341,329 353,335 374,182 360,354 348,443 418,470 387,251 416,244 1,429,200 1,570,408
Change (%) 13.8 9.8 15.5 3.9 2.1 18.4 3.5 15.5 10.6 9.9
Realizations (INR/car) 391,907 392,013 403,063 424,742 428,202 426,382 428,514 418,577 403,394 425,243
Change (%) 2.8 2.5 3.6 8.1 9.3 8.8 6.3 -1.5 4.3 5.4
Net operating revenues 133,769 138,512 150,819 153,057 149,204 178,428 165,942 174,230 576,530 667,804
Change (%) 17.1 12.5 19.7 12.3 11.5 28.8 10.0 13.8 15.4 15.8
RM Cost (% of sales) 67.4 66.9 68.5 66.0 67.9 67.7 68.2 67.5 67.4 67.8
Staff Cost (% of sales) 3.5 3.0 3.3 3.9 3.9 2.9 3.5 3.7 3.4 3.5
Other Cost (% of sales) 12.9 13.9 13.8 14.8 13.4 12.4 13.1 12.5 13.8 12.8
EBITDA 21,673 22,457 21,701 23,500 22,157 30,374 25,229 28,410 88,962 106,170
EBITDA Margins (%) 16.2 16.2 14.4 15.4 14.9 17.0 15.2 16.3 15.4 15.9
Non-Operating Income 2,065 4,736 4,065 3,744 4,833 8,126 8,000 3,949 14,610 24,908
Interest 190 178 244 203 181 197 200 222 815 800
Depreciation 6,716 6,694 7,221 7,608 6,389 6,300 6,500 7,087 28,239 26,276
PBT 16,832 20,321 18,301 19,433 20,420 32,003 26,529 25,050 74,518 104,003
Effective Tax Rate (%) 28.2 26.3 23.8 28.6 27.2 25.1 26.8 28.5 28.0 26.8
PAT 12,081 14,973 13,943 13,868 14,862 23,980 19,433 17,907 53,654 76,182
Adjusted PAT 12,081 14,973 13,943 13,868 14,862 23,980 19,433 17,907 53,654 76,182
Change (%) 58.5 73.6 68.2 8.0 23.0 60.2 39.4 29.1 44.6 42.0
E:MOSL Estimates
January 2017 70
December 2016 Results Preview | Sector: Automobiles
Tata Motors
Bloomberg TTMT IN CMP: INR487 TP:INR613 (+26%) Buy
Equity Shares (m) 3395.9
We expect JLR’s (including JV) volume to be flat YoY (+9% QoQ). Net
M. Cap. (INR b)/(USD b) 1652 / 24
realization should increase 15% YoY (flat QoQ) led by ramp-up of
52-Week Range (INR) 599 / 266
1,6,12 Rel Perf. (%) 10 / 6 / 25
F-Pace and increase in share of China. EBITDA margin would
contract 200bp YoY (and +200bp QoQ) to 12.4%. Adjusted PAT is
likely to decline ~21% YoY (+33% QoQ) to GBP325m.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
S/A volume grew 8.4% YoY (-2% QoQ) led by a 36% rise in PVs due
Net Sales 2,756 2,866 3,289 3,815
to the launch of Tiago, while CVs declined by 1% due to the
EBITDA 402.4 353.7 503.4 619.3 demonetization impact. Margin is likely to contract 240bp YoY
NP 125.2 92.2 186.9 257.6 (-30bp QoQ) to 3.3%, as the share of CVs decreases. Adjusted PAT is
Adj. EPS (INR) 36.9 27.2 55.0 75.9 likely to be -INR3.6b (vis-à-vis -INR0.3m in 3QFY16).
EPS Gr. (%) -15.5 -26.3 102.7 37.8 Consolidated PAT would fall 16% YoY (+256% QoQ) to INR29.2b.
BV/Sh. (INR) 237.9 264.1 315.9 388.5 We are increasing our FY17 EPS estimates by 7% while downgrade
RoE (%) 18.3 10.8 19.0 21.5 our FY18 estimates by 17% to factor in for Fx hedge loss.
RoCE (%) 14.3 8.4 13.9 16.3 The stock trades at 8.9x FY18E and 6.4x FY19E EPS. Buy.
Payout (%) 0.7 13.3 8.8 6.4
Key issues to watch
Valuations
Impact of Brexit on JLR business.
P/E (x) 13.2 17.9 8.9 6.4
Current demand trends for JLR and outlook, particularly in China
P/BV (x) 2.0 1.8 1.5 1.3
EV/EBITDA (x) 4.4 5.3 3.5 2.4
and the US.
Div. Yield (%) 0.0 0.6 0.8 0.8
Update on Chery JV operations and CV business outlook.
Quarterly Performance
Y/E March FY16 FY17 FY16 FY17E
(Consolidated) 1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
JLR vols. (incl JV) 114,452 116,745 150,461 162,427 134,334 139,227 151,182 183,580 544,085 608,323
JLR Realizations (GBP/unit) 45,206 43,460 42,004 43,991 45,216 47,937 48,177 48,399 43,602 47,526
JLR EBITDA (%) 16.4 12.2 14.4 16.2 12.3 10.3 12.4 14.3 14.9 12.5
JLR PAT (GBP m) 492 52 414 560 265 245 325 558 1584 1392
S/A vol. (units) 117,160 117,439 122,377 146,766 126,839 134,869 132,657 168,608 532,724 562,973
S/A Realizations (INR/unit) 795,852 910,574 817,198 856,454 813,594 765,369 771,109 820,383 6 6
S/A EBITDA (%) 6.1 8.2 5.7 8.1 6.8 3.6 3.3 5.7 6.5 4.9
S/A PAT (INR m) 333 351 -395 5,014 996 -6,621 -3,558 -1,904 -1,297 -10,728
Net Op Income 604,009 615,240 722,564 806,844 658,950 659,004 708,422 839,462 2,755,611 2,865,838
Growth (%) -6.6 1.5 3.3 19.4 9.1 7.1 -2.0 4.0 4.7 4.0
EBITDA 110,068 65,189 93,800 113,872 76,220 62,826 89,260 94,827 365,160 323,132
EBITDA Margins (%) 18.2 10.6 13.0 14.1 11.6 9.5 12.6 11.3 13.3 11.3
Interest Expenses 11,496 12,228 10,915 12,552 11,785 10,249 6,500 10,438 46,234 38,972
PBT before EO Exp 63,398 11,911 41,300 59,567 20,663 9,831 34,560 39,819 158,602 104,874
EO Exp/(Inc) -6,338 33,411 -457 -6,044 -4,851 -162 0 0 18,794 -5,013
PAT 53,251 -17,209 35,244 52,065 18,314 5,747 25,001 29,720 111,083 78,781
Minority Interest -232 -214 -204 -383 -240 -198 -175 -363 -1,059 -976
Share in profit of Associate -708 -139 36 89 4,290 2,735 4,339 6,636 213 18,000
Adj PAT 47,470 9,180 34,690 46,975 18,882 8,191 29,165 35,993 125,170 92,211
Growth (%) (10.9) (72.0) (10.2) 158.4 (60.2) (10.8) (15.9) (23.4) -11.3 -26.3
E: MOSL Estimates
January 2017 71
December 2016 Results Preview | Sector: Automobiles
January 2017 72
December
March2016
2016Results
2015 ResultsPreview
Preview ||Sector:
December Sector:Capital
2016 Results Goods
CapitalPreview
Goods
Technology
Capital Goods
Demonetization to extend near-term pain
Company name
Impending structural reforms to rekindle investment cycle
ABB
Domestic investment cycle: Demonetization impacts capex cyle
Bharat Electronics temporarily; exports hamstrung by weak global demand
BHEL The recent demonetization has temporarily impacted capex activity. CMIE data
Crompton Greaves
indicates that the new investment proposals by India Inc reduced to INR1.3t for the
December quarter as compared to an average of INR2.4t per quarter in the
Crompton Greaves Consumer
preceding nine quarters. The near-term outlook remains cautious, with
Cummins India demonetization impacting fresh investments and challenges such as restrained
GE T&D capex activity by private players. However, policy initiatives and efforts are
underway for (i) expediting government approvals, and (ii) establishing monetary
Havells India
conditions conducive to industrial revival in the medium term.
Larsen & Toubro
We believe investment revival would be triggered by: (i) sustained recovery in
Siemens
consumption demand, and thus, capacity utilization, and (ii) investment push by
Thermax the public sector, leading to a virtuous cycle of cash flow generation.
Voltas Simultaneously, sustained progress in reviving stalled projects is imperative for
attracting new investments and providing much-needed stimulus to aggregate
demand.
By initiating GST, labor and energy sector reforms, the government has partly
addressed concerns about the pace and extent of reforms. Successful
implementation of substantive reforms is essential for structured investment
growth.
Indian machinery exports have decelerated due to factors such as weak global
demand, geopolitical concerns and sharp currency volatility across several
markets. Also, falling crude prices had an adverse impact on global trade, and
thus, investment demand. Project awards in the Middle East have been
muted—in fact, revenue estimates for global industrial players suggest that
sluggishness has continued for around nine quarters.
16.1
16.0
15.6
15.5
14.5
14.0
13.8
13.5
13.5
17.9
12.3
12.2
12.1
12.0
12.0
12.0
11.6
11.6
11.3
11.0
10.2
16.9
10.0
10.0
16.3
16.1
16.0
26.3 9.9
11.7 9.2
15.6
15.5
3.1 8.7
8.4
8.4
8.3
7.2
14.5
14.0
13.8
13.5
13.5
2.7 4.3
12.3
12.2
12.1
12.0
12.0
12.0
19.6
18.2
15.6
16.6
15.3
11.6
11.6
11.3
16.8
21.7
20.9
16.9
31.8
11.0
6.6
1.3
20.5
12.8
16.4
29.0
22.0
28.8
27.5
2.8
10.2
7.5
10.0
10.0
9.2
9.9
3.7
2.8
9.2
8.7
8.4
8.4
8.3
7.2
4.3
-5.2
2QFY14 -3.5
4QFY15 -1.0
-0.8
2QFY16 -1.4
2QFY09
4QFY09
2QFY10
4QFY10
2QFY11
4QFY11
2QFY12
4QFY12
2QFY13
4QFY13
4QFY14
2QFY15
4QFY16
2QFY17
2QFY09
4QFY09
2QFY10
4QFY10
2QFY11
4QFY11
2QFY12
4QFY12
2QFY13
4QFY13
2QFY14
4QFY14
2QFY15
4QFY15
2QFY16
4QFY16
2QFY17
January 2017 74
December 2016 Results Preview | Sector: Capital Goods
Exhibit 4: Book-to-bill stable at 3.0x Exhibit 5: Order intake growth remains muted
Order book (INR b) BTB (x) Order intake YoY %
58
56
52
3.3
3.3
3.3
3.1
3.2
39
3.0
3.1
3.0
2.9
2.8
31
2.6
2.6
17
15
22
14
18
2.4
2.4
2.3
2.3
2.3
2.3
2.2
2.2
2.1
-1
15
-1
-2
-11
-12
3,367
3,263
3,112
3,168
3,127
2,964
2,893
2,958
2,989
3,028
2,943
3,230
3,482
3,594
3,605
3,813
3,717
3,641
3,837
3,922
3,871
-17
-20
-24
-34
4QFY12-47
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
2QFY12
2QFY13
4QFY13
2QFY14
4QFY14
2QFY15
4QFY15
2QFY16
4QFY16
2QFY17
Source: MOSL, Company Source: MOSL, Company
Exhibit 6: Relative performance – Three-month (%) Exhibit 7: Relative performance – One-year (%)
Sensex Index MOSL Capital Goods Index
Sensex Index MOSL Capital Goods Index
108 110
101 102
94 94
87 86
80 78
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
January 2017 75
December 2016 Results Preview | Sector: Capital Goods
ABB
Bloomberg ABB IN CMP: INR1,037 TP: INR1,125 (+8%) Neutral
Equity Shares (m) 211.9
ABB has received an order to supply 1,600 traction transformers
M. Cap. (INR b)/(USD b) 220 / 3
for 800 new electric freight locomotives in India. The transformers
52-Week Range (INR) 1433/950
1,6,12 Rel Perf. (%) -2 / -13 / -11
will be manufactured locally in ABB’s Vadodara facility, supporting
the government’s ‘ Make in India’ initiative.
ABB continues to focus on increased localization and cost
Financial Snapshot (INR b)
Y/E Dec 2015 2016E 2017E 2018E optimization, whereby its direct RM costs have declined to 65.4%
Net Sales 81.4 88.3 99.6 111.3 of revenue, from a peak of 81% in 4QCY10. The company has set an
EBITDA 7.5 7.5 11.1 12.9 internal target to reduce it to 65% over next few years. This has
Adj PAT 3.0 3.7 5.7 6.8 aided margins, despite negative operating leverage.
Adj EPS (INR) 15.8 18.2 26.9 32.2
We expect revenue to register 11% YoY growth, led by execution
EPS Gr (%) 22.8 15.6 48.0 19.3
BV/Sh (INR) 142.0 159.5 186.5 208.9
ramp-up in the project segment. Operating margins are expected
RoE (%) 11.1 11.4 14.5 15.4 to decline 90bp YoY to 10.2%, as contribution from projects
RoCE (%) 17.5 16.3 21.8 22.9 increases (56% of sales as against 63% in 4QCY15). Net profit is
Payout (%) 23.5 25.2 26.1 26.1 likely to increase 5% YoY to INR1.4b. Maintain Neutral.
Valuations
P/E (x) 65.8 57.0 38.5 32.3
P/BV (x) 7.3 6.5 5.6 5.0
EV/EBITDA (x) 29.8 22.9 17.5 13.3 Key issues to watch
Div. Yield (%) 0.4 0.4 0.7 0.8 Management commentary suggests cautious optimism; continued
focus on exports and services to be an important driver, with
projection of strong double-digit revenue and profit growth.
Continued preference for cash generation vis-à -vis profits.
January 2017 76
December 2016 Results Preview | Sector: Capital Goods
Bharat Electronics
Bloomberg BHE IN CMP: INR1,431 TP: INR1,600 (+12%) Buy
Equity Shares (m) 240.0
Bharat Electronics plans to establish a defense system integration
M. Cap. (INR b)/(USD b) 343 / 5
52-Week Range (INR) 1540 / 1009
complex, with a capex of USD120m, to manufacture missile
1,6,12 Rel Perf. (%) -1 / 15 / 0
systems like navigation, seeker, radar, fire control and guidance.
BHE expects order inflow of INR120b-150b in FY17, led by
finalization of key projects like Akash missile.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E BHE has guided revenue growth of 10-12% in FY17, led by
Net Sales 73.0 82.6 95.6 109.3 execution of key orders in hand, like Akash missile, WLR, hand-held
EBITDA 14.6 15.6 17.2 20.3 thermal device, tactical control radar, etc.
NP 13.7 14.4 15.6 17.9 The company has guided that FY17 EBITDA margin would be in the
EPS (INR) 56.9 60.0 69.9 80.3
+/-100bp range of FY16 margin (20%).
EPS Gr. (%) 17.1 5.5 16.5 14.8
BV/Sh (INR) 364.2 336.7 382.4 434.9
BHE plans to explore opportunities in critical infrastructure
RoE (%) 15.6 19.2 18.3 18.5 protection, air traffic management radars, intelligent traffic
RoCE (%) 16.5 17.7 19.4 19.6 management systems, solar power plants and smart city elements.
P/E (x) 25.1 22.2 20.5 17.8 BHE has planned capex of INR23b over the next five years toward
P/BV (x) 3.9 4.2 3.7 3.3 modernization and expansion of existing facilities to support the
EV/EBITDA (x) 18.5 17.3 15.1 12.3
government’s “ Make in India” initiative. Majority of the capex
EV/ Sales (x) 3.8 3.3 2.8 2.3
would be spent on developing BMS test bed, TCS test bed, test bed
for missile system, etc. Maintain Buy.
Key issues to watch
Revenue growth: Key orders (Akash missile, intake INR67b in FY11–
12) are currently under execution for Army and Air Force.
Operating at 60% capacity utilization; possibility of strong operating
leverage.
Quarterly Performance
FY16 FY17
Y/E March FY16 FY17
1Q 2Q 3Q 4Q 1QE 2Q 3QE 4QE
Sales 10997 14692 15172 32148 8714 17033 18500 38388 72952 82636
Change (%) 8.6 13.5 -5.7 9.8 -20.8 15.9 21.9 19.4 6.6 13.3
EBITDA 78 1807 2926 9988 -467 3349 3427 9297 14582 15606
Change (%) -117 52 5 26 -699 85 17 -7 27 7
As of % Sales 0.7 12.3 19.3 31.1 -5.4 19.7 18.5 24.2 20.0 18.9
Depreciation 408 407 414 468 435 455 450 566 1689 1905
Interest 0 3 1 41 0 3 0 -3 45 0
Other Income 1337 1316 1355 1336 1387 1714 1150 1004 5322 5256
PBT 1007 2712 3865 10888 486 4606 4127 9738 18169 18956
Tax 241 654 908 2799 125 1178 908 2338 4515 4550
Effective Tax Rate (%) 23.9 24.1 23.5 25.7 25.7 25.6 22.0 24.0 24.8 24.0
Reported PAT 767 2059 2957 8089 361 3427 3219 7399 13654 14407
Change (%) 199.5 40.1 8.8 11.9 -52.9 66.5 8.9 -8.5 17.6 5.5
Adj PAT 767 2059 2957 8017 361 3427 3219 7399 13654 14407
Change (%) 199.5 40.1 8.8 10.9 -52.9 66.5 8.9 -7.7 17.4 5.5
E: MOSL Estimates
January 2017 77
December 2016 Results Preview | Sector: Capital Goods
BHEL
Bloomberg BHEL IN CMP: INR127 TP: INR110 (-13%) Sell
Equity Shares (m) 2447.6
BHEL is expected to post loss on the operational front, led by
M. Cap. (INR b)/(USD b) 311 / 5
52-Week Range (INR) 175 / 90
continued weakness in gross profit margin. However, we expect
1,6,12 Rel Perf. (%) -2 / -6 / -27
operational performance to improve YoY. We estimate revenue
growth of 13.5% YoY, decline in operating loss from INR16.4b in
3QFY16 to INR7.5b, and decline in net loss from INR11b in 3QFY16
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E at INR6.7b. Loss in 3QFY16 was led by provisioning of INR11.8b for
Net Sales 256.3 314.0 333.9 380.8 dues and inventory for the projects put on hold.
EBITDA -19.6 12.1 17.9 27.1 During the quarter, BHEL bagged an order worth INR4.6b for R&M
PAT -9.1 9.7 13.5 20.8 of the 6x60MW Balimela HEP of Odhisa Hydro Power Corporation
EPS (INR) -3.7 3.9 5.5 8.5
and the 3x60MW Bairaisul HEP of NHPC.
EPS Gr. (%) -163.6 -206.3 39.4 54.2
BV/Sh. INR 135.0 138.1 142.3 148.9
BHEL also secured an order for the supply of 118 sets of IGBT-
RoE (%) -2.7 2.9 3.9 5.8 based traction converters for 3-phase 6,000 HP electric
RoCE (%) -4.1 1.2 2.2 3.5 locomotives valued at INR2b.
Payout (%) -10.8 0.0 0.0 20.0 BHEL is L1 in 12GW of orders, of which it expects 7GW of orders to
Valuations be finalized in FY17.
P/E (x) -32.9 30.9 22.2 14.4
P/BV (x) 0.9 0.9 0.9 5.8
EV/EBITDA (x) -10.2 16.5 8.8 7.2
Key issues to watch
Div Yield (%) 0.3 0.6 0.9 1.4 Continued constraint on execution due to operational issues.
* Consolidated Trends in provisions, particularly for liquidated damages on
project completion.
Quarterly Performance
FY16 FY17
Y/E March FY16 FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q
Sales (Net) 43,617 59,380 53,256 100,048 56,225 66,645 60,500 130,585 256,300 313,954
Change (%) -15.0 -3.4 -14.1 -21.1 28.9 12.2 13.6 30.5 -15.1 22.5
EBITDA -2,093 -4,379 -16,387 3,638 710 1,551 -7,500 17,377 -19,597 12,139
Change (%) -196.1 -250.2 -657.8 -78.4 -133.9 -135.4 -54.2 377.6 -193.4 -161.9
As a % Sales -4.9 -7.4 -30.8 3.6 1.3 2.3 -12.4 13.3 -7.6 3.9
Interest 33 44 52 140 57 50 55 106 268 268
Depreciation 2,425 2,249 2,255 2,428 2,182 2,080 2,500 3,191 9,356 9,953
Other Income 4,924 3,739 1,706 4,139 2,493 1,961 1,800 4,209 14,501 2,899
PBT 373 -2,933 -16,989 5,209 965 1,382 -8,255 18,289 -14,721 12,381
Tax 34 -1,125 -5,969 1,555 188 292 -1,500 3,745 -5,633 2,724
Effective Tax Rate (%) 9.1 38.4 35.1 29.8 19.4 21.1 18.2 20.5 38.3 22.0
Reported PAT 339 -1,808 -11,020 3,596 778 1,090 -6,755 14,544 -9,088 9,657
Change (%) -82.5 -244.8 -618.3 -59.5 129.5 -160.3 -38.7 304.5 -164.0 -206.3
Adj. PAT 339 -1,808 -11,020 3,655 778 1,090 -6,755 14,544 -9,088 9,657
Change (%) -82.5 -244.8 -618.3 -61.7 129.5 -160.3 -38.7 298.0 -163.6 -206.3
E: MOSL Estimates
January 2017 78
December 2016 Results Preview | Sector: Capital Goods
Crompton Greaves
Bloomberg CRG IN CMP: INR61 TP: INR48 (-21%) SELL
Equity Shares (m) 627.0
During the quarter, deal for sale of overseas power business in
M. Cap. (INR b)/(USD b) 38 / 1
Europe, North America and Indonesia to First Reserve for an
52-Week Range (INR) 89 / 39
1,6,12 Rel Perf. (%) -13 / -15 / -10
enterprise value of EUR115m on a debt-free, cash-free basis was
called off owing to non-fulfillment of certain conditions precedent
to the share purchase agreement.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E The management now intends to sell the overseas power business
Net Sales 52.7 59.3 54.7 59.1 on either geographical basis or product-wise basis.
EBITDA 3.7 4.7 5.5 6.5 CRG has reached an agreement to sell its B2B automation business
Adj PAT 1.3 0.3 1.1 2.0 in Spain, UK , Ireland, France and India at an EV of EUR120m.
EPS(INR) 2.1 0.6 1.9 3.2
Successful completion of the deal would help Crompton to reduce
EPS Gr. (%) -51.0 -73.0 232.6 73.1
BV/Sh. (INR) 73.3 73.2 72.7 72.0
the debt on its books.
RoE (%) 3.0 4.2 6.0 8.0 The management intends to monetize ~INR10b of non-core assets,
RoCE (%) 5.1 6.0 7.5 7.9 including additional land at K anjurmarg, to lower standalone
Payout (%) 0.0 107.4 107.4 107.4 business debt. Maintain SELL.
Valuations
P/E (x) 35.3 109.3 32.9 19.0
P/BV (x) 1.0 0.8 0.8 0.8
EV/EBITDA (x) 14.7 7.8 6.3 5.1 Key issues to watch
Div Yield (%) 0.0 1.0 3.3 4.5 Lowering debt in demerged business through asset sale.
* Consolidated
Concrete developments on plans to sell international power
business.
January 2017 79
December 2016 Results Preview | Sector: Capital Goods
CG Consumer Electricals
Bloomberg CROMPTON IN CMP: INR152 TP: INR180 (+18%) Buy
Equity Shares (m) 626.8
We expect CROMPTON’s 3QFY17 operational performance to be
M. Cap. (INR b)/(USD b) 95 / 1
impacted on account of the demonetization-led sluggishness.
52-Week Range (INR) 191 / 126
1,6,12 Rel Perf. (%) -
We expect sales to decline 5% YoY, led by weak demand for
products on account of liquidity tightness witnessed by consumers
following the demonetization.
Financial Snapshot (INR b)
Y/E March 2016E 2017E 2018E 2019E We expect operating profit of INR405m in 3QFY17, a decline of
Net Sales 18.1 37.6 42.9 48.7 51% YoY on account of increase in employee cost, led by provision
EBITDA 2.1 4.0 5.3 6.3 of ESOP cost and negative operating leverage.
Adj PAT 1.1 2.3 3.2 3.9 Operating margin would be 5.3% in 3QFY17 as against 10.2% in
EPS (INR) 1.9 3.7 5.1 6.3
3QFY16. Net profit is expected to be INR175m in 3QFY17 as against
EPS Gr. (%) (70.3) 96.6 37.6 22.5
BV/Sh. (INR) 3.6 5.6 8.3 10.8
INR412m in 3QFY16, a decline of 58.7% YoY.
RoE (%) 52.1 80.9 74.2 66.1
RoCE (%) 27.4 30.2 33.4 34.9
Payout (%) - 40.0 40.0 50.0 Key issues to watch
Valuations
Impact of demonetization on the sales of the company.
P/E (x) 79.8 40.6 29.5 24.1
P/BV (x) 41.6 27.1 18.3 14.1
Details of segmental sales, as CROMPTON intends to improve
EV/EBITDA sales of premium category products.
46.0 23.8 18.0 14.9
(x) Ad spends incurred by the company during the quarter, as
Div Yield (%) - 1.0 1.4 2.2 CROMPTON intends to position itself as an electrical consumer
* Consolidated
durables brand as against its current positioning as a fans brand.
January 2017 80
December 2016 Results Preview | Sector: Capital Goods
Cummins India
Bloomberg K K C IN CMP: INR809 TP: INR836 (-3%) Neutral
Equity Shares (m) 277.2
We expect revenue improvement of 7% YoY, supported by growth
M. Cap. (INR b)/(USD b) 224 / 3
in the industrial (21%) and automotive (9%) segments. Industrial
52-Week Range (INR) 1051 / 747
1,6,12 Rel Perf. (%) 3 / -3 / -25
segment growth would be driven by a pick-up in the infrastructure
(roads and metros) and data center segments. Pick-up in the
domestic demand environment and various pricing actions taken
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E by K K C to regain lost market share post CPCB-2 compliance will
Net Sales 47.0 50.0 56.6 65.5 help domestic revenue to grow 8% YoY in 3QFY17.
EBITDA 7.7 7.7 9.2 11.3 We expect export revenue to improve 4% YoY to INR3.8b in
Adj PAT 7.5 7.2 8.4 10.1 3QFY17. Exports had witnessed a muted growth of 1% in 1QFY17,
EPS (INR) 27.2 26.0 30.2 36.3
led by weak demand in LatAm, Europe and China.
EPS Gr. (%) -4.0 -4.6 16.4 20.0
BV/Sh. (INR) 114.4 124.8 136.9 151.5
EBIDTA margin is expected to improve by 120bp YoY to 14.7%; net
RoE (%) 24.9 22.0 23.1 25.2 profit should grow 3.5% YoY to INR1.7b. Maintain Neutral.
RoCE (%) 25.2 21.9 23.3 25.4
Payout (%) 51.5 51.5 51.5 51.5
Valuations
P/E (x) 29.7 31.1 26.8 22.3 Key issues to watch
P/BV (x) 7.1 6.5 5.9 5.3
Cost optimization possibilities in power gen business, given
EV/EBITDA
28.9 29.0 24.0 19.5 increased localization due to a significant decline in imports post
(x)
Div Yield (%) 1.7 1.7 1.9 2.3 CPCB-2 implementation.
Performance of export segment, as exports remained weak, led
by poor demand in LatAm, Europe and China.
January 2017 81
December 2016 Results Preview | Sector: Capital Goods
GE T&D
Bloomberg GETD IN CMP: INR302 TP: INR320 (+6%) Neutral
Equity Shares (m) 256.1
We expect GETD to register robust revenue growth of 14% YoY to
M. Cap. (INR b)/(USD b) 77 / 1
INR8.5b in 3QFY17. Revenue growth would be driven by
52-Week Range (INR) 477 / 285
1,6,12 Rel Perf. (%) -4 / -12 / -38
execution of the Champa-K urukshetra Phase-I project.
We expect operating profit in 3QFY17 as against loss of INR14m in
3QFY16. Loss at operating level in 3QFY16 was primarily on
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E account of cost overrun on certain projects. Gross margin is likely
Net Sales 34.1 38.3 43.9 50.4 to expand 130bp to 32.9% from 31.6% in 3QFY16.
EBITDA 2.3 2.4 5.0 6.6 GETD is expected to book net profit of INR40m as against loss of
Adj PAT 0.8 1.4 2.7 3.8 INR182m in 3QFY16. Maintain Neutral.
EPS (INR) 3.0 5.6 10.7 15.0
EPS Gr. (%) -35.7 86.3 88.9 40.6
BV/Sh. (INR) 52.1 50.3 55.8 63.6
RoE (%) 5.9 -6.8 20.1 25.1
RoCE (%) 10.1 13.2 24.5 29.7
Payout (%) 59.5 40.0 40.0 40.0
Valuations
P/E (x) 99.9 53.6 28.4 20.2
P/BV (x) 5.8 6.0 5.4 4.8
EV/EBITDA (x) 35.2 32.6 15.5 11.6 Key issues to watch
EV/ Sales (x) 2.4 2.1 1.8 1.5 Progress in the Champa-Kurukshetra Phase-I project.
Div Yield (%) 0.6 -0.5 1.4 2.0
Quarterly Performance
FY16 FY17
Y/E March FY16E FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Sales 7,660 8,729 7,436 9,715 8,546 8,340 8,500 12,892 34,135 38,278
Change (%) 1.2 1.2 1.2 -28.6 11.6 -4.4 14.3 32.7 -7.8 12.1
EBITDA 72 680 -14 850 21 339 370 1,675 2,324 2,405
Change (%) -90.4 -22.4 NA -18.5 -70.3 -50.1 -2,705.6 97.1 -9.0 -9.0
As of % Sales 0.9 7.8 -0.2 8.7 0.2 4.1 4.4 13.0 6.8 6.3
Depreciation 212 215 215 216 217 220 220 234 873 873
Interest 117 143 168 189 226 239 220 221 589 589
Other Income 412 213 117 64 326 435 130 70 427 427
Extra-ordinary Items 0 0 0 0 2,330 0 0 0 0 0
PBT 155 536 -280 509 -2,425 315 60 1,290 1,289 1,370
Tax 54 174 -98 210 -455 109 20 451 508 508
Effective Tax Rate (%) 34.7 32.6 NA 41.3 18.8 34.6 33.3 35.0 39.4 37.1
Reported PAT 102 361 -182 299 -1,970 206 40 839 781 862
Change (%) -67.5 1.8 -803.1 -44.8 -2,041.0 -43.0 -122.0 180.7 0.0 0.0
Adj PAT 102 361 -182 299 360 206 40 839 781 862
Change (%) -64.4 1.8 NA -44.8 254.6 -43.0 NA 180.7 2.0 2.0
January 2017 82
December 2016 Results Preview | Sector: Capital Goods
Havells India
Bloomberg HAVL IN CMP: INR351 TP: INR390 (+11%) BUY
Equity Shares (m) 624.6
We expect HAVL’s 3QFY17 operational performance to be
M. Cap. (INR b)/(USD b) 219 / 3
impacted on account of the demonetization-led sluggishness.
52-Week Range (INR) 460 / 259
1,6,12 Rel Perf. (%) 3 / -2 / 10
Standalone revenue is expected to decline 1% YoY on account of
decline in the demand for products like switchgears (-10% YoY),
electrical consumer durables (-5% YoY) and lighting (-8% YoY). We
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E expect the cables segment, which contributes 41% of the
Net Sales 77.1 59.9 68.9 79.9 company’s revenue, to register 5% YoY growth, led by
EBITDA 8.0 7.7 9.7 11.9 improvement in the prices of the copper (+11% YoY).
Adj PAT 4.8 4.7 7.1 8.5 We expect operating margin to shrink 570bp YoY to 7.8% in
Adj EPS (INR) 7.8 7.5 11.3 13.6
3QFY17, led by negative operating leverage, increase in staff cost,
EPS Gr. (%) -6.0 -3.6 51.0 19.9
BV/Sh(INR) 41.0 44.3 48.6 55.2
and higher ad spend.
RoE (%) 19.0 16.9 23.3 24.6 Net profit is expected to decline 42% YoY. Maintain BUY.
RoCE (%) 20.4 20.4 23.7 25.7
Payout (%) 93.0 63.6 62.1 51.7
Valuations
P/E (x) 45.2 46.9 31.0 25.9
P/BV (x) 8.6 7.9 7.2 6.4 Key issues to watch
EV/EBITDA (x) 25.4 26.4 20.4 16.4 Commentary on the impact of demonetization on demand for the
Div Yield (%) 1.1 1.4 1.7 1.7 company’s product portfolio and outlook for FY18.
* Consolidated Guidance on deployment of cash received from the sale of
Sylvannia to Sanghai Feilo.
January 2017 83
December 2016 Results Preview | Sector: Capital Goods
January 2017 84
December 2016 Results Preview | Sector: Capital Goods
Siemens
Bloomberg SIEM IN CMP: INR1,121 TP: INR1260 Neutral
Equity Shares (m) 356.1
During the quarter, SIEM approved the sale and transfer of its
M. Cap. (INR b)/(USD b) 399 / 6
engineering, design and development services for global wind
52-Week Range (INR) 1355 / 969
1,6,12 Rel Perf. (%) 2 / -11 / -10
power business to a subsidiary, Wind Holdco Sociedada Limitada
(SA), Spain for a consideration of INR75m.
SIEM and Whispering Heights Real Estate Private Limited have
Financial Snapshot (INR b)
Y/E September 2015 2016 2017E 2018E executed an MoU for the transfer of the company’s leasehold
Net Sales 52.6 46.2 47.7 54.3 interest in a property for a consideration of INR6.1b.
EBITDA 4.1 4.1 4.6 5.5 We expect SIEM to register muted YoY revenue decline of 2.1% to
Adj PAT 2.8 3.0 3.3 3.8 INR22.6b, as we exclude revenue of the healthcare division, which
Adj EPS (INR) 23.5 24.8 27.6 32.0
it sold in 3QFY16. Excluding healthcare, we expect robust revenue
EPS Gr (%) 8.2 5.2 11.2 16.1
BV/Sh. (INR) 197.7 212.5 229.2 249.2
growth of 19% YoY, led by strong performance by the industrial
RoE (%) 12.5 12.2 12.5 13.4 and energy segments.
RoCE (%) 11.3 10.7 12.2 12.9 We expect SIEM to register sales of INR22.1b, a growth of 12% YoY
Payout (%) 32.9 34.2 33.8 32.1 (excluding healthcare division). EBITDA is likely to decline 3% YoY to
Valuations INR1.9b and net profit is likely to grow 22% YoY to INR1.4b on
P/E (x) 33.2 31.5 28.3 24.4
higher other income and lower tax rate. Maintain Neutral.
P/BV (x) 3.9 3.7 3.4 3.1
EV/EBITDA (x) 23.3 22.7 19.7 16.4 Key issues to watch
Div. Yield (%) 1.0 1.1 1.2 1.3 Raw material imports account for 55% of raw material cost;
Siemens AG’s network comprises 82% of imports; EUR
depreciating 1% YoY v/s INR could bolster product
competitiveness and margin profile.
January 2017 85
December 2016 Results Preview | Sector: Capital Goods
Thermax
Bloomberg TMX IN CMP: INR780 TP: INR706 (-9%) Sell
Equity Shares (m) 119.2
Revenue is likely to decline 7% YoY, led by constrained execution
M. Cap. (INR b)/(USD b) 93 / 1
environment prevailing in the energy segment. Operating margin is
52-Week Range (INR) 945 / 691
1,6,12 Rel Perf. (%) -7 / -7 / -16
expected to remain stable YoY at 9.3%.
Ordering activity remains muted on a weak macro environment.
We believe domestic orders have remained at the base level
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E (INR5b-7b per quarter), as the company has not announced any
Net Sales 52.6 46.2 47.7 54.3 meaningful order during the quarter.
EBITDA 4.1 4.1 4.6 5.5 Increased internationalization of the business is a vital part of
Adj PAT 2.8 3.0 3.3 3.8 TMX’s ongoing strategy. The company also announced plans to
EPS (INR) 23.5 24.8 27.6 32.0
partly localize operations in SE Asia by setting up subsidiaries. It is
EPS Gr. (%) 8.2 5.2 11.2 16.1
BV/Sh. (INR) 197.7 212.5 229.2 249.2
planning to set up a boiler facility in Indonesia with capex of
RoE (%) 12.5 12.2 12.5 13.4 USD50m. TMX expects the facility to generate revenue of
RoCE (%) 11.3 10.7 12.2 12.9 USD100m over 3-4 years post commissioning of the plant. Maintain
Payout (%) 32.9 34.2 33.8 32.1 Sell.
Valuations
P/E (X) 33.2 31.5 28.3 24.4
P/BV (X) 3.9 3.7 3.4 3.1
EV/EBITDA (X) 23.3 22.7 19.7 16.4
Key issues to watch
Div Yield (%) 1.0 1.1 1.2 1.3
Demand environment in domestic and overseas markets.
Sustainability of margins in energy (10.1% in 2QFY17) and
environment (8% in 2QFY17) segments.
January 2017 86
December 2016 Results Preview | Sector: Capital Goods
Voltas
Bloomberg VOLT IN CMP: INR335 TP: INR370 (+10%) BUY
Equity Shares (m) 330.8
Unitary cooling division (UCP) is likely to report revenue decline of
M. Cap. (INR b)/(USD b) 111 / 2
52-Week Range (INR) 406 / 211
5% YoY, with demonetization impacting demand for ACs. As 3Q is
1,6,12 Rel Perf. (%) 9/7/5
usually a lean quarter for AC sales, the impact would be limited.
We expect revenue decline of 10% YoY in the MEP segment, led
by high base effect (56% YoY growth in 3QFY16). However, the
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E key monitorable would be margins in the segment. VOLT had
Net Sales 58.6 58.9 65.6 73.9 booked a loss of INR86m in 3QFY16 on cost overrun getting
EBITDA 4.4 4.7 5.3 6.8 booked for the UAE project, while the acceleration claim is yet to
Adj PAT 3.9 3.9 4.6 5.8 be booked.
EPS(INR) 11.7 11.8 14.0 17.6
Sharp decline in crude prices has raised apprehensions over the
EPS Gr. (%) 14.0 1.2 19.1 25.3
BV/Sh. (INR) 72.4 80.8 90.8 103.4
pace of order awards and also execution in the Middle East. Even
RoE (%) 15.3 15.4 16.4 18.1 in the domestic market, new project awards remain constrained.
RoCE (%) 14.8 14.6 15.3 16.7 Maintain Buy.
Payout (%) 28.6 28.6 28.6 28.6
Valuations
P/E (x) 32.1 26.4 22.2 17.7
P/BV (x) 4.6 3.9 3.4 3.0 Key issues to watch
EV/EBITDA (x) 25.5 21.2 18.5 14.1 Impact of demonetization scheme on the sales of UCP division
Div Yield (%) 0.8 0.9 1.1 1.4 and outlook for FY18.
Progress on legacy projects and also capital employed in MEP
business.
January 2017 87
December 2016 Results Preview
Cement
Demonetization affects demand recovery
Company name
Volume growth to be muted; prices under pressure
ACC
We expect double-digit YoY volume decline in December, led by high base and
demonetization. However, there should be marginal improvement MoM. We expect
all-India volume to decline 1% YoY in 3QFY17. MOSL cement universe is likely to see
volume decline of 0.9% YoY (+ 2.6% QoQ). We expect (a) pan-India players to report
volume decline of 4-8% YoY, (b) players with capacity headroom (SRCM, JK LC) to
deliver 2-5% YoY increase in volumes, (c) South-based companies to deliver
15%+YoY growth due to lesser impact of demonetization as also low base.
Top picks include Shree Cement, Ramco Cement and Dalmia Cement
The steep ask rate in terms of realization growth should result in a time correction
for cement stocks. We believe this could be an attractive entry opportunity for
stocks with strong operating cash flows, superior return ratios and higher medium-
to-longer-term earnings visibility. We prefer Shree Cement due to superior return
ratios – RoCE of 30%, with 38% EBITDA CAGR over FY16-18. Ramco Cement is likely
to generate free annual cash flows of INR7b-8b, given strong profitability; it
generates a yield of 6-7%. Dalmia Cement trades at an attractive EV/EBITDA of 9.3x
FY18E, given strong earnings growth on sustenance of profitability and lower
interest cost.
Exhibit 1: Expected quarterly performance summary
Sector Sales (INR M) EBDITA (INR M) PAT (INR M)
CMP Var % Var % Var % Var % Var % Var %
RECO Dec-16 Dec-16 Dec-16
(INR) YoY QoQ YoY QoQ YoY QoQ
Cement
ACC 1,320 Neutral 26,566 -6.7 7.5 1,880 -13.0 -16.3 583 -43.2 -30.7
Ambuja Cements 212 Buy 21,800 -7.5 8.8 2,664 -12.4 -3.5 1,612 10.9 -41.8
Grasim Industries 867 UR 24,792 7.2 -0.4 5,238 22.1 -1.2 3,701 42.2 -37.5
India Cements 122 Neutral 11,919 28.2 -8.8 2,011 37.6 -10.4 481 780.8 -22.9
Ramco Cements 575 Buy 9,264 14.1 -8.5 2,627 7.4 -24.8 1,409 19.7 -31.9
Shree Cement 14,131 Buy 18,879 3.3 -5.9 4,941 16.5 -24.7 2,592 151.8 -11.1
Ultratech Cement 3,299 Buy 53,435 -7.0 -1.0 9,634 -7.7 -11.9 5,078 -0.2 -15.5
Cement Sector Aggregate 166,654 -1.0 -0.1 28,995 3.3 -13.6 15,457 24.3 -26.9
UR: Under Review Source: MOSL
16.9
9.3
8.9
8.3
6.3
42
5.7
42
5.5
5.1
3.7
3.2
42
2.5
1.8
1.6
1.6
1.2
0.4
-0.9
-1.3
-5.0
39 36 38 39 37 38 44 43 39 40 43 40 42 49 47 41
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17E
78
78
76
76
73
73
72
71
71
71
70
72
70
68
68
67
67
66
65
65
65
65
65
65
65
337
331
330
299
298
298
296
296
295
293
293
291
288
285
282
280
278
270
3QFY11
1QFY12
3QFY12
1QFY13
3QFY13
1QFY14
3QFY14
1QFY15
3QFY15
1QFY16
3QFY16
1QFY17
3QFY17E
(INR/bag)
January 2017 89
December 2016 Results Preview | Sector: Cement
Exhibit 5: MOSL coverage realization to decline 2% QoQ in Exhibit 6: Profitability to decline 15% QoQ, led by weak
3QFY17 volume and lower operating leverage
Realization (INR/ton) EBITDA (INR/ton)
4,339
4,307
4,294
4,269
4,229
4,226
4,223
4,200
4,179
4,176
4,147
4,100
1,010
4,028
4,017
4,000
3,989
3,962
3,960
3,946
3,873
3,841
966
3,777
948
3,617
857
3,566
837
833
814
806
806
793
788
3,220
759
750
747
728
724
717
714
705
683
681
498
489
566
570
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17E
3QFY11
4QFY11
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17E
Source: Company, MOSL Source: Company, MOSL
Exhibit 7: Relative performance— 3 months (%) Exhibit 8: Relative performance— 1 year (%)
Sensex Index MOSL Cement Index Sensex Index MOSL Cement Index
107 149
98 133
117
89
101
80 85
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
January 2017 90
December 2016 Results Preview | Sector: Cement
January 2017 91
December 2016 Results Preview | Sector: Cement
ACC
Bloomberg ACC IN CMP: INR1320 TP: INR1,321 (+0%) Neutral
Equity Shares (m) 188.0
Dispatches in 4QCY16 are estimated at 5.48mt (-9% YoY). Average
M. Cap. (INR b)/(USD b) 307 / 5
52-Week Range (INR) 1,738/1,173
realizations are expected to be lower by 2% QoQ (-1% YoY) at
1,6,12 Rel Perf. (%) -1/4/12
INR4285/ton due to weak realization in East and North markets.
January 2017 92
December 2016 Results Preview | Sector: Cement
Ambuja Cements
Bloomberg ACEM IN
CMP: INR212 TP: INR246 (+15%) Buy
Equity Shares (m) 1,551.9
Dispatches in 3QCY16 are estimated to decline 7.1% YoY to 5.1mt.
M. Cap. (INR b)/(USD b) 402 / 6
52-Week Range (INR) 282/185
Average realizations are expected to remain flat YoY (-2.1% QoQ) at
1,6,12 Rel Perf. (%) -5/-2/16
INR4,284/ton. Revenue is estimated at INR21.8b (-7.5% YoY).
Quarterly Performance
Y/E December CY15 CY16 CY15 CY16E CY17E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4QE
Sales Volume (m ton)* 5.43 5.95 4.90 5.48 5.97 5.85 4.58 5.09 21.76 21.49 22.02
YoY Change (%) -10.4 1.8 1.9 0.8 9.9 -1.7 -6.5 -7.1 -1.8 -1.2 2.5
Realization (INR/ton) 4,465 4,190 4,277 4,300 4,053 4,344 4,376 4,284 4,306 4,256 4,456
YoY Change (%) 2.6 -9.5 -6.0 -1.8 -9.2 3.7 2.3 -0.4 -3.8 -1.2 4.7
QoQ Change (%) 2.0 -6.2 2.1 0.5 -5.7 7.2 0.7 -2.1
Net Sales 24,246 24,928 20,952 23,558 24,183 25,412 20,043 21,800 93,683 91,438 98,128
YoY Change (%) -8.1 -7.9 -4.2 -1.0 -0.3 1.9 -4.3 -7.5 26.8 7.5 1.4
EBITDA 4,715 3,661 2,944 3,042 4,235 5,813 2,760 2,664 14,362 15,472 17,285
Margins (%) 19.4 14.7 14.1 12.9 17.5 22.9 13.8 12.2 15.3 16.9 17.6
Depreciation 1,578 1,485 1,553 1,641 1,477 1,511 1,595 1,587 6,257 6,170 6,140
Interest 214 316 207 181 182 205 192 185 918 763 625
Other Income 1,336 1,234 898 1,067 1,415 1,368 2,503 1,114 4,535 6,400 7,800
PBT before EO Item 4,259 3,094 2,082 2,287 3,992 5,465 3,477 2,006 11,722 14,939 18,320
Rate (%) 25.4 26.8 26.2 36.4 27.7 26.9 20.3 19.6 27.7 24.7 25.0
Reported Profit 3,177 2,264 1,536 1,100 3,038 3,995 2,770 1,612 8,076 11,415 13,740
Adj PAT 3,177 2,264 1,536 1,454 2,885 3,995 2,770 1,612 8,478 11,256 13,740
YoY Change (%) -29.0 -44.6 -35.8 -43.2 -9.2 76.5 80.4 10.9 -35.8 32.8 22.1
E: MOSL Estimates
January 2017 93
December 2016 Results Preview | Sector: Cement
Grasim Industries
Bloomberg GRASIM IN CMP: INR867 Under review
Equity Shares (m) 93.4
We expect VSF volumes to grow 2% YoY (-1% QoQ) to 123,114 tons
M. Cap. (INR b)/(USD b) 458 / 7
in 3QFY17, while realizations are expected to improve 3.9% YoY
52-Week Range (INR) 5,349/3,242
1,6,12 Rel Perf. (%) 7/15/31
(0.2% QoQ) to INR130,963/ton. We expect Chemicals volumes to
decline 5%YoY. Standalone revenues likely to increase 7%YoY to
INR24.8bn.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
Standalone EBITDA margin is estimated at 21.1%, +2.6pp YoY
Sales 365.9 371.8 403.5 447.1 (-0.2pp QoQ).
EBITDA 60.2 73.4 87.8 103.0
Adj. PAT 22.6 35.5 41.4 53.0 EBITDA is estimated to de-grow 1.2% QoQ (+ 22% YoY) to INR5.24b,
Adj. EPS (INR) 241.7 76.1 88.7 113.4 translating into PAT of INR3.7b (+42.2% YoY).
EPS Gr. (%) 26.8 57.5 16.6 27.8
BV/Sh. (INR) 2,767 624.2 708.0 816.4 The stock trades at 9.8x FY18E consolidated EPS, 6.8x FY18E
RoE (%) 9.2 12.9 13.3 14.9 EV/EBITDA, and implied cement EV/ton of USD103.
RoCE (%) 10.0 12.8 14.1 16.4
Key issues to watch out for
Payout (%) 11.0 6.9 5.6 4.4
Pick-up in cement demand and pricing thereon.
Valuations
Outlook on VSF business, and strategy to utilize upcoming
P/E (x) 17.9 11.4 9.8 7.6
capacities globally.
P/BV (x) 1.6 1.4 1.2 1.1
EV/EBITDA (x) 10.2 8.5 6.8 6.3
Impact of demonetization on caustic soda demand
EV/Ton (x) 125 105 103 98
January 2017 94
December 2016 Results Preview | Sector: Cement
India Cements
Bloomberg ICEM IN
CMP: INR122 TP: INR118 (-3.2%)) Neutral
Equity Shares (m) 307.2
M. Cap. (INR b)/(USD b) 46 / 1 India Cements’ volumes are expected to grow 16% YoY to 2.25mt in
52-Week Range (INR) 156/64 3QFY17 on account of low base and higher infrastructure spend in
1,6,12 Rel Perf. (%) 0/59/76 A.P and Telangana due to creation of new state. We expect
realizations to grow 11% YoY (flat QoQ) to INR5,259/ton. Revenue
Financial Snapshot (INR Billion) is estimated at INR11.9b (+28.2% YoY, -9% QoQ).
Y/E March 2016 2017E 2018E 2019E
Sales 42.3 51.9 54.2 62.1 EBITDA is estimated at INR2.01b, and EBITDA margin is likely to
EBITDA 7.7 8.9 9.1 9.9 decline 0.3pp QoQ to 16.9%, translating into blended EBITDA/ton
NP 1.4 2.7 3.0 3.4 of INR895 (+INR140 YoY). PAT is expected at INR481m (v/s INR55m
Adj. EPS (INR) 4.4 8.9 10.6 12.7 in 3QFY16).
EPS Gr. (%) -11,446 103.5 18.2 20.0
BV/Sh (INR) 118.8 126.2 134.8 145.9 Valuations stand at 11.5x FY18E EPS and 6.7x FY18E EBITDA. The
RoE (%) 3.9 7.0 7.4 8.0 stock trades at US$ D65/t on FY18 replacement cost. Maintain
RoCE (%) 5.9 7.2 7.5 8.1 Neutral.
Payout (%) 25.9 13.5 12.0 0.0
Valuations Key issues to watch out for
P/E (x) 27.7 13.6 11.5 9.6
Visibility on AP demand recovery.
P/BV (x) 1.0 1.0 0.9 0.8
Demand, especially in South India, post demonetization.
EV/EBITDA(x) 8.6 7.1 6.7 6.0
EV/Ton (USD) 67 65 65 64
Pricing outlook in South India.
January 2017 95
December 2016 Results Preview | Sector: Cement
Ramco Cements
Bloomberg TRCL IN
CMP: INR575 TP: INR698 (+21%) Buy
Equity Shares (m) 238.0
M. Cap. (INR b)/(USD b) 146 / 2
3QFY17 volumes are estimated to grow 19% YoY (decline 5% QoQ) to
52-Week Range (INR) 623/327
1.93mt on account of low base as also higher volumes to eastern
1,6,12 Rel Perf. (%) 11/41/75 market. Average realizations are expected to decline 5.6% YoY (flat
QoQ) to 4,769/ton due to firm realizations in southern market.
Financial Snapshot (INR Billion)
EBITDA margin is likely to decline 6.1pp QoQ to 28.4%. EBITDA/ton
Y/E MARCH 2016 2017E 2018E 2019E
(ex-windmill) is estimated at INR1,376 (-INR150 QoQ, -INR149 YoY)
Sales 35.9 39.9 44.2 51.1 due to partial increase in power and fuel cost.
EBITDA 10.5 12.3 14.0 16.8
NP 5.6 7.0 7.5 10.1
Interest cost is likely to decline 35%YoY due to debt repayment as also
Adj EPS (INR) 23.4 29.4 31.5 42.3 re pricing of debt at lower rate.
EPS Gr. (%) 130.3 25.5 6.9 34.4
BV/Sh. (INR) 129.9 155.8 182.6 220.3 PAT is estimated to increase 20% YoY to INR1.4b.
RoE (%) 19.5 20.6 18.6 21.0
RoCE (%) 13.2 14.5 14.3 17.3 The stock trades at 18.3x FY18E EPS, 10.2x FY18E EBITDA, and FY18E
Payout (%) 14.9 11.8 14.8 11.0 EV/ton of USD131. Maintain Buy.
Valuations
P/E (x) 24.5 19.5 18.3 13.6
Key issues to watch out for
EV/EBITDA (x) 14.9 12.3 10.2 8.0
EV/Ton (USD) 149 138 131 123
Volume growth recovery and outlook.
Cement pricing outlook and demand sustainability in South (AP and
Tamil Nadu).
January 2017 96
December 2016 Results Preview | Sector: Cement
Shree Cement
Bloomberg SRCM IN CMP: INR14,131 TP: INR17,096 (+21%) Buy
Equity Shares (m) 34.8
We expect 3QFY17 cement volumes to grow 4.7% YoY (and 7.7%
M. Cap. (INR b)/(USD b) 626 / 9
QoQ) to 4.92mt (including clinker) led by ramp up of new capacity
52-Week Range (INR) 18,519/9,350
1,6,12 Rel Perf. (%) 5/34/42
in eastern market. Realizations to decline 5% QoQ to INR3,765/ton
due to weak realization in its focus markets of North and East.
Financial Snapshot (INR Billion)
Merchant power sale is expected to be meaningfully lower at 100m
Y/E March 2016 2017E 2018E 2019E
units (v/s 538m units in 2QFY17) due to shrp decline in merchant
Sales 72.9 84.3 98.9 112.1 power rates. Power EBITDA is estimated at INR20m (v/s INR622m
EBITDA 16.7 24.1 30.5 36.3
in 2QFY17).
NP 5.9 13.7 20.3
25.3
Adj EPS (INR) 168.0 394.3 582.0 725.4
Revenue is estimated at INR18.88b (+11% YoY) and EBITDA at
EPS Gr. (%) 26.1 96.1 47.6 24.6
INR4.9b, translating into margin of 26.2% (-6.5pp QoQ, +1.14pp
BV/Share (INR) 1,774 2,128 2,663 3,342
YoY). Adjusted PAT is likely to be INR2.6b (v/s INR2.2b in 3QFY16).
RoE (%) 10.2 20.2 24.3 24.2
RoCE (%) 10.6 19.8 23.4 23.7 Valuations stand at 24.3x FY18E EPS, 14.1x FY18E EBITDA, and
Payout (%) 17.4 10.3 8.0 6.4 FY18E EV/ton of USD211. Maintain Buy.
Valuation
P/E (x) 70.3 35.8 24.3 19.5
P/BV (x) 8.0 6.6 5.3 4.2 Key issues to watch out for
EV/EBITDA (x) 27.9 19.0 14.1 11.2 Volume and pricing recovery for North India.
EV/Ton (USD) 267 240 211 174 Update on scale-up of recently commissioned units in East.
New expansion plan.
January 2017 97
December 2016 Results Preview | Sector: Cement
UltraTech Cement
Bloomberg UTCEM IN CMP: INR3,299 TP: INR3,749 (+14%) Buy
Equity Shares (m) 274.4
3QFY17 cement volumes are estimated to de-grow 5.1% YoY (flat
M. Cap. (INR b)/(USD b) 1,077 / 16
QoQ) to 10.88mt due to lower demand in North and West markets.
52-Week Range (INR) 4,130/2,581
1,6,12 Rel Perf. (%) -3/11/34
Realizations are estimated to de-grow 1.4% YoY (and 1.9% QoQ) to
INR4,081/ton.
Financial Snapshot (INR Billion)
We estimate grey cement EBITDA/ton at INR873 (-INR119 QoQ) due
Y/E March 2016 2017E 2018E 2019E
to weak realizations. EBITDA margin is expected to decrease 2.2pp
Sales 238.4 232.5 264.0 295.5
QoQ (and 0.1pp YoY) to 20.3%.
EBITDA 43.5 47.2 61.6 71.9
NP 21.7 26.0 37.0 46.2
EBITDA is estimated to decline 12% QoQ (and 8% YoY) to INR10.9b,
Adj EPS(INR) 79.3 94.6 134.8 168.4
translating into PAT de-growth of 16% QoQ to INR5.1b.
EPS Gr. (%) 7.9 19.3 42.5 24.9
BV/Sh (INR) 755.8 838.8 956.2 1,101.3 The stock trades at 24.5x FY18E EPS, 13.5x FY18E EV/EBITDA, and
RoE (%) 11.0 11.9 15.0 16.4 FY18E EV/ton of USD186. Maintain Buy.
RoCE (%) 9.3 10.2 12.7 14.0
Payout (%) 13.9 12.3 12.9 13.8
Valuation Key issues to watch out for
P/E (x) 41.6 34.9 24.5 19.6 Volume growth recovery and outlook.
P/BV (x) 4.4 3.9 3.5 3.0 Cement pricing outlook and sustainability.
EV/EBITDA (x) 20.5 18.4 13.5 10.8 Update on scale-up of newly commenced Rajasthan plant.
EV/Ton (USD) 200 195 186 175
January 2017 98
December
December 2016 2016 Results
Results Preview Preview
| Consumer
Consumer
Company name Demonetization dents monsoon recovery narrative
Asian Paints Sales likely to decline, resulting in adverse margin effect
Britannia Industries
Discretionary demand likely to suffer
Colgate
We expect our consumer universe’s revenues to remain flat YoY in 3QFY17, with a
Dabur
PAT decline of 1.2%. Demonetization is likely to affect all companies, particularly
Emami those selling products with discretionary demand and having higher proportion of
Godrej Consumer wholesale trade vis-à-vis direct distribution. Hopes of rural demand recovery after
GSK Consumer good monsoon this year were dashed due to demonetization-led cash crunch.
MOSL consumer universe EBITDA is likely to decline 4.5% YoY, with 110bp margin
Hindustan Unilever
contraction. Barring Nestle (likely flat margins YoY), we expect a YoY margin decline
ITC
for all FMCG companies under our coverage due to weak sales growth/sales decline
Jyothy Labs and increasing cost for a few commodities. Adspends, which could have acted as a
Marico buffer to margins, are unlikely to decline steeply enough to protect margin. We
Nestle India expect ITC’s sales to decline 4% YoY (led by a 7% decline in cigarette volumes) and
PAT to fall 3% YoY. HUVR’s sales growth is estimated at 1.5% YoY (volume decline of
Page Industries
1%), with 100bp EBITDA margin contraction. Barring PAGE, for which we expect 13%
Parag Milk Foods
PAT growth YoY, none of the other companies are expected to report any material
Pidilite Industries growth in PAT (11 out of the 18 companies under our coverage expected to report
P&GHH YoY decline in PAT).
Radico K haitan
RM costs, promotions and new launches
United Breweries
PFAD and palm oil prices increased steeply by 70% and 37% YoY, respectively, while
United Spirits
Ti02 and mentha prices saw moderate increases of 4% YoY and 3% YoY,
respectively. Mentha prices over past 20 days are up by 10% YoY, however. LLP and
HDPE prices still remain benign, with low-single-digit growth YoY. Some companies
have started taking selective price hikes/grammage reduction/reduction of offers
following increase in raw material costs. However, promotion intensity remains high
in other categories owing to the weak operating environment. Thus, majority of new
launches are likely to be postponed to 1QFY18.
Sensex Index MOSL Consumer Index Sensex Index MOSL Consumer Index
102
115
99
105
96
93 95
90 85
Nov-16
Dec-16
Sep-16
Oct-16
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Exhibit 5: PFAD prices up 70.5% YoY and 12.6% QoQ Exhibit 6: Palm oil prices rise 36.7% YoY and 12.3% QoQ
Palm Fatty Acid price (INR/MT) Palm Oil (Malaysian Ringgit Per Metric Tonne)
46,904 3,500
3,199
Malaysian Ringgit\ MT
42,000 3,000
33,000 2,500
24,000 2,000
15,000 1,500
Apr-14
Dec-13
Aug-14
Apr-15
Dec-14
Aug-15
Apr-16
Dec-15
Aug-16
Dec-16
Apr-14
Dec-13
Aug-14
Apr-15
Dec-14
Aug-15
Apr-16
Dec-15
Aug-16
Dec-16
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
Exhibit 7: Mentha prices up 2% YoY and 3% QoQ Exhibit 8: TiO2 prices up 3.7% YoY and 1.6% QoQ
750 190
500 150
Jun-14
Jun-15
Jun-16
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Apr-14
Dec-13
Aug-14
Apr-15
Dec-14
Aug-15
Apr-16
Dec-15
Aug-16
Dec-16
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
Asian Paints
Bloomberg APNT IN CMP: INR906 TP: INR1,020 (13%) Neutral
Equity Shares (m) 959.2
We expect Asian Paints’ (APNT) revenue to grow 5% to INR40.3b in
M. Cap. (INR b)/(USD b) 869 / 13
3QFY17, with ~6% rise in domestic decorative volumes.
52-Week Range (INR) 1230 / 825
1,6,12 Rel Perf. (%) -4 / -7 / -1 We note crude prices are up 18% YoY in 3QFY17. The magnitude of
price movement in crude derivatives is lower vis-à-vis crude prices.
Financial Snapshot (INR b) Operating margin should contract 150bp to 18.9% in 3QFY17. We
Y/E March 2016 2017 2018E 2019E estimate 3.6% PAT decline for 3QFY17.
Sales 142.8 153.4 172.2 198.9
EBITDA 27.7 29.6 32.8 37.9
The stock trades at 40x FY18E EPS of INR22.6; maintain Neutral.
Adj. PAT 18.0 19.3 21.7 25.3
Adj. EPS.INR 18.7 20.2 22.6 26.4
EPS Gr. (%) 26.3 7.7 12.2 16.7
BV/Sh.(INR) 58.4 66.2 75.4 88.3
RoE (%) 34.7 32.4 32.0 32.3
RoCE (%) 30.6 29.0 28.9 29.4
Payout (%) 40.4 49.6 50.8 43.6
Key issues to watch for
Valuations
Volume growth trends and demand scenario in urban/rural
P/E (x) 48.4 44.9 40.0 34.3
geographies.
P/BV (x) 15.5 13.7 12.0 10.3
EV/EBITDA (x) 30.6 28.5 25.5 21.9
Demand outlook for industrial paints.
Div. Yield (%) 1.0 1.3 1.5 1.5 Outlook for raw materials/pricing actions.
Britannia Industries
Bloomberg BRIT IN CMP: INR2,851 TP: INR3,380 (+19%) Buy
Equity Shares (m) 120.0
We estimate Britannia’s (BRIT) sales to decline 6% YoY to INR20.2b,
M. Cap. (INR b)/(USD b) 342 / 5
with ~5% volumes decline.
52-Week Range (INR) 3575 / 2507
1,6,12 Rel Perf. (%) -8 / 3 / -8 Sales decline, coupled with higher wheat and sugar prices YoY, will
affect margins. We expect 200bp contraction in operating margin
Financial Snapshot (INR b) YoY. We expect EBITDA and PAT to decline 19.1% and 19.5%,
Y/E March 2016 2017E 2018E 2019E respectively.
Sales 83.3 88.3 104.0 120.9
EBITDA 11.5 11.5 13.4 15.9 The stock trades at 34.7x FY18E EPS of INR82.1; maintain Buy.
Adj. PAT 8.4 8.5 9.9 11.7 Britannia is one of our top picks in the tier-II consumer space.
Adj. EPS. INR 70.1 70.6 82.1 97.8
EPS Gr. (%) 46.3 0.8 16.3 19.1
BV/Sh.(INR) 147.2 187.1 235.8 293.8
RoE (%) 55.9 42.2 38.8 36.9
RoCE (%) 46.0 34.4 32.1 30.9
Payout (%) 28.5 35.0 35.0 35.0
Valuations
Key issues to watch for
P/E (x) 40.7 40.4 34.7 29.1
Volume growth in biscuits.
P/BV (x) 19.4 15.2 12.1 9.7
EV/EBITDA (x) 29.0 28.9 24.4 20.2
Outlook for raw materials.
Div. Yield (%) 0.7 0.9 1.0 1.2 Performance of subsidiaries.
Colgate
Bloomberg CLGT IN CMP: INR895 TP: INR1,200 (+34%) Buy
Equity Shares (m) 272.0
We expect Colgate’s (CLGT) sales to grow 7.5% YoY to INR10b.
M. Cap. (INR b)/(USD b) 244 / 4
Toothpaste volume growth is likely to be ~2%.
52-Week Range (INR) 1033 / 788
1,6,12 Rel Perf. (%) -4 / -1 / -12 We estimate gross margin expansion of 30bp and EBITDA margin
Financial Snapshot (INR b) contraction of 80bp to 24.1%. Hence, we have modeled EBITDA
Y/E March 2016 2017E 2018E 2019E growth of 3.9% and adjusted PAT growth of 3.5% in 3QFY17.
Sales 38.0 41.3 46.7 53.0 The stock trades at 32.9x FY18E EPS of INR27.2; we have Buy rating
EBITDA 9.5 10.0 12.0 14.3 on the stock.
Adj. PAT 6.1 6.1 7.4 9.0
Adj. EPS (INR) 22.3 22.3 27.2 32.9
EPS Gr. (%) 8.7 -0.4 22.4 20.9
BV/Sh.(INR) 37.5 41.6 44.6 48.8
RoE (%) 67.9 56.3 63.2 70.5
RoCE (%) 67.0 55.2 62.0 69.4
Payout (%) 49.1 70.0 70.0 70.0 Key issues to watch for
Valuations Volume growth in toothpaste and market share movement.
P/E (x) 40.1 40.2 32.9 27.2 Ad spends and competitive intensity in toothpaste, especially from
P/BV (x) 23.9 21.5 20.1 18.4 Patanjali.
EV/EBITDA (x) 25.4 24.1 19.8 16.5
Div. Yield (%) 1.2 1.7 2.1 2.6
Dabur
Bloomberg DABUR IN CMP: INR277 TP: INR300 (+8%) Neutral
Equity Shares (m) 1761.5
We expect sales to grow 2% YoY to INR19.9b, led by ~5% domestic
M. Cap. (INR b)/(USD b) 487 / 7
organic volume growth.
52-Week Range (INR) 320 / 231
1,6,12 Rel Perf. (%) -4 / -8 / -4 We expect Dabur’s EBITDA margin to contract 150bp.
Emami
Bloomberg HMN IN CMP: INR1,031 TP: INR1,240 (+20%) Buy
Equity Shares (m) 227.0
We project Emami’s (HMN) sales to grow 5% YoY to INR7.6b, with
M. Cap. (INR b)/(USD b) 234 / 3
~1% volume growth.
52-Week Range (INR) 1261 / 901
1,6,12 Rel Perf. (%) -1 / -6 / 0 We expect gross margin to contract 50bp to 66.1% and EBITDA
margin to contract 100bp to 33.4%. Thus, EBITDA is likely to increase
Financial Snapshot (INR b) 1.9% YoY to INR2.5b.
Y/E March 2016 2017E 2018E 2019E
PAT is expected to decline 6.8% YoY to INR1.8b due to low tax rate of
Sales 23.9 25.9 29.7 34.4
EBITDA 6.8 7.6 8.8 10.3
14.1% in the base quarter.
NP 5.7 5.6 6.9 8.4 The stock trades at 33.7x FY18E EPS of INR30.6; maintain Buy.
EPS (INR) 25.2 24.7 30.6 37.1 Emami remains one of our preferred ideas.
EPS Gr. (%) 17.7 -1.9 23.6 21.3
BV/Sh. (INR) 61.8 83.1 98.7 120.9
RoE (%) 43.4 34.1 33.6 33.8
RoCE (%) 37.9 31.4 35.3 39.1
Payout (%) 27.9 44.5 39.3 32.4
Key issues to watch for
Valuations
P/E (x) 40.9 41.7 33.7 27.8
Volume growth and broad consumer demand across categories.
P/BV (x) 16.7 12.4 10.4 8.5
Outlook for mentha oil prices.
EV/EBITDA (x) 35.0 31.0 26.4 22.0 Competitive intensity, especially from Patanjali.
Div. Yld (%) 0.8 1.1 1.2 1.2 Performance of re-launches this year.
Godrej Consumer
Bloomberg GCPL IN CMP: INR1,532 TP: INR1,655 (+8%) Neutral
Equity Shares (m) 340.5
We expect Godrej Consumer’s revenue to rise 10% YoY to INR25.1b.
M. Cap. (INR b)/(USD b) 522 / 8
52-Week Range (INR) 1710 / 1120 Demand trends in international business remain weak, primarily
1,6,12 Rel Perf. (%) 3 / -4 / 11 driven by macroeconomic trends.
GSK Consumer
Bloomberg SK B IN CMP: INR5,058 TP: INR5,465 (+8%) Neutral
Equity Shares (m) 42.1
We expect GSK Consumer to report net sales of INR9.5b (-3% YoY)
M. Cap. (INR b)/(USD b) 213 / 3
led by 2% volume decline in MFD. In our view, discretionary
52-Week Range (INR) 6675 / 4650
demand in core MFD category is yet to witness an uptrend.
1,6,12 Rel Perf. (%) 0 / -15 / -26
We estimate EBITDA margin to contract 20bp YoY to 16.6%, and
Financial Snapshot (INR b) PAT growth of 1.8% YoY.
Y/E December 2016 2017E 2018E 2019E
Sales 41.9 40.2 45.0 51.3 The stock trades at 28.3x FY18E EPS. We have a Neutral rating on
EBITDA 9.4 8.4 9.5 10.9 the stock.
Adj. PAT 7.0 6.6 7.5 8.5
Adj. EPS (INR) 167.1 157.7 178.8 201.2
EPS Gr. (%) 20.4 -5.6 13.4 12.6
BV/Sh. (INR) 581.5 673.6 774.4 774.4
RoE (%) 30.8 25.1 24.7 24.7
RoCE (%) 30.8 25.2 24.7 24.7
Payout (%) 33.7 35.0 40.0 40.0
Valuations Key issues to watch for
P/E (x) 30.3 32.1 28.3 25.1 Growth in MFD volume.
P/BV (x) 8.6 7.4 6.5 6.5 Outlook for market growth and raw materials.
EV/EBITDA (x) 20.1 24.8 21.5 21.5 Performance of non-MFD portfolio.
Div. Yield (%) 1.1 1.1 1.3 1.3 Competitive intensity, especially from Patanjali.
Hindustan Unilever
Bloomberg HUVR IN CMP: INR821 TP: INR900 (+10%) Neutral
Equity Shares (m) 2163.5
We expect Hindustan Unilever’s revenue to grow 1.5%, with
M. Cap. (INR b)/(USD b) 1776 / 26
underlying ~1% volume decline.
52-Week Range (INR) 954 / 765
1,6,12 Rel Perf. (%) -4 / -6 / -8 PFAD prices have gone up by 70% YoY in 3QFY17 of a low base and
LAB prices are up 3% YoY.
Financial Snapshot (INR b)
We expect operating margin to contract 100bp YoY to 17.4% in
Y/E March 2016 2017E 2018E 2019E
Sales 305.0 315.3 345.1 386.4
3QFY17.
EBITDA 57.3 59.1 67.0 76.9 We estimate EBITDA decline of 4% YoY, but expect PAT to grow
Adj. PAT 41.2 42.7 48.5 55.8 1.9% YoY. The stock trades at 36.6x FY18E EPS of INR22.4; maintain
Adj. EPS (INR) 19.0 19.7 22.4 25.8 Neutral.
EPS Gr. (%) 12.9 3.6 13.7 15.0
BV/Sh.(INR) 29.0 28.5 28.3 29.1
RoE (%) 82.4 68.7 79.1 89.8
RoCE (%) 108.1 89.3 103.2 117.8
Payout (%) 84.0 96.3 91.4 87.2
Valuations
Key issues to watch for
P/E (x) 43.1 41.6 36.6 31.8
Comments on volume growth and consumer demand
P/BV (x) 28.3 28.9 29.0 28.2
environment.
EV/EBITDA (x) 30.5 29.5 26.0 22.6
Div. Yield (%) 1.9 2.3 2.5 2.7
Competitive intensity in S&D and shampoos.
ITC
Bloomberg ITC IN CMP: INR245 TP: INR290 (+19%) Buy
Equity Shares (m) 12070.8
We expect net sales to decline 4% YoY to INR88.1b, with cigarette
M. Cap. (INR b)/(USD b) 2954 / 43
volume declining 7% YoY (base quarter saw volume decline of 5%).
52-Week Range (INR) 266 / 179
1,6,12 Rel Perf. (%) 4/2/9 We expect cigarette EBIT to decline 7.6% YoY. We have factored in
EBITDA decline of 6.4% YoY to INR33.7b for the company.
Financial Snapshot (INR b)
We expect Other FMCG to post revenue decline of ~8% YoY.
Y/E March 2016 2017E 2018E 2019E
Sales 362.2 382.9 426.2 484.0 We estimate PAT decline of 3% YoY to INR25.8b.
EBITDA 137.2 142.2 162.4 187.3 The stock trades at 25.6x FY18E EPS of INR9.6; maintain Buy.
Adj. PAT 93.1 101.0 115.5 132.5
Adj. EPS (INR) 7.7 8.4 9.6 11.0
EPS Gr. (%) -3.5 8.5 14.3 14.6
BV/Sh.(INR) 27.3 31.6 36.1 40.8
RoE (%) 29.3 28.4 28.3 28.5
RoCE (%) 27.8 27.3 27.6 28.3
Payout (%) 88.4 64.4 64.4 64.4
Valuations
P/E (x) 31.7 29.2 25.6 22.3 Key issues to watch for
P/BV (x) 9.0 7.7 6.8 6.0 Trends in cigarette volume.
EV/EBITDA (x) 20.1 19.3 16.6 14.2 Demand outlook for FMCG category and segmental profitability.
Div. Yield (%) 2.8 2.2 2.5 2.9
Jyothy Labs
Bloomberg JYL IN CMP: INR335 TP: INR360 (+7%) Neutral
Equity Shares (m) 181.0
We expect Jyothy Labs’ net sales to grow 1% YoY to INR3.8b.
M. Cap. (INR b)/(USD b) 61 / 1
52-Week Range (INR) 381 / 253 EBITDA margin is likely to contract by 150bp YoY to 12.4%.
1,6,12 Rel Perf. (%) -10 / 12 / 4
We have factored in EBITDA decline of 10% YoY to INR468m.
Financial Snapshot (INR b) The stock trades at 22.1x FY18E EV/EBITDA. Speculation around
Y/E March 2016 2017E 2018E 2019E Henkel deal will overshadow fundamentals in FY17, in our view.
Net Sales 16.6 17.4 19.8 22.8 Maintain Neutral.
EBITDA 2.2 2.5 2.8 3.2
Adj PAT 0.7 1.3 1.5 1.8
Adj PAT for NCD 0.1 0.7 0.8 1.1
Adj.EPS (INR) 4.1 7.2 8.5 10.1
EPS Gr. (%) -41.6 75.7 17.8 18.4
BV/Sh (INR) 46.7 49.5 53.5 59.1
RoE (%) 9.1 15.0 16.5 17.9
RoCE (%) 7.2 12.1 13.5 14.5
Valuations
Key issues to watch for
P/E (x) 81.7 46.5 39.5 33.4
Update on new launches and innovations.
P/BV (x) 7.2 6.8 6.3 5.7
EV/EBITDA 29.3 25.9 22.1 19.4
Update on Henkel call option.
Dividend Yield (%) 1.2 1.2 1.2 1.2 Pick-up in Henkel brands’ performance.
Marico
Bloomberg MRCO IN CMP: INR258 TP: INR300 (+16%) Buy
Equity Shares (m) 1289.6
We expect sales to decline 5% YoY to INR14.5b, with flat domestic
M. Cap. (INR b)/(USD b) 332 / 5
volumes. In our opinion, Parachute volumes would likely remain
52-Week Range (INR) 307 / 208
flat, while Saffola and VAHO volumes would decline 1% and 5%,
1,6,12 Rel Perf. (%) 0 / -1 / 10
respectively (Saffola and VAHO volumes grew 17% and 21%,
Financial Snapshot (INR b) respectively, in the base quarter).
Y/E March 2016 2017E 2018E 2019E We observe copra prices have corrected 10% YoY (two months data
Sales 60.1 60.1 70.1 79.7
available for 3QFY17), while kardi oil prices are up 5% YoY. We are
EBITDA 10.4 10.9 13.1 15.2
modeling 100bp YoY gross margin expansion, with 50bp EBITDA
Adj. PAT 7.2 7.7 9.3 11.0
margin contraction for 3QFY17.
Adj. EPS (INR) 5.6 6.0 7.2 8.5
EPS Gr. (%) 26.1 6.4 21.1 17.7 PAT is projected to decline 8% YoY to INR1.9b.
BV/Sh.(INR) 16.3 20.1 23.5 25.5
The stock trades at 35.6x FY18E EPS of INR7.2; maintain Buy. We
RoE (%) 36.9 32.8 33.1 34.8
like MRCO’s franchise, portfolio strength, management quality and
RoCE (%) 31.4 28.7 29.2 30.7
its multiple growth driver models.
Payout (%) 60.2 50.3 44.3 64.6
Valuations Key issues to watch for
P/E (x) 45.9 43.2 35.6 30.3 Comments on volume growth trends across key categories.
P/BV (x) 15.8 12.8 11.0 10.1 Outlook for raw materials.
EV/EBITDA (x) 31.5 29.7 24.6 21.1
Margin expansion and guidance for international business.
Div. Yield (%) 1.3 1.2 1.2 2.1
Nestle India
Bloomberg NEST IN CMP: INR5,893 TP: INR6,410 (+9%) Neutral
Equity Shares (m) 96.4
We expect Nestle India’s net sales to remain flattish YoY at
M. Cap. (INR b)/(USD b) 568 / 8
INR19.4b, despite Maggi sale for part of the base quarter.
52-Week Range (INR) 7390 / 4990
Demonetization is likely to have detrimental on sales. Maggi re-
1,6,12 Rel Perf. (%) -7 / -7 / 0
launch has been successful, with several new variants. It has already
Financial Snapshot (INR b) clawed back to > 57% market share.
Y/E December 2015 2016E 2017E 2018E We estimate EBITDA margin to also stay flattish YoY at 17.9%.
Sales 81.2 88.4 104.5 120.4
EBITDA and PAT are projected to decline 0.5% YoY (to INR3.5b) and
EBITDA 15.9 17.5 21.6 25.8
5.5% YoY (to INR2b), respectively.
Adj. PAT 11.6 10.8 13.4 16.3
Adj. EPS (INR) 119.9 111.5 139.2 168.7 The stock trades at 42.3x CY17E EPS; maintain Neutral.
EPS Gr. (%) -7.3 -7.0 24.8 21.2
BV/Sh.(INR) 292.3 329.3 381.2 460.1
RoE (%) 40.9 35.9 39.2 40.1
RoCE (%) 40.7 35.9 39.2 40.1
Payout (%) 40.5 49.3 46.7 39.1
Valuations
Key issues to watch for
P/E (x) 49.2 52.8 42.3 34.9
Volume trends and management commentary on demand
P/BV (x) 20.2 17.9 15.5 12.8
EV/EBITDA (x) 34.5 31.3 24.8 20.5
environment.
Div. Yield (%) 0.8 0.9 1.1 1.1 Recovery in sales and market share of Maggi.
Page Industries
Bloomberg PAG IN CMP: INR13,782 TP: INR17,100 (+24%) Buy
Equity Shares (m) 11.2
We expect Page to report net sales of INR4.8b, up 9% YoY, led by
M. Cap. (INR b)/(USD b) 154 / 2
double-digit volume growth.
52-Week Range (INR) 17351 / 9770
1,6,12 Rel Perf. (%) 2 / 1 / -2 We expect EBITDA margin to contract 50bp YoY to 20%, and PAT to
post 13.3% YoY growth to INR650m.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
The stock trades at 44.1x FY18E EPS of INR312.7; maintain Buy.
Sales 17.8 21.1 26.1 32.1
EBITDA 3.8 4.2 5.5 6.8
Adj. PAT 2.3 2.8 3.5 4.5
Adj. EPS (INR) 208.6 247.4 312.7 402.4
EPS Gr. % 18.7 18.6 26.4 28.7
FCF to PAT 0.8 0.6 0.6 0.9
BV/Sh.INR 453.0 576.6 733.0 914.1
RoE (%) 46.0 42.9 42.7 44.0
Key issues to watch for
RoCE (%) 42.6 40.2 41.1 45.3
Payout (%) 49.1 50.0 50.0 55.0
Volume trends and management commentary on demand
Valuations environment.
P/E (x) 66.1 55.7 44.1 34.2 Update on foray into kidswear segment.
EV/EBITDA (x) 40.9 36.4 28.1 22.4 GST impact.
Quarterly Performance (INR m) 26% 25% 24% 27% 26% 23% 25%
Y/E MARCH FY16 FY17 FY16 FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Net Sales 4,489 4,663 4,408 4,343 5,719 5,378 4,805 5,160 17,840 21,062
YoY Change (%) 27.4 15.3 9.0 18.8 15.6 18.1
COGS 1,783 1,808 1,653 1,630 2,570 2,156 1,802 1,868 6,913 8,395
Gross Profit 2,705 2,855 2,755 2,712 3,149 3,222 3,003 3,293 10,927 12,667
Gross margin (%) 60.3 61.2 62.5 62.5 55.1 59.9 62.5 63.8 61.2 60.1
Other Expenditure 1,701 1,844 1,852 1,811 2,057 2,147 2,042 2,182 7,150 8,428
% to sales 37.9 39.6 42.0 41.7 36.0 39.9 42.5 42.3 40.1 40.0
EBITDA 1,004 1,011 904 901 1,092 1,075 961 1,111 3,776 4,239
Margins (%) 22.4 21.7 20.5 20.7 19.1 20.0 20.0 21.5 21.2 20.1
YoY Change 8.8 6.3 6.3 23.3 18.5 12.2
Depreciation 56 58 57 69 59 60 51 50 238 221
Interest 50 37 34 36 39 40 40 50 153 170
Other Income 56 9 2 3 59 62 60 61 62 242
PBT 953 926 814 800 1,053 1,037 929 1,072 3,448 4,090
Tax 327 323 241 241 373 350 279 326 1,116 1,328
Rate (%) 34.3 34.9 29.5 30.2 35.5 33.8 30.0 30.5 32.4 32.5
PAT 626 602 574 558 679 687 650 745 2,332 2,762
YoY Change (%) 8.5 14.0 13.3 33.5 19.0 18.4
E: MOSL Estimates
Pidilite Industries
Bloomberg PIDI IN CMP: INR608 TP: INR700 (+15%) Buy
Equity Shares (m) 512.7
We expect Pidilite’s (PIDI) revenue to grow 1% YoY, led by single-
M. Cap. (INR b)/(USD b) 311 / 5
digit volume growth in Consumer and Bazaar segment.
52-Week Range (INR) 770 / 529
EBITDA margin is expected to contract 100bp YoY to 21%. Base
1,6,12 Rel Perf. (%) -5 / -13 / 5
quarter (3QFY16) had witnessed 600bp YoY EBITDA margin
Financial Snapshot (INR b) expansion.
Y/E March 2016 2017E 2018E 2019E We expect EBITDA and PAT to decline 4% and 3% YoY, respectively.
Sales 54.1 55.9 63.7 73.9 The stock trades at 33.1x FY18E EPS of INR18.4; maintain Buy.
EBITDA 12.2 12.5 13.9 15.6 Pidilite is one of our preferred ideas. Dominant leadership position
Adj. PAT 7.6 8.4 9.4 10.6 in core Adhesives segment imparts strong pricing power. This,
Adj. EPS (INR) 14.8 16.4 18.4 20.6 coupled with its strategy of building adjacencies in portfolio and
EPS Gr. (%) 47.3 10.9 12.2 12.3 potential gains from distribution outreach, drives our long-term
BV/Sh.(INR) 54.3 64.3 79.1 96.2 preference for Pidilite.
RoE (%) 29.9 27.6 25.6 23.5
RoCE (%) 28.5 26.1 24.5 22.7
Payout (%) 28.5 29.6 16.3 14.6
Valuations Key issues to watch for
P/E (x) 41.2 37.1 33.1 29.5 Volume growth in Fevicol.
P/BV (x) 11.2 9.5 7.7 6.3 Outlook for VAM prices.
EV/EBITDA (x) 25.0 24.2 21.4 18.6 Outlook for industrial and construction chemical segments.
Div. Yield (%) 0.7 0.8 0.5 0.5 Progress on Elastomer project (if any).
Radico Khaitan
Bloomberg RDCK IN CMP: INR117 TP: INR120 (+3%) Neutral
Equity Shares (m) 132.6
We expect Radico’s (RDCK ) revenue to remain flat at INR4.2b, with
M. Cap. (INR b)/(USD b) 16 / 0
a 5% decline in volumes.
52-Week Range (INR) 151 / 84
1,6,12 Rel Perf. (%) -3 / 27 / -2 The premium segment should continue accelerating, aided by
uptrading (premiumization) and RDCK ’s strategy to defocus on
Financial Snapshot (INR b) regular brands (given the harsh taxation environment and
Y/E March 2016 2017E 2018E 2019E unfavorable raw material scenario).
Sales 16.4 17.0 19.3 21.2
EBITDA 2.1 1.9 2.2 2.4 We expect operating margin to contract 200bp YoY to 11.1%.
Adj. PAT 0.9 0.7 0.9 1.1 PAT is estimated to decline 27.7% YoY to INR163m.
Adj. EPS (INR) 6.9 5.3 7.1 8.2
EPS Gr. (%) 3.9 -23.5 33.8 16.6 The stock trades at 16.6x FY18E EPS of INR7.1. Maintain Neutral.
BV/Sh.(INR) 69.5 74.3 80.1 86.9
RoE (%) 10.3 7.3 9.1 9.9
RoCE (%) 8.6 6.8 7.7 8.1
Payout (%) 10.8 15.0 15.0 15.0
Valuations
P/E (x) 17.0 22.2 16.6 14.2
Key issues to watch for
P/BV (x) 1.7 1.6 1.5 1.3
Further price hikes, if any.
EV/EBITDA (x) 11.4 12.5 11.3 10.2
Div. Yield (%) 0.6 0.7 0.9 1.1
Price trend and outlook for ENA.
United Breweries
Bloomberg UBBL IN CMP: INR796 TP: INR1,065 (+34%) Buy
Equity Shares (m) 264.4
We expect United Breweries’ revenue to decline 2.9% YoY to
M. Cap. (INR b)/(USD b) 211 / 3
INR10.7b.
52-Week Range (INR) 976 / 690
1,6,12 Rel Perf. (%) -8 / 5 / -19 We build in EBITDA margin contraction of 320bp YoY to 12.7%, and
22.5% EBITDA decline YoY to INR1.4b.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
We estimate 5% PAT growth in 3QFY17, mainly due to low interest
Sales 48.3 49.5 57.4 66.0 costs and tax rate compared to the base quarter.
EBITDA 6.8 6.9 8.8 10.6 The stock trades at 48.7x FY18E EPS of INR16.4. Maintain Buy.
PAT 2.9 3.3 4.3 5.2
EPS (INR) 11.1 12.3 16.4 19.7
EPS Gr. (%) 12.8 11.2 32.6 20.4
BV/Sh.(INR) 79.8 90.2 103.9 120.7
RoE (%) 14.8 14.5 16.9 17.5
RoCE (%) 13.2 12.9 14.7 15.5
Valuations
P/E (x) 71.8 64.5 48.7 40.4 Key issues to watch for
P/BV (x) 10.0 8.8 7.7 6.6 Trends in volume growth and margins.
EV/EBITDA (x) 31.7 30.8 24.7 20.2
Price trend and outlook for raw materials.
EV/Sales (x) 4.4 4.3 3.8 3.2
United Spirits
Bloomberg UNSP IN CMP: INR1,952 TP: INR2,620 (+34%) Buy
Equity Shares (m) 145.3
We expect United Spirits’ (UNSP) revenue to decline 5% YoY to
M. Cap. (INR b)/(USD b) 284 / 4
INR22.9b and have built in 10% YoY volume growth.
52-Week Range (INR) 3017 / 1775
1,6,12 Rel Perf. (%) 0 / -23 / -38 We build in EBITDA margin expansion of 350bp YoY to 10.7% (base
quarter margins stood at 7.2%).
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
We estimate PAT of INR1.1b in 3QFY17, mainly due to low interest
Sales 83.4 86.7 98.0 114.2 costs and low tax rate compared to the base quarter.
EBITDA 8.8 9.2 12.4 15.6 Maintain Buy.
PAT 2.4 4.0 6.6 9.0
EPS (INR) 16.7 27.8 45.7 61.7
EPS Gr. (%) LP 66.0 64.5 35.2
BV/Sh.(INR) 123.1 150.9 193.6 252.5
RoE (%) 19.8 20.3 23.6 24.5
RoCE (%) 8.5 10.6 14.4 17.2
Payout (%) 0.0 0.0 5.5 4.0
Valuations Key issues to watch for
P/E (x) 116.7 70.3 42.8 31.6 Trends in volume growth, premiumization and margins.
P/BV (x) 15.9 12.9 10.1 7.7 Price trend and outlook for ENA.
EV/EBITDA (x) 33.7 31.4 22.8 17.9
Impact of ban on alcohol in certain states.
Div. Yield (%) 0.0 0.0 0.1 0.1
Financials - Banks
Technology
An unusual quarter; Several moving parts
Sharp CASA uptick, weak core profitability but high trading gains
3QFY17 is a historic quarter for banks, with three defining trends (1) sharp
uptick in CASA (expect at least 500bp QoQ rise in CASA) and digitalization drive,
(2) massive flows to bond markets and sharp drop in yields (down ~30bp;
difference between peak and low at 65bp), and (3) collapse in loan growth to a
multi-year low. We believe the current quarter cannot to be extrapolated,
however benefits of demonetization – improved CASA ratio and low interest
rates (led by low inflation) are here to stay.
Weak loan growth (down 4% QoQ for our coverage universe), negative carry on
old currency notes and excess liquidity would impact NIM. Moderation in loan
growth, delayed buying decision for some retail products, and RBI directive on
cards/payments would impact fee income growth. High footfalls and occupation
of complete bandwidth in accepting deposits will impact branch profitability.
Bond yields in India are divergent with global trends, with Indian bond yields
down ~30bp QoQ (difference between peak and low at 65bp). Our interactions
with banks’ indicate that they have realized high trading gains/are sitting on
high MTM gains on investment portfolios. This would be handy to clean the
stress loans from balance sheet. Within our universe, we believe SBIN, PNB, CBK
and AXSB are likely to be large beneficiaries.
We do not see material change in reported asset quality as (a) large corporate
slippages are already taken care of, (b) small value accounts have got
forbearance from the RBI for a quarter, and (c) small value NPAs were
recovered, with borrowers depositing old currency. We would keenly watch
management comments on SME repayments. RBI AQR in FY16 led to high NPAs
and due to weak recoveries till date, provision levels are likely to remain
elevated (ageing of NPAs).
Retail loan growth has moderated during the quarter, as the entire focus of the
management was towards demonetization. We see this as temporary and
expect retail products like vehicle finance, credit cards and personal loans to
bounce back soon. The big impact of demonetization would be shift in the
market share from unorganized to organized credit. This along with low interest
rates and improvement in resolution process for stress loans would benefit
Financials. Our top picks are ICICIBC and YES amongst private banks; SBIN and
PNB amongst PSU banks; and RBL and Equitas amongst emerging banks.
Exhibit 3: State-owned banks— one-year forward P/BV Exhibit 4: Private sector banks— one-year forward P/BV
PSU Banks Sector PB (x) LPA (x) Pvt Banks Sector PB (x) LPA (x)
2.0 1.9 3.5 3.3
2.4
1.4 2.5 2.2
1.1
0.6 0.9
0.2 0.5
Jun-09
Jun-14
Jun-09
Jun-14
Dec-06
Mar-08
Sep-10
Dec-11
Mar-13
Sep-15
Dec-16
Dec-06
Mar-08
Sep-10
Dec-11
Mar-13
Sep-15
Dec-16
5.0
6.0
7.0
8.0
9.0
10.0
4QFY12 1.1 4QFY13 53.5 14.0
Jan-06
January 2017
1QFY13 2.7
1QFY14 54.0 13.5
2QFY13 2.7 Jan-07
3QFY13 2.0 2QFY14 56.5 17.5
4QFY13 1.1 Jan-08 3QFY14 57.6 14.5
1QFY14 3.3 4QFY14 60.1 14.3
2QFY14 1.9 Jan-09
1QFY15 61.2 13.3
3QFY14 2.1 Jan-10 2QFY15 62.7 11.0
Loans (INR t)
4QFY14 1.1
1QFY15 1.9 Jan-11 3QFY15 63.2 10.1
2QFY15 2.1 4QFY15 65.4 9.0
3QFY15 2.6 Jan-12
1QFY16 66.6 9.9
4QFY15 1.9
9.0
4QFY16 11.0 1QFY17 72.6 9.4
1QFY17 3.2
Jan-16 2QFY17 75.7 11.2
2QFY17 2.4
3QFY17E 2.0 3QFY17 73.4 5.8
6.42
41
1QFY14 3.3
3.5 4QFY13 69.0 13.1
2QFY14 3QFY12 3.4
3.6
3.3 1QFY14 70.7 13.5
3QFY14 3.7
1QFY13 3.0 2QFY14 73.3
3.6 14.4
PBs
3.0
16 12 13
55 57 61
4QFY14 3.7 3QFY14 75.0 15.9
13
3QFY13 3.0
3.7
39
1QFY15 2.9 4QFY14 77.4 14.6
of state-owned banks
3.8
2QFY15 1QFY14 2.8 1QFY15 79.5 12.4
3.8
2.8
PSBS
3.8
52 61
3QFY15 2QFY15 82.9 13.1
2.8
PSU
3QFY14 3.8
Deposits (INR t)
76
4QFY15 2.7
3.8
1QFY15 2.7 4QFY15 85.3 10.7
3.9
53
1QFY16
2.7 4.1 1QFY16 87.1 11.0
Private
65
16 15 17 21 17
2QFY16 3QFY15 2.7
4.1 2QFY16 91.6 11.3
2.6
24
3QFY16 4.0
131
Exhibit 6: Deposit growth to pick up sharply
47
4QFY16 2.6
173
32
1QFY17 4.0
Chg YoY (%)
2.5 4.0
2QFY17
49
1QFY17 2.5 2QFY17 102.1 12.0
4.0
35
2.5
80 75 72
3QFY17 3.9 3QFY17 105.9 15.9
2.4
Exhibit 10: Provisions to PPoP (%) to remain elevated in case
125
Source: MOSL, Company
3QFY17 3.8
December 2016 Results Preview | Sector: Financials - Banks
December 2016 Results Preview | Sector: Financials - Banks
Exhibit 11: Relative performance— 3 months (%) Exhibit 12: Relative performance— 1-year (%)
Sensex Index MOSL Financials Index Sensex Index MOSL Financials Index
102 125
99
110
96
95
93
90 80
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
Axis Bank
Bloomberg AXSB IN CMP: INR454 TP: INR519 (+14%) Neutral
Equity Shares (m) 2382.8 In line with the industry trend, we expect loan growth to moderate
M. Cap. (INR b)/(USD b) 1081 / 16
to ~14% YoY. Deposit growth is likely to be higher at ~21% YoY, led
52-Week Range (INR) 638 / 367
by strong CASA inflows. CD ratio would fall from 93% in 2QFY17 to
1,6,12 Rel Perf. (%) -3 / -14 / -1
88%.
Financial Snapshot (INR b) Sequentially, NIM is likely to contract ~15bp to 3.6% due to (a)
Y/E March 2016 2017E 2018E 2019E lower incremental spreads, (b) RBI’s temporary incremental CRR
NII 168.3 180.6 212.1 256.7 hike, and (c) continued high stress addition. Though incremental
OP 161.0 168.4 189.6 222.0 cost of funds would have fallen significantly, this would only
NP 82.2 30.9 55.4 111.8 partially compensate for the negative impact.
NIM (%) 3.8 3.6 3.6 3.6 AXSB had created a stressed asset watch list of INR252.5b (both
EPS (INR) 34.5 13.0 23.2 46.9
fund-based and non-fund based) in 4QFY16. The management has
EPS Gr. (%) 11.2 -62.4 79.1 101.9
guided for materially higher slippages from the watch list, above
BV/Sh. (INR) 216.8 229.8 248.9 287.6
the previous 60% guidance. As at the end of 2QFY17, the watch list
ABV/Sh. (INR) 209.9 202.3 226.5 269.8
stood at INR137.9b. We continue to expect relatively high
RoE (%) 17.1 5.8 9.7 17.5
proportion of slippages in FY17, leading to higher credit costs. High
RoA (%) 1.7 0.5 0.8 1.4
Payout (%) 15.0 0.0 17.6 17.6
provisions may be partially compensated by strong trading gains.
Valuations
AXSB trades at 1.8x FY18E BV and 19.5x FY18E EPS. Neutral.
P/E(X) 13.1 34.9 19.5 9.7 Key issues to watch for
P/BV (X) 2.1 2.0 1.8 1.6 Quantum of slippages from stressed asset watch list.
P/ABV (X) 2.2 2.2 2.0 1.7 Quantum of loans rescheduled under the 5:25, SDR and S4A
Div. Yield (%) 1.1 0.0 0.8 1.6 schemes.
Bank of Baroda
Bloomberg BOB IN CMP: INR148 TP: INR223 (+51%) Buy
Equity Shares (m) 2310.5
We expect balance sheet consolidation to continue, with a YoY
M. Cap. (INR b)/(USD b) 342 / 5
decline in loans in absolute terms. Portfolio rebalancing towards
52-Week Range (INR) 179 / 109
granular loans and SEB loans conversion could weigh on growth.
1,6,12 Rel Perf. (%) -10 / -5 / -6
While deposit intake has been muted in the past few quarters, this
quarter will see a strong revival in deposit growth.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
We expect margins to decline sequentially to 2.1%, led by fall in C-D
NII 127.4 134.6 154.5 186.9 ratio.
OP 88.2 107.8 119.5 140.7 Bulk of the asset quality stress has been taken over the last few
NP -54.0 28.4 43.5 60.6 quarters, and we expect only a marginal deterioration in asset
NIM (%) 2.0 2.1 2.3 2.4 quality. We expect only a marginal increase in GNPAs in 3QFY17.
EPS (INR) -23.4 12.3 18.8 26.2
Fee income would remain muted. However, higher share of non-
EPS Gr. (%) -252.4 NM 52.9 39.3
core income should support earnings.
BV/Sh. (INR) 146 155.9 170.3 190.4
ABV/Sh. (INR) 92 101.2 127.7 159.6 PAT should increase ~50% sequentially; however, return ratios will
RoE (%) -15.3 8.1 11.5 14.5 still remain sub-optimal.
RoA (%) -0.8 0.4 0.6 0.7 The stock trades at 7.9x FY18E EPS and 0.9x FY18E BV. Buy.
Div. Payout (%) 0.0 23.2 23.2 23.2
Valuations
P/E(X) -6.3 12.0 7.9 5.6 Key issues to watch for
P/BV (X) 1.0 0.9 0.9 0.8 Stress addition, mainly from international book.
P/ABV (X) 1.6 1.5 1.2 0.9 Guidance on loan growth, margins and operating expenses.
Div. Yield (%) 0.0 1.7 2.5 3.5
Bank of India
Bloomberg BOI IN CMP: INR108 TP: INR125 (+14) Neutral
Equity Shares (m) 1055.4
Continued asset quality strain and capital conservation efforts
M. Cap. (INR b)/(USD b) 114 / 2
would keep loan growth below the industry average – expect 4%
52-Week Range (INR) 129 / 79
decline on a YoY basis, although deposit growth will pick up
1,6,12 Rel Perf. (%) -9 / 1 / -10
marginally. We expect NIM to decline marginally QoQ to ~1.9%
Financial Snapshot (INR b) Non-interest income is likely to grow ~70% YoY, led by higher non-
Y/E March 2016 2017E 2018E 2019E
core income. Fee income is expected to remain muted.
NII 117.2 107.6 136.1 154.9
OP 60.4 80.1 94.7 100.8 We expect operating profit to decline 26% QoQ (but grow 30% YoY)
NP -60.9 -4.2 19.5 26.5 as a result of lower NII growth and one-off gains booked from stake
NIM (%) 2.1 1.9 2.2 2.2 sale in the previous quarter. Continued deterioration in asset
EPS (INR) -74.5 -4.0 18.5 25.1 quality would keep provisioning elevated.
EPS Gr. (%) NM NM -562.6 35.7
BOI trades at 0.4x FY18E BV and 5.8x FY18E EPS. Maintain Neutral.
ROE (%) -24.5 -1.7 7.5 9.5
ROA (%) -1.0 -0.1 0.3 0.3
BV/Sh. (INR) 283 239 254 273 Key issues to watch for
ABV/Sh. (INR) 61 86 129 184 Stress addition trends and outlook for FY17.
Div. Payout (%) 0.0 0.0 23.2 23.2 Upgrade/recovery trends; management is targeting INR175b in
Valuations
FY17 v/s INR85.5b in FY16.
P/E(X) -1.4 -27.0 5.8 4.3
P/BV (X) 0.38 0.45 0.42 0.39
Quantum of loans rescheduled under the 5:25 scheme.
P/ABV (X) 1.77 1.26 0.84 0.59 Outlook on balance sheet growth and further capital infusion.
Div. Yield (%) 0.0 0.0 3.4 4.7 Update on asset monetization plan to increase Tier I ratio.
Canara Bank
Bloomberg CBK IN CMP: INR264 Under Review
Equity Shares (m) 543.0
We expect slippages to moderate (2% of loans), however, credit
M. Cap. (INR b)/(USD b) 143 / 2
cost is likely to stay elevated (due to ageing of the portfolio) and we
52-Week Range (INR) 339 / 156
pencil in credit costs at ~190bp for the quarter.
1,6,12 Rel Perf. (%) -16 / 19 / 9
Low balance sheet growth and subdued margins (-8bp QoQ) would
Financial Snapshot (INR b) mar core PPoP growth (-23% YoY).
Y/E March 2016 2017E 2018E 2019E
Loan growth is expected to decline 4% YoY, while deposits are
NII 97.6 96.6 102.3 120.1
OP 71.5 87.1 96.1 115.8
expected to increase 4% YoY.
NP -28.1 14.8 20.6 31.7 We expect CBK ’s fee income growth to be muted. However, trading
NIM (%) 1.9 1.8 1.8 1.9 gains are expected to come in strong, leading to 75% YoY growth in
EPS (INR) -51.8 27.2 37.9 58.4 non-interest income.
EPS Gr. (%) NM NM 39.3 54.3
BV/Sh. (INR) 477 499 528 573
Non-core income growth is expected to provide cushion to
ABV/Sh. (INR) 227 242 304 398 provisions; we expect PBT to grow 13%, sequentially. The banking
RoE (%) -10.8 5.6 7.4 10.6 business trades at 0.5x FY18E BV and 7x FY18E EPS. Under Review.
RoA (%) -0.5 0.3 0.3 0.4
Div. Payout (%) 0.0 20.9 23.2 23.2
Valuations
P/E (x) -5.1 9.7 7.0 4.5 Key issues to watch for
P/BV (x) 0.55 0.53 0.50 0.46 Quantum of loans rescheduled under the 5:25, SDR and S4A
P/ABV (x) 1.16 1.09 0.87 0.66
schemes.
Div. Yield (%) 0.0 1.9 2.9 4.4
Outlook on balance sheet growth.
DCB Bank
Bloomberg DCBB IN CMP: INR112 TP: INR128 (+14%) Neutral
Equity Shares (m) 284.4 Loan growth (26% YoY) and deposit growth (32% YoY) would be
M. Cap. (INR b)/(USD b) 32 / 0
significantly above industry average.
52-Week Range (INR) 133 / 69
We expect NII to grow 22% YoY, led by strong loan growth,
1,6,12 Rel Perf. (%) 2 / 11 / 36
although margins are expected to contract ~20bp QoQ.
Non-interest income is expected to grow by ~62% YoY, led by
Financial Snapshot (INR b)
healthy trading gains. Overall, we expect revenue growth to remain
Y/E MARCH 2016 2017E 2018E 2019E
NII 6.2 7.7 9.3 11.5 strong at 30% YoY and PPP growth to be 24% YoY. We model opex
OP 3.5 4.1 4.7 5.9 growth of 35% YoY, led by branch expansion strategy and
NP 1.9 2.0 2.4 3.0 demonetization-related manpower and ATM costs.
NIM (%) 3.9 3.9 3.8 3.8 Credit costs may be elevated this quarter (estimated at 82bp)
EPS (INR) 6.8 7.2 8.5 10.7 owing to stress in SME segment. We expect PBT/PAT growth of
EPS Gr. (%) 0.9 5.0 18.7 25.1
18%/21% YoY.
BV/Sh. (INR) 61.6 68.8 77.3 88.0
DCBB trades at 1.4x FY18E BV and 13.1x FY18E EPS. Maintain
ABV/Sh. (INR) 59.2 65.9 74.2 84.6
RoE (%) 11.8 11.0 11.7 12.9 Neutral.
RoA (%) 1.1 1.0 0.9 0.9 Key issues to watch for
Valuations Management commentary on slippages in SME segment.
P/E (x) 16.4 15.6 13.1 10.5
Update and commentary on balance sheet growth strategy.
P/BV (x) 1.8 1.6 1.4 1.3
CASA ratio and NIM performance.
P/ABV (X) 1.9 1.7 1.5 1.3
Equitas Holdings
Bloomberg EQUITAS IN CMP: INR148 TP: 240 (+62%) Buy
Equity Shares (m) 335.7
We expect NII growth of 40% YoY, led by healthy loan growth of
M. Cap. (INR b)/(USD b) 50 / 1
24%+ YoY and margin expansion. Margins (calculated) would
52-Week Range (INR) 206 / 134
improve ~13bp QoQ, led by sharp fall in cost of funds owing to
1,6,12 Rel Perf. (%) -/-/-
strong inflow of deposits.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
Non-interest income would be ~INR300m (+20%YoY).
NII 5.1 8.4 11.1 14.4 Operating expenses are expected to grow significantly by ~70% YoY
OP 3.2 4.1 4.8 6.3 (v/s 37% YoY growth in total income), driven by greater employee
NP 1.7 2.0 2.3 3.0
and other expenses as a result of increased focus on collections
NIM (%) 11.6 12.4 10.2 9.1
during the past few months.
EPS (INR) 6.2 6.0 6.8 8.9
EPS Gr. (%) 56.1 -3.2 14.1 29.9 We expect asset quality to remain largely stable, with the company
BV/Sh. (INR) 50 67 74 83 witnessing relatively strong collection efficiency. We factor in
ABV/Sh. (INR) 49 66 72 79 provisions of INR150m during the quarter. The stock trades at 2x
RoE (%) 13.3 11.2 9.7 11.4
FY18E BV. Maintain Buy.
RoA (%) 3.0 2.3 1.7 1.5
Div. Payout (%) 0.0 0.0 0.0 0.0
Valuations
P/E(X) 24.0 24.8 21.7 16.7
Key issues to watch for
P/BV (X) 3.0 2.2 2.0 1.8 Update on the transition progress.
P/ABV (X) 3.1 2.3 2.1 1.9 Commentary on growth and asset quality in MFI.
Div. Yield (%) 0.0 0.0 0.0 0.0
Federal Bank
Bloomberg FB IN CMP: INR66 TP: INR106 (+60%) Buy
Equity Shares (m) 1719.0
We expect 21% YoY (-1% QoQ) loan growth, aided by greater focus
M. Cap. (INR b)/(USD b) 113 / 2
on corporate credit growth. Traction in SME, agriculture and retail
52-Week Range (INR) 86 / 41
loans would be maintained. We expect NIM to contract marginally
1,6,12 Rel Perf. (%) -5 / 11 / 14
by 7bp QoQ (but expand 13bp YoY).
Financial Snapshot (INR b)
Y/E Mar 2016 2017E 2018E 2019E We build in higher opex growth of 20% YoY, led by demonetization-
NII 25.0 29.3 33.4 41.6 related expenses.
OP 14.2 18.7 21.0 27.0 Non-interest income would grow by 50%+ YoY, led by strong
NP 4.8 7.8 9.4 12.2
trading gains, leading to strong PPoP growth of 41% YoY.
NIM (%) 3.2 3.2 3.1 3.1
EPS (INR) 2.8 4.5 5.5 7.1 We expect slippages to increase marginally owing to stress in SME
EPS Gr. (%) -52.9 63.5 20.6 29.7 book. We expect trading gains to be utilized for shoring up the
BV/Sh. (INR) 47 51 55 60 coverage ratio. Accordingly, we factor in higher credit cost.
ABV/Sh. (INR) 43 47 51 57
ROE (%) 6.0 9.3 10.4 12.3 PBT/PAT is expected to grow 14/15% YoY. We maintain Buy with a
ROA (%) 0.5 0.8 0.8 0.8 target price of INR106. FB trades at 1.2x FY18E BV and 12.1x FY18E
Payout (%) 29.3 23.2 23.2 23.2 EPS.
Valuations Key issues to watch for
P/E(X) 23.8 14.5 12.1 9.3
Outlook on asset quality.
P/BV (X) 1.4 1.3 1.2 1.1
P/ABV (X) 1.5 1.4 1.3 1.2 Strategy on balance sheet growth.
Div. Yield (%) 1.1 1.4 1.7 2.2
HDFC Bank
Bloomberg HDFCB IN CMP: INR1,186 TP: INR1,510 (+27%) Buy
Equity Shares (m) 2528.2
We expect loan growth to be ~15% YoY due to constrained growth
M. Cap. (INR b)/(USD b) 2999 / 44
strategy post demonetization and FCNR (B) linked loans
52-Week Range (INR) 1318 / 929
repayments; however it will still remain ~2x the system growth.
1,6,12 Rel Perf. (%) -2 / 4 / 7
Fee income growth would continue to lag loan growth in the near
term; however, trading gains should compensate.
Financial Snapshot (INR b)
Y/E MARCH 2016 2017E 2018E 2019E
Computed NIM is likely to decline 15bp QoQ owing to controlled
NII 275.9 321.5 385.3 471.9 loan growth amidst strong deposit inflows. Opex growth is expected
OP 213.6 247.6 299.8 373.1 to be ~16% YoY.
NP 123.0 146.5 176.6 214.7 Moderation in core PPP growth would lead to 16% YoY PAT growth,
NIM (%) 4.7 4.6 4.6 4.5 lower than the trend rate of 20%. Reversal of contingency
EPS (INR) 48.6 57.9 69.8 84.9
provisions may lead to 20% YoY growth – not factored in our
EPS Gr. (%) 19.3 19.1 20.5 21.6
estimates. GNPA would remain stable QoQ at ~1.1 %.
BV/Sh. (INR) 287 331.8 385.3 450.5
ABV/Sh. (INR) 284 325.9 378.0 436.9 HDFCB trades at 3.1x FY18E BV and 17x FY18E EPS. Comfort on
RoE (%) 18.3 18.7 19.5 20.3 earnings (~20% CAGR over FY16-19) remains high. Maintain Buy.
RoA (%) 1.9 1.9 1.9 1.9
Key issues to watch for
Payout (%) 22.9 23.4 23.4 23.4
Performance in retail loan/SME portfolio— especially in segments
Valuations
P/E(X) 24.4 20.5 17.0 14.0 like CV/CE.
P/BV (X) 4.1 3.6 3.1 2.6 Trends in digital banking/payment industry and various initiatives
P/ABV (X) 4.2 3.6 3.1 2.7 by the bank.
Div. Yield (%) 0.8 1.0 1.2 1.4 Overall B/S growth outlook and economic recovery.
ICICI Bank
Bloomberg ICICIBC IN CMP: INR251 TP: INR332 (+32%) Buy
Equity Shares (m) 5813.3 We expect loan growth to moderate to 4.5% YoY. Retail loan growth
M. Cap. (INR b)/(USD b) 1460 / 21 has picked up over the last two years. However, demonetization
52-Week Range (INR) 298 / 181 may have resulted in a temporary moderation.
1,6,12 Rel Perf. (%) -5 / 4 / -6 Slower growth, coupled with a YoY decline in NIM (due to lower C-D
ratio) should lead to moderate growth in NII on a YoY basis.
Financial Snapshot (INR b) Fee income growth will remain muted. We have factored in ~2%
Y/E March 2016 2017E 2018E 2019E YoY growth in fee income, led by low corporate fees. Trading gains
NII 212.2 208.3 242.9 282.3 should be healthy. Overall, we expect non-interest income to
OP 238.6 260.7 230.5 265.4 decline 12% YoY owing to gains booked on stake sale in PruLife in
NP 97.3 100.1 104.7 126.4 3QFY16.
NIM (%) 3.6 3.2 3.3 3.3 Gross slippages are expected to remain high in 3QFY17, with
EPS (INR) 16.7 17.2 18.0 21.7 slippage ratio estimated at ~7%. Outstanding watch list (fund based
EPS Gr (%) -13.2 2.9 4.6 20.8 and non-fund based) stood at INR324.9b in 2QFY17.
BV/Sh (INR)* 132.9 145.2 158.0 173.4 We expect PAT to decline 26% YoY, led by higher operating
ABV/Sh (INR)* 117.3 118.3 127.6 145.7 expenses and elevated credit costs. ICICIBC trades at 1.1x FY18E
RoE (%) 11.3 10.4 10.0 11.3 core BV and 9.4x FY18E EPS. Buy.
RoA (%) 1.4 1.3 1.2 1.3
Valuations
AP/E (x) 11.7 10.5 9.4 7.2 Key issues to watch for
AP/BV (x) 1.5 1.2 1.1 0.9 Movement of watch list accounts.
AP/ABV (x) 1.7 1.5 1.3 1.1 Plans on monetization of stakes in various ventures.
Div. Yield (%) 2.0 1.8 1.9 2.3 Outlook on asset quality and trend on further relapse from RL.
* BV adj for invt in subsidiaries Quantum of loans rescheduled under the 5/25 scheme.
IDFC Bank
Bloomberg IDFCBK IN CMP: INR60 Under Review
Equity Shares (m) 3392.6
We expect 22% YoY (5% QoQ) loan growth, aided by greater focus
M. Cap. (INR b)/(USD b) 203 / 3
on retail banking. Though incremental deposits raised in 3Q would
52-Week Range (INR) 83 / 43
aid cost of funds, we expect NIM (calculated) to remain largely
1,6,12 Rel Perf. (%) -11 / 31 / -2
stable at 2%, led by lower asset yields.
Financial Snapshot (INR b) Non-interest income would be ~INR2.5b (-40% QoQ due to one-off
Y/E March 2H2016 2017E 2018E 2019E gains in 2Q), led by moderate fee income growth. Trading gains are
NII 8.5 20.5 25.3 31.1 expected to be healthy. Operating expenses are likely to grow 15%
OP 7.4 18.4 22.9 31.2 QoQ (v/s 16% QoQ de-growth in total income), driven by costs
NP 4.7 10.6 14.3 19.3 associated with expansion of retail and rural banking franchise and
NIM (%) 2.5 2.2 2.2
demonetization-related overheads, leading to 33% QoQ decline in
EPS (INR) 3.1 4.2 5.7
EPS Gr. (%) 34.8 35.2
PPP (flat YoY).
BV/Sh. (INR) 40.2 42.6 45.8 50 We expect high provisioning at ~INR1.05b.
ABV/Sh. (INR) 37.8 39.4 42.1 46
The stock trades at 1.3x FY18E BV and 14.2x FY18E EPS. Under
RoE (%) 7.5 9.5 11.9
RoA (%) 1.1 1.1 1.3 Review
Valuations
P/E(X) 19.2 14.2 10.5
Key issues to watch for
P/BV (X) 1.4 1.3 1.2
P/ABV (X) 1.5 1.4 1.3
Outlook on balance sheet growth and costs.
Div. Yield (%) 1.0 1.4 1.9 Retail franchise building plans and update.
Indian Bank
Bloomberg INBK IN CMP: INR225 TP: INR314 (+40%) Buy
Equity Shares (m) 480.3
We expect an uptick in deposit growth to 5.6% v/s 3.2% in 2QFY17
M. Cap. (INR b)/(USD b) 108 / 2
and 2.1% in FY16. Net loans are expected to decline ~5% YoY owing
52-Week Range (INR) 276 / 76
to muted credit environment. Decline in cost of funds would be
1,6,12 Rel Perf. (%) -8 / 51 / 95
negated by excessive liquidity and reducing yields, leading to ~17bp
Financial Snapshot (INR b) decline in margins on a QoQ basis.
Y/E March 2016 2017E 2018E 2019E Fee income would be subdued. Trading gains growth is expected to
NII 44.5 49.7 55.2 66.8
drive 62% YoY growth in non-interest income.
OP 30.3 39.6 41.9 48.6
NP 7.1 14.6 15.3 18.5
We expect slippage ratio to remain elevated at 2.7% and credit
NIM (%) 2.5 2.6 2.7 2.9 costs to increase to 1.6% v/s 1.1% in 2QFY17, as INBK looks to
EPS (INR) 14.8 30.4 31.9 38.5 improve provision coverage; however, trading gains will provide
EPS Gr. (%) -29.2 105.3 5.0 20.5 cushion to earnings
BV/Sh. (INR) 281 304 328 358 INBK trades at 0.7x FY18E BV and 7.1x FY18E EPS. Maintain Buy.
ABV/Sh (INR) 202 222 262 305
RoE (%) 5.5 10.4 10.1 11.2
RoA (%) 0.4 0.7 0.7 0.7
Key issues to watch for
Div. Payout (%) 23.2 23.2 23.2 23.2
Outlook on business growth and asset quality remains the key
Valuations
P/E (x) 15.2 7.4 7.1 5.9 factor to monitor.
P/ BV (x) 0.8 0.7 0.7 0.63 Quantum of loans rescheduled under the 5/25 scheme.
P/ABV (x) 1.1 1.0 0.9 0.74 View on margins with an improvement in liquidity and lower
Div. Yield (%) 0.7 2.7 2.8 3.4 interest rates.
IndusInd Bank
Bloomberg IIB IN CMP: INR1,101 TP: INR1,405 (+28%) Buy
Equity Shares (m) 595.0 We expect strong loan/deposit growth of ~25%/~38% YoY in
M. Cap. (INR b)/(USD b) 655 / 10
3QFY17. Continuation of positive growth trend in the CV/CFD
52-Week Range (INR) 1255 / 799
segment would remain a key factor to monitor. Overall, NIM is
1,6,12 Rel Perf. (%) 1 / 2 / 14
likely to remain largely stable QoQ at 3.8-3.9%, led by lower cost of
Financial Snapshot (INR Billion) funds.
Y/E MARCH 2016 2017E 2018E 2019E We expect non-interest income growth to be strong at ~25%,
NII 45.2 59.2 72.7 89.0 helped by high trading gains. We expect moderation in fee growth.
OP 41.4 51.8 64.1 78.9
Opex growth would remain high at ~32%+ YoY, led by higher
NP 22.9 28.3 35.5 44.0
demonetization-related currency management costs.
NIM (%) 4.0 4.3 4.3 4.2
EPS (INR) 38.4 47.6 59.6 74.0 Strong PPP growth (+23% YoY) would keep earnings growth strong
EPS Gr. (%) 13.4 23.9 25.2 24.1 at 22%+ YoY, despite factoring in higher credit costs (+27% YoY
BV/Sh. (INR) 291 332 383 446.9 increase in provisions)
ABV/Sh. (INR) 288 328 379 441.9 IIB trades at 2.9x FY18E BV and 18.5x FY18E EPS, with best-in-class
RoE (%) 16.6 15.3 16.7 17.8 RoA of ~2% and RoE of 17-18%. Buy.
RoA (%) 1.8 1.8 1.9 1.9
Payout (%) 18.5 14.0 14.0 14.0 Key issues to watch for
Valuations Uptick in CV/CE demand would be the key for CFD growth.
P/E (X) 28.6 23.1 18.5 14.9
Corporate asset quality a key monitorable.
P/BV (X) 3.8 3.3 2.9 2.5
P/ABV (X) 3.8 3.4 2.9 2.5
Traction in the non-vehicle consumer lending portfolio.
Div. Yield (%) 0.4 0.5 0.7 0.8
Quarterly Performance
Y/E March FY16 FY17E FY16 FY17
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Kotak Bank (standalone)
Net Interest Income 15,982 16,787 17,662 18,572 19,191 19,954 20,213 21,260 69,004 80,618
% Change (Y-o-Y) 59.5 61.6 66.7 65.4 20.1 18.9 14.4 14.5 63.4 16.8
Operating Profit 5,970 10,448 12,052 11,942 13,150 14,401 13,713 15,684 40,411 56,948
% Change (Y-o-Y) -10.3 42.4 63.4 38.7 120.3 37.8 13.8 31.3 34.8 40.9
Net Profit 1,898 5,695 6,347 6,958 7,420 8,133 8,049 9,564 20,898 33,165
% Change (Y-o-Y) -55.8 28.1 36.6 32.0 291.0 42.8 26.8 37.5 12.0 58.7
Other Businesses
K otak Prime 1,190 1,270 1,260 1,300 1,200 1,300 1,375 1,483 5,025 5,358
K otak Mah. Investments 300 360 390 500 400 530 575 623 1,540 2,128
K otak Mah. Capital Co 30 70 60 170 230 50 210 276 320 766
K otak Securities 670 780 550 510 600 960 700 765 2,515 3,025
International subs 250 320 260 220 130 310 225 235 1,050 900
K otak Mah. AMC & Trustee Co. 200 230 40 250 190 70 150 443 720 853
K otak Investment Advisors 0 0 -10 50 110 10 80 100 50 300
K otak OM Life Insurance 660 480 600 770 710 630 650 646 2,510 2,636
Con.adj and MI -30 230 -40 -180 -240 30 -95 -115 -19 -420
Conso. PAT 5,168 9,435 9,457 10,548 10,750 12,023 11,919 14,019 34,608 48,710
% Change (Y-o-Y) -25.9 31.5 32.0 15.5 108.0 27.4 26.0 32.9 13.7 40.8
E: MOSL Estimates, Quarterly numbers vary from full year number due to difference in reporting
RBL Bank
Bloomberg RBK IN CMP: INR345 TP: 450 (+30%) Buy
Equity Shares (m) 361.7
Loan growth (+ 4%QoQ) and deposit growth (+9% QoQ) would be
M. Cap. (INR b)/(USD b) 125 / 2
significantly above industry average.
52-Week Range (INR) 421 / 274
We expect NII to grow 9% QoQ, led by strong loan growth and
1,6,12 Rel Perf. (%) -/-/-
~10bp QoQ expansion in NIMs (owing to substantial CASA inflow,
sharp fall in bulk rates and recent equity infusion).
Financial Snapshot (INR b)
Y/E MARCH 2016 2017E 2018E 2019E
Overall non-interest income is expected to grow by ~9% QoQ,
NII 8.2 12.2 14.4 19.5 which in our view would be driven by strong growth in trading
OP 5.4 8.7 10.3 14.2 gains. While opex will be high during the quarter owing to branch
NP 2.9 4.4 5.4 7.4 expansion costs and demonetization-related manpower and
NIM (%) 2.7 3.0 2.9 3.0 currency costs, we expect PPP growth to be strong at 9% QoQ.
EPS (INR) 9.0 12.2 14.8 20.5
Asset quality is expected to remain stable this quarter, although
EPS Gr. (%) 27.6 35.0 21.9 38.4
BV/Sh. (INR) 92.0 114.2 126.2 142.7
there may be some stress that could materialize in the SME
ABV/Sh. (INR) 89.5 113.7 125.5 141.7 segment. Credit costs will largely be under control.
RoE (%) 11.2 12.4 12.3 15.3 We expect PBT/PAT growth of 27%/33% QoQ.
RoA (%) 0.9 1.0 1.0 1.0 RBL trades at 2.7x FY18E BV and 23.3x FY18E EPS. Maintain Buy.
Valuations
P/E(X) 38.3 28.3 23.3 16.8 Key issues to watch for
P/BV (X) 3.7 3.0 2.7 2.4 Management commentary on slippages in SME segment.
P/ABV (X) 3.9 3.0 2.7 2.4
Update and commentary on balance sheet growth strategy.
CASA ratio and traction on NIMs.
Yes Bank
Bloomberg YES IN CMP: INR1,163 TP: INR1,500 (+30%) Buy
Equity Shares (m) 421.1
On a lower base, we expect loan growth to be above the industry
M. Cap. (INR b)/(USD b) 490 / 7
average at 33%+ YoY (nearly 5x industry growth rates) on the back
52-Week Range (INR) 1450 / 632
of refinancing opportunities and strong growth in retail banking.
1,6,12 Rel Perf. (%) -3 / 6 / 61
Despite benefits flowing in form of lower cost of funds, excess
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
liquidity, incremental CRR and competitive pressure on the lending
NII 45.7 57.5 72.3 91.8 side would pressurize NIMs (factored a 10bp decline).
OP 43.0 54.5 69.2 87.1 Consequently, NII growth is expected to be healthy at ~27% YoY –
NP 25.4 31.4 40.4 50.2 the best among peers.
NIM (%) 3.4 3.5 3.6 3.7 Non-interest income growth is likely to be ~23% YoY, led by strong
EPS (INR) 60.4 74.5 95.8 119.3
growth from third-party distribution, continued momentum in
EPS Gr. (%) 25.8 23.4 28.6 24.5
financial advisory and higher trading gains.
BV/Sh. (INR) 327.8 386.8 463.0 558.0
ABV/Sh. (INR) 323.4 381.2 456.7 549.9 Led by aggressive franchise expansion, we expect opex growth to
RoE (%) 19.9 20.9 22.6 23.4 remain high (30%+ YoY).
RoA (%) 1.7 1.7 1.8 1.8 Asset quality performance so far has been significantly better than
Div. Payout (%) 19.1 20.3 20.3 20.3 industry; we expect this trend to continue.
Valuations YES trades at 2.5x FY18E BV and 12.1x FY18E EPS. Return ratios also
P/E(X) 19.3 15.6 12.1 9.7
remain strong (RoA of ~1.8% and RoE of 20%+). Maintain Buy.
P/BV (X) 3.5 3.0 2.5 2.1
P/ABV (X) 3.6 3.1 2.5 2.1 Key issues to watch for
Div. Yield (%) 0.9 1.1 1.4 1.8 Implementation of retail strategy on assets and liabilities sides.
Performance on asset quality and quantum of loans rescheduled
under 5:25 scheme/sale to ARCs.
Financials - NBFCs
Company name Expect demonetization-led subdued performance
Bajaj Finance Disbursement growth – the key monitorable; Asset quality impact camouflaged
Bharat Financial Inclusion We expect NBFCs under our coverage universe to report PAT growth of 16%
Dewan Housing YoY in 3QFY17. In our view, disbursements for all NBFCs have been hit on
account of demonetization. Asset quality woes may not be reflected in the
GRUH Finance
quarterly numbers due to the Reserve Bank of India (RBI) dispensation. We
HDFC expect housing finance companies (HFCs), especially those with a low share of
Indiabulls Housing LAP and corporate loans, to perform relatively well on the asset quality front
LIC Housing Fin compared to NBFC-AFCs. Our discussions with managements indicate that the
business performance was not as bad as envisaged. We believe management
M & M Financial
commentary on the 4Q outlook is the key. Within our NBFC coverage universe,
Muthoot Finance
BHAFIN and LICHF are likely to post strong earnings growth of 25%+ YoY,
Repco Home Fin which is commendable in this environment. HFCs should see a stable quarter
Shriram Transport Fin. in terms of loan growth due to the outstanding sanction pipeline. We would
closely look at the margins performance, considering the sharp reduction in
bond yields and the significant proportion of incremental funding from bonds.
Housing finance companies: HFCs under our coverage universe should deliver
PAT growth of 15% YoY in 3QFY17, driven by a continued focus on the individual
segment. The sharp rally in bond yields was the key positive in the quarter. DHFL
raised INR140b via bonds in the prior quarter, the full benefits of which should
be reflected in the NIM in this quarter, in our view. HDFC is likely to deliver 14%
loan growth, and dividend from the bank will support earnings growth. We
believe players with a high share of self-employed customers and LAP/builder
loans are likely to witness slowdown in disbursements and problems in
collections. However, the numbers might not reflect the stress in the segment
due to the RBI dispensation on NPA recognition.
Asset finance companies: We expect growth for AFCs under our coverage to
slow down sharply from prior quarters, especially in vehicle finance. We expect
SHTF/MMFS to report flat AUM QoQ. BAF, however, will be an exception, with
25%+ AUM growth, driven by all segments, except 2W/3W financing and LAP.
We do not foresee significant asset quality issues for BAF as its customers are
mostly salaried and collections are mainly non-cash based.
Gold financing: Specialized gold financing company, MUTH, is likely to have a
subdued quarter with stable AUM QoQ (+10% YoY). We expect margins to
improve YoY, but remain largely stable QoQ. We believe future movements in
gold prices hold the key.
Microfinance: BHAFIN is likely to report slower AUM growth of ~30%, given
slowdown in disbursements post demonetization. Margins, however, should
remain stable, resulting in ~30% NII growth. The company recently raised
INR7.5b, the benefit of which should be reflected in 2H. Reduction in lending
rates due to declining cost of funds and increase in one-year loan ticket-size by
the RBI should boost demand for microcredit over medium term, in our view.
Exhibit 2: Relative performance— 3 months (%) Exhibit 3: Relative performance— 1-year (%)
Sensex Index MOSL Financials Index Sensex Index MOSL Financials Index
102
120
99 110
96 100
93 90
90 80 Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
Bajaj Finance
Bloomberg BAF IN CMP: INR900 TP: INR1,096 (+22%) Buy
Equity Shares (m) 535.5
We expect AUM growth of 27% YoY in 3QFY17, driven by strong
M. Cap. (INR b)/(USD b) 466 / 7
growth in consumer and commercial lending. LAP and 2W/3W
52-Week Range (INR) 1180 / 535
1,6,12 Rel Perf. (%) -5 / 9 / 40
financing will be a drag on AUM growth.
NII should grow 13% YoY; margins are likely to decline 190bp YoY off
a high base.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
Asset quality is likely to remain stable. As of September 2016,
NII 40.3 51.4 66.3 85.7 GNPAs were at 1.58% and NNPAs at 0.43%.
PPP 25.1 33.3 44.1 58.8 We expect provisions of INR1.9b, as against INR1.7b in 2QFY17 and
PAT 12.8 17.0 22.1 30.4 INR1.6b in 3QFY16.
EPS (INR) 23.9 31.8 41.3 56.7 Net profit is likely to grow 8% YoY to INR4.2b.
EPS Gr. (%) 33.4 33.1 30.1 37.2
The stock trades at 5.1x FY17E and 4.2x FY18E BV. Maintain Buy.
BV/Sh. (INR) 136.8 163.9 199.2 247.6
RoA on AUM (%) 3.2 3.3 3.3 3.4
RoE (%) 21.1 21.1 22.8 25.4
Payout (%) 2.9 14.0 14.0 14.0 Key issues to watch for
Valuations Commentary on business growth momentum due to the impact of
P/E (x) 37.7 28.3 21.8 15.9 demonetization.
P/BV (x) 6.6 5.5 4.5 3.6 Guidance on margin due to changing product mix going forward.
Div. Yield (%) 0.3 0.3 0.3 0.5
Asset quality trends, especially in LAP and 2W/3W businesses.
Performance of businesses such as rural SME lending, lifestyle
financing and e-commerce financing.
Gruh Finance
Bloomberg GRHF IN CMP: INR333 TP: INR339 (+2%) Neutral
Equity Shares (m) 363.4
We expect loan growth to moderate to 15% YoY from 22% YoY in
M. Cap. (INR b)/(USD b) 119 / 2
the prior quarter.
52-Week Range (INR) 370 / 226
1,6,12 Rel Perf. (%) 6 / 15 / 19
Margins are likely to remain largely unchanged sequentially, but
decline modestly on a YoY basis.
NII is likely to grow 11% YoY to INR1.3b.
Financials & Valuation (INR b) Operating expenses are likely to grow 34% YoY and 1% QoQ.
Y/E March 2016 2017E 2018E 2019E We expect asset quality to remain stable despite the impact of
NII 4.2 5.2 6.4 8.2 demonetization. We expect provisions of INR80m for the quarter.
PPP 3.8 4.7 5.8 7.4 Net profit is likely to grow 19% YoY to INR640m.
PAT 2.4 2.9 3.5 4.5
The stock trades at 11.5x FY17E and 9.4x FY18E BV. Maintain
EPS (INR) 6.7 7.8 9.6 12.3
EPS Gr. (%) 19.4 17.0 22.9 27.6 Neutral.
BV/Sh. (INR) 23.0 28.1 34.3 42.1
ABV/Sh. (INR) 23.0 28.1 34.3 42.2
RoA (%) 2.4 2.2 2.2 2.3
RoE (%) 31.5 30.7 30.9 32.2 Key issues to watch for
Payout (%) 34.3 30.0 30.0 31.0 Business outlook, loan growth in various geographies.
Valuations
Movement in borrowing costs and margins.
P/E (x) 49.7 42.5 34.6 27.1
P/BV (x) 14.5 11.9 9.7 7.9 Outlook on asset quality.
Div. Yield (%) 0.7 0.7 0.9 1.1 Management’s outlook on developments in the affordable
housing space.
HDFC
Bloomberg HDFC IN
CMP: INR1,216 TP: INR1,553 (+28%) Buy
Equity Shares (m) 1574.7
We expect moderate earnings growth of 12%+ YoY, in line with
M. Cap. (INR b)/(USD b) 1909 / 28
growth witnessed in the prior quarter.
52-Week Range (INR) 1463 / 1012
1,6,12 Rel Perf. (%) -2 / -1 / -4
We estimate AUM growth at 14%, which will be largely driven by
the individual segment. We expect demonetization to have a
lagged impact on growth, i.e. growth will be impacted more in
Financial Snapshot (INR b)
4QFY17.
Y/E March 2016 2017E 2018E 2019E
NII 87.0 96.9 108.8 124.4 Margins are likely to decline 20+bp YoY, but remain largely stable
PAT 70.9 75.0 84.8 97.1 QoQ. This will drive 6% YoY NII growth for the quarter.
Adj. EPS (INR) 30.6 34.3 36.9 42.1 Cost-to-income ratio will inch up marginally to 8%.
EPS Gr. (%) 5.8 12.2 7.6 14.0 Asset quality has remained healthy over past several quarters,
BV/Sh. (INR) 221.7 245.3 272.5 304.7 and the trend is likely to continue. However, asset quality in
ABV/Sh. (INR) 169.5 193.2 215.9 248.1
corporate loan book would be a key monitorable.
RoAA (%) 2.6 2.5 2.5 2.5
We estimate provisions of INR700m, as against INR950m in
Core RoE (%) 21.4 19.5 18.9 18.1
Payout (%) 43.9 43.5 43.5 43.5
2QFY17.
Valuation The stock trades at 3.7x FY17E AP/ABV and 3.0x FY18E AP/ABV
AP/E (x) 26.1 19.6 16.4 11.7 (price adjusted for value of other businesses and book value
P/BV (x) 5.5 5.0 4.5 4.0 adjusted for investments made in those businesses). Buy.
AP/ABV (x) 4.7 3.5 2.8 2.0
Div. Yield (%) 1.4 1.5 1.7 1.9 Key issues to watch for
Loan growth and uptick in corporate loans.
Impact of demonetization on real estate demand.
Movement in spreads and margins (on individual loans) and
asset quality trends.
Indiabulls Housing
Bloomberg IHFL IN CMP: INR688 TP: INR1,015 (+48%) Buy
Equity Shares (m) 421.3
We expect strong loan growth to continue, driven by retail home
M. Cap. (INR b)/(USD b) 271 / 4
loans.
52-Week Range (INR) 895 / 551
1,6,12 Rel Perf. (%) -14 / -4 / -15 NII is likely to grow 11% YoY in the quarter. Spreads are likely to
contract (but remain over 300bp) due to increased share of home
Financial Snapshot (INR b) loans.
Y/E March 2016 2017E 2018E 2019E Expenses are likely to grow 28% YoY, resulting in modest uptick in
Net Fin inc 28.7 38.9 49.7 63.7 cost-income ratio.
PPP 36.4 45.4 57.0 71.4
EPS (INR) 55.7 69.5 87.7 113.1 Asset quality is expected to remain stable. In 1QFY17, GNPAs were
EPS Gr. (%) 4.1 24.9 26.1 29.0 at 0.83% and NNPAs at 0.34%.
BV/Sh. (INR) 254 281 317 364 PAT is likely to grow 21% YoY to INR7.3b during the quarter.
RoA on AUM (%) 3.3 3.3 3.3 3.4
RoE (%) 27.1 26.0 29.3 33.2 The stock trades at 2.3x FY17E and 2.0x FY18E BV. Maintain Buy.
Payout (%) 76.0 52.5 50.0 58.5
Key issues to watch for
Valuations
P/E (x) 12.4 9.9 7.8 6.1 AUM growth trend and growth guidance post demonetization.
P/BV (x) 2.7 2.5 2.2 1.9 Movement in incremental spreads and margins.
P/ABV (x) 2.7 2.5 2.2 1.9 Asset quality trends in corporate segment and loan against
Div. Yield (%) 6.5 5.3 6.4 8.2 property.
Updates on acquisition of retail bank, NorthOak Bank, in the UK.
Muthoot Finance
Bloomberg MUTH IN CMP: INR288 TP: INR373 (+29%) Buy
Equity Shares (m) 398.0
AUM is expected to grow 10% YoY, but remain largely stable on a
M. Cap. (INR b)/(USD b) 114 / 2
sequential basis at INR275b.
52-Week Range (INR) 405 / 170
1,6,12 Rel Perf. (%) -3 / 2 / 57
Calculated margins are likely to improve YoY to ~11% led by better
auction realization and increase in lending rates. Moreover, cost of
funds is also declining.
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
As a result, NII is expected to grow 31% YoY to INR7.6b.
NII 25.4 29.7 34.4 40.1 Asset quality is likely to remain stable with GNPL of ~2.2%.
PPP 14.8 17.6 20.6 24.6 We estimate provisions of INR200m, as against INR171m in 2QFY17
PAT 8.1 11.0 12.8 15.6 and INR74m in 1QFY17.
EPS (INR) 20.3 27.5 32.0 39.0 The stock trades at 1.8x FY17E and 1.6x FY18E BV. Maintain Buy.
BV/Sh.(INR) 140.8 158.4 178.7 203.6
RoA on AUM (%) 3.4 4.2 4.2 4.2
RoE (%) 15.1 18.4 19.0 20.4
Div. Yld. (%) 2.1 2.9 3.3 4.1
Valuations Key issues to watch for
P/E (x) 14.2 10.5 9.0 7.4 Management commentary on business growth and steps taken to
P/BV (x) 2.0 1.8 1.6 1.4
sustain AUM growth in the wake of demonetization.
Movement in yields and margins, with declining cost of funds.
Progress in gold auctions.
Healthcare
Company name Pricing pressure in the US to keep growth under check
Alembic Pharmaceuticals
Biocon
We expect our pharma universe to report sequentially flat EBITDA growth in
Cadila Healthcare
Cipla 3QFY17, largely led by pricing pressure and higher R&D expenditure. Also,
Divi's Laboratories increased US regulatory scrutiny is resulting in higher remediation expenses and
Dr Reddy’ s Labs
de-risking of key products. This, in turn, should weigh down on operating
Glenmark Pharma
GSK Pharma margins for our coverage universe.
Ipca Laboratories Glenmark is expected to exhibit strong growth in the US, led by Z etia FTF and a
Lupin series of other generic launches. Aurobindo should report stable US sales, driven
Ranbaxy Labs
Sanofi India by key launches (including Crestor). On the other hand, Sun and Lupin should
Sun Pharma continue witnessing a sequential decline in the US business on the back of
Torrent Pharmaceuticals competition in key products.
After a strong 1HFY17, the domestic pharma business is expected to face
headwinds from seasonal weakness and demonetization. Although the chronic
business may benefit at the margin due to demonetization, the acute segment
may be see some impact in the near term.
Among MNCs, Sanofi is likely to report better numbers, while GSK should face
some pressure from the ongoing supply issues.
The pace of approvals has picked up at the US FDA. However, the lack of key
approvals, higher R&D spends and regulatory concerns in the domestic/US
markets are likely to keep growth under check.
We maintain our top picks – Aurobindo, Sun Pharma, Fortis and Granules.
Sensex Index MOSL Health care Index Sensex Index MOSL Health care Index
120
104
110 100
100 96
90 92
80 88
Nov-16
Dec-16
Sep-16
Oct-16
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Alembic Pharma
Bloomberg ALPM IN CMP: INR605 TP: INR640 (+6%) Neutral
Equity Shares (m) 188.5
We expect Alembic Pharma (ALPM) to post 12.3% YoY decline in
M. Cap. (INR b)/(USD b) 114 / 2
3QFY17 reported sales to INR8b. International business is expected
52-Week Range (INR) 700 / 514
1,6,12 Rel Perf. (%) -4 / 7 / -15
to decline 34.4% YoY owing to lower contribution from gAbilify,
while India business is expected to witness 14.2% YoY growth aided
by strong traction within the Anti-Infective portfolio.
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
Reported EBITDA is likely to decline 55% YoY to INR1.7b, with
Sales 31.5 31.9 38.5 45.1
EBITDA margin contracting 2070bp YoY, primarily on account of
EBITDA 10.0 6.7 8.9 10.8 lower gAbilify sales in 3QFY17 numbers.
NP 4.8 4.4 5.8 6.9 We expect reported PAT to decrease 57.7% YoY to INR1.1b, in line
EPS (INR) 38.2 23.5 30.7 36.5 with operational performance.
EPS Gro. (%) 154.6 -38.4 30.4 18.8 We believe increase in competition in gAbilify, coupled with high
BV/Sh. (INR) 84.9 102.4 127.1 157.6 R&D expense and rise in depreciation due to planned capex of
RoE (%) 38.8 25.1 26.8 25.6 INR15b over next 2-3 years, will keep profit growth under check.
RoCE (%) 50.6 23.5 25.6 24.9 The stock trades at 19.7x FY18E EPS—in line with peers. We
Valuations maintain our Neutral rating with a target price of INR640 (20x
P/E (x) 15.8 25.7 19.7 16.6 FY18E EPS).
P/BV (x) 7.1 5.9 4.8 3.8
EV/EBITDA (x) 11.1 16.7 12.7 10.2
Key issues to watch out
EV/Sales (x) 3.5 3.5 2.9 2.4
Contribution of Chronic portfolio and growth strategy.
Div. Yield (%) 0.7 0.8 0.8 0.8 Performance of US operations amid market pressure.
Outlook on future ANDA launches/filings.
Alkem Labs
Bloomberg ALK EM IN CMP: INR1670 TP: INR1800 (+8%) Buy
Equity Shares (m) 119.6 After growing strongly (~20% YoY) over past two quarters,
M. Cap. (INR b)/(USD b) 200 / 3
revenues are expected to increase 13% YoY in 3Q. The slowing
52-Week Range (INR) 1853 / 1175
1,6,12 Rel Perf. (%) -3 / 25 / 5
pace of growth can be attributed to seasonal weakness and
demonetization. Additionally, we expect revenues to be weighed
Financial Snapshot (INR Billion)
down by NPPA-led downward price erosions.
Y/E March 2016 2017E 2018E 2019E
EBITDA margin is expected to decline 80bp YoY and 130bp QoQ on
Sales 49.9 59.2 68.0 80.5
the back of high base effect, seasonality factor and
EBITDA 8.5 10.7 12.5 15.3 demonetisation.
NP 7.7 9.2 10.1 11.8 We expect PAT to grow 10% YoY, while tax rate is expected to inch
EPS (INR) 64.7 77.3 84.4 98.4 up to ~14% from mid-single-digit in 1HFY17.
EPS Gro. (%) 67.4 19.3 9.3 16.6 ALK EM's US business could potentially double from ~USD150m in
BV/Sh. (INR) 293.0 354.7 420.1 496.3 FY16 to ~USD300m over next 3-4 years, driven by a strong pipeline
RoE (%) 23.8 23.9 21.8 21.5 of ~50 pending ANDAs.
RoCE (%) 17.6 22.0 20.2 25.0 Lower base effect will continue to have a positive impact, as the
Valuations US will still contribute ~22% to sales, much lower than peers at
P/E (x) 25.8 21.6 19.8 17.0 ~40%+. Maintain Buy.
P/BV (x) 5.7 4.7 4.0 3.4
EV/EBITDA (x) 23.3 18.4 15.1 11.9 Key issues to watch out
Impact of demonetization.
Update on visibility of approval post EIR at Ankleshwar facility.
Pick-up in chronic business.
Aurobindo Pharma
Bloomberg ARBP IN CMP: INR666 TP: 1050(+58%) Buy
Equity Shares (m) 585.2
We expect Aurobindo (ARBP) to post 10% YoY sales growth to
M. Cap. (INR b)/(USD b) 390 / 6
INR38.5b in 3QFY17, aided by sustained traction in the US.
52-Week Range (INR) 895 / 582
We expect US business (~58% of formulation sales) to grow 18%
1,6,12 Rel Perf. (%) -9 / -10 / -25
YoY in 3Q. Europe and RoW sales are expected to exhibit modest
3% YoY growth, while API sales are estimated to grow ~5% YoY in
3Q.
Financial Snapshot (INR Billion)
EBITDA margin is likely to expand 100bp YoY to 24.5% (stable
Y/E MARCH 2016 2017E 2018E 2019E
sequentially). Overall EBITDA is estimated to grow 15% YoY to
Sales 139.0 155.2 178.5 203.3
INR9.45b. We expect reported PAT at INR6.1b, compared to
EBITDA 32.1 37.7 44.6 50.8
NP 19.8 24.6 29.2 33.3
INR5.3b in the corresponding quarter last year.
EPS (INR) 33.9 42.0 49.9 56.9 The stock trades at 13.3x FY18E EPS, which is at ~15% discount to
EPS Gro. (%) 25.5 23.9 18.9 14.0 peers. We maintain Buy as we expect the valuation gap to narrow
BV/Sh. (INR) 120.6 160.1 207.5 261.8 on account of the company’s increasing profitability, strong
RoE (%) 32.5 29.9 27.2 24.2 earnings growth trajectory (25% CAGR) and improving free cash
RoCE (%) 20.8 20.6 20.7 19.8 flow. Maintain Buy.
Valuations
P/E (x) 19.7 15.9 13.3 11.7 Key issues to watch out
P/BV (x) 5.5 4.2 3.2 2.5 Debt reduction during the quarter.
EV/EBITDA (x) 13.2 11.2 9.2 7.7 Outlook on US business (~ 35-40 launches expected over next 12
EV/Sales (x) 3.0 2.7 2.3 1.9 months).
Div. Yield (%) 0.2 0.3 0.3 0.4 Profitability of acquired Actavis business in Europe.
Biocon
Bloomberg BIOS IN CMP: INR936 TP: INR750 (-20%) Sell
Equity Shares (m) 200.0
Biocon’s revenue is likely to increase 12% YoY to INR9.3b, driven by
M. Cap. (INR b)/(USD b) 187 / 3
18% growth in CRO division, 12% growth in bio-pharma sales and
52-Week Range (INR) 1020 / 431
1,6,12 Rel Perf. (%) 1 / 28 / 71
licensing income at INR67m.
EBITDA is expected to increase 22% YoY to INR2.2b, with EBITDA
margins at 24.3%.
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
We expect PAT to grow to INR1.4b (up 34% YoY), primarily owing to
Sales 34.5 40.5 49.2 62.2
stable revenue growth and EBITDA margin improvement. The key
EBITDA 7.9 9.6 12.1 15.4 thing to watch would be the impact of fire at the R&D center of
NP 4.6 5.4 6.9 9.0 Syngene.
EPS (INR) 23.2 27.1 34.3 45.0 K ey growth drivers for FY17E/18E will be 1) commercialization and
EPS Gro. (%) 15.5 16.5 26.5 31.4 ramp-up of the insulin plant in Malaysia, 2) ramp-up in CRO
BV/Sh. (INR) 202.7 221.9 246.1 278.0 division, 3) contribution from API/immuno-suppressants supplies to
RoE (%) 11.5 12.2 13.9 16.2 partners and 4) branded formulations in India. However, capex for
RoCE (%) 15.9 8.7 10.1 14.7 long-term initiatives is likely to exert pressure on profitability and
Valuations return ratios in the near term.
P/E (x) 40.3 34.6 27.3 20.8 The stock trades at 27.3x FY18E earnings. Maintain Sell.
P/BV (x) 4.6 4.2 3.8 3.4
EV/EBITDA (x) 24.0 19.8 15.8 12.2
Div. Yield (%) 0.5 0.7 0.9 1.2
Key issues to watch out
Update on Middle-East problems.
Progress on Rh-Insulin/Glargine in Europe/US and other out-
licensing opportunities.
Cadila Healthcare
Bloomberg CDH IN CMP: INR362 TP: INR450 (+24%) Buy
Equity Shares (m) 1023.7
Cadila Healthcare's (CDH) 3QFY17 revenue is likely to grow 6.4%
M. Cap. (INR b)/(USD b) 370 / 5
YoY to INR25.8b, driven by 5% YoY growth in the US formulations
52-Week Range (INR) 429 / 296
1,6,12 Rel Perf. (%) -10 / 11 / 9
business. Growth in the US formulations business is expected to be
largely driven by the recent launch of authorized generic of Asacol
HD.
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
Overall export formulations are expected to grow 5.4% YoY to
Sales 97.5 100.3 120.5 141.4
INR13.7b, while domestic formulation is likely to grow 13.4% YoY to
EBITDA 23.0 22.0 28.9 34.6 INR10.1b.
NP 15.8 13.9 19.2 23.4 We expect EBITDA to decline 4% YoY to INR5.5b and the margin to
EPS (INR) 15.4 13.6 18.7 22.9 contract 230bp. Adj. PAT is also likely to decline 5.5% YoY to
EPS Gro. (%) 37.7 -11.8 37.5 22.2 INR3.7b.
BV/Sh. (INR) 52.3 61.5 75.9 94.4 We believe CDH has made investments in the right areas, and will
RoE (%) 32.8 23.9 27.2 26.8 start accruing benefits over next 2-3 years. We expect sharp ramp-
RoCE (%) 23.3 18.9 22.8 23.7 up in the US business post successful remediation of Moraiya
Valuations warning letter. We estimate 10% EPS CAGR for FY16-18E, with
P/E (x) 23.5 26.6 19.4 15.8 better return ratios over next two years.
P/BV (x) 6.9 5.9 4.8 3.8 The stock trades at 19.3x FY18E EPS. Maintain Buy.
EV/EBITDA (x) 16.7 17.5 13.0 10.6
Div. Yield(%) 0 0 0 0 Key issues to watch out
Update on US FDA resolution for Moraiya facility.
Outlook for recovery in domestic formulations.
Progress on improvement in balance sheet.
Cipla
Bloomberg CIPLA IN CMP: INR568 TP: INR525 (-8%) Neutral
Equity Shares (m) 802.9
We expect Cipla’s revenues to grow 25.6% YoY to INR39b in
M. Cap. (INR b)/(USD b) 456 / 7
3QFY17.
52-Week Range (INR) 658 / 458
1,6,12 Rel Perf. (%) -2 / 14 / -16
Export formulation business is expected to grow 25.5% YoY to
INR21.7b. Domestic business is also expected to grow 15% YoY to
INR13.7b, driven by traction in Respiratory business. Impact of
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
demonetization will be the key to watch. Export API sales are
Sales 136.8 155.2 182.2 210.1
expected to report 11.8% YoY growth to INR2.4b.
EBITDA 25.0 27.3 35.5 43.1 EBITDA is likely to grow 30.3% YoY to INR6.9b, with margin
NP 15.1 14.5 20.5 26.0 expansion of 70bp to 17.7%, owing to lower gNexium sales
EPS (INR) 18.8 18.1 25.6 32.4 compared to 3QFY16. We expect reported PAT to increase 18.3%
EPS Gro. (%) 34.0 -3.8 41.2 26.6 YoY to INR4.07b.
BV/Sh. (INR) 147.4 161.8 184.4 213.7 We believe that earnings acceleration and potential upgrades on
RoE (%) 12.8 11.2 13.9 15.1 successful EU inhaler portfolio monetization would help it sustain
RoCE (%) 10.6 8.8 11.1 12.5 current multiples going forward (24x one-year forward P/E). The
Valuations stock trades at 22.2x FY18E earnings. Maintain Neutral.
P/E (x) 30.2 31.4 22.2 17.5
P/BV (x) 3.9 3.5 3.1 2.7
Key issues to watch out
EV/EBITDA (x) 20.0 18.1 13.7 10.9 Launch of combination inhaler in UK market (USD450m market
Div. Yield (%) 0.4 0.4 0.4 0.4 size).
Margin improvement in Medpro operations (acquired in July
2014).
Sustained strong growth in domestic formulations (38% of sales).
Divis Laboratories
Bloomberg DIVI IN CMP: INR753 TP: INR975 (+29%) Neutral
Equity Shares (m) 265.5
Divis Laboratories (DIVI) is likely to register 21.5% YoY growth in
M. Cap. (INR b)/(USD b) 200 / 3
3QFY17 revenue to INR10.3b on the back of lower base and muted
52-Week Range (INR) 1380 / 745
1,6,12 Rel Perf. (%) -35 / -32 / -38
2QFY17 growth.
Adjusted EBITDA is also likely to exhibit 21% YoY growth to INR3.9b,
with margins at 37.5% aided by lower raw material costs.
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
We expect PAT to increase 12.1% YoY to INR2.8b, in line with
Sales 37.7 42.9 48.4 54.8
EBITDA growth during this quarter.
EBITDA 14.1 16.1 18.4 21.1 Management expects FY17 revenue to grow at low-to-mid-teens,
NP 11.1 12.0 13.5 15.1 with EBITDA margin sustaining at 37%.
EPS (INR) 41.9 45.4 51.0 57.0 Steep correction in the stock price over past few days is attributed
EPS Gro. (%) 30.6 8.3 12.3 11.9 to form 483 observations which the company received for its Unit 2
BV/Sh. (INR) 161.5 178.4 206.4 237.8 API plant. Notably, this plant accounts for more than 60% of
RoE (%) 28.6 26.7 26.5 25.7 revenue for Divi’s. Delay in the commissioning of the new plant is
RoCE (%) 28.4 26.5 26.4 25.6 another key concern for the company.
Valuations The stock trades at 14.8x FY18E earnings. Maintain Neutral.
P/E (x) 18.0 16.6 14.8 13.2
P/BV (x) 4.7 4.2 3.6 3.2
EV/EBITDA (x) 14.2 12.2 10.5 8.9 Key issues to watch out
Div. Yield (%) 2.1 2.2 2.6 2.9 Clarity on Unit 2 483s.
Ramp-up at Vizag SEZ .
Outlook for growth beyond FY18.
Dr Reddy’s Labs
Bloomberg DRRD IN CMP: INR3,091 TP: INR3,000 (-3%) Neutral
Equity Shares (m) 170.5
Dr Reddy’s Lab is expected to report subdued numbers in 3QFY17,
M. Cap. (INR b)/(USD b) 527 / 8
with revenue declining 6.1% YoY to INR37.2b and PAT down 22.4%
52-Week Range (INR) 3689 / 2750
1,6,12 Rel Perf. (%) -4 / -8 / -3
to INR4.5b. This is primarily due to the lack of new launches in the
US and increased generic competition in gVidaza.
US business is likely to decline 13.6% YoY to INR8.96b, while Russia
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
and CIS region sales are expected to decline in single-digits due to
Sales 154.7 146.9 172.6 200.9
currency devaluation. However, India business is expected to report
EBITDA 39.1 26.5 39.7 48.8 robust 12% YoY growth in 3QFY17
NP 22.6 14.1 24.2 29 EBITDA is expected to decline 4% YoY to INR7.8b and the margin to
EPS (INR) 132.3 82.7 141.7 170 contract 430bp YoY to 21%, weighed down by higher remediation
EPS Gro. (%) 1.7 -37.5 71.3 19.9 costs and increased competition in the key products.
BV/Sh. (INR) 752 814 942 1087 PAT is expected to decline 22.4% YoY with taxes at 23% in 3QFY17.
RoE (%) 18.8 10.6 16.1 16.8 Even though near-term earnings growth is muted due to recent
RoCE (%) 13.9 7.9 12.9 14.2 warnings letters, we believe the company is focusing on the right
Valuations areas for growth in the US. Stock trades at 21.8x FY18E earnings.
P/E (x) 23.4 38.7 22.6 18.8 Maintain Neutral.
P/BV (x) 4.1 3.9 3.4 2.9
EV/EBITDA (x) 13.2 20.4 13.4 10.7
Key issues to watch out
Div. Yield (%) 0.6 0.4 0.7 0.8 Update on USFDA resolution of warning letters for Srikakulam,
Duvvada and Miryalaguda API plants.
FY18 outlook for both generics and PSAI businesses.
Glenmark Pharma
Bloomberg GNP IN CMP: INR899 TP: INR990 (+10%) Neutral
Equity Shares (m) 271.3
We expect Glenmark Pharmaceuticals (GNP) to report robust 36%
M. Cap. (INR b)/(USD b) 244 / 4
YoY growth in overall revenues to INR23.4b, driven by buoyant
52-Week Range (INR) 993 / 672
1,6,12 Rel Perf. (%) 2 / 12 / -7
performance in the US and India market.
The India branded business is likely to grow 15% YoY, while the US
generic segment is expected to grow 70.6% YoY, primarily aided by
Financial Snapshot (INR Billion)
Y/E MAR 2016 2017E 2018E 2019E
the gZ etia launch. LatAm business is expected to witness a 19% YoY
Sales 75.9 95.7 109.9 125.0
decline in 3Q sales owing to no sales in Venezuela. We also do not
EBITDA 13.7 24.7 27.3 26.9 factor any out-licensing income in our 3QFY17 assumptions.
NP 7.0 11.7 14.0 17.1 EBITDA is likely to increase 59% YoY to INR5.4b. Nevertheless, we
EPS (INR) 24.9 41.4 49.7 60.5 expect margins to increase 340bp YoY to 23% on the back of Z etia
EPS Gro. (%) 42.0 66.4 20.1 21.6 launch in Dec-16. Adjusted PAT is expected at INR3.1b, up 82.9%
BV/Sh. (INR) 151.3 202.9 260.8 317.6 YoY, aided by lower tax expenses.
RoE (%) 16.4 20.4 19.1 19.0 We expect GNP to gradually reduce its net debt over FY16-18E,
RoCE (%) 12.7 20.6 19.3 17.2 resulting in an improvement in D/E from 1.0x in FY16 to 0.6x by
Valuations FY18E. We also expect a gradual improvement in return ratios over
P/E (x) 36.1 21.7 18.1 14.9 the same period.
P/BV (x) 5.9 4.4 3.4 2.8 The stock trades at 18.1x FY18E EPS. Maintain Neutral.
EV/EBITDA (x) 20.1 11.1 9.8 9.6
Div. Yield (%) 0.2 0.3 0.3 0.3
Key issues to watch out
New ANDA filings in complex category.
Update on free-cash generation and debt repayment schedule.
Progress of NCE/NBE pipeline and potential out-licensing
prospects.
Granules India
Bloomberg GRAN IN CMP: INR110 TP: INR160 (+46%) Buy
Equity Shares (m) 216.7
We expect Granules India (GRAN) to post 5% YoY growth in 3QFY17
M. Cap. (INR b)/(USD b) 24 / 0
reported sales to INR3.6b.
52-Week Range (INR) 151 / 91
1,6,12 Rel Perf. (%) -3 / -21 / -29
However, reported EBITDA is likely to increase 8.1% YoY to
INR732m, with EBITDA margin expanding 60bp YoY, primarily owing
to lower raw material costs and better business mix.
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
We expect reported PAT to increase 43.8% YoY to INR391m, in line
Sales 14.3 14.3 16.7 24
with operational performance.
EBITDA 2.8 2.9 3.5 5.3 We expect GRAN to report 34% PAT CAGR over FY16-18E, driven by
NP 1.2 1.6 2 2.9 improving traction in finished dosages formulations. However, the
EPS (INR) 5.5 7 8 11.7 story beyond FY18 is much rosier, as we see more approvals in the
EPS Gro. (%) 22.3 27.3 14.3 46.3 US for the OTC and Rx business and ramp-up is expected in
BV/Sh. (INR) 30.7 40.9 59.2 68.3 Omnichem JV, which will drive both revenue and profitability. At
RoE (%) 21.6 20 16.5 18.3 CMP, the stock trades at 11x FY18E EPS. We maintain Buy with
RoCE (%) 14 11.5 9.9 12 target price of INR160 (@16x FY18E EPS).
Valuations
P/E (x) 20.1 15.7 13.7 9.4
Key issues to watch out
P/BV (x) 3.6 2.7 1.9 1.6
Contribution of Auctus portfolio and outlook on ANDA filings.
EV/EBITDA (x) 11 11.4 8.6 6.1
Performance of Omnichem JV operations.
Div. Yield (%) 0.6 0.9 1.4 2
Outlook for growth beyond FY18E.
GSK Pharma
Bloomberg GLXO IN CMP: INR2,747 TP: INR3,150 (+15%) Neutral
Equity Shares (m) 84.7
In 3QFY17, we expect GlaxoSmithK line Pharmaceuticals (GLXO) to
M. Cap. (INR b)/(USD b) 233 / 3
report 10% YoY increase in revenues to INR8b.
52-Week Range (INR) 3850 / 2600
EBITDA is also likely to increase 48.3% YoY to INR1.5b, with the
1,6,12 Rel Perf. (%) -2 / -19 / -20
margin expanding 490bp YoY to 19%.
We expect adjusted PAT to increase 40.2% YoY to INR1.16b. Growth
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
and profitability are expected to gradually improve with volume
ramp-up in key NLEM products.
Sales 27.4 30.5 34.3 38.4
EBITDA 4.5 4.9 6.2 7.6
We believe GLXO has strong parent support, superior brand
NP 3.7 4.3 5.2 6.1 portfolio (competitive advantage), high payout ratio (~100%) and
EPS (INR) 44.2 50.4 61.8 71.6 industry-leading return ratios (RoCE of 50%+).
EPS Gro. (%) -29.2 14.1 22.6 16.0 However, the current valuation of 44.5x FY18E EPS adequately
BV/Sh. (INR) 200.2 170.1 151.4 142.5 reflects the recovery in business over this period, in our view.
RoE (%) 22.1 29.6 40.8 50.3 Maintain Neutral.
RoCE (%) 21.2 27.2 38.4 48.7
Valuations
P/E (x) 62.2 54.5 44.5 38.4
P/BV (x) 13.7 16.1 18.1 19.3 Key issues to watch out
EV/EBITDA (x) 48.5 45.7 36.4 29.9 New product introductions in FY17-18E.
Div. Yield (%) 2.4 2.5 2.5 2.5 Market performance of products impacted by DPCO 2013.
Ipca Laboratories
Bloomberg IPCA IN CMP: INR550 TP: INR540 (-2%) Neutral
Equity Shares (m) 126.2
We expect Ipca Laboratories (IPCA) to witness 18.4% YoY growth in
M. Cap. (INR b)/(USD b) 69 / 1
overall revenues, aided by strong domestic anti-malarial sales.
52-Week Range (INR) 744 / 402
Domestic formulation is expected to exhibit robust 16% YoY
1,6,12 Rel Perf. (%) -2 / 16 / -29
growth, while total API sales would witness 34.4% YoY growth.
EBITDA is likely to grow 36.5% YoY, with margin improving 200bp
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
YoY to 15% in 3QFY17. However, profitability is still lower due to
negative operating leverage (US import alerts and weak traction in
Sales 28.9 32.7 38.1 44.6
EBITDA 3.4 4.9 6.6 8.2
institutional business).
NP 1.3 2.1 3.7 4.9 We expect reported PAT to improve to INR567m, with taxes at 30%
EPS (INR) 10.5 17.0 29.4 39.0 in 3QFY17.
EPS Gro. (%) -46.9 61.8 72.8 32.7 While we believe that the regulatory overhang would weigh on
BV/Sh. (INR) 181.0 195.4 220.4 253.6 valuation multiples, growth in the domestic business remains
RoE (%) 5.9 9.0 14.1 16.5 healthy. We expect IPCA to clock FY16-18E EPS CAGR of 75% on the
RoCE (%) 5.5 7.9 12.1 14.1 back of 15% revenue CAGR and recovery in EBITDA margin to 18%.
Valuations Stock trades at 18.7x FY18E EPS. Maintain Neutral.
P/E (x) 52.3 32.3 18.7 14.1
P/BV (x) 3.0 2.8 2.5 2.2
EV/EBITDA (x) 15.1 11.9 11.9 0.0
Div. Yield (%) 0.0 0.5 0.8 1.1 Key issues to watch out
Update on resolution of USFDA regulatory issues.
Outlook for institutional tender business.
Impact of emerging market currency weakness.
Lupin
Bloomberg LPC IN CMP: INR1,494 TP: INR1,825 (+22%) Buy
Equity Shares (m) 447.5
We expect Lupin's (LPC) 3QFY17 revenue to grow 19.4% YoY to
M. Cap. (INR b)/(USD b) 669 / 10
IN42.4b, aided by buoyant performance in US generic segment
52-Week Range (INR) 1912 / 1294
(gGlumetza and gFortamet sales, consolidation of Gavis financials).
1,6,12 Rel Perf. (%) -4 / -2 / -21
India business is expected to exhibit 13% YoY growth to INR9.8b.
Japan sales are expected to improve 20.3% YoY to INR4.5b in
Financial Snapshot (INR Billion)
3QFY17, aided by currency tailwinds.
Y/E MARCH 2016 2017E 2018E 2019E
EBITDA is estimated to improve 19.7% YoY to INR10.5b, with
Sales 142.1 174.6 205.6 232.1
EBITDA margin at 24.7%.
EBITDA 37.5 45.2 55.1 63.8
Reported PAT is likely to grow 17.8% YoY to IN6.2b, slower than
NP 22.7 27.7 34.7 40.1
EPS (INR) 50.4 61.6 77.0 89.0
EBITDA growth, due to higher interest expenses.
EPS Gro. (%) -5.7 22.2 25.1 15.5 K ey growth drivers for FY17/18 will be the strong product pipeline
BV/Sh. (INR) 243.8 295.6 362.1 440.6 for the US, including higher contribution from oral contraceptives
RoE (%) 22.9 22.8 23.4 22.2 and launches in niche areas of ophthalmic and dermatology. The
RoCE (%) 16.8 15.3 16.4 16.4 stock trades at 19.4x FY18E EPS. Maintain Buy.
Valuations
P/E (x) 29.6 24.3 19.4 16.8
Key issues to watch out
P/BV (x) 6.1 5.1 4.1 3.4
Gavis sales ramp-up.
EV/EBITDA (x) 19.5 15.6 12.5 10.4
Div. Yield (%) 0.5 0.6 0.6 0.6
Outlook on future ANDA launches and Gavis integration.
Impact of new competition in Glumetza and Fortamet.
Outlook on inorganic growth initiatives.
Sanofi India
Bloomberg SANL IN CMP: INR4,290 TP: INR5,200 (+21%) BUY
Equity Shares (m) 23.0
We expect Sanofi India's (SANL) revenue to grow 8.1% YoY in
M. Cap. (INR b)/(USD b) 99 / 1
4QCY16 to INR6.1b. High growth of brands like Lantus, Allegra,
52-Week Range (INR) 4770 / 3850
Amaryl M, Enterogermina, Avila, Vaxlgrip and Cardace, and new
1,6,12 Rel Perf. (%) -1 / -5 / -5
product launches should drive SANL’s revenue growth.
EBITDA is also likely to grow 27.4% YoY to INR1.4b during this
Financial Snapshot (INR Billion)
quarter.
Y/E December 2015 2016 2017E 2018E
We expect PAT to increase 14.8% YoY to INR809m.
Sales 21.9 23.9 27.0 30.5
EBITDA 4.6 5.6 6.5 7.4
We expect earnings growth momentum to sustain over next few
Net Profit 2.4 3.3 4.0 4.6 years, led by strong revenue CAGR of 13% over CY15-17E and
Adj. EPS (INR) 103.2 142.2 172.8 198.9 ~210bp margin expansion from current levels.
EPS Gr. (%) 20.6 37.8 21.6 15.1 The stock trades at 24.8x CY17E EPS. Maintain Buy.
BV/Sh. (INR) 725.2 797.8 889.4 1,007.1
RoE (%) 14.2 17.8 19.4 19.7
RoCE (%) 16.1 17.8 19.6 20.2
Payout (%) 41.6 49.0 47.0 40.8
Key issues to watch out
Valuations
Amortization of goodwill and brands acquired from Universal
P/E (x) 41.6 29.9 24.6 21.4
Medicare.
P/BV (x) 5.9 5.3 4.8 4.2
Clarity on nature of reversal of recently withdrawn NPPA
EV/EBITDA (x) 20.3 16.0 13.5 11.5
guidelines.
Div. Yield (%) 1.2 1.4 1.6 1.6
Sun Pharma
Bloomberg SUNP IN CMP: INR638 TP: INR925 (+45%) Buy
Equity Shares (m) 2406.1
Sun Pharmaceuticals (SUNP) is likely to register 13.5% YoY growth in
M. Cap. (INR b)/(USD b) 1534 / 23
revenues, primarily driven by Benicar AG launch.
52-Week Range (INR) 898 / 572
India business is expected to grow 9% YoY to INR20.6b, while the
1,6,12 Rel Perf. (%) -12 / -15 / -24
US business is likely to report 11.1% YoY jump in revenues.
We expect margins to improve to 33.4% in 3QFY17 compared to
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
30.6% in 3QFY16. Overall EBITDA is expected to grow 23.7% YoY to
INR26.8b over a low base.
Sales 277.4 309.3 334.0 373.5
EBITDA 79.6 97.6 115.1 132.7
We expect total reported PAT at INR17.5b, compared to INR14.1b
NP 47.1 66.9 91.3 103.2 in 3QFY16 and INR22.3b in 2QFY17.
EPS (INR) 19.6 30.6 37.9 42.9 We believe SUNP is an attractive Indian play on specialty business in
EPS Gro. (%) -0.7 56.4 24.0 13.1 the US. We maintain Buy rating in light of its multiple earnings
BV/Sh. (INR) 130.5 143.5 174.4 210.3 triggers (MK -3222, RBXY integration benefits and specialty product
RoE (%) 16.5 20.3 23.9 22.3 pipeline), superior execution track record, high RoIC (30%) and
RoCE (%) 18.7 22.3 24.8 23.9 cash-rich balance sheet (net cash of USD850m). The stock trades at
Valuations 16.8x FY18E EPS.
P/E (x) 32.6 23.0 16.8 14.9
P/BV (x) 4.9 4.4 3.7 3.0
Key issues to watch out
EV/EBITDA (x) 18.4 14.0 11.1 9.0
Update on resolution of USFDA warning letter and 483
Div. Yield (%) 0.0 0.9 0.9 0.9
observations on Halol.
Turnaround of Ranbaxy’s business.
Outlook on competitive landscape for Taro’s products.
Torrent Pharmaceuticals
Bloomberg TRP IN CMP: INR1,351 TP: INR1,750 (+30%) Buy
Equity Shares (m) 169.2
We expect Torrent Pharmaceuticals (TRP) to post 4% YoY decline in
M. Cap. (INR b)/(USD b) 229 / 3
3QFY17 reported sales to INR14.7b. US business is expected to
52-Week Range (INR) 1768 / 1186
decline 36.3% YoY owing to lower contribution from gAbilify, while
1,6,12 Rel Perf. (%) 0 / -1 / -11
India business is expected to witness 13% YoY growth with
successful integration of Elder’s portfolio.
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
Reported EBITDA is likely to decline 42% YoY to INR3.5b, with
EBITDA margin contracting 1570bp YoY, primarily on account of
Sales 66.8 60.8 70.8 82.2
EBITDA 27.2 15.2 18.4 22.2
lower gAbilify sales in 3QFY17 numbers.
NP 10.1 9.8 13.3 16.2 We expect reported PAT to decrease 35.4% YoY to INR2.25b, in line
EPS (INR) 59.7 57.7 78.4 96.0 with operational performance.
EPS Gro. (%) 78.9 -3.4 35.8 22.4 We expect core earnings (excluding one-offs) trajectory to remain
BV/Sh. (INR) 200.3 237.2 287.2 348.6 strong (forecast 20% CAGR over FY16-18E) as we think margin
RoE (%) 34.4 26.4 29.9 30.2 upside in domestic portfolio is still not fully reflected. The stock
RoCE (%) 40.7 19.3 25.4 27.7 trades at 17.2x FY18E EPS, which is at 20% premium over its last
Valuations five-year average valuations. Maintain Buy.
P/E (x) 22.6 23.4 17.2 14.1
P/BV (x) 6.7 5.7 4.7 3.9
Key issues to watch out
EV/EBITDA (x) 8.9 16.1 12.8 12.8
Contribution of Elder Pharma portfolio and growth strategy.
Div. Yield (%) 2.6 1.3 1.7 2.1 Performance of Brazilian operations amid market pressure.
Outlook on future ANDA launches.
Logistics
Company name EX IM trade continues to suffer
Allcargo No major impact of demonetization on EX IM trade
Concor
EX IM originating container rail volume declined ~ 2% YoY in October-November 2016
Gateway Distriparks
as trade continues to be weak.
Margins are unlikely to see meaningful improvement due to increased competitive
intensity.
Sequential improvement in earnings for CCRI would be due to low base in 2QFY17.
GDPL’s earnings are likely to be flat sequentially.
0.8
0.8
0.8
0.8
0.7
0.7
0.7
0.7
0.8
0.8
0.8
0.8
0.6
0.6
0.7
0.7
0.7
0.7
0.9
0.8
Apr'15
May'15
Apr'16
May'16
June'15
Aug'15
Dec'15
June'16
Aug'16
Apr'15
May'15
Apr'16
May'16
June'15
Aug'15
Dec'15
June'16
Aug'16
Sep'15
Jan'16
Feb'16
Mar'16
Sep'16
Sep'15
Jan'16
Feb'16
Mar'16
Sep'16
Oct'16
July'15
Oct'15
July'16
July'15
Oct'15
July'16
Oct'16
Nov'15
Nov'16
Nov'15
Nov'16
Source: Indian Rail, MOSL Source: Indian Rail, MOSL
Exhibit 4: EX IM lead distance declined YoY in October- Exhibit 5: Domestic lead distance flat YoY for October-
November 2016 November 2016
EXIM average lead (kms) YoY (%) Domestic average lead (kms) YoY (%)
(0) (2) (0) (3) (2) (2) 1 4 6 3 2 0 3
(4) (5) (4) (3) (2) (7) (6)
(3)
(7) (7) (7) (5) (8) (2) 1
(4) (4) (5) (3) (4)
(8) (6) (10) (7) (7) (10)(10)
1,362
1,381
1,364
1,375
1,369
1,382
1,418
1,295
1,304
1,368
1,388
1,452
1,446
1,419
1,334
1,390
1,393
1,386
1,359
1,337
948
907
921
923
932
926
917
927
908
910
913
930
882
857
890
861
864
860
871
856
Apr'15
May'15
Apr'16
May'16
Apr'15
May'15
Apr'16
May'16
June'15
Aug'15
Dec'15
June'16
Aug'16
June'15
Aug'15
Dec'15
June'16
Aug'16
Sep'15
Jan'16
Feb'16
Mar'16
Sep'16
Sep'15
Jan'16
Feb'16
Mar'16
Sep'16
July'15
Oct'15
July'16
Oct'16
July'15
Oct'15
July'16
Oct'16
Nov'15
Nov'16
Nov'15
Nov'16
Source: Indian Rail, MOSL Source: Indian Rail, MOSL
Jul-16
Jun-15
Jun-16
Nov-15
Apr-15
May-15
Apr-16
May-16
Aug-15
Dec-15
Aug-16
Jan-15
Feb-15
Mar-15
Sep-15
Jan-16
Feb-16
Mar-16
Sep-16
Oct-15
Oct-16
Jul-15
Jul-16
Nov-15
Nov-16
May-15
May-16
Jan-15
Mar-15
Sep-15
Jan-16
Mar-16
Sep-16
Allcargo
Bloomberg AGLL IN CMP: INR179 TP: INR196 (+9%) Buy
Equity Shares (m) 252.1
We expect AGLL to report EBITDA of INR1.3b (+11% YoY, +4% QoQ)
M. Cap. (INR b)/(USD b) 45 / 1
and PAT of INR680m (+10% YoY, +6% QoQ), led by volume growth
52-Week Range (INR) 222 / 135
1,6,12 Rel Perf. (%) 8 / 3 / -13
and higher margins.
We estimate MTO volumes at 125k TEU (-2% QoQ, +8% YoY) and
Financial snapshot (INR b)
CFS volumes at 73k TEU (+6% QoQ, +11% YoY); the rise in volumes
Y/E March 2016 2017E 2018E 2019E would be led by recovery in macro trade.
Sales 56.6 57.9 62.2 67.1 We estimate EBITDA/PAT CAGR of 5%/10% over FY16-18, and
EBITDA 5.2 5.1 5.7 5.9 expect return ratios to improve from ~13% to ~17%, driven by
NP 2.7 2.6 3.2 3.6 margin expansion and reduction in capex intensity in the business.
EPS (INR) 10.8 10.5 12.8 14.3 The stock trades at 14x FY18E EPS of INR12.8. Maintain Buy.
EPS Growth (%) 17.2 (2.7) 22.1 11.7
BV/Share (INR) 87.5 71.0 81.2 92.5
RoE (%) 13.2 13.3 16.9 16.5
RoCE (%) 11.2 10.8 13.7 13.9
Valuations
P/E (x) 16.6 17.0 14.0 12.5 Key issues to watch for
P/BV (x) 2.0 2.5 2.2 1.9 (a) Volume data, and (b) set up of logistics park in Jhajjar.
EV/EBITDA (x) 9.4 8.5 7.1 6.1
Concor
Bloomberg CCRI IN CMP: INR1,151 TP: INR1,317(+14%) Neutral
Equity Shares (m) 195.0
We expect CCRI to report net sales of INR13.4b (-5% YoY, -3%
M. Cap. (INR b)/(USD b) 224 / 3
QoQ), led by (a) realization decline of 12% YoY (flat QoQ), and (b)
52-Week Range (INR) 1544 / 1051
1,6,12 Rel Perf. (%) 2 / -19 / -19
volume growth of 8% YoY (decline of 2% QoQ).
We expect EXIM volumes to improve 7% YoY and expect domestic
Financial snapshot (INR b) volumes to grow 15% YoY.
Y/E March 2016 2017E 2018E 2019E We estimate EBITDA at INR2.6b (-6% YoY, +15% QoQ) and PAT at
Sales 63.1 59.8 65.0 73.0
INR1.8b (-12% YoY, +15% QoQ).
EBITDA 11.6 10.5 13.0 14.3
The stock trades at 15.4x/13.9x FY18E/FY19E EV/EBITDA. CCRI
NP 7.9 7.1 9.0 9.8
remains a direct play on the upcoming dedicated freight corridor
EPS (INR) 40.6 36.3 45.9 50.2
(DFC) project, which will multiply its asset turnover and
EPS Gr. (%) -24.9 -10.7 26.6 9.3
significantly improve profitability. Neutral.
BV/Sh (INR) 409.4 431.0 458.3 488.2
RoE (%) 10.2 8.6 10.3 10.6
RoCE (%) 9.8 8.3 10.0 10.3
Payout (%) 40.0 40.5 40.5 40.5
Valuations Key issues to watch for
P/E (x) 28.3 31.7 25.1 22.9 EX IM and domestic volumes, and realizations.
P/BV (x) 2.8 2.7 2.5 2.4 Progress on MMLPs and DFC projects.
EV/EBITDA (x) 17.1 19.2 15.4 13.9
Div. Yield (%) 1.2 1.1 1.3 1.5
Gateway Distriparks
Bloomberg GDPL IN CMP: INR255 TP: INR313 (+23%) Buy
Equity Shares (m) 108.6
We expect GDPL to report net sales of INR2.9b (+10% YoY, +3%
M. Cap. (INR b)/(USD b) 28 / 0
52-Week Range (INR) 360 / 206
QoQ), led by increased volumes in Rail and CFS businesses.
1,6,12 Rel Perf. (%) 9 / -16 / -23
We estimate EBITDA at INR592m (-4% YoY, +2% QoQ) and EBITDA
margin at 20.1%. We estimate adjusted PAT at INR243m (-17% YoY,
Financial snapshot (INR b) -3% QoQ).
Y/E March 2016 2017E 2018E 2019E The stock trades at 9.9/8x FY18E/FY19E adjusted EV/EBITDA.
Sales 10.5 11.6 12.3 14.0
GDPL remains a direct play on the upcoming dedicated freight
EBITDA 2.5 2.4 2.9 3.5
corridor project, which will multiply its asset turnover and
NP 1.2 1.0 1.7 2.2
significantly improve profitability. Buy.
EPS (INR) 11.4 9.6 15.6 20.0
EPS (INR)* 8.7 7.6 11.7 14.3
EPS Gr. (%)* -31.3 -12.8 54.1 22.5 Key issues to watch for
RoE (%) 10.1 8.3 12.8 15.2
Volume growth, realization and per TEU profitability.
RoCE (%) 7.5 7.7 10.7 12.7
Payout (%) 81.7 59.0 45.1 45.4
Valuations
P/E (x) 22.4 26.6 16.3 12.7
Adj. P/E (x) 29.4 33.7 21.9 17.8
EV/EBITDA (x) 2.2 2.2 2.0 1.9
EV/EBITDA (x)* 11.8 12.5 9.9 8.0
Div. Yield (%) 16.6 17.6 14.0 11.5
* Adjusted for Blackstone’s stake
Media
Company name Demonetization-led pain to be felt across Media
D B Corp Aggregate earnings to remain flat
Dish TV India Expect muted ad revenue growth: We expect ad revenue for our Media universe to
Hathway Cable & Datacom grow at a meager ~1% YoY, lower than the 7-13% growth in the preceding four
HT Media quarters. Both broadcasters and print companies are likely to face the brunt of
Jagran Prakashan demonetization. The ad pain is expected to be more debilitating for print media,
PVR given higher reliance on local/retail advertisers, who are most impacted by the cash
Sun TV
squeeze. Z ee’s ad growth is expected to moderate to ~4% YoY after six quarters of
strong ad revenues. Apart from FMCG, Telecom, Auto, Consumer Durables, and
Z ee Entertainment
Traditional Retail too have cut back on ad spends. Regional/niche channels and
publishers are expected to take a bigger hit. Our industry interactions suggest that a
full recovery could be expected by 1QFY18.
Expect aggregate Media universe earnings to remain flat YoY: Aggregate Media
sector earnings are expected to remain flat YoY, largely led by a decline in
profitability of print and distribution platforms. Z ee/SUNTV are expected to clock
earnings growth of 10%/13% YoY. Within the print pack, DB Corp, Jagran, HT Media
and HMVL’s earnings are expected to decline by 3%, 16%, 31% and 9%, respectively.
While DB Corp’s relative outperformance v/s its print peers is courtesy a lower base,
Jagran is expected to report a lower dip in profitability than smaller UP rivals HT
Media/HMVL due to its stronger foothold in the government ad revenue pie. Dish
TV too is expected to see an impact on profitability as both recharges and activation
take a hit following demonetization. However, normalization of the same is
expected to be swift.
Expect monetization to improve over the next two quarters for Pay TV operators;
increased activity toward Phase III seeding: We expect monetization for Pay TV
operators to improve over the next two quarters as all stay orders on DAS III
implementation have been now lifted by the Delhi High Court. This should drive
increased MSO share in digital cable revenue—the key to improve economics of
MSOs as well as pricing for broadcasters and DTH operators. However, with Phase
I/II monetization remaining sub-par, we expect MSOs to be more cautious in Phase
III markets. We expect subscriber additions to remain flat QoQ for Dish TV due to
demonetization. We model 0.6m gross additions for Dish TV during the quarter
compared with an estimated 0.67m in 2QFY17.
-5
-8
11
4 4 4
2
11.6
1QFY14
2QFY14
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17E
29,000 500
22,000 350
15,000 200
Jun-08
Jun-09
Jun-10
Jun-11
Jun-12
Jun-13
Jun-14
Jun-15
Jun-16
Dec-08
Dec-09
Dec-10
Dec-11
Dec-12
Dec-13
Dec-14
Dec-15
Dec-16
Sensex Index MOSL Media Index Sensex Index MOSL Media Index
102 120
99 110
96 100
93 90
90 80
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
D B Corp
Bloomberg DBCL IN CMP: INR374 TP: INR450 Buy
Equity Shares (m) 183.4
We expect ad growth for print media to be impacted by
M. Cap. (INR b)/(USD b) 69 / 1
demonetization. Print media companies receive ~55% of ad
52-Week Range (INR) 448 / 287
1,6,12 Rel Perf. (%) 3 / -1 / 11
revenues from local advertisers that have been most impacted.
Despite low base, we expect weak 2% YoY ad growth (~INR4b) for
DBCL in 3QFY16. Circulation revenue is likely to grow 11% YoY to
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
INR1.27b.
Net Sales 20.5 22.8 25.7 28.7
DBCL’s aggregate revenue is likely to grow 5% YoY to INR6.13b, as
EBITDA 5.4 6.4 7.3 8.2 print ad revenue, which accounts for ~65% of overall revenue,
Adj. Net Profit 3.0 3.7 4.3 5.0 remains under pressure.
Adj. EPS (INR) 16.2 20.0 23.5 27.4 Raw material cost is expected to increase 2% YoY despite an
Adj. EPS Gr. (%) -7.4 23.6 17.6 16.2 expected 5% YoY growth in newsprint prices. DBCL has been trying
BV/Sh (INR) 73.3 82.3 92.9 105.2 to reduce newsprint consumption to salvage margins. We expect
RoE (%) 22.6 25.7 26.9 27.6 EBITDA margin to decline by ~240bp YoY to 29.5%.
RoCE (%) 20.0 23.0 24.3 25.2 Startup losses related to the Bihar footprint expansion are
Div. Payout (%) 81.5 55.0 55.0 55.0 expected to continue at 2Q levels.
Valuations We estimate net profit at INR1.04b, down 3% YoY.
P/E (x) 23.1 18.7 15.9 13.7 We have cut our FY17/FY18 ad revenue estimates by ~6% each,
P/BV (x) 5.1 4.5 4.0 3.6 and consequently, our EPS estimates by 8%/9% to factor in the
EV/EBITDA (x) 12.9 10.4 8.9 7.6
demonetization impact. We revise our target price to INR450 (17x
Div. Yield (%) 2.9 2.5 2.9 3.3
December 2018E EPS). The stock trades at 18.7x/15.9 FY17E/FY18E
EPS. Buy.
Key things to watch for
YoY ad growth (we expect 2%).
EBITDA margin (we expect 29.5%).
Quarterly Performance (INR Million)
Y/E March FY16 FY17 FY17E
FY16
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Sales 4,734 4,781 5,859 5,143 5,704 5,287 6,137 5,706 20,516 22,835
YoY (%) -3.2 -0.4 5.6 5.9 20.5 10.6 4.8 11.0 1.9 11.3
Operating Expenses 3,515 3,654 3,991 4,001 3,892 3,782 4,326 4,391 15,161 16,391
EBITDA 1,218 1,127 1,868 1,142 1,812 1,505 1,811 1,315 5,355 6,443
YoY (%) -9.5 -8.7 1.2 -4.4 48.7 33.6 -3.1 15.2 -5.6 20.3
EBITDA margin (%) 25.7 23.6 31.9 22.2 31.8 28.5 29.5 23.0 26.1 28.2
Depreciation 208 215 233 222 211 216 227 226 878 880
Interest 21 27 19 24 34 6 25 26 92 91
Other Income 68 53 37 122 41 41 51 52 281 187
PBT 1,057 938 1,654 1,017 1,608 1,325 1,610 1,115 4,666 5,660
Tax 393 337 585 375 568 440 572 400 1,690 1,981
Effective Tax Rate (%) 37.2 35.9 35.4 36.8 35.3 33.2 35.5 35.9 36.2 35.0
Adj PAT 665 601 1,068 642 1,040 885 1,039 714 2,976 3,679
YoY (%) -16.0 -11.8 1.6 0.4 56.5 47.3 -2.8 11.2 -7.3 23.6
Dish TV India
Bloomberg DITV IN CMP: INR85 TP: INR115 Buy
Equity Shares (m) 1064.8
We expect DITV’s revenue to increase 3% YoY and 2% QoQ on a
M. Cap. (INR b)/(USD b) 90 / 1
reported basis to INR7.93b.
52-Week Range (INR) 110 / 65
1,6,12 Rel Perf. (%) -2 / -13 / -19
Subscription revenue is expected to increase 2% QoQ to INR7.42b as
demonetization is expected to impact both monthly recharges as
well as fresh set-top box seeding.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
We expect gross additions of 0.6m and net additions of 0.28m. ARPU
Net Sales 30.6 31.7 36.0 40.7
is expected to be flat QoQ at INR162 per subscriber per month.
EBITDA 10.2 10.9 13.0 15.7 EBITDA margin is expected to be largely flat QoQ at 34.4%.
Adj. NP 6.9 2.1 3.6 5.4 We expect net profit of INR0.44b in 3QFY17.
Adj. EPS (INR) 6.5 2.0 3.3 5.1 The stock trades at EV/EBITDA of 8.8x FY17E and 6.9x FY18E. Buy.
Adj. EPS Gr.(%) NA -69.7 69.4 52.5
BV/Sh (INR) 3.6 5.5 8.9 14.0
RoE (%) NA 43 46 45
RoCE (%) 12.7 11.4 14.3 18.1
Div. Payout(%) NA NA NA NA
Valuations
P/E (x) 13 43 25 17 Key things to watch for
P/BV (x) NA 15.3 9.6 6.1 Quarterly gross adds (we expect 0.6m).
EV/EBITDA (x) 9.6 8.8 6.9 5.5 ARPU (we expect INR162).
EV/Sub (INR) 6,789 6,082 5,152 4,514 EBIDTA margin (we expect 36.2%)
Hathway Cable
Bloomberg HATH IN CMP: INR37 TP: INR47 Buy
Equity Shares (m) 830.5
We expect standalone revenue to grow 5% QoQ to INR3.38b.
M. Cap. (INR b)/(USD b) 31 / 0
Cable subscription revenue is expected to grow 5% QoQ to
52-Week Range (INR) 45 / 24
1,6,12 Rel Perf. (%) 1 / 10 / -19
INR1.16b.
EBITDA is expected to grow 7% QoQ to INR569m on overall basis,
and 11% QoQ on an ex-activation basis to INR349m. EBITDA margin
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
is likely to largely remain flat QoQ at ~16.8%. On an ex-activation
Net Sales 20.8 22.7 26.4 29.3
basis too, EBITDA margin is likely to largely remain flat QoQ at 10%
EBITDA 3.9 4.0 5.7 7.3 We expect net loss to largely remain flat QoQ at INR0.41b in
EBITDA # 1.6 2.2 5.1 6.9 3QFY17.
Adj. NP -1.6 -2.0 -1.1 0.2 The stock trades at attributable EV/EBITDA (ex-activation) of 27.4x
Adj. EPS (INR) -1.9 -2.4 -1.4 0.3 FY17E and 11.9x FY18E. Maintain Buy.
Adj. EPS Gr. (%) NA NA NA NA
BV/Sh (INR) 16.3 13.2 11.5 11.8
RoE (%) -11.3 -16.6 -11.0 2.3
RoCE (%) -2.6 -4.7 -0.1 6.9
Valuations
Key things to watch for
P/E (x) -19.4 -15.0 -27.1 134.9
EV/EBITDA (x)* 15.4 15.1 10.7 8.1
Cable subscription revenue growth (we expect 5% QoQ).
EV/EBITDA (x)*# 37.2 27.3 11.9 8.6
EBITDA margin (we expect 16.8%).
EV/Sub (INR)* 4,858 4,928 4,965 4,819 EBITDA margin (ex-activation) (we expect 10%).
* Based on attributable EBITDA and subs post
minority stake; # (ex-activation)
HT Media
Bloomberg HTML IN CMP: INR75 TP: INR85 Neutral
Equity Shares (m) 232.8
We expect revenue to decline 3% YoY to INR6.59b.
M. Cap. (INR b)/(USD b) 17 / 0
Print ad revenue is likely to decline 8% YoY to INR4.71b, impacted
52-Week Range (INR) 96 / 70
1,6,12 Rel Perf. (%) 3 / -5 / -22
by languishing English print ad revenue and demonetization. Hindi
ad revenue is also likely to decline 5% YoY to INR1.72b.
Radio ad revenue growth is expected to moderate to 18% YoY to
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
INR381m.
Net Sales 25.0 25.7 28.6 31.2
We expect circulation revenue to increase 4% YoY to INR0.8b.
EBITDA 3.1 2.8 3.4 3.7 EBITDA margin is expected to decline by ~220bp YoY to 15.2%.
Adj. NP 1.7 1.2 1.6 1.8 Adjusted net profit is likely to decline YoY to INR0.47b, primarily led
Adj. EPS (INR) 7.3 5.4 7.0 8.0 by higher interest outgo related to new radio licenses and trickle-
Adj. EPS Gr. (%) -16.2 -26.1 29.4 14.5 down impact of revenue decline.
BV/Sh (INR) 99.2 106.5 115.5 125.7 The stock trades at 13.8x FY17E and 10.7x FY18E EPS. We revise
RoE (%) 7.7 5.2 6.3 6.6 our target price to INR85 (11x December 2018E EPS). Neutral.
RoCE (%) 8.7 7.0 7.9 8.4
Div. Payout (%) 4.3 4.3 4.3 4.3
Valuations
P/E (x) 10.2 13.9 10.7 9.4
P/BV (x) 0.8 0.7 0.6 0.6
Key things to watch for
EV/EBITDA (x)* 4.6 4.6 3.1 2.2 YoY English ad growth (we expect 9% YoY de-growth).
Div. Yield (%) 0.4 0.3 0.4 0.5 Hindi ad growth (we expect 5% YoY de-growth).
* Proportionate
EBITDA margin (we expect 9.4%).
Jagran Prakashan
Bloomberg JAGP IN CMP: INR181 TP: INR215 Buy
Equity Shares (m) 326.9
We expect advertising revenue to grow 3% YoY to INR4.45b.
M. Cap. (INR b)/(USD b) 59 / 1
Advertising revenue (ex-Radio) is expected to grow 3% YoY to
52-Week Range (INR) 213 / 144
1,6,12 Rel Perf. (%) 4/4/6
INR3.78b. We expect circulation revenue to grow 4% YoY to
INR1.06b.
We estimate Radio revenue at INR0.68b and EBITDA at INR0.23b.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
Aggregate revenue is expected to grow 1% YoY to INR5.83b.
Net Sales 21.1 22.9 25.4 28.3
We estimate EBITDA at INR1.59b and EBITDA margin at 27.2%.
EBITDA 6.0 6.3 7.1 8.0 Adjusted earnings are expected at INR0.78b, down 16% YoY.
Adj. NP 3.4 3.5 4.0 4.5 While our numbers factor in a further 3% cut in FY18 EPS for
Adj. EPS (INR) 10.5 10.8 12.2 13.9 demonetization impact, our target price remains unchanged at
Adj.EPS Gr (%) 44.6 2.7 13.8 14.0 INR215 (16x December 2018E EPS). The stock trades at 16.7x FY17E
BV/Sh (INR) 49.3 55.4 63.5 73.4 and 14.7x FY18E EPS. Buy.
RoE (%) 24.7 20.7 20.6 20.4
RoCE (%) 24.8 16.6 16.9 17.1
Div. Payout (%) 40.5 38.1 33.5 29.4
Valuations
P/E (x) 17.2 16.7 14.7 12.9
P/BV (x) 3.7 3.2 2.8 2.5 Key things to watch for
EV/EBITDA (x) 10.1 9.1 7.9 6.8 YoY ad growth (we expect 3%).
Div. Yield (%) 2.0 1.9 1.9 1.9 YoY ad growth (ex-Radio City) (we expect ~ 3%).
EBITDA margin (we expect 27.2%).
PVR
Bloomberg PVRL IN CMP: INR1,173 TP: INR1,429(+22%) Buy
Equity Shares (m) 46.7
Hindi movie, D ang al reported stellar net box office collection (NBO)
M. Cap. (INR b)/(USD b) 55 / 1
of INR2.4b until December 31, 2016 in India. This should boost
52-Week Range (INR) 1334 / 646
1,6,12 Rel Perf. (%) 9 / 19 / 42
3QFY17 performance of PVR, which has ~20% market share.
We broadly expect average ticket prices (ATP) to remain flattish,
Financial Snapshot (INR Billion) given poor content overall (except for D ang al), SPH improvement
Y/E March 2016 2017E 2018E 2019E of ~5%, and advertisement income growth of 10-11%. SSG is
Sales 18.7 21.2 26.0 32.8 expected to decline ~3% – the decline would be lower than we had
EBITDA 3.3 3.5 4.8 6.2 anticipated initially. The base quarter was very strong, with 19.7%
NP 1.2 1.0 1.7 2.7 footfall growth to 18.8m and 37% occupancy.
EPS (INR) 25.5 20.4 35.8 57.0 On a high base, we expect 10% revenue growth to INR5.5b. EBITDA
EPS Gr (%) 664.3 -20.2 75.9 58.9 is expected to increase 3.3% to INR881m, while EBITDA margin is
BV/Sh (INR) 186.2 204.0 234.4 282.9 expected to decline 100bp to 16%.
RoE (%) 18.7 10.4 16.4 22.0 We expect PAT to decline 15.6% YoY to INR258m.
RoCE (%) 14.5 8.8 12.4 17.8
Payout (%)
Valuations 45.7 57.3 32.6 20.5
P/E (x) 6.3 5.7 5.0 4.1 Key things to watch for
P/BV (x) 19.3 18.7 13.0 9.7 Footfalls, occupancy rate during the quarter.
EV/EBITDA 0.3 0.3 0.7 1.1
(x)
Impact of demonetization on ATP and SPH.
Div Yield (%) 18.7 21.2 26.0 32.8
SITI Cable
Bloomberg SITINET IN CMP: INR38 TP: INR45 Buy
Equity Shares (m) 678.3
We expect reported revenue to grow 16% QoQ to INR3.35b,
M. Cap. (INR b)/(USD b) 25 / 0
52-Week Range (INR) 42 / 31
primarily led by higher activation and broadband revenue.
1,6,12 Rel Perf. (%) 7 / -1 / -2
Cable subscription revenue is expected to grow 6% QoQ to
~INR1.48b as digitization-led triggers for subscription remain
elusive in 3Q and are expected to pick up in 4Q.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
Activation revenue is expected to more than double QoQ to
Net Sales 11.9 12.5 17.4 21.0 INR0.76b in 3QFY17, as seeding picks up post a subdued 1H. We
EBITDA 3.0 3.0 6.5 8.5 have factored in set-top box seeding of ~0.8m for 3Q.
EBITDA# 0.9 0.7 5.4 7.5 Carriage revenue expected to decline QoQ to INR0.72b in 3Q.
Adj. NP 0.0 -0.8 2.4 2.9 EBITDA is expected to nearly double QoQ to INR0.96b, primarily led
Adj. EPS (INR) 0.0 -0.9 2.7 3.2 by higher activation and broadband revenue. On an ex-activation
Adj. EPS Gr. (%) NM NM NM NM basis, EBITDA is expected to improve to INR197m in 3Q from
BV/Sh (INR) 9.1 9.5 14.1 17.7 INR90m in 2QFY17.
RoE (%) 0.1 -10.2 23.5 20.0 We expect net profit of INR167m v/s net loss of ~INR469m in 2Q.
RoCE (%) 6.4 1.4 18.2 17.3 The stock trades at attributable EV/EBITDA (ex-activation) of 6.7x
Valuation FY18E. Maintain Buy with a DCF-based target price of INR45.
P/E (x) NM NM 13.8 11.8
EV/EBITDA (x)* 13.7 14.2 6.3 4.7 Key things to watch for
EV/ EBITDA 47.8 63.2 7.5 5.3 Subscription revenue growth (6% QoQ).
(x)*
EV/Sub (INR)* 3,335 3,457 3,346 3,201 Activation revenue (we expect INR0.76b).
* Based on attributable EBITDA and subs post EBITDA margin (we expect 28.6%).
minority stake; # (ex-activation)
Sun TV
Bloomberg SUNTV IN CMP: INR524 Under Review
Equity Shares (m) 394.1
We expect Sun TV’s revenue to grow 9% YoY to INR6.25b.
M. Cap. (INR b)/(USD b) 206 / 3
Advertising and broadcasting revenue is expected to grow 5% YoY
52-Week Range (INR) 567 / 312
1,6,12 Rel Perf. (%) 5 / 43 / 20
to INR3.4b as demonetization impact sets in.
We expect domestic subscription revenue to grow 5% QoQ to
INR2.4b.
Financial Snapshot (INR Billion)
Sun TV’s EBITDA/EBIT is estimated to grow ~9%/13% YoY to
Y/E March 2016 2017E 2018E 2019E
Net Sales 24.0 26.7 30.8 34.4
INR4.78b/INR3.73b. PAT is expected to grow 13% YoY to
EBITDA 17.1 18.8 22.1 24.7 INR2.44b.
Adj. Net Profit 8.3 10.0 11.9 13.4 The stock trades at 20.6x FY17E and 17.3x FY18E EPS. Under
Adj. EPS (INR) 21.1 25.4 30.3 33.9 Review.
Adj. EPS Gr. (%) 13.0 20.2 19.4 12.0
BV/Sh (INR) 92.2 100.3 109.8 120.6
RoE (%) 23.4 25.3 27.6 28.1
RoCE (%) 24.1 26.3 28.7 29.3
Div. Payout (%) 59.0 59.1 59.4 58.9
Valuations
P/E (x) 24.8 20.6 17.3 15.4 Key things to watch for
P/BV (x) 5.7 5.2 4.8 4.3 YoY ad growth (we expect 5%).
EV/EBITDA (x) 11.3 10.1 8.4 7.5 QoQ domestic subscription growth (we expect 5%).
Div. Yield (%) 2.5 2.9 3.4 3.8
Z ee Entertainment
Bloomberg Z IN CMP: INR458 TP: INR590 Buy
Equity Shares (m) 960.4
We expect advertising revenue to grow 4% YoY to INR9.79b, as the
M. Cap. (INR b)/(USD b) 439 / 6
demonetization impact is largely expected to wipe off gains from
52-Week Range (INR) 589 / 350
1,6,12 Rel Perf. (%) 2/1/4
the festive season.
Subscription revenue is likely to grow 11% YoY to INR5.81b.
(Domestic subscription to grow 12% YoY to INR4.7b).
Financial Snapshot (INR Billion)
Y/E MARCH 2016 2017E 2018E 2019E
Total revenue growth is expected to moderate to 3% YoY
Net Sales 58.3 66.2 74.9 86.2
(INR16.5b), led by demonetization-led ad pain and lack of any
EBITDA 15.0 18.4 23.2 28.0 syndication and movie-based revenue triggers.
Adj. NP 10.2 13.3 16.9 20.3 We are building in ~11% YoY increase in content cost.
Adj. EPS (INR) 10.6 11.7 17.7 21.3 We expect EBITDA margin to largely remain flat YoY at 26.5%.
Adj. EPS Gr. (%) 3.9 10.1 51.6 20.4 Sports losses are expected to be minimal at INR126m.
EPS ex-&TV (INR) 11.8 12.4 18.4 21.0 Adjusted PAT is expected to grow ~10% YoY to INR3.02b.
RoE (%) 27.0 29.4 30.7 29.9 We have cut our FY17/FY18 earnings estimates by 5%/8.5% to
RoCE (%) 17.7 19.6 23.4 25.0 factor in the demonetization impact and sluggishness in FMCG ad
Div. Payout (%) 21.3 19.3 18.4 19.3 spends (contributes ~55% to TV ad spends). Our revised TP is
Valuations INR590 (29x December 2018E EPS (ex-&TV) plus INR19/share
P/E (x) 43.2 39.3 25.9 21.5 towards &TV DCF less INR19/share towards preference share
P/E ex-&TV (x) 38.8 37.0 24.9 21.8 liability). The stock trades at 39.3x FY17E and 25.9x FY18E EPS. Buy.
EV/EBITDA (x) 29.5 22.4 17.4 13.8
Div. Yield (%) 0.5 0.5 0.7 0.9 Key things to watch for
YoY ad growth (we expect 4%).
Sports loss (we expect INR126m).
Metals
Company name Across-the-board price increase drives strong
Hindalco performance
Hindustan Z inc NMDC, Nalco and Vedanta benefit from volume and price increases
JSW Steel
Nalco Across-the-board increase in commodity prices
NMDC
Metal stocks continue benefiting from across-the-board rise in metal prices and
volume ramp-up. Steel prices in 3QFY17 were up 9-12% QoQ or INR3,000-3,800 per
SAIL
ton, led by a seasonally weak base (monsoon) and cost-led price increase. Among
Tata Steel
base metals, zinc/lead average LME was up 11%/15% to USD2,511/USD2,156 per
Vedanta
ton. Z inc LME is up ~USD930 per ton (~60%) since the recent low in 4QFY16, driven
by supply tightness. Aluminum LME was up 6% QoQ to USD1,710 per ton, driven by
steady demand, slower supply ramp-up in China and cost pressure. Alumina was up
29% QoQ to USD302 per ton on increased demand in China, transportation issues
and cost factors.
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
Source: MOSL, Company
Exhibit 5: Domestic steel demand growth – trailing 12-month (YoY %)
Domestic steel
consumption declined in Cons. (mt) Trailing 12m Growth (%)
October. It grew by 4.6%
8.1
10.0
7.4
7.3
7.3
7.2
7.2
7.1
7.1
7.1
7.0
6.9
6.9
6.9
6.9
6.8
6.7
6.7
6.7
YoY in November. YTD
6.7
6.7
6.6
6.6
6.6
6.6
6.5
6.5
6.3
6.3
6.3
6.3
6.2
6.2
6.1
8.0
5.9
5.9
5.9
5.9
5.8
5.7
5.6
5.5
5.4
5.1
5.1
Jun-14
Jun-15
Apr-13
Jun-16
Aug-13
Apr-14
Dec-13
Feb-14
Aug-14
Apr-15
Dec-14
Apr-16
Feb-15
Aug-15
Dec-15
Feb-16
Aug-16
Oct-13
Oct-14
Oct-15
Oct-16
Source: MOSL, Company
Jun-13
Jun-14
Apr-12
Aug-12
Apr-13
Jun-15
Jun-16
Dec-12
Apr-14
Feb-13
Aug-13
Dec-13
Feb-14
Aug-14
Apr-15
Dec-14
Feb-15
Aug-15
Apr-16
Dec-15
Oct-12
Feb-16
Aug-16
Oct-13
Oct-14
Oct-15
Oct-16
9.8 10.1
8.6 9.2
7.7 8.1 8.0 7.9 8.2 7.8 8.3
3.3 3.8 3.6
3.1 3.0 3.1 3.1 3.1 2.6 3.3
2.9
3.2 3.8 3.6 3.1
2.8 2.9 2.9 2.7 2.7 2.9 2.8
2.1 2.1 2.1 2.4 2.1 2.3 2.3 2.7 2.2 2.6 2.6
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
Source: MOSL, Company
53
46
39
32
25
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
Source: MOSL, Company
Exhibit 11: Global aluminum production trend Exhibit 12: China aluminum production trend
Production YoY Production YoY
2.9 50
5,400 23.0
2.6 40
4,800 14.0
m tons
2.3 30
4,200 5.0 2.0 20
Jul-14
Jul-15
Jul-16
Apr-15
Apr-16
Jan-15
Jan-16
Oct-14
Oct-15
Oct-16
Jul-15
Jul-16
Apr-15
Apr-16
Jan-15
Jan-16
Oct-14
Oct-15
Oct-16
Source: MOSL, Company, Bloomberg Source: MOSL, Company, Bloomberg
1,700
USD/t
2.9
m tons
1,600
2.3
1,500
1,400 1.7
Jul-16
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Source: MOSL, Bloomberg
Exhibit 18: Relative performance – three-month (%) Exhibit 19: Relative performance – one-year (%)
Sensex Index MOSL Metals Index Sensex Index MOSL Metals Index
118 180
111 155
104 130
97 105
90 80
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
Hindalco
Bloomberg HNDL IN CMP:INR159 TP:INR234 (+47%) Buy
Equity Shares (m) 2065.2
Standalone: We estimate standalone EBITDA to increase by 11%
M. Cap. (INR b)/(USD b) 328 / 5
QoQ (91% YoY) to INR12.8b on higher aluminum realization.
52-Week Range (INR) 185 / 59
Aluminum segment EBITDA is estimated to increase by 16% QoQ to
1,6,12 Rel Perf. (%) -10 / 29 / 93
INR9b on higher realization. Aluminum sales volumes are estimated
Financial Snapshot (INR Billion)
to be broadly flat QoQ at 318kt. LME aluminum averaged
Y/E March 2016 2017E 2018E 2019E USD1,660/t (up 3% QoQ). While average cash LME is higher, we
Sales 1,000.5 1,010 1,089 1,106
estimate the benefit to Hindalco will be lower due to hedges.
EBITDA 106.1 132.1 141.0 146.0
Copper volumes are estimated to be down by 7% QoQ to 95kt.
NP 24.7 38.2 45.7 51.0
Novelis: We estimate Novelis to report adjusted EBITDA of
Adj. EPS (INR) 12.0 18.5 22.1 24.7
USD273m, up 1% QoQ. Adj. EBITDA/t is estimated at USD350 (v/s.
EPS Gr(%) -11.5 54.6 19.6 11.5
USD349 in 2QFY17). Volumes are estimated to be flat YoY at 779kt.
BV/Sh. (INR) 101.8 112.3 132.8 155.9
RoE (%) 11.6 17.3 18.1 17.1
RoCE (%) 5.9 8.2 8.9 9.2
Payout (%) 13.7 8.9 7.4 6.6
Valuations
P/E (x) 13.0 8.4 7.0 6.3
P/BV 1.5 1.4 1.2 1.0 Key issues to watch for
EV/EBITDA (x) 8.3 6.4 5.6 5.0 Lower margins in aluminum.
Div. Yield (%) 0.9 0.9 0.9 0.9 Foreign exchange rate impact at Novelis.
Hindustan Z inc
Bloomberg HZ IN CMP:INR251 TP: INR282 (+12%) Neutral
Equity Shares (m) 4225.3
We expect HZ L’s EBITDA to increase 61% QoQ (+2x YoY) to
M. Cap. (INR b)/(USD b) 1061 / 16
INR33.8b on normalization in production and higher product prices.
52-Week Range (INR) 290 / 136
Z inc LME is up 11% QoQ to USD2,511/t, while lead LME is up 15%
1,6,12 Rel Perf. (%) -10 / 38 / 70
QoQ to USD2,156/t. Z inc production is estimated to increase 57%
Financial Snapshot (INR Billion) QoQ to 233kt. Lead production is estimated to increase 19% QoQ to
Y/E March 2016E 2017E 2018E 2019E 37kt.
Sales 142.3 181.5 212.4 210.6 We estimate PAT to increase 54% QoQ to INR29.3b.
EBITDA 67.8 105.9 129.9 125.9
NP 83.6 90.8 107.2 106.7
Adj. EPS (INR) 19.8 21.5 25.4 25.3
EPS Gr(%) 2.1 8.6 18.1 -0.5
BV/Sh. (INR) 88.5 103.0 121.3
RoE (%) 20.7 22.5 22.6 19.4
RoCE (%) 20.6 26.7 27.1 23.4
Payout (%) 164.9 32.7 27.7 27.8
Valuations
P/E (x) 12.7 11.7 9.9 10.0
P/BV 2.8 2.4 2.1 1.8 Key issues to watch for
EV/EBITDA (x) 10.5 7.4 5.5 5.1 Delay in recovery of volumes at Rampura Agucha.
Div. Yield (%) 11.0 2.4 2.4 2.4 Decline in global zinc prices.
JSW Steel
Bloomberg JSTL IN CMP: INR163 TP: INR195 (+20%) Buy
Equity Shares (m) 2417.2
Consolidated EBITDA is estimated to decline by 17% QoQ to
M. Cap. (INR b)/(USD b) 394 / 6
INR24.4b due to increase in raw material cost and impact on
52-Week Range (INR) 189 / 95
volumes due to demonetization of currency. Adj. PAT is estimated
1,6,12 Rel Perf. (%) -2 / 13 / 52
to decline by 43% QoQ to INR4.2b.
Standalone EBITDA is estimated to decline 16% QoQ to INR22.8b.
Financial Snapshot (INR Billion)
Volumes are estimated to be down 7% QoQ (+40% YoY) to 3.6mt
Y/E March 2016 2017E 2018E 2019E
Sales 418.8 580.4 651.6 654.2
due impact of demonetization. Realization is estimated to increase
EBITDA 60.7 115.7 138.1 139.0
12% QoQ to ~INR35,700/t, coming off a weaker base (monsoon in
Adj. PAT -0.1 29.6 45.2 46.1 2Q) and cost pressure-led price increases. EBITDA margin estimated
Adj. EPS (INR) 0.0 12.3 18.7 19.1 at INR6,392/t, down from INR7,077/t in 2Q.
EPS Gr(%) -100.5 -35,195 52.4 2.0
BV/Sh. (INR) 77.5 87.2 103.3 119.9
RoE (%) 0.0 14.9 19.6 17.1
RoCE (%) 2.7 7.6 9.0 8.4
Payout (%) -36.6 12.4 8.0 7.8
Valuation
P/E (x) -4,521.9 12.9 8.5 8.3 Key issues to watch for
P/BV 2.0 1.8 1.5 1.3 Steel price hikes and impact of coking coal.
EV/EBITDA (x) 14.6 7.5 5.9 5.4 Domestic steel demand growth.
Div. Yield (%) 0.7 0.8 0.8 0.8
Nalco
Bloomberg NACL IN CMP: INR66 TP: INR75 (+17%) Buy
Equity Shares (m) 1932.9
We estimate Nalco’s 3QFY17 EBITDA to more than double QoQ to
M. Cap. (INR b)/(USD b) 127 / 2
INR3.5b on higher alumina volumes, aluminum and alumina
52-Week Range (INR) 72 / 30
realization.
1,6,12 Rel Perf. (%) 15 / 55 / 65
Aluminum sales volume is estimated to decline marginally QoQ to
96kt.
Financial Snapshot (INR Billion)
Aluminum LME is up 6% QoQ to USD1,710/t. Realized premium is
Y/E March 2016 2017E 2018E 2019E
estimated at USD153/t, up from USD132/t in 2QFY17.
Sales 68.2 73.3 80.0 80.0
EBITDA 9.4 11.9 16.8 16.9
Alumina realization is estimated at USD290/t, up 9% QoQ.
NP 7.0 7.1 9.3 9.5
Adj. EPS (INR) 2.7 3.7 4.8 4.9
EPS Gr(%) -43.4 36.9 29.7 2.4
BV/Sh. (INR) 50.1 53.7 56.4 59.2
RoE (%) 5.4 7.1 8.7 8.5
RoCE (%) 7.5 8.3 11.7 11.5
Payout (%) 74.0 56.8 43.8 42.8
Valuations
P/E (x) 21.6 15.8 12.2 11.9
Key issues to watch for
P/BV 1.2 1.1 1.0 1.0
Availability of coal for captive power plant.
EV/EBITDA (x) 9.9 7.0 4.6 4.3
Div. Yield (%) 3.0 3.0 3.0 3.0
LME price trend, utilization of smelter.
NMDC
Bloomberg NMDC IN CMP: INR134 TP: INR162 (+21%) Buy
Equity Shares (m) 3163.9
NMDC’s EBITDA is estimated to increase 79% QoQ to INR14.7b on
M. Cap. (INR b)/(USD b) 425 / 6
higher realization and volumes.
52-Week Range (INR) 143 / 75
Iron ore sales volumes are estimated to increase by 24% QoQ (38%
1,6,12 Rel Perf. (%) 8 / 44 / 45
YoY) to 10mt, aided by increase in domestic demand.
Financial Snapshot (INR Billion)
Domestic iron ore realization is up 14% QoQ to INR2,284/t on price
hikes taken amid increase in international iron ore prices and strong
Y/E March 2016E 2017E 2018E 2019E
Sales 64.6 82.4 91.0 95.3
domestic demand.
EBITDA 32.3 43.7 50.6 53.0 PAT is estimated to increase 37% QoQ to INR10.6b.
Adj. PAT 33.2 34.6 34.2 35.7
Adj. EPS (INR) 8.4 10.9 10.8 11.3
EPS Gr(%) -49.7 30.7 -1.0 4.3
BV/Sh. (INR) 75.9 74.9 78.5 82.6
RoE (%) 15.9 12.8 14.2 13.7
RoCE (%) 15.6 11.9 13.3 12.9
Payout (%) 177.0 65.9 66.5 63.8
Valuation
Key issues to watch for
P/E (x) 14.6 11.2 11.3 10.8
Increase in global iron ore prices.
P/BV 1.6 1.6 1.6 1.5
Stronger-than-expected iron ore demand.
EV/EBITDA (x) 10.9 7.8 7.2 6.9
Div. Yield (%) 9.0 4.9 4.9 4.9
SAIL
Bloomberg SAIL IN CMP: INR51 TP: 28 (-45%) Sell
Equity Shares (m) 4130.4
We estimate SAIL to turn EBITDA negative in 3QFY17 at INR2.2b on
M. Cap. (INR b)/(USD b) 209 / 3
increase in coking coal prices and impact of demonetization on
52-Week Range (INR) 56 / 34
volumes.
1,6,12 Rel Perf. (%) -2 / 10 / 2
Realization is estimated to increase 12% QoQ to INR34,816/t,
coming off a weak base (monsoon in 2Q) and cost pressure-led
Financial Snapshot (INR Billion)
price increase.
Y/E March 2016 2017E 2018E 2019E
EBITDA/t loss is estimated at ~INR730, as against profit of
Sales 395.0 450.5 574.5 673.4
EBITDA -28.6 0.7 5.3 63.9
~INR310/t in 2Q.
NP -37.0 -43.0 -58.9 -5.7
PAT loss is estimated at INR14.9b, up from INR6b in 2Q.
Adj. EPS (INR) -9.0 -10.4 -14.3 -1.4
EPS Gr(%) -271.5 16.1 37.1 -90.4
BV/Sh. (INR) 95.5 84.7 70.4 69.1
RoE (%) -8.8 -11.5 -18.4 -2.0
RoCE (%) -6.0 -3.4 -3.7 3.4
Payout (%) 0.0 0.0 0.0 0.0
Valuation
P/E (x) -5.5 -4.7 -3.4 -35.8 Key issues to watch for
P/BV 0.5 0.6 0.7 0.7 Commissioning of ISP and Bhilai capacity expansion.
EV/EBITDA (x) -19.5 929.4 132.5 11.3
Div. Yield (%) 0.0 0.0 0.0 0.0
Tata Steel
Bloomberg TATA IN CMP: INR405 TP: 321 (+52%) Sell
Equity Shares (m) 971.4
India: We estimate Tata Steel’s standalone EBITDA to increase 22%
M. Cap. (INR b)/(USD b) 394 / 6
QoQ to INR23.3b on higher realization. Volumes are estimated at
52-Week Range (INR) 441 / 211
2.6mt, down 2% QoQ, despite the ramp-up at K alinganagar, on
1,6,12 Rel Perf. (%) -3 / 25 / 54
impact of demonetization. Blended sales realization is estimated to
Financial Snapshot (INR Billion)
increase by INR3,600/t QoQ to INR44,000/t. Steel EBITDA is
estimated at INR9,086/t, up from INR7,297/t in 2Q.
Y/E March 2016 2017E 2018E 2019E
Sales 1,172 1,125 1,288 1,292
Europe: EU steel margin is estimated to decline by USD14/t QoQ to
EBITDA 76 125 161 166
USD53/t on higher raw material cost. Volumes are estimated to be
Adj. PAT 7 7 36 40 up 7% QoQ to 2.4mt. EBITDA is estimated at INR8.7b, down from
Adj. EPS (INR) 7.7 7.7 37.1 40.7 INR10.3b in 2Q.
EPS Gr(%) 168.6 -0.1 383.3 9.9 Consolidated EBITDA is estimated at INR33b, an increase of 6%
BV/Sh. (INR) 152 113 141 172 QoQ. PAT is estimated at INR5.1b, an improvement from a loss of
RoE (%) 4.6 5.8 29.2 26.0 INR1.1b in 2QFY17.
RoCE (%) 5.4 6.0 8.5 8.6
Payout (%) -28.6 -36.0 23.8 21.8
Valuation
P/E (x) 51.2 51.3 10.6 9.6 Key issues to watch out
P/BV 2.6 3.5 2.8 2.3
Imports from China and global iron ore prices.
EV/EBITDA (x) 15.2 9.9 7.7 7.2
Div. Yield (%) 2.0 2.0 2.0 2.0
Vedanta
Bloomberg VEDL IN CMP:INR217 TP:INR202 (+15%) Neutral
Equity Shares (m) 3717.0
We estimate VEDL’s EBITDA to increase 44% QoQ to INR67b on
M. Cap. (INR b)/(USD b) 806 / 12
higher prices and volumes in zinc and aluminum. Other
52-Week Range (INR) 249 / 58
commodities are also supportive.
1,6,12 Rel Perf. (%) -5 / 59 / 140
Ex-Cairn and HZ L, we estimate EBITDA to increase by 41% QoQ to
INR21.9b, driven by an increase in aluminum prices and volumes.
Financial Snapshot (INR Billion)
Iron ore EBITDA is estimated to be up ~3x QoQ to INR3.6b on an
Y/E March 2016E 2017E 2018E 2019E
Sales 644.3 749.4 857.4 897.1
increase in iron ore prices and a recovery in volumes post a lull 2Q
EBITDA* 110.4 186.3 215.3 217.7
(due to monsoon).
NP 31.9 79.4 101.5 103.7 HZ L EBITDA is estimated to increase by 63% QoQ to INR33.8b on
Adj. EPS (INR) 10.8 21.4 27.3 27.9 higher zinc/lead prices and volumes.
EPS Gr(%) -37.3 6.4 153.7 30.6 Cairn India EBITDA is estimated to increase by 24% QoQ to
BV/Sh. (INR) 151.8 176.9 191.3 206.5 INR12.8b on higher oil realization.
RoE (%) 7.9 13.0 14.8 14.0
RoCE (%) 7.4 12.5 13.9 13.3
Payout (%) 48.9 24.7 19.3 18.9
Valuation
P/E (x) 19.9 10.0 7.8 7.7 Key issues to watch for
P/BV 1.3 1.1 1.0 1.0 Progress on ramp-up of 1.25mtpa smelter.
EV/EBITDA (x) 9.2 6.0 4.9 4.5
Movement in base metal prices.
Div. Yield (%) 2.1 2.1 2.1 2.1
Note: Sesa-Sterlite merged entity basis
* attrib.
Despite rise in crude oil prices, the OMCs have broadly been able to take price
hikes to maintain gross marketing margin of ~INR2.7/liter (including freight) on
diesel and petrol in the quarter.
The gross marketing margins are higher than INR2.3/liter during the regulation
era. We expect marketing margins to remain higher than regulated era margins.
Valuation and view
Against the backdrop of a lower oil price regime, auto fuel pricing freedom and
stable marketing margins, we retain OMCs (IOCL/HPCL/BPCL) as our top picks.
We expect strong performance from MRPL due to revival in GRM in the quarter.
RIL is expected to report improvement in GRM in the quarter. While core
earnings growth would be significant, telecom losses would cap consolidated
earnings and return ratios.
Although volume growth would continue for CGD players, we might see margin
compression in the industrial segment due to increase in LNG prices. Cut in APM
price is negative for ONGC/OINL; however, OPEC and non-OPEC efforts to cut oil
production should revive realizations, benefitting ONGC/OINL.
107 118
103 107
99 96
95 85
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
105 16
70 8
35 0
0 (8)
2QFY05
1QFY07
4QFY08
3QFY10
2QFY12
1QFY14
4QFY15
3QFY17
2QFY05
1QFY07
4QFY08
3QFY10
2QFY12
1QFY14
4QFY15
3QFY17
Source: Bloomberg, MOSL Source: Bloomberg, MOSL
6 0
4
(10)
2
0 (20)
Gasoline
LPG
Naphtha
Jet/K ero
Diesel
Fuel Oil
2QFY05
1QFY07
4QFY08
3QFY10
2QFY12
1QFY14
4QFY15
3QFY17
(1)
2QFY05
1QFY07
4QFY08
3QFY10
2QFY12
1QFY14
4QFY15
3QFY17
Exhibit 11: Polymer spreads declined (INR/kg): PE , PP, PVC Exhibit 12: POY spread down 1.7% QoQ; PSF spreads down
spreads change -2.7%/-4.0%/0.9% QoQ 1.6% QoQ (INR/kg)
PE PP PVC POY PSF
80 80
60
60
40
40
20
0 20
2QFY11 3QFY12 4QFY13 1QFY15 2QFY16 3QFY17 2QFY11 3QFY12 4QFY13 1QFY15 2QFY16 3QFY17
Source: Bloomberg, Company, MOSL Source: Bloomberg, Company
Exhibit 13: We model nil subsidy for OMCs in FY17 and FY18
(INR b) FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16E FY17E FY18E
Fx Rate (INR/USD) 40.3 46.0 47.5 45.6 47.9 54.5 60.6 61.1 65.5 67.4 70.0
Brent (USD/bbl) 82 85 70 86 114 111 108 86 48 49.3 60
Product-wise Gross Under recoveries (INR b)
Petrol 73 52 52 27 0 0 0 0 0 0 0
Diesel 353 523 93 348 819 915 628 109 0 0 0
K erosene 191 282 174 200 278 296 306 248 116 114 126
LPG* 156 176 143 205 284 399 465 366 161 174 242
Total 773 1,033 461 780 1,385 1,610 1,399 723 276 287 368
Sharing of Gross Under recoveries (INR b)
Government 353 713 260 410 829 1,000 707 273 263 270 332
Upstream 257 329 145 303 552 600 671 428 13 17 36
OMC's 163 (9) 56 67 0 10 21 22 0 0 0
Total 773 1033 461 780 1,385 1,610 1,399 723 276 287 368
Sharing of Gross Under recoveries (%)
Government 46 69 56 53 60 62 51 38 95 94 90
Upstream 33 32 31 39 40 37 48 59 5 6 10
OMC's 21 (1) 12 9 0 1 2 3 0 0 0
Total 100 100 100 100 100 100 100 100 100 100 100
*LPG includes DBTL component Source: Company, MOSL
Exhibit 14: Petrol-diesel price difference (INR/liter) Exhibit 15: Diesel in over-recovery zone post deregulation
40 Diesel (under)/over recovery (INR/ltr)
3
Petrol - Diesel price
difference (INR/ltr)
30
2
20 1
10 0
0 (1)
Jun-15
Jun-16
Nov-15
Nov-16
May-15
May-16
Dec-14
Aug-15
Aug-16
Feb-15
Mar-15
Sep-15
Dec-15
Jan-16
Mar-16
Sep-16
Dec-16
Jun-12
Jun-15
Dec-16
Dec-10
Dec-13
Sep-11
Mar-
Sep-14
Mar-
13
16
Source: PPAC, MoPNG, MOSL Source: PPAC, MoPNG, MOSL
Exhibit 16: With almost nil subsidy, model ONGC’s net Exhibit 17: Expect higher LNG volumes in 3QFY17 (mmscmd)
realization for 3QFY17 at USD50/bbl and lower production in RIL’s KG-D6
Net Realization Subsidy Burden Gross Realization RIL K G-D6 PLNG GSPL GAIL India 105
96 95 97 95 96
94
100
114
101 101
110
110
110
109
109
108
107
91
103
102
90 95
86 87 97
57 59
90
76
51
5 64
38 36
85
62
48
56
43 46 25
2Q 49 2 51
43 46 44 29
63
50
61
63
48
62
74
46
44
64
63
63
62
40 24 25 25
35
80
3Q 36 40
20 21 22 24 23 75
23 24 24 25
3Q 48
4Q 51
1Q 40
2Q 45
3Q 46
4Q 33
1Q 47
2Q 41
4Q 56
1Q 59
3Q 44
4Q 35
1Q 46
2Q 48
3Q 50
2Q 47
9 8 8
70
1Q 47
12 14 13 13 12 12 12 11 11 10
65
60
FY13 FY14 FY15 FY16 FY17 3QFY14 1QFY15 3QFY15 1QFY16 3QFY16 1QFY17 3QFY17E
Source: Company, MOSL Source: Company, MOSL
11.5
11.5
11.5
10.8
10.6
10.4
10.1
10.1
10.1
9.6
9.5
9.3
8.7
8.4
8.3
7.7
7.6
7.6
3
7.3
1 1 2 3 5
0 3 4 7
2 3 3 5
1 2 4 1
3
9
8
7
7
7
7
6
6
6
6
5
5
5
5
4
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q
FY13 FY14 FY15 FY16 FY17
Source: MOSL, Company
BPCL
Bloomberg BPCL IN
CMP: INR656 TP: INR756 (+15%) Buy
Equity Shares (m) 1446.2
M. Cap. (INR b)/(USD b) 948 / 14
We expect OMCs’ (IOCL, BPCL, HPCL) core earnings to improve, led
52-Week Range (INR) 695 / 366 by improvement in refining margins QoQ. Also, on a reported basis,
1,6,12 Rel Perf. (%) 7 / 21 / 44 earnings would increase due to inventory gains during 3QFY17.
Financial snapshot (INR b) We model nil subsidy-sharing for OMCs; the subsidy in 3QFY17
Y/E March 2016 2017E 2018E 2019E would entirely be borne by the government.
Sales 1,884 1,844 2,182 2,275
EBITDA 142 142 150 154 We peg BPCL’s refinery throughput at 6.43mmt for 3QFY17 v/s
Adj. PAT 80 80 81 86
5.87mmt in 3QFY16 and 6.39mmt in 2QFY17.
Adj. EPS (INR) 55.2 55.5 56.3 59.8
EPS Gr.% 104.1 67.0 2.1 7.7
BV/Sh.INR 193.8 230.2 267.3 306.6
We expect BPCL to report PAT of INR22.5b in 3QFY17 (+73% QoQ,
RoE (%) 31.6 26.2 22.6 20.8 +52% YoY).
RoCE (%) 18.8 16.0 15.1 14.9
Payout*(%) 33.0 34.3 34.1 34.3 BPCL trades at 11.6x FY18E EPS and 2.4x FY18E BV (adjusted for
Valuation investments), with ~3% dividend yield. Buy.
P/E (x) 11.8 11.8 11.6 10.9
P/BV (x) 3.4 2.8 2.4 2.1
Key issues to watch for
EV/EBITDA (x) 8.2 8.3 7.7 7.3
(a) Inventory and forex change impact, (b) GRM, (c) Kochi refinery
Div. Yld (%) 2.4 2.5 2.5 2.7
expansion, and (d) update on Mozambique/Brazil E&P blocks.
GAIL
Bloomberg GAIL IN
CMP: INR440 TP: INR429 (-2%) Neutral
Equity Shares (m) 1268.5
M. Cap. (INR b)/(USD b) 558 / 8
We expect GAIL to report a PAT of INR9.6b (+45% YoY and +4%
52-Week Range (INR) 456 / 291 QoQ). We model nil subsidy sharing for GAIL in 3QFY17 (v/s nil in
1,6,12 Rel Perf. (%) 2 / 13 / 18 3QFY16 and 2QFY17).
Financial snapshot (INR b) We estimate EBITDA at INR16.8b in 3QFY17 v/s INR10.8b in 3QFY16
Y/E March 2016 2017E 2018E 2019E and INR15.1b in 2QFY17.
Sales 516.1 528.2 544.5 729.7
EBITDA 39.7 65.0 77.9 90.4 Segmental EBIT (pre-subsidy) is expected to be INR15.6b, up 52%
Adj. PAT 23.0 36.4 46.2 56.7
YoY, led by turnaround in petchem division profitability and likely
Adj. EPS (INR) 18.1 28.7 36.4 44.7
higher gas transmission profitability.
EPS Gr. (%) -23.2 58.3 26.9 22.8
BV/Sh.(INR) 241.1 263.2 286.3 314.7
RoE (%) 7.7 12.9 13.2 14.9 GAIL trades at 12.1x FY18E EPS of INR36.4. Maintain Neutral.
RoCE (%) 6.5 9.6 10.9 12.3
Payout (%) 36.5 32.2 36.5 36.5 Key issues to watch for
Valuations (a) Petchem profitability, (b) profitability in gas trading business,
P/E (x) 24.3 15.3 12.1 9.8 (c) progress of pipeline projects worth USD4b, (d) pending tariff
P/BV (x) 1.8 1.7 1.5 1.4
revisions for key pipelines, and (e) transmission volumes post
EV/EBITDA (x) 12.9 8.6 6.8 5.6
RasGas contract renegotiation.
Div. Yield (%) 1.3 2.0 2.5 3.2
HPCL
Bloomberg HPCL IN
CMP: INR461 TP: INR543 (+18%) Buy
Equity Shares (m) 1017.0
M. Cap. (INR b)/(USD b) 469 / 7
We expect OMCs’ (IOCL, BPCL, HPCL) core earnings to improve, led
52-Week Range (INR) 486 / 212 by improvement in refining margins QoQ. Also, on a reported basis,
1,6,12 Rel Perf. (%) 6 / 36 / 58 earnings would increase due to inventory gains during 3QFY17.
Financial snapshot (INR b) We model nil subsidy-sharing for OMCs; the subsidy in 3QFY17
Y/E MARCH 2016 2017E 2018E 2019E would entirely be borne by the government.
Sales 1,793 1,734 1,922 2,002
EBITDA 76.2 100.8 94.9 99.5 We peg refinery throughput at 4mmt for 3QFY17 (v/s 4.57mmt in
Adj. PAT 38.6 53.6 45.9 46.9 3QFY16 and 4.04mmt in 2QFY17).
Adj. EPS (INR) 38.0 52.7 45.1 46.2
EPS Gr. (%) 41.3 38.8 (14.4) 2.3
We expect HPCL to report PAT of INR15.6b in 3QFY17 (+50% YoY;
BV/Sh.(INR) 182.1 214.7 243.9 273.9
RoE (%) 22.4 26.6 19.7 17.8
+123% QoQ).
RoCE (%) 13.0 14.7 10.5 9.4
Payout (%) 36.4 35.1 35.1 35.1 HPCL trades at 10.2x FY18E standalone EPS and 1.9x FY18E BV. Buy.
Valuations
P/E (x) 12.1 8.7 10.2 10.0 Key issues to watch for
P/BV (x) 2.5 2.1 1.9 1.7 (a) GRM,
EV/EBITDA (x) 8.0 6.9 7.7 7.7
(b) impact of forex and inventory change, and
Div. Yield (%) 2.5 3.4 2.9 3.0
(c) Bhatinda refinery profits.
Indraprastha Gas
Bloomberg IGL IN CMP: INR935 TP: INR898 (-4%) Neutral
Equity Shares (m) 140.0
We expect IGL to report volumes of 4.4mmscmd and PAT of INR1.4b
M. Cap. (INR b)/(USD b) 131 / 2
(up 36% YoY, flat QoQ) for 3QFY17.
52-Week Range (INR) 960 / 484
1,6,12 Rel Perf. (%) 14 / 53 / 76
We expect 3QFY17 CNG volumes at 3.38mmscmd (+10% YoY, -2.5%
QoQ). We model total volumes of 4.4/4.8mmscmd in FY17/FY18.
Financial Snapshot (INR b)
Y/E MARCH 2016 2017E 2018E 2019E
Sales 36.7 36.2 41.5 45.7
Due to increased gas cost, IGL has hiked CNG prices by INR1.85/kg.
EBITDA 7.6 10.0 10.4 11.0 However, it is yet to pass on the increased gas cost to industrial
Adj. PAT 4.2 5.9 6.1 6.7 consumers. In 3QFY17, EBITDA/scm could be lower than INR6.5 in
Adj. EPS (INR) 29.7 42.0 43.7 47.6 1QFY17 and INR6.1 in 2QFY17.
EPS Gr. (%) -4.9 41.2 4.0 9.0
BV/Sh.(INR) 172.6 204.4 237.5 273.4 We expect IGL to report EBITDA of INR2.5b (+33% YoY, -4.4% QoQ)
RoE (%) 18.4 21.8 19.8 18.6 for 3QFY17.
RoCE (%) 17.1 21.0 18.8 17.8
Payout (%) 20.2 19.1 20.6 21.0 The stock trades at 21.4x FY18E EPS of INR43.7. Neutral.
Valuation
P/E (x) 31.4 22.3 21.4 19.7 Key issues to watch for
P/BV (x) 5.4 4.6 3.9 3.4 (a) Likely increase in volumes following lower gas prices, and
EV/EBITDA (x) 16.6 12.4 11.5 10.4
(b) EBITDA margin.
Div. Yield (%) 0.6 0.9 1.0 1.1
IOC
Bloomberg IOCL IN CMP: INR343 TP: INR464 (+35%) Buy
Equity Shares (m) 4855.9
We expect OMCs’ (IOCL, BPCL, HPCL) core earnings to improve, led
M. Cap. (INR b)/(USD b) 1666 / 24
by improvement in refining margins QoQ. Also, on a reported basis,
52-Week Range (INR) 352 / 173
1,6,12 Rel Perf. (%) 17 / 46 / 58
earnings would increase due to inventory gains during 3QFY17.
MRPL
Bloomberg MRPL IN CMP: INR108 TP: INR115 (+7%) Buy
Equity Shares (m) 1752.7
We expect MRPL to report EBITDA of INR16b (v/s INR6.2b in
M. Cap. (INR b)/(USD b) 188 / 3
2QFY17). We estimate adjusted PAT of INR11.3b (v/s INR4.1b in
52-Week Range (INR) 112 / 52
1,6,12 Rel Perf. (%) 2 / 61 / 58
2QFY17).
Oil India
Bloomberg OINL IN CMP: INR457 TP: INR508 (+11%) Buy
Equity Shares (m) 601.1
We expect OINL to report adjusted PAT of INR5.6b (v/s INR4.1b in
M. Cap. (INR b)/(USD b) 275 / 4
3QFY16 and INR5.8b in 2QFY17).
52-Week Range (INR) 465 / 301
1,6,12 Rel Perf. (%) 4 / 25 / 11
We estimate EBITDA at INR7.8b (up 25% YoY and 5% QoQ). We
estimate gross and net realization at USD47.8/bbl, with no subsidy
Financial snapshot (INR b)
Y/E MARCH 2016 2017E 2018E 2019E
sharing burden.
Sales 92.7 91.8 114.2 118.4
EBITDA 31.2 39.4 43.6 45.1 Our Brent price assumption is USD49.3/60/bbl for FY17/18.
Adj. PAT 23.3 26.9 32.5 33.5 The stock trades at 8.4x FY18E EPS of INR54. We remain positive on
Adj. EPS (INR) 38.8 44.7 54.1 55.7 OINL due to attractive valuations and high dividend yield of ~4%.
EPS Gr. (%) -7.2 15.3 21.1 2.8 Buy.
BV/Sh.(INR) 377.9 402.2 431.7 461.9
RoE (%) 10.5 11.5 13.0 12.5 Key issues to watch for
RoCE (%) 8.3 8.5 9.6 9.3 (a) Subsidy sharing, (b) DD&A charges, and (c) oil & gas
Payout (%) 48.3 45.6 45.6 45.6 production volumes.
Valuations
P/E (x) 11.8 10.2 8.4 8.2
P/BV (x) 1.2 1.1 1.1 1.0
EV/EBITDA 8.9 7.0 6.3 6.0
(x)
Div. Yield (%) 3.5 3.7 4.6 4.8
ONGC
Bloomberg ONGC IN CMP: INR194 TP:INR223 (+15%) Neutral
Equity Shares (m) 12833.3
We expect ONGC to report adjusted PAT of INR44.5b in 3QFY17
M. Cap. (INR b)/(USD b) 2494 / 37
(v/s INR49.7b in 2QFY17 and INR40.8b in 3QFY16).
52-Week Range (INR) 210 / 125
1,6,12 Rel Perf. (%) -2 / 28 / 18
We estimate EBITDA at INR97.1b (v/s INR95.4b in 2QFY17 and
INR86.4b in 3QFY16). We estimate gross and net realization at
Financial snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
USD50.1/bbl, as we expect the entire subsidy to be borne by the
Sales 1,293 1,293 1,573 1,646
government.
EBITDA 452 505 659 730
Adj. PAT 176 193 263 312 The stock trades at 9.7x FY18E consolidated EPS of INR20, with
Adj. EPS 13.6 14.8 20.0 23.8 implied dividend yield of 3-4%. Neutral.
(INR)
EPS Gr. (%) -0.7 9.9 36.3 18.7
BV/Sh.(INR) 144 150 155 161
RoE (%) 9.5 10.1 13.1 15.1
RoCE (%) 8.7 8.5 10.8 12.4
Payout (%) 73.2 71.0 75.9 73.6
Valuation
Key issues to watch for
P/E (x) 14.3 13.1 9.7 8.2
(a) Subsidy sharing, (b) DD&A charges, (c) oil & gas production
P/BV (x) 1.4 1.3 1.3 1.2
volumes, and (d) new investments in KG Basin following new
EV/EBITDA 6.1 6.0 4.7 4.0
(x) deep water gas pricing policy.
Div. Yield (%) 4.4 4.6 6.7 7.7
Petronet LNG
Bloomberg PLNG IN CMP: INR375 TP: INR411 (+11%) Buy
Equity Shares (m) 750.0
We expect PLNG to report PAT of INR3.3b (+87% YoY, -27% QoQ)
M. Cap. (INR b)/(USD b) 281 / 4
and EBITDA of INR5.3b (+68% YoY, -27% QoQ) for 3QFY17.
52-Week Range (INR) 411 / 230
1,6,12 Rel Perf. (%) -1 / 29 / 46
We model Dahej LNG volumes at 3.3mmt in 3QFY17.
Financial snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
Dahej terminal utilization is above ~110% and long-term growth
Sales 271.3 263.8 281.0 375.4
would depend on Dahej’s ramp-up and K ochi terminal’s pipeline
EBITDA 15.9 23.6 30.4 40.7 connectivity.
Adj. PAT 8.4 14.9 20.2 27.3
Adj. EPS (INR) 11.2 19.8 26.9 36.3 As against 15mmt capacity, PLNG has ~16mmt (RasGas: 8.5, new
EPS Gr. (%) 12.2 76.6 35.6 35.2 contracts: ~7.5) long-term take-or-pay contracts.
BV/Sh.(INR) 85.0 99.3 118.6 144.7
RoE (%) 14.0 21.5 24.7 27.6 The stock trades at 13.9x FY18E consolidated EPS of INR26.9.
RoCE (%) 11.0 16.1 20.7 25.9 Maintain Buy.
Payout (%) 24.0 28.1 28.1 28.1
Key issues to watch for
Valuation
(a) Ramp-up at Dahej terminal, (b) progress on Kochi-Mangalore
P/E (x) 33.4 18.9 13.9 10.3
pipeline, (c) spot volumes and marketing margin on spot volumes.
P/BV (x) 4.4 3.8 3.2 2.6
Petronet LNG’s earnings are largely protected due to take-or-pay
EV/EBITDA (x) 1.1 1.1 0.9 0.6
Div. Yield (%) 0.7 1.3 1.7 2.3
contracts with ‘ off-takers’.
Reliance Industries
Bloomberg RIL IN CMP: INR1,069 TP: INR1,002 (-6%) Neutral
Equity Shares (m) 3240.0
We expect RIL to report GRM of USD11.3/bbl (v/s USD10.1/bbl in
M. Cap. (INR b)/(USD b) 3463 / 51
2QFY17 and USD11.5/bbl in 3QFY16.
52-Week Range (INR) 1129 / 889
1,6,12 Rel Perf. (%) 6 / 11 / 3
RIL’s refining segment profit is likely to improve QoQ due to
improvement in GRMs. Petchem profitability is expected to
Financial snapshot (INR b)
increase YoY, led by improved petchem.
Y/E March 2016 2017E 2018E 2019E
Net Sales 2,331.6 2,400.7 2,759.4 2,768.4
We expect RIL to report standalone PAT of INR80.0b (+10% YoY).
EBITDA 401.4 435.9 470.7 468.7
Reported consolidated numbers would include shale gas business,
Net Profit 274.2 297.5 321.2 324.2
Adj. EPS 93.0 100.9 109.0 110.0
but with a one-quarter lag.
(INR)
EPS Gr. (%) 20.5 8.5 8.0 0.9
BV/Sh. (INR) 814.7 901.2 994.4 1,088.5
RIL trades at 9.8x FY18E adjusted EPS of INR109. RIL's new
RoE (%) 12.0 11.8 11.5 10.6 refining/petchem projects are likely to add to earnings from
RoCE (%) 8.9 9.3 9.7 9.3 2HFY18/FY19, but Telecom business would be a drag on
Payout (%) 13.5 14.4 14.4 14.4 profitability. Maintain Neutral.
Valuations
Adj. P/E (x) 11.5 10.6 9.8 9.7 Key issues to watch for
P/BV (x) 1.3 1.2 1.1 1.0 GRM.
EV/EBITDA 1.8 1.6 1.2 1.1 Petchem margins.
(x)
EV/Sales (x) 10.3 8.6 7.1 6.4 KG-D6 production.
Update on Telecom venture.
Retail
Company name Hit by double whammy of demonetization, weak festive season
Jubilant Foodworks
Barring Titan, sales likely to be anemic for retail peers
Exhibit 2: SHOP to post flat LTL sales in 3QFY17 on a base of Exhibit 3: Jubilant Foodworks’ SSS to decline by 14% in
17.4% LTL sales growth in 3QFY16 3QFY17
LTL Sales growth (%)
17.4 SSS Growth (%)
15.5
12.5 12.0 12.7
11.0
10.0
8.4
19.8
16.1
7.7
6.3
6.6
1.9
6.6
4.6
3.2
2.0
2.9
4.2
5.0 5.5
4.0
5.5 5.9 2.2
-2.6
-3.4
-2.4
-5.3
-3.2
3.7 0.8 0.1
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
Jun-13
Jun-14
Jun-15
Jun-16
Sep-12
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Source: Company, MOSL Source: Company, MOSL
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
Source: Company, MOSL
65 67
950
911
60 61
876
838
55 55
797
761
726
19 20 19
679
632
602
576
17 17 17 17
552
16
515
489
14 15 15 15 15 15
465
439
411
12 12 13
Jun-13
Jun-14
Jun-15
Jun-16
Dec-12
Mar-13
Sep-13
Dec-13
Mar-14
Sep-14
Dec-14
Mar-15
Sep-15
Dec-15
Mar-16
Sep-16
Dec-16
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
Exhibit 7: Relative performance – three months (%) Exhibit 8: Relative performance – one-year (%)
Sensex Index MOSL Retail Index Sensex Index MOSL Retail Index
108
112
101
104
94 96
87 88
80 80
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
Jubilant Foodworks
Bloomberg JUBI IN CMP: INR860 TP: INR900 (+5%) Neutral
Equity Shares (m) 65.8
We expect JUBI’s revenues to decline 8% YoY. 3QFY17 SSSG is likely
M. Cap. (INR b)/(USD b) 57 / 1
to be negative at around 14%. Discretionary spending was expected
52-Week Range (INR) 1502 / 761
to improve in 2HFY17, but it is likely to be impacted by
1,6,12 Rel Perf. (%) 0 / -28 / -45
demonetization. Commodity inflation continues.
We expect EBITDA margin to contract 200bp YoY to 9.5%, and
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
EBITDA to decline 24% YoY to INR552m.
Sales 24.4 25.4 30.4 37.8
We estimate PAT to decline 55.6% to INR130m.
EBITDA 2.6 2.4 3.4 4.6 The stock trades at 46.4x FY18E EPS of INR18.5. Maintain Neutral.
Adj. PAT 1.0 0.7 1.2 1.8
Adj. EPS (INR) 15.0 10.8 18.5 27.2
EPS Gr. (%) -11.7 -28.1 72.3 46.6
BV/Sh.(INR) 111.3 121.0 121.3 134.7
RoE (%) 13.4 8.9 15.3 20.2
RoCE (%) 14.1 9.2 15.3 21.1
Payout (%) 16.7 23.2 13.5 44.2 Key issues to watch for
Valuations Clarity on appointment of new CEO.
P/E (x) 57.5 80.0 46.4 31.7 Demand outlook for QSR and Pizza space, as well as competition.
P/BV (x) 7.7 7.1 7.1 6.4 Performance of D u n k i n D o n u t s and margin guidance.
EV/EBITDA (x) 21.0 22.7 16.0 11.5 Changes in expansion and capex strategy (if any).
Div. Yield (%) 0.3 0.3 0.3 1.4
Quarterly Performance
Y/E March FY16 FY17 Consol. Consol.
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE FY16 FY17E
No of Stores 911 950 990 1026 1049 1081 1111 1146 1026 1146
LTL Growth (%) 4.6 3.2 2.0 2.9 -3.2 4.2 -14.0 2.0 3.2 -2.7
Net Sales 5,707 5,875 6,339 6,180 6,089 6,655 5,832 6,808 24,383 25,385
YoY Change (%) 14.4 14.0 6.7 13.3 -8.0 10.2 17.5 4.1
Gross Profit 4,320 4,474 4,880 4,728 4,675 4,979 4,402 5,133 18,583 19,189
Gross Margin (%) 75.7 76.1 77.0 76.5 76.8 74.8 75.5 75.4 76.2 75.6
Other Expenses 3,647 3,870 4,153 4,015 4,098 4,336 3,850 4,463 15,943 16,746
EBITDA 673 604 727 713 577 643 552 671 2,640 2,443
EBITDA Growth % -14.2 6.4 -24.0 -6.0 0.4 -7.4
Margins (%) 11.8 10.3 11.5 11.5 9.5 9.7 9.5 9.9 10.8 9.6
Depreciation 292 307 316 328 326 366 389 423 1,282 1,504
Other Income 29 29 24 29 31 43 31 11 110 115
PBT 411 326 436 415 282 320 194 258 1,467 1,054
Tax 135 107 143 136 92 104 64 86 483 347
Rate (%) 32.9 33.0 32.8 32.9 32.7 32.5 33.1 33.5 32.9 32.9
Adjusted PAT 276 219 293 278 190 216 130 172 984 707
YoY Change (%) -31.1 -1.3 -55.6 -38.2 -20.2 -28.1
E: MOSL Estimates
Shoppers Stop
Bloomberg SHOP IN CMP: INR295 TP: INR300 (+2%) Neutral
Equity Shares (m) 82.2
We expect SHOP’s revenue to grow 5% YoY to INR9.6b.
M. Cap. (INR b)/(USD b) 24 / 0
Same-store sales (SSS) are estimated to be flat on a base of 17.4%
52-Week Range (INR) 420 / 265
LTL sales growth.
1,6,12 Rel Perf. (%) -2 / -21 / -30
EBITDA margin is likely to contract 250bp to 5.3% in 3QFY17; we
have factored in EBITDA decline of 28.8% and PAT decline of 52% to
Financial Snapshot (INR b)
INR113m.
Y/E March 2016 2017E 2018E 2019E
The stock trades at 32.2x FY18E EPS of INR9.2; maintain Neutral.
Sales 34.1 36.2 41.6 47.8
EBITDA 2.2 1.4 2.4 3.1
Adj. PAT 0.5 0.3 0.8 1.1
Adj. EPS (INR) 5.8 3.0 9.2 13.8
EPS Gr. (%) 19.3 -47.7 201.0 50.0
BV/Sh.(INR) 95.6 101.1 110.4 124.4
RoE (%) 6.3 3.1 8.8 11.9
RoCE (%) 6.2 4.3 7.8 9.8
Payout (%) 0.0 0.0 0.0 0.0
Valuations Key issues to watch for
P/E (x) 50.6 96.9 32.2 21.5 Comments on same-store performance; margin outlook.
P/BV (x) 3.1 2.9 2.7 2.4 Update on Omni-channel strategy.
EV/EBITDA (x) 12.0 17.9 10.6 7.8 Guidance on HyperCITY’s breakeven.
Quarterly performance
Y/E March FY16 FY17 FY16 FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
LTL Sales Gr % 12.7 0.1 17.4 5.9 5.5 2.2 0.0 2.7 9.0 2.6
Deptt Stores 73 74 76 77 81 82 81 82 77 82
Net Sales 6,846 8,769 9,118 8,959 7,559 9,395 9,573 9,652 34,132 36,180
YoY Change (%) 11.8 2.5 19.1 9.7 10.4 7.1 5.0 7.7 11.9 6.0
Total Exp 6,677 8,359 8,405 8,437 7,485 9,065 9,066 9,152 31,960 34,768
EBITDA 169 410 712 523 74 330 507 500 2,173 1,412
Growth % -45.2 -26.2 33.0 6.5 -56.4 -19.3 -28.8 -4.3 15.0 -35.0
Margins (%) 2.5 4.7 7.8 5.8 1.0 3.5 5.3 5.2 6.4 3.9
Depreciation 199 309 211 258 372 243 226 163 977 1,003
Interest 139 135 158 141 159 143 155 105 573 562
Other Income 207 242 58 50 237 225 58 50 213 570
PBT 37 207 402 174 -220 170 185 282 836 417
Tax 16 87 166 72 -85 63 72 112 346 163
Rate (%) 41.9 42.0 41.2 41.5 38.5 37.1 39.0 39.7 41.4 39.0
Adjusted PAT 22 120 236 102 -136 107 113 170 490 254
YoY Change (%) 188.1 -24.5 71.3 -1.2 -726.9 -11.0 -52.2 67.2 20.3 -48.1
E: MOSL Estimates;
Titan Company
Bloomberg TTAN IN CMP: INR359 TP: INR360 (0%) Neutral
Equity Shares (m) 887.8
We expect TTAN’s revenue to increase 12% to INR38b.
M. Cap. (INR b)/(USD b) 318 / 5
The jewelry division witnessed 40% YoY like-to-like sales growth in
52-Week Range (INR) 445 / 296
the festive period, and also saw abnormally high sales on 8
1,6,12 Rel Perf. (%) 9 / -9 / -2
November. Retails sales growth for Tanishq stood at 15% for
3QFY17.
Financial Snapshot (INR b)
During the quarter, TTAN added only four Tanishq stores (12ksf).
Y/E March 2016 2017E 2018E 2019E
We factor in EBITDA growth of 12% in 3QFY17, with underlying flat
Sales 111.8 119.6 137.5 155.4
EBITDA 8.6 10.4 11.6 13.4
margins of 8.3%, and 0.9% PAT growth.
Adj. PAT 7.1 7.8 8.7 10.1
The stock trades at 36.8x FY18E EPS of INR9.8; maintain Neutral.
Adj. EPS (INR) 8.0 8.7 9.8 11.3
EPS Gr. (%) -13.4 8.9 11.5 16.2
BV/Sh.(INR) 40.4 46.3 52.7 60.3
RoE (%) 21.3 20.2 19.7 20.1
RoCE (%) 21.8 20.4 19.8 20.0
Payout (%) 30.0 30.0 30.0 30.0
Valuation
Key issues to watch for
P/E (x) 44.6 41.0 36.8 31.6
P/BV (x) 8.9 7.7 6.8 5.9
Comments on consumer demand for Jewelry and Watches.
EV/EBITDA (x) 36.9 30.4 27.3 23.3 Expansion initiatives.
Div. Yield (%) 0.7 0.7 0.8 0.9 Update on the new Golden Harvest Scheme.
Quarterly Performance
Y/E March FY16 FY17 FY16 FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Net Sales 26,868 26,547 33,984 24,372 27,825 26,364 38,062 27,343 111,770 119,594
YoY Change (%) -7.1 -25.5 17.3 -1.5 3.6 -0.7 12.0 12.2 -5.5 7.0
Total Exp 24,872 24,717 31,041 22,414 25,067 23,760 34,918 25,445 103,179 109,189
EBITDA 1,996 1,830 2,807 1,958 2,759 2,604 3,144 1,898 8,591 10,405
EBITDA Growth % -27.3 -39.9 11.6 -21.2 38.2 42.3 12.0 -3.1 -20.4 21.1
Margins (%) 7.4 6.9 8.3 8.0 9.9 9.9 8.3 6.9 7.7 8.7
Depreciation 227 240 250 254 261 260 283 265 971 1,068
Interest 118 87 114 104 88 117 131 129 423 465
Other Income 395 326 440 452 297 277 440 466 1,612 1,479
PBT 2,045 1,829 2,883 2,052 2,706 2,504 3,171 1,970 8,809 10,350
Tax 530 365 627 156 471 667 894 556 1,678 2,588
Rate (%) 25.9 20.0 21.7 7.6 17.4 26.6 28.2 28.2 19.0 25.0
Adjusted PAT 1,516 1,464 2,257 1,896 2,236 1,837 2,276 1,413 7,131 7,763
YoY Change (%) -14.5 -39.0 18.3 -11.9 47.5 25.5 0.9 -25.5 -13.4 8.9
E : M O S L E s tim ates
Technology
Company Name In the middle of old and (potentially) new problems
Cyient Gradual recovery to continue at TECHM; seasonality and BFSI keep 3Q
HCL Technologies
Hexaware Technologies expectations modest
Infosys
K PIT Technologies Expectations laid low by macro and seasonality…
L&T Infotech After a seasonally strong 1H offered nothing to write home about, compounding of
MindTree Consulting
furloughs in the third quarter keeps our expectations muted. The situation would be
Mphasis
NIIT Tech further accentuated by the depreciation of GBP, EUR, AUD and JPY against the USD.
Persistent Systems The brunt of client-specific and other issues has been evident in:
TCS INFO’s termination of a contract with RBS’ standalone UK bank, Williams & Glyn
Tech Mahindra
Wipro (W&G), leading to gradual ramp down of as many as 3,000 employees, which is
Z ensar Technologies expected to kick off in 3Q.
MTCL’s revenue decline in 2Q, and lack of visible revival in 3Q from top client
spending bumps, pricing pressure and delayed ramp-up of projects.
WPRO’s organic growth guidance of -1% to +1% for 3Q despite improvement
measures under the new leadership.
Exhibit 2: Double-digit USD revenue growth (YoY) seen only in HCLT amongst tier-I
Revenue (USD m) Revenue (INR b)
Company 3QFY17E 3QFY16 YoY (%) 2QFY17 QoQ (%) 3QFY17E 3QFY16 YoY (%) 2QFY17 QoQ (%)
TCS 4,363 4,145 5.3 4,374 (0.2) 295 274 7.6 293 0.6
Infosys 2,532 2,407 5.2 2,587 (2.1) 171 159 7.5 173 (1.3)
Wipro 1,914 1,838 4.1 1,916 (0.1) 139 129 8.1 138 0.9
HCLT 1,735 1,566 10.8 1,722 0.7 117 103 13.2 115 1.7
TECHM 1,091 1,015 7.5 1,072 1.7 74 67 9.9 72 2.7
Aggregate 11,635 10,971 6.1 11,672 (0.3) 795 732 8.7 790 0.6
EBITDA Margin (%) PAT (INR b)
Company 3QFY17E 3QFY16 YoY (%) 2QFY17 QoQ (%) 3QFY17E 3QFY16 YoY (%) 2QFY17 QoQ (%)
TCS 27.2 28.3 (110) 27.7 (50) 63 61 2.3 66 (5.1)
Infosys 26.5 27.2 (70) 27.3 (80) 35 35 0.8 36 (3.2)
Wipro 19.7 20.8 (110) 19.3 40 22 22 (2.1) 21 5.8
HCLT 21.2 21.5 (40) 21.8 (60) 20 19 2.8 20 (2.1)
TECHM 15.6 16.9 (130) 14.9 69 7 8 (4.2) 6 12.8
Aggregate 23.8 24.7 (97) 24.1 (36) 146 145 1.0 149 (1.9)
Source: Company, MOSL
6.0
4.4
3.5 3.9
3.1 2.9 2.8 3.2
2.7 3.1
2.1 1.91.7 2.0 1.7 2.1
1.5
1.0 0.91.3 1.3
0.2 0.3 0.4
-1.0
TCS INFO WPRO HCLT TECHM
Exhibit 5: YoY traction seen picking up only at HCLT, led by Volvo IT acquisition (YoY,CC,%)
10.3
10.8
14.0
12.4
15.0
12.0
15.8
13.6
11.4
13.1
13.1
9.8
9.9
6.8
7.9
8.9
6.6
8.3
8.4
6.0
7.6
9.5
7.2
7.1
9.2
8.1
Exhibit 6: TCS and HCLT to outperform peers organically in 3Q (revenue growth, QoQ,
USD, %)
1.7
3
0.7
-0.1
1
-1
-0.2
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
Source: Company, MOSL
Exhibit 7: Incremental revenue to revive at TECHM, aided by acquisitions; cross-currency movements unsupportive again
TCS Infosys Wipro HCL Tech Tech Mahindra Cross currency impact on USD revenues (bp)
200 Incremental revenue (USD m)
150
100
(50) -40
50 (70) (80) (70) (80)
0 (110) (110) (120)
-50 (140)(140)(140) (140)
(160)
-100
NITEC
TCS
MPHL
K PIT
CYL
INFO
MTCL
PSYS
TECHM
WPRO
LTI
HEXW
Z ENT
HCLT
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
Exhibit 8: Margins lower across the board in YoY terms (EBITDA margin, %)
TCS Infosys HCL Tech Wipro Tech Mahindra
30
27.2
26 26.5
22 21.2
19.7
18
15.6
14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17
12.0
9.5
8.1
6.2
6.1
4.6
4.3
4.2
3.7
3.2
3.1
3.1
3.0
2.9
2.3
2.1
2.1
1.8
1.7
1.6
0.7
0.7
0.6
0.6
0.4
0.4
0.2
0.2
0.0
-0.2
-0.8
-0.3
-0.3
-0.6
-1.0
-1.2
-1.4
-1.4
-1.6
-3.5
-1.9
-3.4
-2.5
-3.7
-3.0
Persistent Hexaware K PIT Tech. Mindtree Mphasis Cyient NIIT Tech Z ensar LTI
Systems
Exhibit 14: Relative performance— 3m (%) Exhibit 15: Relative performance— 1Yr (%)
Sensex Index MOSL Technology Index Sensex Index MOSL Technology Index
101 115
99 105
97 95
95 85
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
Cyient
Bloomberg CYL IN CMP: INR494 TP: INR600 (+21%) Buy
Equity Shares (m) 112.2
We expect CYL’s USD revenue to grow 0.2% QoQ in 3QFY17 (+1.6%
M. Cap. (INR b)/(USD b) 55 / 1
QoQ in CC).
52-Week Range (INR) 555 / 371
In the core services business, CYL’s revenue is expected to decline
1,6,12 Rel Perf. (%) -2 / 4 / -4
by 1.8% QoQ, led by cross-currency headwinds. We expect a CC
decline of 0.4% in core services revenue because of seasonal
Financial Snapshot (INR b)
Y/E Mar 2016 2017E 2018E 2019E weakness on the high base of 2Q formed by the 7.4% QoQ growth.
Sales 31.0 36.3 42.6 47.9 The movement of Rangsons towards achieving its 50% annual
EBITDA 4.2 5.0 6.2 6.8 growth guidance is expected to be bulky in 2H, in line with which
PAT 3.3 3.9 5.0 5.3 we expect USD16m revenue in 3Q (+16% QoQ).
EPS (INR) 30.7 34.6 44.2 47.5 Margins are expected to decline by 50bp QoQ to 13.5% because of
EPS Gr. (%) -1.9 12.8 27.7 7.5
cross-currency headwinds and higher incremental revenue from
BV/Sh. (INR) 186.6 210.9 241.8 275.1
lower-margin Rangsons.
RoE (%) 16.5 16.4 18.3 17.3
RoCE (%) 15.1 15.4 17.2 16.2 PAT estimate for the quarter is INR1b, up 6% QoQ. Higher other
Payout (%) 22.8 30.0 30.0 30.0 income is a function of translation gains in 3Q, compared to a loss
Valuations in the previous quarter.
P/E (x) 15.6 13.9 10.9 10.1 The stock trades at 13.9x FY17E and 10.9x FY18E EPS. Maintain Buy.
P/BV (x) 2.6 2.3 2.0 1.7
Key issues to watch for
EV/EBITDA (x) 11.1 9.1 6.9 5.9
Update on problem verticals like Semiconductor and Energy.
Div yld (%) 1.5 2.2 2.8 3.0
Outlook for Rangsons for FY17/18 and progress on synergy
through DLM.
Margin trajectory going ahead.
HCL Technologies
Bloomberg HCLT IN CMP: INR
INR859 TP: INR960 (+12%) Buy
Equity Shares (m) 1412.9
We expect HCLT’s USD revenue to grow 0.7% QoQ in 3QFY17 and
M. Cap. (INR b)/(USD b) 1214 / 18
2.1% QoQ on a constant currency basis. Impact from cross currency
52-Week Range (INR) 890 / 707
movement should shave off ~140bp from revenue growth.
1,6,12 Rel Perf. (%) 7 / 17 / -2
We expect momentum to continue in the IMS business. Deal
signings over the last many quarters, and growth so far provide
Financial Snapshot (INR b)
visibility and confidence in execution of its 12-14% revenue growth
Y/E June 2016 2017E 2018E 2019E
Sales 311.4 466.3 539.3 602.7
guidance.
EBITDA 68.2 100.5 114.5 121.8
EBIT margin is likely to decline by 60bp to 19.5% because of
PAT 56.7 80.5 90.4 96.3 continued investments in the business. EBIT margin of 19.5% over
EPS (INR) 40.1 56.7 63.2 67.2 the remainder of the year is likely to lead to 19.9% EBIT margin for
EPS Gr. (%) -20.3 41.2 11.5 6.3 FY17 – near the mid-point of the 19.5-20.5% guidance range.
BV/Sh. (INR) 200.2 232.5 273.7 319.0 PAT estimate for the quarter is INR19.7b, -2.1% QoQ, on the back of
RoE (%) 21.5 26.6 25.5 23.2 lower margins.
RoCE (%) 19.9 24.2 23.5 21.6 The stock trades at 15.2x FY17E and 13.6x FY18E EPS. Maintain Buy.
Payout (%) 42.4 35.3 30.1 28.3
Valuation
P/E (x) 21.4 15.2 13.6 12.8 Key issues to watch for
P/BV (x) 4.3 3.7 3.1 2.7 Commentary on performance expectations for FY17.
EV/EBITDA 12.0 10.7 9.0 8.1 Deal signings.
(x)
Div yld (%) 2.0 2.3 2.2 2.2 Organic growth in IMS and traction in Engineering.
Hexaware Technologies
Bloomberg HEXW IN CMP: INR213 TP: INR230 (+8%) Neutral
Equity Shares (m) 301.8
We expect USD revenue to grow 0.2% QoQ to USD135.5m (1% QoQ
M. Cap. (INR b)/(USD b) 64 / 1
CC).
52-Week Range (INR) 274 / 178
The expectation is on the back of volume growth in the underlying
1,6,12 Rel Perf. (%) 4 / -4 / -14
business, partly offset by seasonality and furloughs, and further by
cross-currency headwinds (-80bp).
Financial Snapshot (INR b)
EBITDA margin expanded 180bp QoQ in 3QCY16 despite part-
Y/E Dec 2015 2016E 2017E 2018E
Sales 31.2 35.1 40.4 45.4
impact of wage hikes. The management has been guiding for better
EBITDA 5.4 5.7 6.8 7.1 profitability compared to revenue growth in 2HCY16.
PAT 3.9 4.2 4.7 4.8 However, 4Q margins too are expected to be impacted by part
EPS (INR) 12.9 13.6 15.5 15.9 wage hikes. We expect EBITDA margin to remain flat QoQ at 17.4%.
EPS Gr. (%) 22.1 5.4 13.7 2.8 This would lead to EBITDA margin of 16% for CY16, lower than the
BV/Sh. (INR) 47.4 51.4 61.5 71.1 management’s desired level of 17%.
RoE (%) 28.9 27.7 27.5 24.0 Our PAT estimate for the quarter is INR1,155m, up 3.7% from the
RoCE (%) 27.7 25.1 26.4 23.5 previous quarter, on the back of higher other income led by
Payout (%) 64.5 38.8 24.8 30.2 translation gains.
Valuation The stock trades at 14.6x CY16E and 12.8x CY17E earnings. Neutral.
P/E (x) 15.4 14.6 12.8 12.5
P/BV (x) 4.2 3.9 3.2 2.8 Key issues to watch for
EV/EBITDA 10.1 9.9 8.1 7.5 Large deal pipeline and traction post the increased S&M spend.
(x)
Div yld (%) 4.3 2.8 2.0 2.5 Commentary on sustenance of revenue growth.
Margin outlook for the next year.
Infosys
Bloomberg INFO IN CMP: INR998 TP: INR1,250 (+25%) Buy
Equity Shares (m) 2285.6
INFO revised its revenue guidance for FY17 downward after 2Q to
M. Cap. (INR b)/(USD b) 2282 / 33
8-9% CC from 10.5-12% earlier. Termination of the RBS contract and
52-Week Range (INR) 1278 / 900
worsening of the macro has led to a further dampened outlook.
1,6,12 Rel Perf. (%) 3 / -13 / -12
In CC terms, our revenue growth estimate is -1% QoQ on the back
of seasonal weakness and the RBS ramp-down. Cross-currency
Financial Snapshot (INR b)
headwinds of 110bp are likely to lead to USD revenue decline of
Y/E Mar 2016E 2017E 2018E 2019E
Sales 624.4 687.5 781.1 865.6
2.1% QoQ.
EBITDA 170.8 184.6 210.3 230.3 A 1% CC decline in revenue in 3Q would result in an ask rate of 0-4%
PAT 134.9 141.0 157.1 171.5 for 4Q in order to achieve the revised guidance.
EPS (INR) 59.0 61.7 68.7 75.0 We expect EBITDA margin to decline 80bp QoQ to 26.5%, as
EPS Gr. (%) 9.4 4.5 11.4 9.2 revenue growth momentum gets affected.
BV/Sh. (INR) 270.3 300.3 332.8 369.1 Our PAT estimate is INR34.9b, -3.2% QoQ, led by lower revenue and
RoE (%) 24.7 22.8 22.8 22.5 profitability.
RoCE (%) 23.2 21.6 21.7 21.4 The stock trades at 16.2x FY17E and 14.5x FY18E earnings. Buy.
Payout (%) 41.9 50.3 43.7 45.3
Valuations
Key issues to watch for
P/E (x) 16.9 16.2 14.5 13.3
TCV of deal wins during the quarter.
P/BV (x) 3.7 3.3 3.0 2.7
Commentary around contribution of newly-launched services.
EV/EBITDA (x) 11.3 10.1 8.7 7.7
Commentary around macro, verticals, margins and pricing.
Div Yield (%) 2.5 3.1 3.0 3.4
KPIT Technologies
Bloomberg K PIT IN CMP: INR137 TP: INR170 (+24%) Neutral
Equity Shares (m) 200.5
Revenue performance has been lumpy for K PIT, with guidance of a
M.Cap. (INR b) /(USD b) 34/1
better 2H compared to 1H.
52-Week Range (INR) 197 / 108
1, 6, 12 Rel. Per (%)
We expect the impact of seasonal weakness, and pressure in ERP
2/-7/-23
implementation to continue weighing on overall performance,
further accentuated by cross-currency movements.
Financial Snapshot (INR b)
We expect revenue of US123m, down 0.6% QoQ in USD terms and
Y/E Mar 2016 2017E 2018E 2019E
up 0.5% QoQ CC.
Sales 32.2 33.2 36.9 40.4
EBITDA 4.4 4.0 5.0 5.3
Cost optimization methods, operational efficiency improvement
PAT 3.0 2.5 3.1 3.2
and increased fresher hiring are likely to lead to margin expansion
EPS (INR) 14.1 12.6 15.6 16.3 (+100bp QoQ) post the cumulative 515bp decline in EBITDA margin
EPS Gr. (%) 19.0 -10.3 23.7 4.0 over the last two quarters.
BV/Sh. (INR) 69.0 80.8 96.4 112.7 Our PAT estimate is INR619m, up 10.2% QoQ because of the
RoE (%) 21.0 16.9 17.6 15.5 compounding of higher margins and other income.
RoCE (%) 24.3 18.9 20.9 19.2 K PIT trades at 10.8x FY17E and 8.8x FY18E earnings. Maintain
Payout (%) 10.6 15.8 12.8 12.3 Neutral.
Valuations Key issues to watch for
P/E (x) 9.7 10.8 8.8 8.4 Growth in IES, Engineering services and top client.
P/BV (x) 2.0 1.7 1.4 1.2
Margin performance and guidance.
EV/EBITDA (x) 5.4 5.1 3.6 2.9
Commentary on deal wins across segments.
Div yld (%) 1.1 1.5 1.5 1.5
Plan to recoup revenue growth and profitability.
L&T Infotech
Bloomberg LTI IN CMP: INR695 TP: INR800 (+15%) Buy
Equity Shares (m) 175.0
LTI has been seeing strong traction across its portfolio, which we
M. Cap. (INR b)/(USD b) 122 / 2
expect to continue into 3Q.
52-Week Range (INR) 716 / 595
We expect the confluence of this traction, with seasonality and
1,6,12 Rel Perf. (%) - / -/ -
cross-currency movements to result in 0.6% QoQ revenue growth
to USD241m. This would translate into constant currency revenue
Financial Snapshot (INR b)
growth of 1.4% QoQ.
Y/E March FY16 FY17E FY18E FY19E
Net Sales 58.5 64.6 72.8 81.4
LTI has been making investments to augment its S&M capabilities,
EBITDA 10.4 12.4 13.4 14.2 which is likely to keep margins under check.
PAT 9.2 9.6 10.3 10.9 We expect 50bp decline in EBITDA margin to 18.5% because of
EPS (INR) 52.4 54.9 58.6 62.1 increased costs.
Gr. (%) 21.5 4.7 6.8 5.9 Our PAT estimate for the quarter is INR2.4b, which implies 1.8%
BV / Sh (INR) 115.6 144.1 174.6 206.9 QoQ growth.
ROE (%) 45.3 42.3 36.8 32.5 The stock trades at 12.7x FY17E and 11.3x FY18E earnings. Buy.
ROCE (%) 39.9 45.2 39.5 35.7
Payout (%) 59.6 40.0 40.0 40.0
Valuations Key issues to watch for
P /E (x) 13.3 12.7 11.9 11.2 Health and outlook of top accounts and E&U vertical.
P / BV (x) 6.0 4.8 4.0 3.4 Margin trajectory, going forward, given the increased
EV/EBITDA 11.6 9.5 8.6 7.9 investments.
Div. Yield 4.5 3.2 3.4 3.6 Growth in Digital.
(%)
MindTree
Bloomberg MTCL IN CMP: INR526 TP: INR520 (-1%) Neutral
Equity Shares (m) 167.7
MTCL’s performance continues to be weighed upon by [ 1] cross-
M. Cap. (INR b)/(USD b) 88 / 1
currency movements, [ 2] project cancellations, [ 3] slower ramp-up
52-Week Range (INR) 804 / 400
at large clients, and [ 4] continued weakness in Bluefin.
1,6,12 Rel Perf. (%) 16 / -19 / -31
We expect these factors to result in 0.3% decline in revenue to
USD193m. We are modeling 0.4% QoQ growth in CC terms.
Financial Snapshot (INR b)
Y/E Mar 2016 2017E 2018E 2019E
We don’t see margins reviving till revenue growth bounces back.
Sales 46.9 52.6 60.3 68.1
Ongoing optimization measures and cessation of revenue decline
EBITDA 8.3 7.1 9.3 9.7 are likely to result in flat margins QoQ.
PAT 6.0 4.5 6.1 6.4 We expect the trend of robust deal wins to continue. The company
EPS (INR) 35.9 26.6 36.2 38.1 won deals with TCV of USD888m LTM (average of USD222m per
EPS Gr. (%) 16.5 -25.8 36.1 5.3 quarter), of which 36% is Digital.
BV/Sh. (INR) 142.4 153.5 175.3 195.3 Our PAT estimate for the quarter is INR1.1b, which implies 11.6%
RoE (%) 27.4 18.0 22.0 20.6 QoQ growth and 30% YoY decline.
RoCE (%) 30.6 19.6 25.0 22.9 The stock trades at 19.8x FY17E and 14.5x FY18E earnings. Neutral.
Payout (%) 29.3 47.0 33.1 39.3
Valuations Key issues to watch for
P/E (x) 14.7 19.8 14.5 13.8 Update on top clients, pricing pressure and outlook, going
P/BV (x) 3.7 3.4 3.0 2.7 forward.
EV/EBITDA (x) 10.1 11.8 8.9 8.3 Margin trajectory, going forward, given the increased investments
Div Yld (%) 2.0 2.4 2.3 2.9 and revenue growth issues.
Deal wins during the quarter and growth in Digital.
Mphasis
Bloomberg MPHL IN CMP: INR534 TP: INR560 (+5%) Neutral
Equity Shares (m) 210.1
In 2QFY17, HP channel revenue grew for the first time in 20
M. Cap. (INR b)/(USD b) 112 / 2
quarters. This is expected to remain stable with the renewed MSA
52-Week Range (INR) 622 / 404
coming into effect after the completion of the transaction between
1,6,12 Rel Perf. (%) 1 / -3 / 4
HPE and Blackstone.
We expect revenue growth of 0.7% QoQ (1.4% QoQ CC), driven by
Financial Snapshot (INR b)
Y/E Mar 2016 2017E 2018E 2019E
stability in HP channel and Digital Risk and continued traction in the
Sales 60.9 60.6 66.8 73.4 Direct International business.
EBITDA 9.0 9.5 10.5 11.3 Margins are likely to be lower in 3Q on account of wage hikes. We
PAT 7.2 8.9 11.3 12.0 estimate a 160bp decline in EBIT margin to 13%.
EPS (INR) 34.5 42.2 54.0 57.2 MPHL had raised its EBIT margin guidance by 100bp at the end of
EPS Gr. (%)* 6.8 22.4 28.1 5.9
BV/Sh. (INR) 299.4 317.2 344.7 375.5
4QFY16 to 14-16% for FY17, and expressed confidence in achieving
RoE (%) 12.3 13.7 16.3 15.9 the higher end of the range.
RoCE (%) 11.2 12.8 15.8 15.6 Our PAT estimate is INR1.9b (-9.9% QoQ).
Payout (%) 0.0 87.7 40.7 38.4 The stock trades at 12.7x FY17E and 9.9x FY18E EPS. Neutral.
Valuations
P/E (x) 15.5 12.7 9.9 9.3
P/BV (x) 1.8 1.7 1.5 1.4 Key issues to watch for
EV/EBITDA (x) 9.8 2.1 1.3 0.6 Outlook for Digital Risk given an interest rate cycle reversal.
Div yld (%) 0.0 6.9 4.1 4.1
Deal TCV during the quarter in Direct Channel (organic business),
*Annualized values for 5m FY14
and focus areas.
Performance in Direct International business, and outlook for the
year.
NIIT Technologies
Bloomberg NITEC IN CMP: INR 437 TP: INR450 (+3%) Neutral
Equity Shares (m) 61.2
We expect revenue growth for NITEC to remain subdued in 3Q
M. Cap. (INR b)/(USD b) 27 / 0
(0.5% QoQ CC).
52-Week Range (INR) 594 / 370
Although deal wins have been strong for NITEC in recent quarters,
1,6,12 Rel Perf. (%) 3 / -14 / -29
project completions and delays in the commencement of new deals
have been keeping revenue growth under check.
Financial Snapshot (INR b)
Y/E March FY16 FY17E FY18E FY19E This would be further aggravated by cross-currency movement,
Sales 26.8 28.1 30.9 33.3 which is likely to result in 0.7% decline in revenue: 120bp negative
EBITDA 4.7 4.6 5.2 5.5 impact.
PAT 2.8 2.7 3.1 3.3 Deal wins in international geographies are expected to continue
EPS (INR) 45.7 38.6 50.2 54.3 showing strength.
EPS Gr. (%) 143.7 -15.6 30.1 8.1
We expect EBITDA margin to expand by 70bp QoQ to 16.9%, aided
BV/Sh (INR) 259.8 283.1 320.2 360.0
by higher international revenue.
RoE (%) 19.0 14.2 16.6 16.0
RoCE (%) 18.6 15.7 15.6 15.0 Our PAT estimate is INR712m, down 1.1% QoQ, driven by the
Payout (%) 21.9 28.5 21.9 22.1 decline in revenue.
Valuation The stock trades at 11.3x FY17E and 8.7x FY18E earnings. Neutral.
P/E (x) 9.6 11.3 8.7 8.1
P/BV (x) 1.7 1.5 1.4 1.2 Key issues to watch for
EV/EBITDA (x) 4.9 4.9 4.0 3.4 Traction in the international business.
Div Yield (%) 2.3 2.5 2.5 2.7 Demand environment and update on ramp-up delays.
Deal wins.
Persistent Systems
Bloomberg PSYS IN CMP: INR647 TP: INR700 (+8%) Neutral
Equity Shares (m) 80.0
Revenue growth is expected to be strong at PSYS, led by the
M. Cap. (INR b)/(USD b) 52 / 1
Enterprise segment and pick-up in the recently announced IBM
52-Week Range (INR) 797 / 501
Watson deal.
1,6,12 Rel Perf. (%) 8 / -3 / -3
Growth in ISV, however, is likely to continue following the same
trajectory as earlier. Aided by these factors, we expect 3QFY17
Financial Snapshot (INR b)
revenue to grow 3.2% QoQ to USD108.5m.
Y/E March 2016 2017E 2018E 2019E
EBITDA margin is likely to expand, as revenue from the IBM Watson
Sales 23.1 29.0 33.9 38.1
IoT deal continues to gradually increase. However, 2Q had a one-
EBITDA 4.2 4.7 6.3 7.0
time tailwind of 150bp because of accounting changes relating to
Adj. PAT 3.0 2.9 3.6 4.4
leave encashment, which won’t be present in 3Q. We expect 60bp
Adj. EPS (INR) 37.2 36.2 45.0 54.8
QoQ EBITDA margin expansion to 16.7%.
EPS Gr. (%) 2.3 -2.6 24.2 21.8
Our PAT estimate for the quarter is INR680m, down 7.4% QoQ
BV/Sh.(INR) 211.0 236.0 245.6 256.5
owing to lower other income. A sharp decline in the cash balance is
RoE (%) 19.5 16.7 19.2 22.5
likely to result in lower absolute yield.
RoCE (%) 18.9 17.0 15.4 18.3 The stock trades at 17.9x FY17E and 14.4x FY18E earnings. Neutral.
Payout (%) 29.6 33.1 26.7 21.9
Valuations
Key issues to watch for
P/E (x) 17.4 17.9 14.4 11.8
Performance and outlook for top clients in ISV (ex-IBM).
P/BV (x) 3.1 2.7 2.6 2.5
Commentary on traction with Enterprise customers and potential
EV/EBITDA (x) 10.2 9.3 6.8 6.0
of winning large deals.
Outlook on sustainable profit margins in the near to medium
Div. Yield (%) 1.7 1.9 1.9 1.9
term.
TCS
Bloomberg TCS IN CMP: INR 2,379 TP: INR2,500 (+5%) Neutral
Equity Shares (m) 1970.4
TCS saw a deferment to the tune of ~USD27m in an India-based
M. Cap. (INR b)/(USD b) 4687 / 69
contract, which is expected to get added in 3Q.
52-Week Range (INR) 2740 / 2055
A 0.6% tailwind from the deferment coupled with seasonal weakness
1,6,12 Rel Perf. (%) 8 / -2 / -4
leads us to expect 1.5% CC growth.
Cross-currency movement is expected to shave off 160bp from
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E
revenue, leading to 0.1% QoQ decline in USD terms.
Sales 1,086.5 1,183.9 1,340.7 1,478.0
A pullback in discretionary spend has been weighing on TCS’
EBITDA 306.8 322.8 364.5 386.1 performance; outlook on deal wins, project delays and budgets
PAT 242.7 263.1 290.9 311.7 would be keenly watched.
EPS (INR) 123.5 133.8 148.0 158.6 Our EBIT margin estimate for 3Q stands at 25.5% QoQ (-50bp QoQ),
EPS Gr. (%) 11.5 8.3 10.6 7.2 below the lower end of the guided range of 26-28%. There is a
BV/Sh. (INR) 371.4 423.5 501.0 580.7 possibility of TCS’ margins being lower than the range for FY17 lest
RoE (%) 38.2 33.4 30.8 28.0 there is a pick-up in profitability in 4Q.
RoCE (%) 36.8 32.4 30.0 27.3 Our PAT estimate stands at INR62.5b (-5.1% QoQ). The decline
Payout (%) 35.2 34.8 37.7 39.5 would be led by lower revenue, profitability and other income.
Valuations The stock trades at 17.8x FY17E and 16.1x FY18E earnings. Neutral.
P/E (x) 19.3 17.8 16.1 15.0
P/BV (x) 6.6 5.4 4.6 3.9 Key issues to watch for
EV/EBITDA (x) 14.4 13.4 11.6 10.6 Outlook on revenue from TCS Japan.
Div. yield (%) 1.8 2.0 2.3 2.6 Traction in new Digital initiatives (automation/solutions).
Outlook for BFSI vertical, going ahead.
Tech Mahindra
Bloomberg TECHM IN CMP: INR500 TP: INR550 (+10%) Buy
Equity Shares (m) 984.7
We expect 3.1% QoQ CC growth in TECHM’s revenue. In USD terms,
M. Cap. (INR b)/(USD b) 492 / 7
we expect TECHM’s revenue to grow by 1.7% QoQ – 140bp negative
52-Week Range (INR) 564 / 405
impact of cross-currency movement.
1,6,12 Rel Perf. (%) 7 / -1 / -7
In Telecom, 2H is expected to be strong because of seasonality in
Comviva. Moreover, Enterprise is also likely to do well in 3Q, as
Financial Snapshot (INR b)
Y/E Mar 2016 2017E 2018E 2019E
revenue got deferred in 2Q, resulting in a spillover effect. On an
Sales 264.9 291.0 328.6 360.7
organic basis, we expect 2.5% CC growth.
EBITDA 43.4 44.6 52.8 57.1 Revenue will also include one-month addition of Target, which
Adj. PAT 31.2 28.4 32.0 35.2 should result in an additional 0.6pp in growth.
Adj. EPS (INR) 35.1 32.0 36.0 39.5 We expect EBITDA margin to expand by 70bp to 15.6%. A reversal
EPS Gr. (%) 18.4 -8.7 12.5 9.8 of the one-time expense incurred in 2Q would result in a 100bp
BV/Sh.(INR) 165.6 176.7 203.1 233.0 tailwind, which is likely to be partly offset by cross-currency
RoE (%) 23.4 19.1 19.3 18.5 movement.
RoCE (%) 20.1 16.0 16.7 16.3 We expect PAT to grow 12.8% QoQ to INR7.3b, also led by
Payout (%) 34.2 28.3 24.3 22.1 normalization of the ETR (23.5% in 3Q v/s 30.8% in 2Q).
Valuation The stock trades at 15.6x FY17E and 13.9x FY18E earnings. Buy.
P/E (x) 14.3 15.6 13.9 12.6
Key issues to watch for
P/BV (x) 3.0 2.8 2.5 2.1
Performance of the Telecom segment.
EV/EBITDA (x) 9.1 9.4 7.5 6.4
Comments on profitability including LCC.
Div. Yield (%) 2.4 1.8 1.8 1.8
TCV of deal wins in the Enterprise segment.
Wipro
Bloomberg WPRO IN CMP: INR476 TP: INR560 (+18%) Neutral
Equity Shares (m) 2466.0
We expect revenue to decline by 0.1% in USD terms and growth of
M. Cap. (INR b)/(USD b) 1173 / 17
1.3% QoQ in constant currency terms; a negative impact of 140bp is
52-Week Range (INR) 607 / 410
likely on account of depreciation of currencies against the USD.
1,6,12 Rel Perf. (%) 3 / -13 / -19
In 2Q, WPRO had guided for 0-2% QoQ growth in 3Q. However, this
Financial Snapshot (INR b) includes incremental revenue from the acquisition of Appirio. Our
Y/E Mar 2016 2017E 2018E 2019E CC revenue growth estimate bakes in 0.3% QoQ CC organic growth
Sales 512.4 556.2 618.8 672.0 and 1pp contribution from Appirio (1-month revenue).
EBITDA 108.1 109.2 127.5 134.5 We expect EBIT margin in IT Services to decline by 60bp because of
PAT 88.9 84.4 95.8 107.1
flattish organic revenue and the integration of lower margin
EPS (INR) 36.1 34.3 39.5 44.1
Appirio.
EPS Gr. (%) 2.9 -5.1 15.2 11.8
BV/Sh. (INR) 189.7 198.8 225.7 251.8 We expect overall EBIT margin to expand by 40bp, led by improved
RoE (%) 20.3 17.7 18.5 18.5 profitability in the Products business.
RoCE (%) 16.7 14.4 16.3 16.0 Our PAT estimate is INR21.9b, 5.8% QoQ growth on account of
Payout (%) 16.6 37.4 32.9 34.0 improved profitability and higher other income.
Valuations
The stock trades at 13.9x FY17E and 12.6x FY18E earnings. Neutral.
P/E (x) 13.2 13.9 12.1 10.8
P/BV (x) 2.5 2.4 2.1 1.9 Key issues to watch for
EV/EBITDA (x) 9.8 9.5 7.7 7.0 Revenue growth guidance for 4QFY17.
Div Yld (%) 1.3 2.7 2.7 3.1 Stabilization of the Energy vertical.
Commentary on large deal wins and ramp-up schedule.
Z ensar Technologies
Bloomberg Z ENT IN CMP: INR944 TP: INR1,250 (+32%) Buy
Equity Shares (m) 45.4
We expect revenue of USD118m, representing growth of 1.6% QoQ.
M. Cap. (INR b)/(USD b) 43 / 1
This would translate into 2.1% QoQ CC growth. While EUR and GBP
52-Week Range (INR) 1136 / 805
have depreciated against USD, Z AR’s appreciation will slightly offset
1,6,12 Rel Perf. (%) -5 / -7 / -15
the negative impact.
Financial Snapshot (INR b) The quarter will include ~2 months of revenue from the acquisition
Y/E March 2016 2017 2018 2019 of Foolproof, which should add 1.6pp. Organic revenue growth is
Net Sales 29.6 31.6 37.1 42.2 likely to be 0.5% QoQ CC, as higher-than-usual furloughs are likely
EBITDA 4.3 4.5 5.9 6.5 to be offset by ramp-up in recent deal wins.
PAT 3.1 3.1 4.2 4.5
Despite the pruning of non-core/low-yield business, we expect
EPS (INR) 68.2 69.5 92.5 99.2
EBITDA margin to remain flat because of the requirement of
Gr. (%) 17.0 1.4 33.1 7.2
investments to boost capabilities and augment sales and marketing.
BV / Sh (INR) 314.4 369.0 441.4 518.3
ROE (%) 24.0 20.3 22.8 20.7 Post this, we expect margin expansion in the remainder of the year.
ROCE (%) 28.5 25.4 28.5 26.7 Our PAT estimate is INR820m, +19.4% QoQ on account of a jump in
Payout (%) 17.6 20.3 18.6 19.2 other income (translation gains).
Valuations
The stock trades at 13.6x FY17E and 10.2x FY18E earnings. Buy.
P /E (x) 13.8 13.6 10.2 9.5
P / BV (x) 3.0 2.6 2.1 1.8 Key issues to watch for
EV/EBITDA 9.5 8.5 6.0 5.0 Traction in Digital, large deals and other new initiatives.
Div. Yield (%) 1.3 1.5 1.8 2.0 Margin outlook, given the need for reinvestment.
Progress on restructuring.
Telecom
Company name Huge disruption; overhaul of market structure
Bharti Airtel
Voice and data traffic shifting toward RJio
Bharti Infratel
RJio’s freebees and demonetization hurting overall usage
Idea Cellular
Despite being seasonally strong, the third quarter this year is expected to be dismal
for the telecom industry. RJio’s welcome offer with free data/voice – which started
on 5 September 2016 – has significantly diluted voice and data usage in the industry.
Additionally, the demonetization-led cash crunch has led to lower voice/data
recharges, particularly in the initial two weeks, impacting both traffic and pricing.
Bharti and Idea’s revenues are expected to decline 6-7% QoQ (down 1-3% YoY) with
EBITDA margins down by about 300-400bp.
Voice revenues to decline 4-5% QoQ: 3QFY17 saw a shift in outgoing voice
usage toward RJio. However, the impact was seen on pricing instead of voice
minutes. This is because RJio’s free usage reduced Bharti and Idea’s outgoing
minutes but increased incoming traffic. Given that there is a paltry
INR0.14/minute interconnect charge on income minutes compared to
~INR0.60/min charge on outgoing minutes, we believe voice pricing should be
impacted significantly. Also, telcos are rationalizing high-ARPU subscriber plans
to match RJio’s pricing. Assuming price decline of ~5-6% QoQ and voice traffic
growth of ~2% QoQ, we expect voice revenues for Bharti and Idea to decline
~4% QoQ and 0-2% YoY, respectively.
Data revenues to see sharper decline: The impact on the data business is likely
to be much steeper as many subscribers have shifted to RJio’s free data offering.
As announced on 30-November, RJio reached the 50m subscriber mark, which is
nearly 35-40% of the industry’s 15m broadband subscribers (as per September
TRAI report) and ~5% of voice subscribers. Further, demonetization is expected
to have had a considerable impact on the industry’s data business, which mostly
relies on the higher-ticket-size data recharges (95% prepaid subscribers in the
Indian telecom market). Given that RJio recorded data usage of about
27GB/sub/month, it is likely to have eaten up significant amount of business of
other operators. We expect Bharti and Idea’s data revenues to decline steeply
by 14-17% QoQ and 4-7% YoY, respectively, in 3QFY17 on the back of ~10-15%
QoQ data price decline and 2-5% QoQ lower data traffic.
Bharti’s Africa business to report flat revenue QoQ, 30bp EBITDA margin
improvement: After the decline last quarter due to the sale of businesses in two
African regions (Burkina Faso and Sierre Leone), Bharti’s Africa revenues are
expected to remain flat QoQ this quarter at USD909m. Nigeria, which contributes
about one-third of Africa revenues, saw flat currency (Naira) movement, leading to
flat revenue expectation in INR terms too. We expect Africa EBITDA margin to
improve 30bp to 24% due to cost-rationalization measures.
Our view: We expect Bharti and Idea’s revenue and EBITDA to decline sharply as
the industry undergoes a complete overhaul. Bharti Infratel should see healthy
recovery in tenancies, driving its growth further.
10 9
7 7 8 8 8 7
6 7 9 7
5 6 5 5 4 6 6 5 3 5 5 4
3 3 2 2 2 1 1
-1
-6 -3 -5
Jul-16
Jul-14
Jul-15
Jun-16
Jun-14
Jun-15
Nov-13
Nov-14
Nov-15
May-16
Apr-14
May-14
Apr-15
May-15
Apr-16
Aug-15
Dec-15
Aug-16
Sep-16
Dec-13
Aug-14
Dec-14
Feb-15
Mar-15
Sep-15
Jan-16
Feb-16
Mar-16
Sep-13
Jan-14
Feb-14
Mar-14
Sep-14
Jan-15
Oct-13
Oct-14
Oct-15
Source: TRAI, MOSL
-2
-6
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17E
Source: Company, MOSL
58
51
44
37
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
3QFY17E
-1.2 -1.1
-1.9
-2.9
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
2QFY15
3QFY15
4QFY15
1QFY16
2QFY16
3QFY16
4QFY16
1QFY17
2QFY17
Source: Company, MOSL
Sensex Index MOSL Telecom Index Sensex Index MOSL Telecom Index
103 110
101 100
99 90
97 80
95 70
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
Wireless KPIs
FY14 FY15 FY16 FY17 YoY QoQ
2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3QE (%) (%)
EOP Wireless SUBS (m)
Bharti (India) 193 199 206 209 212 217 226 231 235 243 251 256 260 264 8.3 1.4
Idea 127 129 136 139 144 151 158 162 167 172 175 176 179 182 5.7 1.7
RCOM 116 118 112 110 111 107 111 111 112 102 104 99 100
Vodafone - India 156 160 167 170 174 179 184 185 188 194 198 199 201
AV. Wireless Subs (m)
Bharti (India) 192 196 202 207 211 214 222 228 233 239 247 253 258 262 9.4 1.5
Idea 126 128 133 138 142 148 155 160 165 170 174 176 178 180 6.4 1.6
RCOM 122 117 115 111 111 109 109 111 112 107 103 102 100
Vodafone - India 156 158 164 169 172 177 182 185 187 191 196 199 200
ARPU (INR/month)
Bharti (India) 192 195 196 202 198 202 198 198 193 192 194 196 188 174 -9.4 -7.4
Idea 165 170 174 181 176 180 179 180 173 174 179 180 173 159 -9.1 -8.1
RCOM 121 125 128 135 136 141 144 137 134 138 152 144 148
Vodafone - India 191 193 192 193 187 189 184 184 178 175 177 176 171
MOU/Sub
Bharti (India) 437 434 437 435 418 416 418 424 404 405 415 414 406 406 0.2 0.0
Idea 368 376 397 401 384 388 400 408 383 387 387 379 368 370 -4.4 0.5
RCOM 277 288 296 311 307 315 330 316 307 313 329 328 347
Vodafone - India 334 334 335 336 321 319 321 327 316 316 317 314 306
Revenue per min (p)
Bharti (India) 44.0 44.8 44.9 46.5 47.2 48.6 47.5 46.8 47.6 47.5 46.8 47.3 46.3 42.9 -9.7 -7.4
Idea 44.8 45.3 43.7 45.1 45.8 46.3 44.9 44.2 44.7 44.4 46.4 47.7 47.0 42.9 -3.4 -8.8
RCOM 43.5 43.5 43.1 43.5 44.2 44.7 43.7 44.3 43.7 44 46.3 45.2 44.6
Vodafone - India 57.2 57.7 57.3 57.4 58.2 59.3 57.4 56.2 56.2 55.3 55.8 56.2 55.3
Wireless traffic (B min)
Bharti (India) 251 255 265 271 264 267 278 290 282 290 308 315 313 319 9.9 1.7
Idea 139 145 157 165 162 171 185 196 189 196 202 199 196 200 2.1 2.3
RCOM 102 102 102 103 102 103 108 105 103 100 102 100 97.9
Vodafone - India 156 158 164 170 166 169 174 181 177 181 186 187 184
Comparative valuation
CMP EPS (INR) PE (x) EV/EBIDTA (x) RoE (%)
Sector / Companies Reco.
(INR) FY15 FY16E FY17E FY15 FY16E FY17E FY15 FY16E FY17E FY15 FY16E FY17E
Telecom
Bharti Airtel 314 Buy 12.4 9.4 13.4 25.3 33.4 23.4 6.1 5.8 4.7 7.3 5.3 7.1
Bharti Infratel 353 Buy 17.2 17.8 19.7 20.5 19.8 17.9 10.3 8.8 7.5 17.2 16.6 16.2
Idea Cellular 74 Sell -6.3 -12.9 -11.4 -11.8 -5.7 -6.5 8.1 8.8 7.8 -9.2 -21.9 -24.1
Sector Aggregate 37.2 90.5 44.8 7.0 6.7 5.6 5.3 2.1 4.2
Source: Company, MOSL
Bharti Airtel
Bloomberg BHARTI IN CMP: INR309 TP: INR410 Buy
Equity Shares (m) 3,997.0
We expect consol. revenue to decline 2.4% QoQ (flat YoY) to
M. Cap. (INR b)/(USD b) 1678/26
INR240.5b, impacted by RJio’s free offer. We expect India wireless
52-Week Range (INR) 437/327
revenue to decline sharply by 5.9% QoQ (-0.8% YoY) to INR138.6b
1,6,12 Rel Perf. (%) -1 / 18 / 15
and Africa revenue to be flat QoQ at ~USD909b.
Consol. EBITDA margin is expected to decline 210bp QoQ to
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
~36.2%, led by India wireless margin contraction of 310bp to
Net Sales 965.3 975.1 1,010.0 1,112.9
39.3%, partly offset by 30bp improvement in Africa EBITDA
EBITDA 340.1 358.5 366.2 414.7 margin to 24%.
Adj. NP 47.5 49.6 37.7 53.6 Consolidated net profit of INR10.9b is expected to decline 25%
AdjEPS(INR) 11.9 12.4 9.4 13.4 QoQ (-2% YoY).
AdjEPS Gr(%) 72.5 -11.1 -20.7 8.2
India wireless ARPU is expected to come down 7.4% QoQ (-9.4%
BV/Sh (INR) 164.2 174.4 182.2 194.0
YoY) to INR174, as voice ARPU shrinks by 5% and data ARPU by
RoE (%) 7.4 7.3 5.3 7.1
18%.
RoCE (%) 5.9 5.8 5.0 5.9
Bharti trades at proportionate EV/EBITDA of 6.4x FY17E and 6.1x
Payout (%) 11.9 13.8 17.4 12.2
FY18E. Maintain Buy.
Valuations
P/E (x) 26.2 25.1 33.1 23.2 Key monitorables:
P/BV (x) 1.9 1.8 1.7 1.6 Consol. revenue (expect 2.4% decline QoQ).
EV/EBITDA x 6.3 6.4 6.1 5.0 India wireless revenue (expected to decline 5.9% YoY).
Div. Yld (%) 0.4 0.4 0.4 0.4 Consol. EBITDA margin (expected at 36.2%, -210bp QoQ).
India wireless EBITDA margin (expected at 39.3%, -310bp QoQ).
Bharti Infratel
Bloomberg BHIN IN CMP: INR342 TP: INR435 Buy
Equity Shares (m) 1,888.7
We expect revenue to grow 8.1%/2% on YoY/QoQ to INR33.6b.
M. Cap. (INR b)/(USD b) 843/13
52-Week Range (INR) 505/244 Consol. rental revenue (including Ind-AS) is expected at INR21.1b,
1,6,12 Rel Perf. (%) -7 / 32 / 66 up 1.6% QoQ and 7.1% YoY. Energy and other reimbursements are
expected to grow 2.5% QoQ.
Financial Snapshot (INR Billion) We expect consol. EBITDA to improve 1.6% QoQ to INR14.7b.
Y/E March 2016 2017E 2018E 2019E EBITDA margin is expected to contract 20bp QoQ to 43.8% owing to
Net Sales 123.3 133.2 146.2 159.0 pressure on rental rates.
EBITDA 54.1 58.4 64.7 70.5 We expect PAT to grow 0.8% QoQ to INR7.8b.
Adj. NP 22.5 31.9 33.0 36.4 Bharti Infratel trades at an attractive valuation of EV/EBITDA of
AdjEPS INR 11.8 17.2 17.8 19.7 10.6x FY17E and 9.1x FY18E. Maintain Buy.
Gr. (%) 48.1 64.0 50.5 14.1
BV/Sh (INR) 96.7 98.5 111.3 126.0
RoE (%) 12.7 17.2 16.6 16.2
RoCE (%) 11.2 12.8 12.9 12.7
Payout (%) 39.0 26.9 26.0 23.6
Key monitorables
Valuations
Consol. co-location additions (we expect a steady rise of ~ 5,800 v/s
P/E (x) 28.7 19.7 19.1 17.3
P/BV (x) 3.5 3.5 3.1 2.7
avg. of 2,000 in 1HFY17).
EV/EBITDAx 11.5 10.5 9.0 7.8
Consol. revenue per sharing operator (expected to decline 0.4%
Div. Yld (%) 1.2 1.1 1.1 1.1 QoQ due to tenancy renewal risks).
Idea Cellular
Bloomberg IDEA IN
CMP: INR81 TP: INR75 Sell
Equity Shares (m) 3,597.8
M. Cap. (INR b)/(USD b) 632/10
Idea’s consolidated revenue is expected to decline 6.6% QoQ (~3.6%
52-Week Range (INR) 204/130
YoY) to INR86.9b.
1,6,12 Rel Perf. (%) 2 / 13 / 23 Voice RPM is likely to drop 6% on price decline and unfavorable mix
of incoming/outgoing minutes due to RJio’s free plans.
Financial Snapshot (INR Million) We expect Idea to report voice traffic growth of 2.1% QoQ (flat YoY).
Y/E March 2016 2017E 2018E 2019E MoU per subscriber per month at 370 is estimated to be down 0.5%
Net Sales 359.8 355.5 358.9 392.4 QoQ and 6% YoY.
EBITDA 130.3 101.5 96.4 110.2 EBITDA margin is expected to contract ~420bp QoQ/840bp YoY to
Adj. NP 30.8 -22.6 -46.4 -41.1 26.4% due to weak revenues and increased network cost.
AdjEPS (INR) 8.6 -6.3 -12.9 -11.4 We expect Idea to report net loss for the first time since its listing, at
Adj.EPSGr(%) 56.5 -170.7 -250.7 82.0
INR6.3b v/s INR 7.6b same period last year and INR 915m last
BV/Sh(INR) 71.6 65.3 52.4 42.4
quarter.
RoE (%) 12.6 -9.2 -21.9 -24.1
Idea trades at an EV/EBITDA of 8.2x FY17E and 8.7x FY18E.
RoCE (%) 7.1 2.7 0.3 1.3
Payout (%) 8.4 0.0 0.0 0.0
Valuations Key monitorables
P/E (x) 9.4 -12.8 -6.2 -7.0 Voice RPM trajectory (we expect RPM to decline 6% QoQ), voice
P/BV (x) 1.1 1.2 1.5 1.9 traffic (we expect 3.7% QoQ growth).
EV/EBITDA(x) 5.3 8.5 9.2 8.1 Data revenue performance (we expect 17% decline QoQ).
Div. Yield (%) 0.7 0.0 0.0 0.0 EBITDA margin (we expect ~ 420bp contraction QoQ).
Utilities
Company name Expect muted profit growth for Utilities universe
CESC Power Grid to outperform on strong capitalization momentum
Coal India
Amongst our Utilities sector coverage universe, we expect Power Grid to report
JSW Energy
strong set of numbers. Other companies would at best report muted profit growth.
NTPC Power Grid’s 3QFY17 PAT is likely to increase 23% YoY to INR19b.
Power Grid Corp.
We expect NTPC’s PAT to grow ~5% YoY to INR21.7b on lower other income. NTPC’s
commercial capacity is flat QoQ at 45.9GW. JSW Energy is likely to be impacted by
under-utilization of its Vijaynagar plant. We estimate Vijaynagar operated at just
~50% PLF in 3QFY17 v/s 96% in 3QFY16. JSWE’s PAT is likely to decline 54% YoY to
INR1.4b on lower generation and higher fuel cost due to higher coal prices. CESC’s
PAT would be broadly flat YoY at INR1.4b, as gain from increase in regulated equity
base would be offset by impact from the negative bid for the captive coal block.
Coal India is likely to disappoint, with EBITDA (ex-OBR) decline estimated at ~19%
YoY to INR40b. Realization would be flat YoY at INR1,378/t while volumes would
grow 4% YoY to 142mt. Provisioning for the wage hike would impact profitability.
Generation growth tepid: Electricity generation was up 4.8% YoY in 3QFY17 (YTD
5.1%). Coal-based generation grew at a similar rate; however, the pace of growth
has improved in the last couple of months. Conventional generation capacity stood
at 262GW (up 6.5% YoY). System PLF was down 67bp to 50% YTD December 2016.
For coal-based plants, PLF was down 243bp to 59% YTD December 2016.
ST prices remain low: Short-term (ST) prices on IEX were marginally higher QoQ at
INR2.37/kWh. IEX day-ahead volumes were up 13% YoY to 10bu in 3QFY17. Growth
was led by the southern region.
100
3QFY17 is up 4.8% YoY.
99
99
98
97
97
96
95
95
95
94
94
94
93
92
92
90
90
90
89
89
89
89
88
87
87
86
86
86
86
85
85
85
84
84
83
82
81
79
79
79
78
77
77
76
16 15
13 14
12 12 1213 12 12
10 9 10 8 8
6 5
7 686 5 7
536 6 6 7
5 6
4 4 4 3
1 2 1 1 2021
0 -1
Jun-13
Jun-14
Jun-15
Apr-13
Jun-16
Aug-13
Apr-14
Dec-13
Apr-15
Feb-14
Aug-14
Dec-14
Apr-16
Feb-15
Aug-15
Dec-15
Feb-16
Aug-16
Dec-16
Oct-13
Oct-14
Oct-15
Oct-16
Source: MOSL, CEA
PLF was up 100/125bp in Exhibit 3: NTPC coal-based power plants monthly PLF (%)
November/December.
NTPC coal-based monthly PLF - %
However, PLF incentives are
89.6
88.9
87.4
87.2
85.3
83.9
83.1
82.5
82.2
81.7
81.7
81.6
81.5
81.5
81.3
80.9
80.4
79.4
79.4
79.0
78.5
78.2
78.0
77.8
77.7
likely to be lower, as few
77.1
76.7
76.5
76.2
75.7
74.0
73.7
73.6
72.3
72.3
69.8
Jul-15
Jul-16
Nov-14
Nov-15
Nov-16
May-14
May-15
May-16
Jan-14
Mar-14
Sep-14
Jan-15
Mar-15
Sep-15
Jan-16
Mar-16
Sep-16
Source: MOSL, CEA
Commercialized Commissioned
1565
1160 1255
1105
800 800
565 675 650 660
500 500 450525
99 110 20 20 15 0 0 0
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
Regulated Equity
1Q14
2Q14
3Q14
4Q14
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
Source: MOSL, Company
Capitalized Capex
172
71 68 64 66 67 70
49 58 47 49 50 51 45 51 51 45 50 56 53 53
25
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
Source: MOSL, Company Data
Regulated equity base is Exhibit 7: Power Grid regulated equity base (INR b)
up 13% YoY.
Regulated equity
404 420
370 382 388
305 316 328
265 276 293
1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17
2Q17
3Q17
Jun-15
Jun-16
Apr-14
Dec-13
Feb-14
Aug-14
Apr-15
Dec-14
Feb-15
Aug-15
Apr-16
Dec-15
Feb-16
Aug-16
Dec-16
Oct-14
Oct-15
Oct-16
Source: MOSL, Company
Exhibit 2: Dispatches grew 6.8% YoY in December
Jun-15
Jun-16
Apr-14
Dec-13
Apr-15
Feb-14
Aug-14
Dec-14
Apr-16
Feb-15
Aug-15
Dec-15
Feb-16
Aug-16
Dec-16
Oct-14
Oct-15
Oct-16
Source: MOSL, Company
Exhibit 3: Inventory at mines declined MoM in December (26mt destocked YTD FY17)
COAL inventory - mt
58 55
54 52 52 49
46 49 45 48 47 44
40 37 44 42 41 38
39 39
37 35 32 32 34 38 35 32
32 32 29 31 33
Jun-14
Jun-15
Jun-16
Apr-14
Aug-14
Apr-15
Dec-14
Apr-16
Feb-15
Aug-15
Dec-15
Feb-16
Aug-16
Dec-16
Oct-14
Oct-15
Oct-16
3,616
3,566
3,347
3,114
3,045
2,555
2,317
2,305
2,256
2,220
2,218
2,183
2,164
2,143
2,061
2,023
1,934
1,885
1,879
1,803
1,783
1,769
1,723
1,718
1,715
1,608
1,605
1,515
1,469
1,448
1,447
1,361
1,293
1,285
1,227
Jul-14
Jul-15
Jul-16
Nov-14
Nov-15
Nov-16
May-14
May-15
May-16
Jan-14
Mar-14
Sep-14
Jan-15
Mar-15
Sep-15
Jan-16
Mar-16
Sep-16
Source: MOSL, Company
99 110
96 100
93 90
90 80
Jul-16
Jun-16
Nov-16
Apr-16
May-16
Dec-15
Aug-16
Dec-16
Jan-16
Feb-16
Mar-16
Sep-16
Oct-16
Nov-16
Dec-16
Sep-16
Oct-16
CESC
Bloomberg CESC IN
CMP: INR646 TP: INR940 Buy
Equity Shares (m) 133.2
We expect CESC’s PAT to be broadly flat YoY at INR1.45b (on Ind-AS
M. Cap. (INR b)/(USD b) 86 / 1
basis) as steady increase in capitalization is offset by the impact of
52-Week Range (INR) 683 / 405
1,6,12 Rel Perf. (%) 10 / 7 / 20
negative bid on the captive coal block.
Sales volume growth is estimated at 2% YoY to 2,284MU.
Financial Snapshot (INR Million) Profitability of Dhariwal is likely to improve with the commissioning
Y/E MARCH 2016 2017E 2018E 2019E of 34MW PPA with Noida.
Sales 119.0 137.1 149.0 157.0
EBITDA 28.5 32.9 35.6 36.8
NP 3.7 6.4 9.4 10.3
EPS (INR) 27.8 48.4 70.7 77.6
EPS Gr. (%) 86.6 73.9 46.2 9.8
BV/Sh. (INR ) 470.5 439.4 498.1 563.7
RoE (%) 6.0 10.6 15.1 14.6
RoCE (%) 9.1 10.2 11.2 11.3
Payout (%) 36.0 20.7 14.1 12.9
VALUATION
P/E (x) 17.0 13.0 8.9 8.1 Key issues to watch for
P/BV (x) 1.0 1.4 1.3 1.1 Performance of Spencer.
EV/EBITDA (x) 6.8 6.4 5.7 5.3 Commissioning of full 187MW PPA with Noida.
Div. Yield (%) 2.1 1.6 1.6 1.6
Coal India
Bloomberg COAL IN
CMP: INR306 TP: INR297 Neutral
Equity Shares (m) 6207.4
We expect Coal India’s EBITDA (ex-OBR) to decline 19% YoY to
M. Cap. (INR b)/(USD b) 1901 / 28
INR40b, as realization is estimated to be flat YoY while cost is
52-Week Range (INR) 350 / 272
1,6,12 Rel Perf. (%) -1 / -1 / -11
expected to rise on wage hike provisioning.
Dispatches are up 4% YoY to 143mt. FSA volumes are estimated to
Financial Snapshot (INR Million) decline 6% YoY to 110mt on weak demand by power sector. E-
Y/E MARCH 2016 2017E 2018E 2019E auction volumes are up 80% YoY to ~27mt on special e-auctions.
Net Sales 756.4 753.0 823.2 885.8 FSA realization is estimated to increase 2% YoY to INR1,303/t.
EBITDA 187.5 132.8 172.3 198.1 While realization has been disappointing over the past couple of
NP 142.7 99.7 114.2 129.4 quarters, we expect the quarter to benefit from increase in share
Adj.EPS (INR) 22.6 16.1 18.4 20.8 of dispatches from higher grade mines and non-power sector.
EPS Gr. (%) 4.0 -29.0 14.6 13.3 E-auction realization is estimated to increase 8% QoQ to
BV/Sh. (INR) 53.6 48.7 48.8 48.9
INR1,450/t due to increase in share of lower grade special e-
RoE (%) 42.2 32.9 37.7 42.6
auction volumes.
RoCE (%) 40.0 33.4 40.5 45.7
PAT is estimated to decline 22% YoY to INR28.7b on weak
Payout (%) 145.5 99.6 99.6 99.6
operating performance.
VALUATION
P/E (x) 12.8 18.0 15.7 13.9
P/BV (x) 5.4 5.9 5.9 5.9 Key issues to watch for
EV/EBITDA 6.4 9.0 7.2 6.4 E-auction volumes and realization.
(x)
Div. Yield (%) 9.5 4.6 5.3 6.0 Global coal prices.
JSW Energy
Bloomberg JSW IN
CMP: INR61 TP: INR85 Buy
Equity Shares (m) 1640.1
We expect JSW Energy’s PAT to decline 54% YoY to INR1.5b due to
M. Cap. (INR b)/(USD b) 100 / 1
52-Week Range (INR) 88 / 54
under-utilization of Vijaynagar plant and increase in cost of imported
1,6,12 Rel Perf. (%) 7 / -25 / -32
coal.
Vijaynagar is estimated to have operated at ~50% PLF v/s 96% in
Financial Snapshot (INR Million) 3QFY16.
Y/E March 2016 2017E 2018E 2019E Imported coal price average is estimated to increase by ~USD14/t
Sales 996.9 872.6 914.5 1,028.1 QoQ to USD72/t.
EBITDA 41.4 37.1 34.5 34.7
NP 12.5 8.4 5.3 2.4
EPS (INR) 7.6 5.1 3.2 1.5
EPS Gr. (%) -10.0 -32.4 -36.8 -54.9
BV/Sh. (INR ) 52.0 54.9 55.9 55.0
RoE (%) 15.5 9.6 5.9 2.6
RoCE (%) 12.5 9.9 8.9 8.0
Payout (%) 26.3 38.9 61.6 136.7
VALUATION
P/E (x) 9.2 11.0 17.4 38.7 Key issues to watch for
P/BV (x) 1.3 1.0 1.0 1.0 International coal prices.
EV/EBITDA (x) 6.8 6.3 7.3 8.1 Short-term power market prices.
Div. Yield (%) 2.9 3.5 3.5 3.5
Quarterly Performance
FY16 FY17
Y/E March FY16 FY17E
1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Net Sales 21,070 25,314 26,491 26,814 24,500 20,470 20,531 21,756 99,690 87,257
YoY Change (%) -17.6 12.4 11.3 22.5 16.3 -19.1 -22.5 -18.9 6.3 -12.5
Total Expenditure 12,897 15,332 14,579 15,436 13,328 10,843 12,052 13,931 58,244 50,154
EBITDA 8,173 9,983 11,913 11,378 11,173 9,627 8,478 7,825 41,446 37,103
Margins (%) 38.8 39.4 45.0 42.4 45.6 47.0 41.3 36.0 41.6 42.5
Depreciation 1,984 2,240 2,650 2,627 2,398 2,471 2,545 2,586 9,502 10,000
Interest 2,640 3,511 4,491 4,389 4,293 4,356 4,225 3,871 15,032 16,745
Other Income 691 898 264 247 416 516 390 238 2,100 1,560
PBT before EO expense 4,239 5,129 5,035 4,610 4,899 3,316 2,098 1,606 19,013 11,919
Extra-Ord expense 0 -1,500 0 0 0 0 0 0 -1,500 0
PBT 4,239 6,629 5,035 4,610 4,899 3,316 2,098 1,606 20,513 11,919
Tax 1,155 1,537 1,816 1,543 1,248 1,167 566 237 6,051 3,218
Rate (%) 27.2 23.2 36.1 33.5 25.5 35.2 27.0 14.8 29.5 27.0
Minority Interest & Profit/
310 172 12 12 -14 -25 69 246 507 276
Loss of Asso. Cos.
Reported PAT 2,775 4,920 3,206 3,054 3,665 2,174 1,462 1,123 13,955 8,425
Adj PAT 2,775 3,767 3,206 3,054 3,665 2,174 1,462 1,123 12,897 8,425
YoY Change (%) -15.2 16.4 -19.0 -5.9 32.1 -42.3 -54.4 -63.2 -6.0 -34.7
Margins (%) 13.2 14.9 12.1 11.4 15.0 10.6 7.1 5.2 12.9 9.7
E: MOSL Estimates
NTPC
Bloomberg NTPC IN
CMP: INR165 TP: INR199 Buy
Equity Shares (m) 8245.5
We estimate a modest 5% YoY growth in adjusted PAT to
M. Cap. (INR b)/(USD b) 1359 / 20
INR21.7b in 3QFY17. Generation business PAT is likely to grow 7%
52-Week Range (INR) 170 / 117
1,6,12 Rel Perf. (%) 1 / 8 / 11
YoY to INR19.5b while other income is estimated to decline 9%
YoY to INR2.3b.
Financial Snapshot (INR Million) PLF incentives are expected to be insignificant.
Y/E MARCH 2016 2017E 2018E 2019E Commercial capacity is estimated to remain unchanged at
Net Sales 787.1 822.9 963.5 1,107. 45.9GW.
2
EBITDA 191.6 230.7 300.4 381.4 NTPC shifted to coal sampling ‘ at wagon’ from ‘ at secondary
NP 101.6 97.8 117.9 142.4 crusher’. The impact of this change will be a key variable to watch
Adj.EPS (INR) 12.3 11.9 14.3 17.3 for.
EPS Gr. (%) 1.7 -3.8 20.6 20.8
BV/Sh. (INR) 108.2 115.2 124.1 135.4
RoE (%) 11.9 10.6 11.9 13.3
RoCE (%) 7.3 6.9 8.1 9.5
Payout (%) 27.2 33.7 31.5 28.9
VALUATION
P/E (x) 10.5 13.5 11.2 9.3
P/BV (x) 1.2 1.4 1.3 1.2 Key issues to watch for
EV/EBITDA (x) 11.1 11.0 9.0 7.2 PLF for coal-based projects and generation loss.
Div. Yield (%) 2.5 2.8 3.1 3.7 Core RoE and incentives.
Impact of shift in GCV determination.
Arvind
Bloomberg ARVND IN CMP: INR358 TP: INR444 (+24%) Buy
Equity Shares (m) 258.2
We expect single-digit growth in the textiles segment, with margin
M. Cap. (INR b)/(USD b) 92 / 1
improvement following inventory gains (cotton price increase).
52-Week Range (INR) 424 / 236
Based on our industry checks and management interaction, we
1,6,12 Rel Perf. (%) 3 / 8 / -1
believe (a) all formats (EBO/MBO/K ey Accounts (K A)) in the B&R
Financial Snapshot (INR Billion)
division did well in October due to festive season, (b) all formats
performed poorly in November due to demonetization, and (c) the
Y/E March 2016 2017E 2018E 2019E
Sales 84.5 92.7 106.2 120.8
EBO and K A format have returned to normalcy in December, while
EBITDA 10.7 10.5 13.4 15.6 MBO is still impacted.
NP 3.6 3.8 6.2 7.7 We expect ARVND’s revenue to grow 6% YoY (but decline 2% QoQ)
EPS (INR) 14.0 14.8 24.0 29.8 to INR22.9b in 3QFY17, driven by impact on brand and retail
EPS Gr. (%) 6.3 5.6 61.9 24.0 segments due to demonetization.
BV/Sh. (INR) 112.8 148.9 168.1 191.8
RoE (%) 12.9 11.3 15.2 16.5 We expect EBITDA margin to decline 90bp YoY (but expand 210bp
RoCE (%) 10.5 9.5 12.0 13.3 QoQ) to 12.1%, and estimate EBITDA at INR2.77b (-1.3% YoY).
Div Payout (%) 20.5 29.0 20.8 20.8 Adjusted PAT is likely to grow 7.7% to INR1.12b. Buy.
Valuations
Key things to watch for
P/E (x) 25.5 24.1 14.9 12.0
P/BV (x) 3.2 2.4 2.1 1.9
Impact of demonetization in the brand and retail (B&R) segment.
EV/EBITDA (x) 11.6 11.0 8.5 7.1 Performance of newly acquired brands and newer formats.
Div Yield (%) 0.7 1.0 1.1 1.4 Realizations in textiles segment.
Bata India
Bloomberg BATA IN CMP: INR463 TP: INR483 (+4%) Buy
Equity Shares (m) 128.5
Bata’s revenue has declined 10-15% in November – sales were
M. Cap. (INR b)/(USD b) 59 / 1
severely affected in the first week of demonetization, but
52-Week Range (INR) 614 / 400
somewhat improved thereafter. Bata rolled out some company-
1,6,12 Rel Perf. (%) 12 / -15 / -13
level schemes in the second week of demonetization, the response
to which has been in line with management expectations.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E We expect revenue to decline 8% YoY (and 2.7% QoQ) to INR5.68b
Sales 24.3 23.1 26.0 29.5 in 3QFY17.
EBITDA 2.7 2.4 3.0 3.7
EBITDA is likely to decline 32% YoY to INR540m, with margin decline
NP 1.4 1.4 1.8 2.3
of 340bp to 9.5%.
EPS (INR) 11.2 10.9 14.2 17.7
EPS Gr. (%) -31.2 -2.8 30.5 24.5 On a high base, adjusted PAT is expected to decline 30% YoY to
BV/Sh.(INR) 92.0 100.4 111.0 124.5 INR314m.
RoE (%) 13.1 11.3 13.4 15.0
RoCE (%) 13.2 11.4 13.5 15.1
Payout (%) 25.4 22.2 25.5 23.9
Valuations Key things to watch for
P/E (x) 41.5 42.7 32.7 26.3 SSS growth during the quarter.
P/BV (x) 5.1 4.6 4.2 3.7 Share of accessories in total revenue.
EV/EBITDA (x) 20.8 23.4 18.2 14.4 Impact on margins due to promotional campaigns.
Dividend yield 0.8 0.4 0.6 0.8 New store additions.
Quarterly Performance
Y/E March FY16 FY17 FY16 FY17E
Consolidated 1Q 2Q 3Q 4Q 1Q 2Q 3QE 4QE
Net Sales 6,849 5,747 6,176 5,447 6,746 5,837 5,682 5,012 24,220 23,145
YoY Change (%) 10.1 4.9 15.0 10.9 -1.5 1.6 -8.0 -8.0 NM -4.4
Total Expenditure 6,015 5,267 5,378 4,894 5,926 5,302 5,142 4,560 21,554 20,784
EBITDA 834 480 798 553 820 535 540 451 2,666 2,361
Margins (%) 12.2 8.4 12.9 10.2 12.2 9.2 9.5 9.0 11.0 10.2
Depreciation 194 192 195 206 162 160 170 180 788 679
Interest 5 6 4 3 7 13 4 3 18 14
Other Income 78 97 71 104 110 141 110 100 350 450
PBT before EO expense 713 380 669 447 761 504 476 368 2,210 2,118
Extra-Ord expense 430 318 0 0 0 0 0 0 747 0
PBT 1,143 697 669 447 761 504 476 368 1,463 2,118
Tax 240 154 224 169 257 158 162 125 787 720
Rate (%) 33.7 40.6 33.5 37.7 33.8 31.3 34.0 34.0 35.7 34.0
Reported PAT 902 543 445 279 504 346 314 243 2,185 1,398
Adj PAT 473 226 445 279 504 346 314 243 1,439 1,398
YoY Change (%) -22.3 -42.1 27.4 10.5 6.6 53.2 -29 -12.9 315.9 -3
Margins (%) 6.9 3.9 7.2 5.1 7.5 5.9 5.5 4.8 5.9 6.0
E: MOSL Estimates
Castrol (India)
Bloomberg CSTRL IN CMP: INR386 TP: INR499 (+29%) Buy
Equity Shares (m) 494.6
We expect revenue to remain flat YoY (and grow 3% QoQ) at
M. Cap. (INR b)/(USD b) 191 / 3
INR7.8b due to the combined effect of YoY flat volume at 46.4m
52-Week Range (INR) 495 / 354
liters and realization at INR169/liter.
1,6,12 Rel Perf. (%) -4 / -1 / -17
We expect CSTRL to report EBITDA of INR2.2b (+4% YoY, +4%
Financial Snapshot (INR b) QoQ). EBITDA margin would be 27.8%, higher than 26.6% in
Y/E Dec 2014 2015 2016E 2017E 4QCY15.
Sales 33.9 33 33.6 36
We estimate net profit at INR1.5b (+4% YoY, +5% QoQ).
EBITDA 7.2 9.3 9.9 10.3
Adj. PAT 4.7 6.4 6.6 7.1 The stock trades at 28.8x CY16E and 27x CY17E EPS. Buy.
Adj. EPS (INR) 9.6 12.8 13.4 14.3
EPS Gr. (%) 6.1 33.8 4.2 6.7
BV/Sh.(INR) 10 11.6 12.9 14.3
RoE (%) 76 118.4 108.8 104.6
RoCE (%) 76.2 118.5 109.1 104.7
Payout (%) 92.7 87.1 90.3 90.3
Valuations Key issues to watch for
P/E (x) 45.9 34.3 28.8 27 (a) Volume growth.
P/BV (x) 43.8 37.8 29.8 26.9 (b) Operating margin expansion.
EV/EBITDA (x) 29.8 22.8 18.2 17.3 (c) Launch of new products.
Div. Yield (%) 1.9 2.2 2.6 2.8 (d) Competitive pressure from other players.
Coromandel International
Bloomberg CRIN IN CMP: INR304 Under Review
Equity Shares (m) 291.3
We expect revenue to grow 3% YoY (decline 21% QoQ) to INR28.4b
M. Cap. (INR b)/(USD b) 88 / 1
in 3QFY17 on a low base.
52-Week Range (INR) 307 / 146
1,6,12 Rel Perf. (%) 20 / 23 / 57 EBITDA margin is likely to expand 220bp YoY (shrink 260bp QoQ) to
8.2%. EBITDA should grow 41% YoY to INR2.33b.
Financial Snapshot (INR Billion)
We expect adjusted PAT to grow 83% YoY to INR1,177m on a very
Y/E March 2016 2017E 2018E 2019E
low base.
Sales 115.2 116.4 129.8 143.1
EBITDA 7.7 9.6 10.6 12.6
NP 3.4 4.7 5.8 7.4
EPS (INR) 11.8 16.3 20.0 25.5
EPS Gr. (%) -14.9 37.8 22.7 27.6
BV/Sh. (INR) 83.2 92.3 103.9 119.2
RoE (%) 14.9 18.5 20.4 22.8
RoCE (%) 10.8 13.6 15.6 18.8
Valuations
Key issues to watch for
P/E (x) 25.6 18.6 15.2 11.9
Performance of exports in the non-subsidy business.
P/BV (x) 3.6 3.3 2.9 2.5
EV/EBITDA (x) 14.1 10.4 9.1 7.4
EV/Sales (x) 0.9 0.9 0.7 0.7
Dynamatic Tech
Bloomberg DYTC IN CMP: INR2,960 TP: INR3,388 (+14%) Buy
Equity Shares (m) 6.3
We expect revenue to grow 5% YoY (flattish QoQ) to INR3.81b in
M. Cap. (INR b)/(USD b) 19 / 0
3QFY17, led by weak performance in the Indian Hydraulics division.
52-Week Range (INR) 3650 / 1482
YoY growth is likely to decline, led by demonetization.
1,6,12 Rel Perf. (%) -1 / 21 / 21
EBITDA margin is likely to expand 300bp YoY to 11.3%. EBITDA is
Financial Snapshot (INR Billion) expected to grow 43% YoY to INR430m.
Y/E March 2016 2017E 2018E 2019E We estimate adjusted PAT at INR85m as against profit of INR25m in
Sales 14.9 15.6 17.3 19.1
3QFY16. Buy.
EBITDA 1.4 1.8 2.2 2.7
NP 0.1 0.4 0.7 1.1
EPS (INR) 19.4 67.6 112.9 166.7
EPS Gr. (%) -30.6 249.1 67.0 47.6
BV/Sh(INR) 406.2 489.6 602.5 769.2
RoE (%) 4.7 15.1 20.7 24.3
RoCE (%) 6.8 10.3 12.3 22.4
Valuations
P/E (x) 152.8 43.8 26.2 17.8 Key issues to watch for
P/BV (x) 7.3 6.0 4.9 3.8 Execution outlook and ramp-up for the Aerospace division.
EV/EBITDA (x) 16.8 13.3 10.8 8.7 Impact of demonetization in Indian Automotive division.
EV/Sales (x) 1.6 1.6 1.4 1.2
Info Edge
Bloomberg INFOE IN CMP: INR859 TP: INR1,050 (+22%) Buy
Equity Shares (m) 121.7
We expect standalone revenue to grow 23% YoY to INR2.1b.
M. Cap. (INR b)/(USD b) 105 / 2
Recruitment segment (~75% of business) is likely to grow 23% YoY
52-Week Range (INR) 1012 / 690
to INR1.6b. We estimate real estate portal, 99acres.com’s revenue
1,6,12 Rel Perf. (%) -3 / 4 / -1
at INR285m (up 5% YoY) and that of matrimonial portal,
Jeevansathi.com at INR146m (up 25% YoY).
Financial Snapshot (INR b)
Y/E March 2016 2017E 2018E 2019E Our EBITDA margin estimate for the quarter stands at 29.7%
Sales 7.2 8.5 9.5 10.7 compared to 33.1% in 2QFY17 and 22.2% in 3QFY16. We expect the
EBITDA 1.6 2.5 2.8 3.2 YoY margin improvement to be led by reduced advertisement and
PAT 1.4 2.4 2.5 2.9 marketing spends, especially in 99acres.com.
EPS (INR) 13.0 18.4 20.7 23.5
We expect PAT to grow 163% YoY to INR573m. In 3QFY16, there
EPS Gr. (%) -5.3 42.1 12.5 13.4
BV/Sh. (INR) 145.3 162.2 175.2 190.4 were exceptional items, including capital gains on
RoE (%) 9.2 12.0 12.3 12.9 policybazaar.com.
RoCE (%) 9.2 12.0 12.3 12.8
Key issues to watch for
Payout (%) 37.0 35.7 37.5 35.6
Valuation
Impact of consolidation in the real estate segment, and outlook on
P/E (x) 65.5 46.1 41.0 36.1 ad spends, given the state of competitive dynamics.
EV/EBITDA (x) 54.6 34.8 30.1 26.1 Traction in the recruitment business from segments other than IT.
EV/Sales (x) 11.9 10.3 8.9 7.8 Commentary around monetization in Z omato.com.
Inox Leisure
Bloomberg INOL IN CMP: INR231 TP: INR206 (-11%) Sell
Equity Shares (m) 96.2
INOL’s 3QFY17 performance would be buoyed by stellar box office
M. Cap. (INR b)/(USD b) 22 / 0
collections by D ang al. This movie has garnered net box office
52-Week Range (INR) 293 / 170
collection (NBO) of INR2.4b until December 31, 2016 in India. We
1,6,12 Rel Perf. (%) 4 / -4 / -6
expect the impact of demonetization to be lower than our
expectations, led by D ang al’s collections.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E We expect revenue to grow 5% YoY (and 5% QoQ) to INR3.12b.
Sales 11.6 12.2 14.5 17.2
EBITDA margin is likely to decline 120bp YoY to 16.6%. We expect
EBITDA 1.9 1.7 2.4 2.8
EBITDA to decline 1.9% YoY to INR518m.
NP 0.8 0.4 0.8 1.0
EPS (INR) 8.4 4.1 8.6 10.9 We expect PAT to decline 6.7% YoY to INR178m. Sell.
EPS Gr. (%) 284.0 -51.2 108.3 27.0
BV/Sh. (INR) 61.4 65.4 73.6 84.0
RoE (%) 14.9 6.2 11.8 13.2
RoCE (%) 13.2 6.6 10.4 11.6
Valuations
Key things to watch for
P/E (x) 27.5 56.3 27.0 21.3
Footfalls during the quarter due to demonetization.
P/BV (x) 3.8 3.5 3.2 2.8
Number of screen additions.
EV/EBITDA (x) 13.8 16.0 11.4 9.6
InterGlobe Aviation
Bloomberg INDIGO IN
CMP: INR843 TP: INR1,015 (+20%) Neutral
Equity Shares (m) 360.4
We expect INDIGO to report revenue of INR58.2b in 3QFY17 (+35%
M. Cap. (INR b)/(USD b) 304 / 4
52-Week Range (INR) 1372 / 702
YoY, +40% QoQ) and EBITDAR of INR22.2b (+34% YoY, +130% QoQ).
1,6,12 Rel Perf. (%) -2 / -17 / -37 We model yield at INR4.1 and RPK at 12.2b (+35% YoY). Any
deviation in yield would have a meaningful impact on our
Financial Snapshot (INR Billion) estimates.
Y/E March 2016 2017E 2018E 2019E
We expect net profit to grow 44% YoY to INR9.4b.
Sales 161.4 202.1 277.1 325.8
EBITDA 30.1 30.1 38.4 46.9 We model ASK at 55.9b/69.9b in FY17/FY18 v/s 42.8b in FY16, and
NP 19.9 21.0 26.1 32.9 RPK at 46.6b/58.5b in FY17/FY18 v/s 35.9b in FY16, driven by an
EPS (INR) 55.2 58.3 72.5 91.2 increase in fleet size.
EPS Gr. (%) 52.1 5.7 24.3 25.9 We model INDIGO’s fleet at 127 aircraft as at end-3QFY17 (v/s 107
BV/Sh (INR) 50.9 60.1 71.5 85.9 aircraft as at end-FY16), and at 136/154 aircraft by end-FY17/FY18.
RoE (%) 176.5 105.1 110.2 116.0
The stock trades at 14.4x/11.6x FY17E/FY18E reported EPS of
RoCE (%) 42.9 46.8 55.2 83.0
INR58.3/INR72.5 and at an EV of 8.4x/7.2x FY17E/FY18E adjusted
Payout (%) 93.4 84.3 84.3 84.3
EBITDAR. Maintain Neutral.
Valuations
P/E (x) 15.3 14.4 11.6 9.2
P/BV (x) 16.6 14.0 11.8 9.8 Key issues to watch for
Adj.EV/EBITDAR(x) 8.5 8.4 7.2 6.6 Induction of new aircraft in the fleet.
Div. Yield (%) 9.8 9.9 7.5 6.1
Fuel costs and their impact on yields.
Jain Irrigation
Bloomberg JI IN CMP: INR93 Under Review
Equity Shares (m) 443.1
We expect revenue to grow 5% YoY to INR14.47b in 3QFY17.
M. Cap. (INR b)/(USD b) 41 / 1
52-Week Range (INR) 109 / 47 EBITDA is likely to increase 14% YoY to INR1.74b. We expect EBITDA
1,6,12 Rel Perf. (%) 5 / 27 / 21 margin to expand 90bp YoY to 12%.
We expect adjusted PAT at INR49m as against a loss of INR265m in
Financial Snapshot (INR Billion)
3QFY16. Buy.
Y/E March 2016 2017E 2018E 2019E
Sales 62.9 69.0 78.2 88.6
EBITDA 8.2 9.7 11.3 13.1
NP 1.0 2.6 3.8 5.4
EPS (INR) 2.2 5.5 7.6 10.0
EPS Gr. (%) 17.7 153.6 37.2 31.9
BV/Sh (INR) 60.5 65.1 66.9 71.1
RoE (%) 4.0 8.6 11.7 14.8
RoCE (%) 8.2 10.0 10.8 12.5
Valuations
P/E (x) 42.5 16.8 12.2 9.3 Key things to watch for
P/BV (x) 1.5 1.4 1.4 1.3 Receivable days in the MIS business.
EV/EBITDA (x) 9.4 7.7 6.3 5.4 Execution of solar pump orders and new tenders.
EV/Sales (x) 1.2 1.1 0.9 0.8 Debt reduction.
Just Dial
Bloomberg JUST IN CMP: INR343 TP: INR426 (+24%) Buy
Equity Shares (m) 70.2
JD Omni has temporarily shut down while paid campaign additions
M. Cap. (INR b)/(USD b) 24 / 0
are likely to be impacted due to demonetization. Advertisement
52-Week Range (INR) 903 / 318
campaigns are expected to start from 4QFY17.
1,6,12 Rel Perf. (%) -11 / -42 / -63
We expect flattish revenue YoY (-5% QoQ) at INR1.7b in 3QFY17.
Financial Snapshot (INR Billion)
We expect EBITDA margin to contract 580bp YoY (but expand
Y/E March 2016 2017E 2018E 2019E
360bp QoQ) to 16%. Consequently, we expect EBITDA to de-grow
Sales 6.9 7.5 8.4 9.4
27% YoY to INR274m.
EBITDA 1.7 1.1 1.3 1.7
NP 1.4 1.1 1.3 1.6 PAT should decline 18.3% YoY to INR221m. Buy.
EPS (INR) 20.4 15.6 18.5 23.0
EPS Growth (%) 3.7 -23.4 18.4 24.1
BV/Sh (INR) 96.7 110.0 125.6 145.6
RoE (%) 21.1 15.1 15.7 16.9
RoCE (%) 21.1 15.1 15.7 16.9
Payout (%) 0.0 14.8 15.7 12.6
Key things to watch for
Valuations
Performance of Search Plus.
P/E (x) 16.8 21.9 18.5 14.9
Addition of paid campaigns; impact of demonetization on this.
P/BV (x) 3.5 3.1 2.7 2.4
EV/EBITDA (x) 18.1 26.4 21.0 16.0
Promotional campaigns.
Div Yield (%) 0.0 0.8 1.0 1.0 Employee addition.
Kaveri Seed
Bloomberg K SCL IN CMP: INR414 TP: INR489 (+18%) Buy
Equity Shares (m) 69.1
We expect revenue to grow 15% YoY to INR1.06b.
M. Cap. (INR b)/(USD b) 29 / 0
52-Week Range (INR) 472 / 300 We estimate EBITDA at INR63m, with 6% margin in 3QFY17 v/s
1,6,12 Rel Perf. (%) 0 / -5 / 9 EBITDA of INR129m and margin of 14% in 3QFY16.
We expect adjusted PAT of INR26m in 3QFY17. Buy.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
Sales 8.9 7.2 8.7 10.5
EBITDA 1.9 1.7 2.2 2.7
NP 1.7 1.6 2.0 2.5
EPS (INR) 24.9 23.1 28.8 36.3
EPS Gr. (%) -42.9 -7.6 25.1 25.9
BV/Sh (INR) 131.3 138.8 149.6 165.5
RoE (%) 20.7 17.1 20.0 23.1
RoCE (%) 22.2 18.5 21.7 25.0
Payout (%) 48.1 67.6 62.4 56.1
Valuations Key things to watch for
P/E (x) 16.5 17.8 14.2 11.3 Impact on cotton acreages due to reduced sowing.
P/BV (x) 3.1 3.0 2.7 2.5 Cotton yields.
EV/EBITDA (x) 15.0 16.5 12.5 9.7 Any write-offs.
Div Yield (%) 2.5 3.2 3.7 4.2
Manpasand Beverages
Bloomberg MANB IN CMP: INR556 TP: INR761 (+44%) Buy
Equity Shares (m) 57.1
We expect revenue to grow 10% YoY to INR989m in 3QFY17,
M. Cap. (INR b)/(USD b) 32 / 0
impacted due to demonetization. Typically, this is a lean quarter,
52-Week Range (INR) 776 / 389
and hence, the impact is not much.
1,6,12 Rel Perf. (%) -11 / -4 / 5
EBITDA margin is likely to decline 170bp YoY to 18.1% and EBITDA is
Financial Snapshot (INR Billion) likely to be flat YoY at INR179m.
Y/E March 2016 2017 2018E 2019E
We expect PAT to grow 35% YoY to INR66m. Buy.
Sales 5.6 7.7 12.1 20.2
EBITDA 1.1 1.5 2.4 4.0
NP 0.5 0.9 1.4 2.2
Adj EPS (INR) 10.1 14.9 23.8 39.0
EPS Gr. (%) 26.7 47.6 59.4 64.0
BV/Sh. (INR) 120.2 204.7 222.4 249.7
RoE (%) 11.4 8.6 9.9 16.5
RoCE (%) 12.2 9.7 11.1 18.6
Valuations
Key issues to watch for
P/E (x) 52.4 35.5 22.2 13.6
Update on capex plans post fund-raising.
P/BV (x) 4.4 2.6 2.4 2.1
EV/EBITDA (x) 23.1 16.5 12.3 7.2
Update on advertisement campaigns and plans ahead.
EV/Sales (x) 4.6 3.2 2.4 1.4
Fruits Up performance and outlook for 4QFY17.
MCX
Bloomberg MCX IN CMP: INR1,243 TP: INR1,450 (+17%) Buy
Equity Shares (m) 51.0
Total volumes at MCX traded during the quarter stood at INR13.7t,
M. Cap. (INR b)/(USD b) 65 / 1
down 16.1% QoQ and up 5.2% YoY.
52-Week Range (INR) 1420 / 726
However, during the quarter, MCX increased its pricing by ~25%.
1,6,12 Rel Perf. (%) 6 / 28 / 36
This drives our revenue estimate for the quarter to INR601m, up
0.6% QoQ and 21% YoY.
Financial Snapshot (INR Billion)
Y/E MAR 2016 2017E 2018E 2019E
Our EBIT margin estimate for the quarter is 25.2%, down 40bp QoQ
Sales 2.1 2.5 4.0 5.3
and compares with 14% in 3QFY16.
EBITDA 0.6 0.9 2.1 3.2 We do not expect much change in costs; including in advertisement
PAT 0.4 1.5 2.5 3.4 expenses, which have declined after FY16.
EPS (INR) 23.4 28.6 47.4 65.2 Our PAT estimate is INR343m, up 5.2% YoY. We are modeling an
EPS Gr. (%) -5.0 22.4 66.0 37.5 ETR of 25% for 3QFY17.
BV/Sh. (INR) 236.1 259.4 283.5 316.7
RoE (%) 3.5 11.5 17.5 21.7
RoCE (%) 8.8 11.3 17.2 21.4 Key things to watch for
Payout (%) 0.0 63.6 51.0 37.1 Any move to enter the commodities space by potential
Valuation competitors like NSE.
P/E (x) 53.2 43.5 26.2 19.1 Cost base and impact on margins.
P/BV (x) 5.3 4.8 4.4 3.9 Pace of reforms under SEBI.
Monsanto India
Bloomberg MCHM IN CMP: INR2,254 TP: INR2,616 (+16%) Under Review
Equity Shares (m) 17.3
We expect revenue to grow 15% YoY to INR1.77b in 3QFY17.
M. Cap. (INR b)/(USD b) 39 / 1
52-Week Range (INR) 2745 / 1520 EBITDA is estimated to grow 7% YoY to INR498m, with 210bp fall in
1,6,12 Rel Perf. (%) -2 / -10 / -2 margin to 28.2%.
We expect adjusted PAT to decline by 3% YoY to INR448m.
Financial Snapshot (INR Billion)
Y/E March 2016 2017E 2018E 2019E
Sales 5.4 6.1 7.3 8.7
EBITDA 1.1 1.3 1.7 2.0
NP 1.0 1.2 1.5 1.8
EPS (INR) 60.1 68.4 87.2 106.6
EPS Gr. (%) -2.3 13.8 27.5 22.2
BV/Sh (INR) 239.4 235.6 250.6 285.0
RoE (%) 26.4 28.8 35.9 39.8
RoCE (%) 26.5 28.8 35.9 39.8
Payout (%) 61.6 105.6 82.8 67.8
Valuations
P/E (x) 37.5 32.9 25.9 21.2
Key things to watch for
P/BV (x) 9.4 9.6 9.0 7.9 Trends in shift of crop to corn due to increasing corn prices.
EV/EBITDA (x) 36.1 29.2 22.9 18.8 Age profile of corn seeds sold.
Div Yield (%) 1.3 2.7 2.7 2.7 Realizations in glyphosate.
PI Industries
Bloomberg PI IN CMP: INR825 TP: INR959 (+16%) Buy
Equity Shares (m) 136.6
We expect revenue to grow 10% YoY (decline 2% QoQ) to INR5.62b.
M. Cap. (INR b)/(USD b) 113 / 2
52-Week Range (INR) 922 / 495 We estimate 230bp margin expansion to 22.8%, and expect EBITDA
1,6,12 Rel Perf. (%) -2 / 17 / 21 to grow 22% YoY to INR1.28b.
We estimate adjusted PAT at INR939m, as against INR704m in
Financial Snapshot (INR Billion)
3QFY16, growth of 33.5%. Buy.
Y/E March 2016 2017E 2018E 2019E
Sales 21.0 24.9 30.1 36.1
EBITDA 4.3 5.6 7.2 8.9
NP 3.0 4.3 5.2 6.5
EPS (INR) 22.1 31.3 38.4 47.6
EPS Gr. (%) 22.8 41.6 22.6 24.0
BV/Sh. (INR) 85.8 111.6 143.3 182.9
RoE (%) 29.2 31.7 30.1 29.2
RoCE (%) 26.8 30.4 29.9 29.2
Valuations
P/E (x) 37.4 26.4 21.5 17.4 Key things to watch for
P/BV (x) 9.6 7.4 5.8 4.5 CSM growth and order book.
EV/EBITDA (x) 26.7 20.3 15.5 12.2 Agrochemical business updates for FY17.
EV/Sales (x) 5.5 4.6 3.7 3.0
SH Kelkar
Bloomberg SHK L IN CMP: INR335 TP: INR338 (+1%) Buy
Equity Shares (m) 144.6
We expect revenue to grow 5% YoY (but decline 2% QoQ) to
M. Cap. (INR b)/(USD b) 49 / 1
INR2.4b in 3QFY17, impacted by demonetization.
52-Week Range (INR) 362 / 201
1,6,12 Rel Perf. (%) 10 / 60 / 31 EBITDA margin is likely to decline 130bp YoY to 16.7%. EBITDA is
expected to be flat YoY at INR403m.
Financial Snapshot (INR Billion)
We estimate PAT at INR242m as against INR234m in 3QFY16 – a
Y/E March 2016 2017 2018E 2019E
growth of 4%. Buy.
Sales 9.3 10.4 12.3 14.3
EBITDA 1.5 1.8 2.3 2.9
NP 0.8 1.1 1.5 1.9
Adj EPS (INR) 5.5 7.5 10.1 13.0
EPS Gr. (%) 4.2 34.8 35.7 28.3
BV/Sh. (INR) 52.7 57.8 64.6 73.4
RoE (%) 12.6 13.5 16.6 18.9
RoCE (%) 16.9 19.5 24.4 28.3
Valuations Key issues to watch for
P/E (x) 60.4 44.8 33.0 25.7 Impact on inventory due to demonetization.
P/BV (x) 6.4 5.8 5.2 4.6 Growth in acquired flavors entity, HTT.
EV/EBITDA (x) 31.3 27.0 20.5 16.2 Management commentary on new client acquisition and shift of
EV/Sales (x) 5.2 4.7 3.9 3.3 production from Netherlands to Vapi facility.
PBT 278 131 334 407 442 375 367 477 1,150 1,660
Tax 83 61 100 147 167 132 125 162 391 585
Rate (%) 29.8 46.4 29.9 36.2 37.7 35.1 34.0 34.0 34.0 35.2
Minority Interest & Profit/Loss of Asso. Cos. 0 0 0 0 0 0 0 0 0 0
Reported PAT 195 70 234 260 275 243 242 315 759 1,075
Adj PAT 195 70 234 260 275 243 242 315 759 1,075
YoY Change (%) - - 413.4 24.0 41.3 246.0 3.6 21.2 197.6 41.7
Margins (%) 8.8 3.4 10.2 9.8 10.8 9.9 10.0 10.8 8.2 10.4
E: MOSL Estimates
SRF
Bloomberg SRF IN
CMP: INR1,554 TP: INR1,922 (+24%) Buy
Equity Shares (m) 57.4
Fluorochemicals (refrigerants) is a distribution-based business. We
M. Cap. (INR b)/(USD b) 76/1
believe the domestic part of the business has got impacted by
52-Week Range (INR) 1496/1019
demonetization, but as 3Q is a lean season, not much impact would
1,6,12 Rel Perf. (%) 4/-8/3
be evident in consolidated financials.
Financial Snapshot (INR Billion) Also, prices of caprolactum (a major raw material for technical
Y/E March 2016 2017 2018E 2019E textiles) have increased from USD1,300/ton to USD1,800/ton in a
Sales 46.0 47.5 55.8 64.0 short span of time. SRF maintains inventory for a month and prices
EBITDA 9.6 9.9 12.2 14.5 its sales based on average raw material costs.
NP 4.2 4.6 6.1 7.6
EPS (INR) 73.7 81.0 106.8 129.7
We expect SRF’s revenue to grow 4.5% YoY to INR11.47b and
EPS Gr. (%) 39.7 9.9 31.8 21.4
EBITDA to decline 4% YoY to INR2.24b. EBITDA margin could decline
BV/Sh. (INR) 456.8 523.0 610.5 722.8 180bp YoY to 19.5% and adjusted PAT could decline 8.1% YoY to
RoE (%) 17.0 16.2 18.5 19.4 INR0.97b.
RoCE (%) 19.4 18.3 22.1 25.2
Valuations Key things to watch for
P/E (x) 21.1 19.2 14.6 12.0 Growth in the chemicals segment (particularly specialty
P/BV (x) 3.4 3.0 2.5 2.2 chemicals).
EV/EBITDA (x) 11.9 11.5 9.3 7.5 Client additions and capex plans in specialty chemicals.
EV/Sales (x) 2.5 2.4 2.0 1.7 Margins in the technical textiles and packaging segments.
Tata Elxsi
Bloomberg TELX IN CMP: INR1,419 TP: INR1,766 (+25%) Buy
Equity Shares (m) 31.1
We expect revenue to grow 13% YoY (and 2% QoQ) to INR3.1b in
M. Cap. (INR b)/(USD b) 44 / 1
3QFY17, driven by the automotive and broadcast divisions.
52-Week Range (INR) 2396 / 1022
1,6,12 Rel Perf. (%) 5 / -17 / -40 EBITDA margin is likely to expand 76bp YoY to 25%. EBITDA should
grow 17% YoY to INR773m.
Financial Snapshot (INR Billion)
We estimate PAT at INR494m as against INR399m in 3QFY16, a
Y/E March 2016 2017 2018E 2019E
growth of 23.8% YoY. Buy.
Sales 10.8 12.4 14.7 17.3
EBITDA 2.5 3.0 3.6 4.3
PAT 1.5 1.9 2.3 2.8
EPS (INR) 49.7 60.2 73.6 88.4
EPS Gr. (%) 50.5 21.1 22.2 20.1
BV/Sh. (INR) 123.9 157.7 195.3 235.8
RoE (%) 46.3 42.8 41.7 41.0
Key things to watch for
RoCE (%) 46.3 42.8 41.7 41.0
Impact of EUR depreciation.
Payout (%) 33.8 43.8 48.9 36.2
Impact of Brexit on the company’s operations and clients.
Valuations
P/E (x) 28.2 23.3 19.0 15.8
P/BV (x) 11.3 8.9 7.2 5.9
EV/EBITDA (x) 16.9 13.6 10.9 8.8
Div. Yield (%) 1.0 1.6 2.1 2.9
TTK Prestige
Bloomberg TTK PT IN CMP: INR5,717 TP: INR4,896 (-14%) Hold
Equity Shares (m) 11.7
We expect revenue to grow 12% YoY to INR5.1b in 3QFY17. The
M. Cap. (INR b)/(USD b) 67 / 1
impact of demonetization will not be very sharp on TTK , as the
52-Week Range (INR) 6550 / 4010
current year will include incremental sales from the acquired entity,
1,6,12 Rel Perf. (%) 8 / 25 / 17
Horwood (a high margin business). There was disruption in demand
in November. However, healthy sales in October and demand
Financial Snapshot (INR Billion)
recovery in December have softened the impact.
Y/E March 2016 2017 2018E 2019E
Sales 15.3 17.3 20.1 22.7 We expect EBITDA margin to decline 50bp YoY to 12.5%. EBITDA
EBITDA 1.8 2.1 2.7 3.2 should increase 8% YoY to INR627m.
NP 1.2 1.3 1.6 2.1
We expect adjusted PAT to be flattish at INR377m.
EPS (Rs) 100.7 107.8 139.9 178.6
EPS Gr. (%) 29.6 7.0 29.8 27.7
Sales 620.3 675.1 748.7 849.1
RoE (%) 17.2 16.6 19.7 22.4
RoCE (%) 17.3 16.2 18.7 22.1
Valuations
Key things to watch for
P/E (x) 56.7 53.0 40.8 32.0
Performance of the appliances division post demonetization.
P/BV (x) 9.2 8.5 7.6 6.7
Outlook on exports and recent acquisition of Horwood
EV/EBITDA (x) 36.3 32.5 25.1 20.3
Homeware.
EV/Sales (x) 4.3 3.9 3.3 2.9
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or
indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive
compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues
Disclosure of Interest Statement Companies where there is interest
Analyst ownership of the stock No
Served as an officer, director or employee No
A graph of daily closing prices of securities is available at www.nseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes